metronidazole has been researched along with amoxicillin in 1652 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 40 (2.42) | 18.7374 |
| 1990's | 411 (24.88) | 18.2507 |
| 2000's | 500 (30.27) | 29.6817 |
| 2010's | 502 (30.39) | 24.3611 |
| 2020's | 199 (12.05) | 2.80 |
| Authors | Studies |
|---|---|
| Ishikawa, H; Katsura, Y; Matsumoto, Y; Nishino, S; Sakane, K; Takasugi, H; Tomishi, T | 1 |
| Ishikawa, H; Katsura, Y; Matsumoto, Y; Morinaga, C; Nishino, S; Ohno, M; Sakane, K; Takasugi, H | 1 |
| Inoue, Y; Ishikawa, H; Katsura, Y; Matsumoto, Y; Morinaga, C; Sakane, K; Takasugi, H; Tomishi, T | 1 |
| Inoue, Y; Ishikawa, H; Katsura, Y; Matsumoto, Y; Morinaga, C; Nishino, S; Sakane, K; Takasugi, H | 1 |
| Christenson, B; Elebring, T; Fägerhag, J; Gatti, R; Klintenberg, AC; Kühler, TC; Lamm, B; Olwegård-Halvarsson, M; Shcherbuchin, V; Sjöström, JE; Swanson, M | 1 |
| Abedi, JK; Carcanague, D; Jones, J; Joubran, C; Kühler, TC; Shue, YK; Uria-Nickelsen, M; Wuonola, MA | 1 |
| Cheng, N; Shu, C; Xie, JS; Zhang, MY; Zhu, DX | 1 |
| Matsuda, K; Matsumoto, S; Matsumoto, Y; Sasaki, H; Takasugi, H; Tawara, S; Yoshida, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Angelini, P; Curini, M; Epifano, F; Genovese, S; Menghini, L; Pagiotti, R | 1 |
| Anderson, KW; Diamond, WJ; Kirakodu, S; Mietzner, TA; Montelaro, RC; Novak, KF; Peyyala, R | 1 |
| Bryk, A; Kanervo-Nordström, A; Könönen, E; Niemi, P | 1 |
| Li, J; Wang, MW; Yu, H; Zhang, P; Zhao, W; Zhu, Y | 1 |
| Calvet, L; Devine, R; Dubreuil, L; Jean-Pierre, H; Jumas-Bilak, E; Marchandin, H; Mercier, G; Morio, F | 1 |
| Emami, S; Foroumadi, A; Khoshayand, MR; Mirzaei, J; Safari, F; Shafiee, A; Siavoshi, F | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Emami, S; Falahati, M; Foroumadi, A; Lotfali, E; Massarrat, S; Rajabalian, S; Rineh, A; Safari, F; Shafiee, A; Siavoshi, F | 1 |
| Betriu, C; Culebras, E; Gómez, M; López, F; Picazo, JJ; Rodríguez-Avial, I | 1 |
| Hsueh, PR; Huang, YT; Liao, CH; Lin, HY; Liu, CY; Yen, LC | 1 |
| Karlowsky, JA; Laing, NM; Zhanel, GG | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Appelbaum, PC; Ednie, LM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Fang, SH; Lai, CH; Rao, YK; Sing, YT; Tzeng, YM | 1 |
| Bose, P; Gaddam, SK; Goud, PS; Keshavayya, J; Peethambar, SK; Reddy, KR; Somashekar, BC; Sridhara, AM | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chang, CS; Chen, LY; Kao, MC; Kuo, SC; Lai, CH; Lin, CD; Lin, HJ; Liu, JF; Lu, DY; Sing, YT; Tang, CH | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cheng, WC; Hsu, TL; Liou, JM; Tseng, YY; Wong, CH; Wu, MS | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abdel-Maksoud, MS; Ali, EMH; Oh, CH | 1 |
| Beteck, RM; Jesumoroti, OJ; Legoabe, LJ; Patel, OPS | 1 |
| Kohl, S; Pickering, LK | 1 |
| de Graaff, J; Tijhof, CJ; van Winkelhoff, AJ | 1 |
| Katelaris, P | 1 |
| Burette, A; Glupczynski, Y | 1 |
| Kosunen, TU; Rautelin, H; Seppälä, K | 1 |
| Bates, T; Roberts, JV | 1 |
| Barakat, HF; Dajani, YF; Masoud, AA; Sartawi, SA; Uri, FI | 1 |
| Corbishley, CM; Goggin, PM; Jackson, PA; Marrero, JM; Northfield, TC; Spychal, RT | 1 |
| Diver-Haber, A; Jonas, A; Keller, N; Oderda, G; Yahav, J | 1 |
| Chittajallu, RS; Howie, CA; McColl, KE | 1 |
| Färkkilä, M; Hakala, K; Kosunen, TU; Nuutinen, H; Rautelin, H; Seppälä, K; Väänänen, H | 1 |
| Ayesu, K; Calam, J; Li, SK; Moss, SF; Playford, RJ | 1 |
| Hardegger, U; Wüst, J | 1 |
| Ardill, JE; Chittajallu, RS; McColl, KE; Neithercut, WD | 1 |
| Abri, O; Gemperle, A; Hopfenmüller, W; Kraas, E; Langmark, H; Löhde, E; Scholz, L | 1 |
| Hemrika, DJ; Schutte, MF; ten Velden, JJ; van de Geijn, EJ; Yedema, CA | 1 |
| Brandao, MJ; Castro, LP; Chausson, Y; Coelho, LG; Costa, EL; Maia, AF; Passos, MC; Rodrigues, DC | 1 |
| Barten, G; Gerber, B; Splitt, G; Wilken, H; Zacharias, K | 1 |
| Garner, J; Henderson, G; Morris, A | 1 |
| Kosunen, TU; Rautelin, H; Renkonen, OV; Seppälä, K; Vainio, U | 1 |
| Ben Amitai, D; Dinari, G; Garty, BZ; Zahavi, I | 1 |
| Heatley, RV | 1 |
| Börsch, G; Labenz, J | 2 |
| Brandstätter, G; Dragosics, B; Hentschel, E; Hirschl, A; Nemec, H; Schütze, K; Taufer, M | 1 |
| Baron, JH; Gummett, PA; Karim, QN; Logan, RP; Misiewicz, JJ; Walker, MM | 2 |
| Beattie, S; Keane, C; Leen, E; O'Morain, C; Patchett, S | 1 |
| Abbas, F; de Graaff, J; Pavicic, MJ; van Winkelhoff, AJ | 2 |
| Barbieux, JP; de Muret, A; Dorval, ED; Loulergue, J; Metman, EH | 1 |
| Bär, W; Gebel, M; Haruma, K; Lange, P; Müller, MJ; Schorn, T; Soudah, B; Varrentrapp, M; Wagner, S | 1 |
| Bergström, S | 1 |
| Berger, J; Hirschl, AM; Hirschl, MM; Rotter, ML | 1 |
| López-Brea, M; López-Lavid, C; Martín, E; Sanz, JC | 1 |
| Chittajalu, R; Dahill, SW; el Nujumi, AM; Fullarton, GM; Hilditch, TE; MacDonald, AM; McColl, KE | 1 |
| Boyanova, L; Lamouliatte, H; Megraud, F | 1 |
| de Graaff, J; Pavicić, MJ; van Winkelhoff, AJ | 1 |
| Castro, Lde P; Chausson, Y; Coelho, LG; Passos, MC | 1 |
| Austin, TW; Feng, J | 1 |
| Chomarat, M; Dubost, J; Kalfon, F | 1 |
| Hudson, M; Nwokolo, CU; Pounder, RE; Prewett, EJ; Sawyerr, AM; Smith, JT | 1 |
| Baldan, N; Freeman, E | 1 |
| Abu-Fanas, SH; Drucker, DB; Ganguli, LA; Hull, PS; Reeder, JC | 1 |
| Lee, FD; Nakshabendi, IM; Peebles, SE; Russell, RI | 1 |
| Rauws, EA; Tytgat, GN | 1 |
| Bolin, TD; Duncombe, VM; Linklater, JM; Pereira, SP | 1 |
| Elta, GH | 1 |
| Carpenter, HA; Ormand, JE; Phillips, SF; Talley, NJ | 1 |
| Korsten, MA; Lateef, SK; Lieber, CS; Paronetto, F; Uppal, R | 1 |
| Chraïbi, DI; Girond, S; Michel, G | 1 |
| Abbas, F; de Graaff, J; Goené, RJ; Rodenburg, JP; van Winkelhoff, AJ; Winkel, EG | 2 |
| Keane, C; Mathai, E; McKenna, D; O'Morain, C; O'Riordan, T; Sweeney, E; Tobin, E | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 2 |
| Dorman, EB; Mellow, CG; Morton, RP | 1 |
| Davey, MR; van Iddekinge, B | 1 |
| Stassen, LP; van der Werken, C; van Vroonhoven, TJ | 1 |
| García Sánchez, JE; García-Rodríguez, JA; Muñoz-Bellido, JL; Trujillano, I | 1 |
| Coco, JW; Pankey, GA | 1 |
| Mikx, FH; Oosterwaal, PJ; Renggli, HH; van den Brink, ME | 1 |
| Barrier, J; Becue, J; Chartier, M; Cirau-Vigneron, N; Giraud, JR; Landes, P; Leng, J; Raudrant, D; Reme, JM | 1 |
| Amery, K; Lemba, P; Levi, D | 1 |
| Beale, AS; Gisby, J | 1 |
| Baudet, J; Bernard, P; Buisson, P; Lerat, M; Mares, P; Montero, M; Mulard, C; Quereux, C; Santarelli, J; Valette, C | 1 |
| Bondonny, JM; Delmas, P; Galifer, RB; Janin, A; Revillon, Y; Robert, M; Schmitt, M | 1 |
| Burdon, DW; Curran, F; Hall, C; Keighley, MR | 1 |
| Friese, S; Loriaux, SM; Meewis, JM; Willems, FT | 1 |
| Askew, C; Kingston, RD; Lawson, W; Lomax, J | 1 |
| Lewis, MA; MacFarlane, TW; McGowan, DA | 1 |
| Mola, G | 1 |
| Aantaa, K; Paavonen, J; Räsänen, J; Vesterinen, E | 1 |
| Börsch, G; Rühl, GH | 1 |
| Courtieu, AL; Derriennic, M; Launay, C; Reynaud, A | 1 |
| Giles, JA | 1 |
| Barrat, J; Marpeau, L; Pigné, A; Tessier, F; Tison, E | 1 |
| Ahmed-Jushuf, IH; McKeown, J; Murray, AE | 1 |
| Brown, EM; Coles, EC; Depares, J; Hughes, AB; Jones, S; Morgan, JR; Robertson, AA | 1 |
| Beale, AS; Gisby, J; Sutherland, R | 1 |
| Friese, S; Loriaux, SM; Pricker, GJ; Willems, FT | 1 |
| Loriaux, SM; Piot, P; Stolz, E; van der Meijden, WI | 1 |
| Biswas, AK; Symonds, J | 1 |
| Berg, AO; Soman, MP | 1 |
| Barrier, J; Bercau, G; Ciraru-Vigneron, N; Felten, A; Leaute, JB; Nguyen Tan Lung, R; Sauvanet, E; Zylbertrest, T | 1 |
| Bourgault, AM; Lamothe, F | 1 |
| Armstrong, JA; Goodwin, CS; Wee, SH; Wilson, DH | 1 |
| Gaudin, G | 1 |
| Opferkuch, W | 1 |
| Bercelhamer, JE; Reingold, S | 1 |
| Amin, NM | 1 |
| Donovan, IA; Drumm, J; Lowe, P; Wise, R | 1 |
| Flenley, DC | 1 |
| Deforges, L; Duval, J; Soussy, CJ | 1 |
| McEvoy, B | 1 |
| Balsdon, MJ | 1 |
| Bøe, O; Iversen, OE; Mehl, A | 1 |
| Anver, MR; Battles, JK; Blumenauer, LL; Gonda, MA; Gorelick, PL; Haines, DC; Russell, RJ; Ward, JM | 1 |
| Flynn, MJ; Li, G; Slots, J | 1 |
| Alvarez Baleriola, I; Bermejo, F; Boixeda, D; de Rafael, L; García Plaza, A; Gisbert, JP; Martín de Argila, C | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 2 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Brenciaglia, MI; Dubini, F; Fornara, AM; Scaltrito, MM | 2 |
| Contreras, L; Giglio, M; Hoffenberg, P; Ossa, P; Reyes, V; Weitz, JC | 1 |
| Foltz, CJ; Fox, JG; Shames, B; Yan, L | 2 |
| Gormsen, MH; Kivilaakso, E; Pikkarainen, P; Seppälä, K; Sipponen, P | 1 |
| Bujanover, Y; Gilat, T; Hallak, A; Konikoff, FM; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E | 1 |
| Asnicar, MA; Chong, SK; Croffie, JM; Fitzgerald, JF; Lee, CH; Lou, Q; Zimmerman, SE | 1 |
| de Boer, WA; Tytgat, GN | 2 |
| Beattie, S; Gilvarry, J; Hamilton, H; Keane, CT; O'Morain, CA; Sweeney, EC; Xia, HX | 1 |
| Ardill, JE; Chittajallu, RS; el-Omar, EM; Howie, C; McColl, KE; Penman, ID | 1 |
| Blecker, U; Hart, J; Kirschner, BS; McKeithan, TW | 1 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Bargiggia, S; Bianchi Porro, G; Lazzaroni, M; Maconi, G; Minguzzi, M | 1 |
| Cederbrant, G; Kahlmeter, G; Kamme, C; Schalén, C | 1 |
| de Graaff, J; Pavicić, MJ; Pavicić-Temming, YA; van Winkelhoff, AJ | 1 |
| Khan, MM | 1 |
| Ahmed, W; Lodi, TZ; Qureshi, H; Syed, S; Zuberi, SJ | 1 |
| Hahm, JS; Kim, HJ; Park, KN | 1 |
| Edwards, R; Gazis, A; Greenwood, D; Ispahani, P; Turner, P; Weston, V | 1 |
| Atoyebi, W; Bell, GD; Bolton, GH; Bowden, AF; Brown, C; Burridge, SM; Jones, PH; Powell, KU | 1 |
| Brydon, WG; Eastwood, MA; Ferguson, A; Hudson, N; Palmer, KR | 1 |
| Murty, VL; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yoshida, Y | 1 |
| Beattie, S; Collins, RM; Keane, C; McCarthy, C; O'Morain, C; Patchett, S | 1 |
| de Boer, WA; Driessen, WM | 1 |
| Awad, RW; Hawker, PC; Ward, KL | 1 |
| Choi, JH; Jung, MH; Kim, NY; Lee, KH; Oh, HS; Wee, SH | 1 |
| Borchard, F; Müller, W; Peters, U; tho Pesch, S | 1 |
| Barone, A; Ciaglia, RN; Iacono, VJ; Ramaglia, L; Sbordone, L | 1 |
| Bellas, C; Boixeda, D; Manzanal, A; Montalban, C; Redondo, C | 1 |
| Giannikos, N; Kalogeropoulos, N; Karameris, A; Mavrogeorgis, A; Papatheodorou, G; Rokkas, T | 1 |
| Banerjee, S; el-Omar, E; McColl, KE | 1 |
| Barbosa, AJ; de Carvalho, AS; Mendes, EN; Moura, SB; Queiroz, DM; Rocha, GA | 1 |
| Mannur, KR; Palmer, BV; Ross, WB | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| Lee, WY; Lin, JT; Wang, JT; Wang, TH; Wu, MS; Yang, JC | 1 |
| Asaka, M; Horita, S; Inoue, K; Kato, M; Kimura, T; Kudo, M; Meguro, T; Ohtaki, T | 1 |
| Kadish, U; Neeman, A | 1 |
| Branger, C; Redondo, A; Rey, A; Tessier, C | 1 |
| Goh, KL; Lo, YL; Parasakthi, N; Peh, SC; Tan, KK; Wong, NW | 1 |
| Holtmann, G; Layer, P | 1 |
| Campbell, DR; Cherian, R; McGregor, DH; Weston, AP | 1 |
| Bondonny, JM; Delmas, P; Galifer, RB; Revillon, Y; Robert, M; Schmitt, M | 1 |
| Karita, M; Morshed, MG; Okita, K; Ouchi, K | 1 |
| Kosunen, TU; Rautelin, H; Seppälä, K; Tee, W | 1 |
| Axon, AT | 1 |
| Alvisi, C; Bianchi Porro, G; Boldorini, R; Fiocca, R; Lazzaroni, M; Luinetti, O; Perego, M; Solcia, E; Trespi, E; Villani, L | 1 |
| Bleck, J; Gebel, M; Gladziwa, U; Haruma, K; Manns, M; Schmidt, H; Soudah, B; Wagner, S | 1 |
| Corinaldesi, R; De Giorgio, R; Gasperoni, S; Paparo, GF; Poli, L; Stanghellini, V; Tucci, A; Varoli, O | 1 |
| Reilly, TG; Walt, RP | 1 |
| Boyd, EJ; Boyd, HK; Chinzon, D; Eisig, JN; Iriya, K; Laudanna, AA; Zaterka, S | 1 |
| Chang, FY; Chen, TS; Lee, SD; Tsay, SH | 1 |
| Berman, D; George, J; Groisman, GM; Harpaz, N | 1 |
| Beglinger, C; Binek, J; Frei, R; Fried, R; Mossi, S; Schaufelberger, H; Sieber, CC; Stalder, GA | 1 |
| Ammann, R; Bauer, S; Flury, R; Meyenberger, C; Wirth, HP; Wüst, J; Zala, G | 1 |
| Barbosa, AJ; Castro, LP; Coelho, LG; Lima Júnior, GF; Mendes, EN; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA | 1 |
| de Graaff, J; Douqué, NH; Pavicić, MJ; Steures, RW; van Winkelhoff, AJ | 1 |
| Correa, P; Fontham, ET; Hunter, FM; Johnson, WD; Malcom, GT; Rood, JC; Ruiz, B; Sobhan, M | 1 |
| Arber, N; Gilat, T; Gorea, A; Hallak, A; Moshkowitz, M; Peled, Y; Santo, M; Tiomny, E | 1 |
| Ardill, JE; Dorrian, CA; el-Omar, E; McColl, KE; Penman, I | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Corfield, A; McNulty, CA; Mountford, RA; Read, A; Safe, AF; Warren, B; Watson, B | 1 |
| Hoshino, E; Noda, T; Sato, T; Uematsu, H | 1 |
| Ciancio, S | 1 |
| Hammar, CH; Jaspersen, D | 1 |
| Bell, GD; Bolton, G; Bowden, AN; Brown, C; Burridge, SM; Gant, PW; Harrison, G; Powell, KU; Purser, K; Rameh, B | 1 |
| Agema, A; Degener, JE; Dijkstra, PK; Sikkema, B; van der Goot, L; van der Meer, AL; Voesten, HG | 1 |
| Laine, L | 2 |
| Coelho, LG; Cunha-Melo, JR; Lima Júnior, GF; Mendes, EN; Moura, SB; Oliveira, CA; Passos, MC; Queiroz, DM; Resende, LM; Rocha, GA | 1 |
| Brook, I | 1 |
| Mela, GS; Savarino, V; Termini, R; Vigneri, S | 1 |
| Brandstätter, G; Dragosics, B; Hentschel, E; Hirschl, AM; Kundi, M; Rotter, ML; Schütze, K; Taufer, M | 1 |
| Barbara, L; Biasco, G; Corinaldesi, R; Gasperoni, S; Paparo, GF; Ricci-Maccarini, M; Stanghellini, V; Tucci, A; Varoli, O | 1 |
| Asaka, M; Inoue, K; Kato, M; Kimura, T; Kudo, M; Meguro, T; Miyazaki, T | 1 |
| Karita, M; Li, Q; Okita, K | 1 |
| Holm, JP; Ruijs, GJ; van der Linden, MC; van Erp, EJ | 1 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 1 |
| Brandstätter, G; Dragosics, B; Hentschel, E; Hirschl, AM; Nemec, H; Schütze, K; Taufer, M; Wurzer, H | 1 |
| Graham, DY | 1 |
| Genta, RM; Graham, DY; Klein, PD; Lew, GM; Malaty, HM; Ramirez, FC | 1 |
| Ewig, S; Nikorowitsch, R; Schaal, KP; Staib, P; Steudel, A; Vaupel, HA; von Kempis, J | 1 |
| de Graaff, J; Ernst, JP; Overbeek, BP; Pavicić, MJ; van den Bergh, JP; van Winkelhoff, AJ | 1 |
| Allardyce, RA; Bagshaw, PF; Munster, DJ; Phillips, K | 1 |
| De Graaff, J; Namavar, F; Pavicić, MJ; van Winkelhoff, AJ; Verboom, T | 1 |
| Moolenaar, W; ten Bokkel Huinink, J; Thijs, JC; van Zwet, AA; Wolfhagen, MJ | 1 |
| Badve, S; Finlayson, C; Khulusi, S; Lloyd, R; Marrero, JM; Mendall, MA; Northfield, TC; Patel, P | 1 |
| Karita, M; Nakazawa, T; Okita, K; Sugiyama, T; Tsuda, M | 1 |
| Majka, J; Piotrowski, J; Slomiany, A; Slomiany, BL | 1 |
| Axon, AT; Bate, CM; Bell, GD; Emmas, CE; Green, JR; Kerr, GD; Taylor, MD; Tildesley, G | 1 |
| Slots, J; van Winkelhoff, AJ | 1 |
| Fennerty, MB; Vakil, N | 1 |
| Davis, S | 1 |
| Cheng, AF; Chung, SC; Lau, JY; Leung, VK; Li, AK; Ling, TK; Suen, R; Sung, JJ | 1 |
| Chen, CY; Lin, CY; Lin, XZ; Sheu, BS; Shiesh, SC; Yang, HB | 1 |
| Larsson, H; Sjöström, JE | 1 |
| Alvarez Baleriola, I; Boixeda, D; de Rafael, L; García Plaza, A; García, M; Gisbert, JP; Martín de Argila, C | 1 |
| Alván, G; Blomgren, K | 1 |
| Artan, R; Gelen, T | 1 |
| Alvisi, C; Bargiggia, S; Bianchi Porro, G; Cesana, B; Fiocca, R; Franceschi, M; Lazzaroni, M; Luinetti, O; Maconi, G; Perego, M; Solcia, E; Trespi, E; Villani, L | 1 |
| Acuña, R; Albornoz, V; Figueroa, G; Portell, DP; Toledo, MS; Troncoso, M; Vigneaux, J | 1 |
| Beattie, AD; Curry, GW; Morton, R; Park, RH; Taha, AS | 1 |
| Hoshiko, K; Maeda, K; Murayama, H; Nakahara, T; Nakayama, Y; Oda, K; Oh, K; Okabe, N; Okada, M; Okumura, M; Seo, M; Shirotani, T | 1 |
| Hentschel, E | 1 |
| Bátovský, M; Dorociak, F; Duris, I; Jurgos, L; Kratochvílová, H; Majercík, M; Pauer, M; Paulen, P; Simkovicová, M; Valko, L | 1 |
| Barrett, DA; Cederberg, C; Goddard, AF; Idström, JP; Jessa, MJ; Shaw, PN; Spiller, RC | 1 |
| Lambert, JR | 1 |
| Lobetti, RG; Vaughan-Scott, T | 1 |
| Amiji, MM; Patel, VR | 1 |
| Satoh, K | 2 |
| Fox, JG; Hayward, A; Murphy, JC; Perkins, SE; Shen, Z; Yan, LL | 1 |
| Denk, H; Graf, K; Ratschek, M; Spath, P; Stupnicki, T; Taufer, M | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Polson, RJ; Rosengren, H | 1 |
| Lambert, JR; Midolo, PD; Turnidge, J | 1 |
| Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C | 1 |
| Cammarota, G; Fedeli, G; Gasbarrini, G; Montalto, M; Papa, A; Tursi, A | 1 |
| Bermejo, F; Boixeda, D; de Rafael, L; Gisbert, JP; Martín de Argila, C; Redondo, C | 1 |
| Baniukiewicz, A; Bielański, W; Gabryelewicz, A; Hahn, EG; Jedynak, M; Konturek, PC; Konturek, SJ; Kwiecień, N; Sito, E | 1 |
| Gabryelewicz, A | 1 |
| de Boer, WA; Driessen, WM; Jansz, AR; Tytgat, GN | 1 |
| Estrada, R; Garcia, F; Laine, L; Stein, C; Trujillo, M | 1 |
| Cilleruelo Pascual, ML; Echávarri Olavarría, F; Manzanares López-Manzanares, J; Medina Benítez, E; Molina Arias, M; Román Riechman, E; Urruzuno Tellería, P | 1 |
| Braga, PC; Brenciaglia, MI; Dubini, F; Fornara, AM; Scaltrito, MM | 1 |
| Das, K; Goenka, MK; Kocbhar, R; Nijhawan, R; Vaiphei, K | 1 |
| Dammann, HG | 1 |
| Axon, AT; Bate, CM; Bell, GD; Martin, JL; Richardson, PD; Taylor, MD; Tildesley, G | 1 |
| Beastall, G; Beattie, AD; Morton, R; Park, RH; Taha, AS | 1 |
| Behler, EM; Chey, WD; Crause, I; Elta, GH; Scheiman, JM | 1 |
| Buiatti, E; Kato, I; Muñoz, N; Oliver, W; Vivas, J | 1 |
| Daróczy, J; Ferenczi, K; Kalas, D; Pálos, G; Prónai, L | 1 |
| Dankert, J; ten Kate, FJ; Tytgat, GN; van der Ende, A; van der Hulst, RW; Weel, JF | 1 |
| Alder, JD; Ewing, PJ; Mitten, MJ; Oleksijew, A; Tanaka, SK | 1 |
| Chua, RT; Lee, SD; Lin, HJ; Perng, CL; Tsay, SH; Wang, K | 1 |
| Ahmed, W; Qureshi, H; Zuberi, SJ | 1 |
| Beyer, J; Clement, J; Flamm, RK; Tanaka, SK | 1 |
| Böcker, W; Kleinfelder, JW; Lange, DE; Müller, RF; Preus, HR; Topoll, HH | 1 |
| Kawano, S; Murakami, M; Saita, H; Tsuji, S | 1 |
| Ishino, Y; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yamamoto, H; Yoshida, Y | 1 |
| Chi, CH; Lin, XZ; Sheu, BS; Shiesh, SC; Su, IJ; Yang, HB | 1 |
| Goh, KL; Navaratnam, P; Peh, SC | 1 |
| Redding, PJ; Smith, AM; Taylor, A | 1 |
| Carmichael, JM; Patchin, GM; Wieland, KA | 1 |
| Epstein, SR | 1 |
| Alvarez Baleriola, I; Boixeda, D; Gisbert, JP; Jiménez, I; Pajares, JM; Pérez García, JI; Redondo, C | 1 |
| Bruno, M; Grosso, S; Peyre, S; Rizzi, R; Sategna-Guidetti, C | 1 |
| Asahara, M; Chiba, T; Fujimori, T; Fukuda, H; Kawanami, C; Kinoshita, Y; Matsumoto, S; Matsushima, Y; Waki, S | 1 |
| Barrio, A; Cilleruelo, ML; Madruga, D; Manzanares, J; Martínez, MJ; Medina, E; Román, E; Sanz, JC; Sarría, J; Sebastián, M; Urruzuno, P | 1 |
| Aubert, E; Berge, T; Breder, O; Farup, P; Flaaten, B; Haug, JB; Høie, O; Lerang, F; Moum, B; Søberg, T; Tolås, P | 1 |
| Barrett, DA; Erah, PO; Goddard, AF; Shaw, PN; Spiller, RC | 1 |
| Biasco, G; Paparo, GF; Tucci, A | 1 |
| Holbrook, WP; Kinane, DF; Kitsiou, N; Mooney, J; Sigurdsson, T | 1 |
| Miederer, S | 1 |
| Labenz, J | 1 |
| Adachi, H; Ahmed, T; Hori, T; Matsubara, T; Nakahara, A; Sumazaki, R; Takita, H; Yamada, M | 1 |
| Akahane, T; Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Shimizu, T | 1 |
| Cartwright, K; Dooley, J; Fairclough, P; Mani, V; Oakley, C; Swarbrick, E | 1 |
| Boyle, S; Jacyna, M; Martin, J | 1 |
| Aubert, E; Berge, T; Efskind, PS; Haug, JB; Hauge, T; Henriksen, M; Lerang, F; Moum, B; Nicolaysen, K; Odegaard, A; Ragnhildstveit, E; Søberg, T; Tolås, P | 1 |
| Jarczyk, G; Jarczyk, J; Jedrzejczyk, W; Raczyńska, A | 1 |
| Jönsson, KA; Sörberg, M; Ström, M | 1 |
| Peterson, WL | 1 |
| Anania, MC; Annibale, B; D'Ambra, G; Delle Fave, G; Iannoni, C; Luzzi, I; Marcheggiano, A; Marignani, M; Paoletti, M | 1 |
| Kimura, M; Seki, H; Urakami, Y | 1 |
| Berglundh, T; Edlund, T; Ericsson, I; Lindhe, J; Persson, LG | 1 |
| Becker, T; Börsch, G; Labenz, J; Peitz, U; Siehoff, S; Tillenburg, B | 1 |
| Goddard, AF; Spiller, RC | 1 |
| Harris, A | 1 |
| Damianos, AJ; McGarrity, TJ | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Dmitrović, B; Horvat, D; Ivandić, A; Kovacić, D; Mićunović, N; Mihaljević, S; Paulini, D; Vcev, A; Vceva, A; Volaric, M; Vuković, D | 1 |
| Ortiz, JA; Palacín, C; Sacristán, A; Tarragó, C | 1 |
| Fillat, O; Herrero, E; Karcz, D; Kulig, J; Márquez, M; Ortiz, JA; Popiela, T; Tabor, J; Torres, J | 1 |
| Kim, MJ; Michener, R; Triadafilopoulos, G | 1 |
| Alvarez, I; Bellas, C; Boixeda, D; Calleja, JL; Manzanal, A; Montalban, C; Redondo, C | 1 |
| Breuer, T; Genta, RM; Graham, DP; Graham, DY; Gurer, IE; Kim, JG; Osato, M | 1 |
| Myers, D | 1 |
| Abraira, V; Alvarez Baleriola, I; Boixeda, D; García Plaza, A; Gisbert, JP; Martín De Argila, C | 1 |
| Haruma, K; Kajiyama, G; Mashiba, H; Mukai, T; Okamoto, S; Sasaki, N; Sumii, K; Taniyama, K; Uemura, N; Yamaguchi, S | 1 |
| Chan, CK; Ching, CK; Lai, CL; Lai, KC; Lam, SK; Ong, L; Wong, BC | 1 |
| Bobrzyński, A; Rudnicka, L; Stachura, J | 1 |
| Hogan, J; Krasner, N; Lombard, M; Purkayastha, SK; Tan, WC | 1 |
| Alarcon, T; Domingo, D; López-Brea, M; Sanchez, I | 1 |
| Blazquez, M; Chaumette, MT; Delchier, JC; Haioun, C; Hammel, P; Lamarque, D; Lévy, M; Marty, O | 1 |
| Baker, A; Frantz, JE; Laine, L; Neil, GA | 1 |
| Chesters, SA; Copeman, MB; Cottrill, MR; Mason, I; McKinnon, C; Slatcher, G; Turbitt, ML | 1 |
| Archambault, A; Archimandritis, A; Bazzoli, F; Fedorak, R; Hentschel, E; Megraud, F; Mora, P; Rodrigo, L; Rokkas, T; Skandalis, N; Stamler, D; Wurzer, H | 1 |
| Altin, M; Dinc, I; Dobrucali, A; Eralp, YT; Goksel, S; Tuncer, M | 1 |
| Arora, A; Graham, D; Haber, M; Harford, W; Lanza, F; Rose, P; Siepman, N; Weissfeld, A | 1 |
| Malfertheiner, P; Mégraud, F | 1 |
| Bardhan, KD; Bayerdörffer, E; Bradette, M; Cederberg, C; Chiba, N; Idström, JP; Lind, T; O'Morain, C; Spiller, R; Unge, P; Veldhuyzen van Zanten, S; Wrangstadh, M | 1 |
| Keller, JJ; Rauws, EA; Tytgat, GN; van der Hulst, RW | 1 |
| Batchelder, M; Fox, JG; Hayward, A; Murphy, JC; Palley, L; Shames, B; Yan, L | 1 |
| Bierman, JC; Blanchard, TG; Czinn, SJ; Diters, RW; Leunk, RD | 1 |
| Emami, S; Estrada, R; Laine, L; Trujillo, M | 1 |
| Carrazco, J; Checkley, W; Cordero, L; Gilman, RH; Leon-Barua, R; McDonald, J; Ramirez-Ramos, A; Recavarren-Arce, S; Salazar, G; Valdez, Y; Watanabe, J | 1 |
| Blanco, M; Carpintero, P; Pajares, JM | 1 |
| Ikeda, F; Karita, M; Matsumoto, S; Matsumoto, Y; Tawara, S; Washizuka, Y; Yokota, Y | 1 |
| Bell, JM; Grayson, ML; Lambert, JR; Midolo, PD; Turnidge, JD | 1 |
| Bielański, W; Bobrzyński, A; Budzyński, A; Gedliczka, O; Konturek, S; Stachura, J | 2 |
| Daly, LE; Drumm, B; Durnin, M; Gormally, S; Hetherington, C; Lambert, I; Rowland, M; Thomas, JE | 1 |
| Chuah, SY; Goh, KL; Parasakthi, N; Toetsch, M | 1 |
| Berge, T; Haug, JB; Lerang, F; Moum, B; Sandvei, PK; Tolås, P; Torp, R; Tønnesen, T | 1 |
| Akamatsu, T; Gotoh, A; Katsuyama, T; Kawakami, Y | 1 |
| Fennerty, MB | 1 |
| Cockeram, A; Hunt, RH; Jewell, D; Malatjalian, D; Matisko, A; Schep, G; Sidorov, J; Veldhuyzen van Zanten, S | 1 |
| Bardhan, KD; Cooper, BT; Dixon, MF; Harris, AW; Kerr, GD; Langworthy, H; Levi, S; Misiewicz, JJ; O'Morain, C; Piper, D | 2 |
| Angelucci, D; Cellini, L; Di Campli, E; Diodoro, MG; Grossi, L; Marzio, L | 1 |
| Flemmig, TF; Karch, H; Klaiber, B; Kopp, C; Milián, E | 1 |
| Moayyedi, P | 1 |
| Adamek, RJ; Opferkuch, W; Pfaffenbach, B; Suerbaum, S | 1 |
| Borneff, M; Heinecke, A; Kiencke, C; Knopf, A; Müller, HP; Pohl, S | 1 |
| Abraira, V; Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C; Moreno, L; Redondo, C | 1 |
| Leri, O; Losi, T; Mastropasqua, M; Perinelli, P; Tubili, S | 1 |
| Ardill, JE; el-Nujumi, A; McColl, KE; Oien, K; Williams, C | 1 |
| Collins, BJ; Coombs, GW; Forbes, GM; McCullough, CA; Robins, PD | 1 |
| Daikeler, R; Glaser, J; Hein, J; Schmidt, M; Stolte, M; Vieth, M; Weithofer, G | 1 |
| Ammon, S; Klotz, U; Schneider, E; Treiber, G | 1 |
| Carnicer, J | 1 |
| Barkun, AN; Fallone, CA; Loo, VG | 1 |
| Hibi, K; Imaizumi, H; Koizumi, W; Ohida, M; Okabe, H; Okayasu, I; Saigenji, K; Tanabe, S | 1 |
| Blum, AL; Malfertheiner, P | 1 |
| Björkman, A; Hanberger, H; Nilsson, LE; Nilsson, M; Sörberg, M | 1 |
| García Iriarte, M; García Monge, E; Gómez Angel, D; O'Connor Reina, C | 1 |
| Aviram, R; Beyth, Y; Cohen, I; Cohen, N; Holtzinger, M; Tepper, R | 1 |
| Barbet, JP; Benhamou, PH; Bergeret, M; Dupont, C; Gendrel, D; Kalach, N; Raymond, J | 1 |
| Muli, F; Struthers, JK | 1 |
| Fireman, Z; Kopelman, Y; Moshkowitz, M; Segal, A; Sternberg, A | 1 |
| Calvet Calvo, X | 1 |
| Cummins, AG; Grove, DI; Koutsouridis, G | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Navarro, M | 1 |
| Fujioka, T; Kubota, T; Murakami, K; Sato, R | 1 |
| Berglundh, T; Krok, L; Liljenberg, B; Lindhe, J; Serino, G; Westfelt, E | 1 |
| Flemmig, TF; Karch, H; Klaiber, B; Milián, E | 1 |
| van Winkelhoff, AJ; Winkel, EG | 2 |
| Ara, JR; Bertol, V; Brieva, L; Canellas, A; del Agua, C | 1 |
| Dickson, A; el-Nujumi, A; el-Omar, EM; Hilditch, TE; Kelman, AW; McColl, KE; Murray, LS | 1 |
| Dmitrović, B; Kovac, D; Stimac, D; Takac, B; Vcev, A; Vceva, A | 1 |
| Cheah, PL; Chin, SC; Chuah, SY; Goh, KL; Lo, YL; Parasakthi, N | 1 |
| Azuma, T; Hirai, M; Ito, S; Ito, Y; Kato, T; Kohli, Y; Kuriyama, M; Miyaji, H; Sato, F; Suto, H; Yamazaki, Y | 1 |
| de Boer, WA; Haeck, PW; Mulder, CJ; Otten, MH | 1 |
| Ahsan, K; Hadjiyane, C; Karakurum, A; Mohammed, I; Nawaz, A; Pellecchia, C | 1 |
| Dore, MP; el-Zaatari, FA; Graham, DY; Kwon, DH; Osato, MS | 1 |
| Ahuja, V; Bal, C; Dhar, A; Sharma, MP | 1 |
| Benhamou, PH; Bergeret, M; Dupont, C; Gendrel, D; Kalach, N; Raymond, J; Senouci, L | 1 |
| Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J | 1 |
| Goddard, AF | 1 |
| Hirschl, AM; Makristathis, A; Pasching, E; Rotter, ML; Schütze, K; Wimmer, M | 1 |
| Adamek, RJ; Pfaffenbach, B; Szymanski, C | 1 |
| Biasco, G; Caletti, G; Grigioni, W; Mazzoni, C; Paparo, GF; Poli, L; Stanghellini, V; Tosetti, C; Tucci, A; Varoli, O | 1 |
| Ito, K; Kawada, H; Koga, T; Makino, M; Tabata, K | 1 |
| Doermann, HP; Mégraud, F | 1 |
| Atherton, JC; Cockayne, A; Hawkey, CJ; Jenkins, D; Knifton, A; Stack, WA; Thirlwell, D | 1 |
| Maeda, K; Nishimura, H; Oda, K; Ohkuma, K; Okabe, N; Okada, M; Oki, K; Seo, M; Shirotani, T | 1 |
| Ho, B; Ho, KY; Hua, J; Ng, HC; Yeoh, KG | 1 |
| Cornetta, AM; Gleed, RD; McDonough, PL; Simpson, KW; Strauss-Ayali, D | 1 |
| Agrawal, M; Bhat, N; Dhawan, VK; Nachum, R; Tolbert, L | 1 |
| Kashifard, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Siavoshi, F | 1 |
| Boixeda, D; García Plaza, A; Gisbert, JP; Martín de Argila, C | 2 |
| van der Velden, U; van Winkelhoff, AJ; Winkel, EG | 1 |
| Gamonal, JA; López, NJ | 1 |
| Dickson, A; El-Nujumi, A; El-Omar, E; Hilditch, T; Kelman, A; Knill-Jones, R; McColl, K; Murray, L; Penny, C; Wirz, A | 1 |
| Boixeda, D; Gisbert, JP; Martín de Argila, C | 1 |
| Chang, MH; Hsu, HY; Huang, FC; Lee, PI; Shun, CT | 1 |
| Bardhan, KD; Bayerdörffer, E; Cederberg, C; Hellblom, M; Lind, T; Mégraud, F; O'morain, C; Spiller, R; Unge, P; Veldhuyzen Van Zanten, S; Wrangstadh, M; Zeijlon, L | 1 |
| Klinkenberg-Knol, EC; Kuipers, EJ | 1 |
| Brullet, E; Calvet, X; Campo, R; Rué, M | 1 |
| Beldi, MI; Bellini, HT; Campedelli, F; Gjermo, P; Lana, M; Loureiro, CA; Preus, HR; Rams, TE; Tinoco, EM; Tinoco, NM | 1 |
| Chua, AB; Cutler, A; Ding, RP; Goh, KL; Kandasami, P; Mazlam, MZ; Raj, SM | 1 |
| Fujita, R; Kirihara, K; Kojima, T; Sakurai, K; Takahashi, H; Yamada, M; Yamaguchi, Y | 1 |
| Kimoto, M; Murakami, K | 1 |
| Iijima, K; Kato, K; Ohara, S; Sekine, H | 1 |
| Iwasaki, A | 2 |
| Harasawa, S; Kouda, K; Kurumada, T; Miwa, T; Shirai, T; Tada, U; Takagi, A; Wada, T; Watanabe, S | 1 |
| Ozbakir, O; Turasan, A; Utaş, C; Utaş, S | 1 |
| Batey, RG; Henry, A | 1 |
| Kabala, A; Pawłowski, W; Petsch, B | 1 |
| Bayerdörffer, E; Bradette, M; Farley, A; Leddin, D; Lind, T; O'Morain, C; Sinclair, P; Sipponen, P; Spiller, RC; Unge, P; Wrangstadh, M; Zanten, SJ; Zeijlon, L | 1 |
| Kleibeuker, JH; Kooy, A; Thijs, JC; Van der Wouden, EJ; Zwet, AA | 1 |
| Cheybani, K; Estrada, R; Laine, L; Neil, G; Smith, S; Trujillo, M; Yeramian, P | 1 |
| Listgarten, MA; Worch, KP | 1 |
| Chadwick, VS; Chen, W; Shu, D; Tie, A; Wilson, IR | 1 |
| Clyne, M; Drumm, B; Goggin, N; Imrie, C; Rowland, M; Walsh, D | 1 |
| Breslin, NP; Buckley, MJ; Hyde, DK; Lee, JM; O'Morain, CA | 1 |
| Axon, AT; Everett, S; Langworthy, H; Mapstone, NP; Moayyedi, P; Neville, PM; Tompkins, D | 1 |
| Blaes, A; Brecx, M; Donos, N; Lauermann, M; Reich, E; Sculean, A | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M; Valerio, G | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Chodash, HB; Dawson, BK; Luca, S; Michalos, A; Terranova, R | 1 |
| Debets-Ossenkopp, YJ; Herscheid, AJ; Kuipers, EJ; Kusters, JG; Pot, RG; Vandenbroucke-Grauls, CM | 1 |
| Bozzola, L; Di Mario, F; Fortunato, A; Franceschi, M; Leandro, G; Meli, S; Pilotto, A; Rassu, M; Scagnelli, M; Soffiati, G; Valerio, G | 1 |
| Bhasin, DK; Ray, P; Sharma, BC; Singh, K; Sinha, SK; Vaiphei, K | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Martínez, MJ; Sánchez, I | 1 |
| Betriu, C; Gómez, M; Palau, ML; Picazo, JJ; Sánchez, A | 1 |
| Are, BM; Atzei, A; Carta, M; Cugia, L; Dore, MP; Graham, DY; Maida, A; Manca, A; Massarelli, G; Mura, I; Piana, A; Realdi, G | 1 |
| Dai, S; Du, H; Li, Q; Li, Y; Nie, Y; Sha, W; Wang, H; Wu, H | 1 |
| Choe, YH; Hong, YC; Kim, SK; Lee, DH; Pai, SH; Son, BK | 1 |
| Huang, J; Hunt, RH | 1 |
| Kawashima, M; Maeda, K; Nishimura, H; Ohkuma, K; Okabe, N; Okada, M; Seo, M; Takata, T | 1 |
| Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
| Ende, AV; Hensen, EF; Hoff, BW; Houben, MH; Hulst, RW; Kate, FJ; Rauws, EA; Tytgat, GN | 1 |
| Gubina, M; Ihan, A; Kavcic, B; Krizman, I; Poljak, M; Tepes, B; Zaletel, LK | 1 |
| Bravo, LE; Correa, P; DeLany, JP; Mera, R; Realpe, JL | 1 |
| Keane, CT; McCarthy, ND; McConkey, SJ | 1 |
| Bazzoli, F | 1 |
| Amiji, M; Patel, V; Qaqish, R; Shah, S | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Charbit, Y; Fosse, TB; Hannoun, LR; Hitzig, C; Madinier, IM | 1 |
| Zwimpfer, J | 1 |
| Buis, J; Diner, PA; Franchi, G; Karcenty, B; Soupre, V; Vazquez, MP | 1 |
| Adler, G; Boeck, W; Ellenrieder, V; Glasbrenner, B; Marre, R; Richter, C | 1 |
| Unge, P | 1 |
| Bardhan, KD; Bayerdörffer, E; Delchier, JC; Díte, P; Lind, T; Mégraud, F; O'Morain, C; Sipponen, P; Spiller, R; Veldhuyzen van Zanten, S; Zeijlon, L | 1 |
| Spiller, RC | 1 |
| Barclay, ML; Bochner, F; Menelaou, A; Somogyi, AA | 1 |
| Beikler, T; Ehmke, B; Flemmig, TF; Karch, H; Klaiber, B; Kopp, C; Schmidt, H | 1 |
| Araújo, MG; Berglundh, T; Gröndahl, K; Lindhe, J; Persson, LG | 1 |
| Chen, J; Chen, SY; Wang, JY; Zhang, SS; Zhang, XD | 1 |
| Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM | 1 |
| Beikler, T; Ehmke, B; Flemmig, TF; Karch, H; Klaiber, B | 1 |
| Adamsson, I; Edlund, C; Lundquist, P; Nord, CE; Sjöstedt, S | 1 |
| Abdulle, AM; Adeyemi, EO; Benedict, S; Danial, MF; Helal, T | 1 |
| Howden, CW; Sharma, VK; Vasudeva, R | 1 |
| Mach, T; Zahradnik-Bilska, J | 1 |
| Barkun, AN; Barkun, J; Fallone, CA; Joseph, L; Kostyk, R; Loo, V | 1 |
| Aoyama, N; Kasuga, M; Kita, T; Komada, F; Okumura, K; Shirakawa, K; Tanigawara, Y | 1 |
| Bayerdörffer, E; Burman, CF; Díete, U; Dité, P; Domján, L; Kisfalvi, I; Lonovics, J; Mégraud, F; Pap, A; Sipponen, P; Zeijlon, L | 1 |
| Bullock, P; Price, EH; Workman, MR | 1 |
| Annibale, B; D'Ambra, G; Delle Fave, G; Marcheggiano, A; Martino, G; Paoletti, M | 1 |
| Asaka, M; Ishizuka, J; Kagaya, H; Katagiri, M; Kato, M; Komatsu, Y; Kudo, M; Kudo, T; Nishikawa, K; Sugiyama, T; Sukegawa, M; Takeda, H; Toyota, J | 1 |
| Alonso García, I; García Pérez, A; Giménez Samper, M; Valverde de La Osa, J | 1 |
| Chang, FY; Chau, WK; Fen-Yau Li, A; Huang, CC; Lam, CP; Lee, SD; Ng, WW | 1 |
| Hoshiya, S; Ishida, H; Itoh, T; Ninomiya, H; Saito, S; Shingaki, M; Takahashi, S; Tanaka, A; Tokunaga, K; Watanabe, K | 1 |
| Acevedo, C; Duarte, I; Figueroa, C; Fuster, F; Giancaspero, R; Hola, K; Rollan, A; Schulz, M | 1 |
| Dickson, A; El-Nujumi, A; El-Omar, E; Kelman, A; McColl, KE | 1 |
| Carpio, RE; Fock, KM; Ho, J; Hu, FL; Hu, PJ; Huang, NX; Kachintorn, U; Kullavanijaya, P; Lam, SK; Lesmana, L; Li, YY; Manan, C; Perez, JY; Phornphutkul, K; Qian, SC; Wong, BC; Xiao, SD | 1 |
| Chelvam, P; Fock, KM; Lim, SG | 1 |
| Brullet, E; Calvet, X; Campo, R; Comet, R; García, N; Titó, L | 1 |
| Bravo, JC; Bravo, LE; Correa, P; Realpe, JL; Ruiz, B; van Doorn, LJ | 1 |
| Orda, R; Segal, M; Shalom, A; Wasserman, I | 1 |
| Grilli, R | 1 |
| Bayerdörffer, E | 1 |
| Gamonal, JA; López, NJ; Martinez, B | 1 |
| Happonen, I; Linden, J; Westermarck, E | 1 |
| Andreev, NG; Ismailova, MZ; Maev, IV; Romashkina, MA; Val'tsova, ED | 1 |
| Begum, S; Endo, H; Kawamata, H; Sano, T; Urakami, Y | 1 |
| Barkun, AN; Beech, R; Best, L; Fallone, CA; Friedman, G; Joseph, L; Loo, V; Mayrand, S | 1 |
| Machulla, HK; Plaschka, B; Reichert, S; Riemann, D | 1 |
| Bisson, S; Bojarski, C; Epple, HJ; Fromm, M; Kirstein, FW; Riecken, EO; Schulzke, JD | 1 |
| Adamsson, I; Edlund, C; Nord, CE | 1 |
| Buchmann, R; Heinecke, A; Lange, DE; Müller, RF | 1 |
| Calvet, X; García, N; Gené, E; Gisbert, JP; López, T; Roque, M | 1 |
| Adamthwaite, D; Davidson, G; Katelaris, PH; Lambert, J; Midolo, P; Yeomans, ND | 1 |
| Ammon, S; Kees, F; Klotz, U; Treiber, G | 1 |
| Degger, M; Ecclissato, C; Godoy, AP; Guerzoni, RA; Mendonça, S; Pedrazzoli, J; Sartori, MS | 1 |
| Iida, N; Kurosawa, A; Miwa, H; Nagahara, A; Ogawa, K; Ohkura, R; Sato, N | 1 |
| Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, ML; Wimmer, M | 1 |
| Chmiela, M; Czkwianianc, E; Lawnik, M; Płaneta-Małecka, I; Rudnicka, W | 1 |
| Ireland, RS; Martin, MV; Palmer, NA; Pealing, R | 1 |
| Bratović, I; Gogov, B; Gribajcević, M; Lacević, N; Radović, S; Vukobrat-Bijedić, Z | 1 |
| Delchier, JC | 1 |
| Liu, JX; Shi, XD; Wang, HT; Wu, H | 1 |
| Bassaris, HP; Gogos, CA; Maraziotis, TE; Skoutelis, AT | 1 |
| Ishankulova, DM; Kadyrov, DM; Mansurova, FKh; Odinaev, RI | 1 |
| Bauer, C; Horsmans, Y; Schoonbroodt, D; Wagner, C | 1 |
| Mansi, C; Savarino, V; Vigneri, S | 1 |
| Gribajcević, M; Pasalić, G; Salaka, U; Vanis, N | 1 |
| De Soyza, A; Gould, K; Higgins, B | 1 |
| Boyea, N; Danziger, LH; Hackleman, JM; Neuhauser, MM; Pendland, SL; Prause, JL | 1 |
| Barrera, F; Fuentes, J; Garuz, R; Gomollón, F; Malo, J; Simón, MA; Tirado, M; Valdepérez, J | 1 |
| Piqué, JM | 1 |
| Beck, D; Heep, M; Kist, M; Lehn, N; Strobel, S | 1 |
| Daake, H; Frevel, M; Janisch, HD; Kellner, HU; Krezdorn, HG; Tanneberger, D; Wack, R | 1 |
| Bamba, T; Graham, DY; Hattori, T; Nakajima, S | 1 |
| Huang, AH; Huang, CC; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Ching, CK; Hu, WH; Hui, WM; Lai, KC; Lam, SK; Wong, BC; Wong, WM | 1 |
| Cheah, P; Chin, S; Goh, K; Parasakthi, N; Ranjeev, C; Rosmawati, M; Tan, Y | 1 |
| Ducóns, JA; Ferrero, M; Gomollón, F; Santolaria, S; Sicilia, B; Sierra, E | 1 |
| Aalykke, C; Bekker, C; Bonnevie, O; Bytzer, P; Eriksen, J; Gjørup, T; Hansen, J; Justesen, T; Kjaergaard, J; Kromann-Andersen, H; Rask-Madsen, J; Rune, S; Teglbjaerg, PS; Vilien, M; Vyberg, M; Weywadt, L | 1 |
| Begum, S; Endo, H; Kawamata, H; Oki, Y; Sano, T; Urakami, Y | 1 |
| Aydin, A; Isler, M | 1 |
| Mégraud, F | 1 |
| Cheng, NN; Hu, PJ; Liu, WZ; Ouyang, Q; Wang, JL; Xiao, SD; Zhou, LY | 1 |
| García, S; Gomollón, F; Lago, A; Sicilia, B; Sierra, E; Villar, M | 1 |
| Bozzola, L; Di Mario, F; Franceschi, M; Furlan, F; Leandro, G; Pilotto, A; Rassu, M | 1 |
| Maggi-Solcà, N; Piffaretti, JC; Valsangiacomo, C | 1 |
| Adamsson, I; Edlund, C; Engstrand, L; Seensalu, R | 1 |
| Rosandić, M | 1 |
| Bardhan, K; Bayerdörffer, E; Burman, CF; Delchier, JC; Gromark, P; Hellblom, M; Lind, T; Mégraud, F; Stubberöd, A; Veldhuyzen Van Zanten, SJ; Zeijlon, L | 1 |
| Melchers, K; Paul, R; Postius, S; Schäfer, KP | 1 |
| Andriulli, A; Bergoli, ML; Caruso, N; Clemente, R; Festa, V; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Alizadeh, BZ; Fakheri, H; Fazel, A; Khatibian, M; Malekzadeh, R; Massarrat, S; Merat, S | 1 |
| Kurosawa, A; Miwa, H; Nagahara, A; Ohkura, R; Sato, N; Yamada, T | 1 |
| Korostoff, JM; Listgarten, MA; Worch, KP | 1 |
| Di Mario, F; Franceschi, M; Leandro, G; Pilotto, A; Rassu, M | 1 |
| Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Okimoto, T; Satoh, R | 1 |
| Ohkusa, T; Watanabe, M | 1 |
| Bindayna, KM | 1 |
| Arweiler, N; Blaes, A; Brecx, M; Donos, N; Reich, E; Sculean, A | 1 |
| Palka, M; Zwolińska-Wcisło, M | 1 |
| Avidan, B; Bar-Meir, S; Keller, N; Melzer, E | 1 |
| Bouillot, P; Choux, M; Fuentes, S; Lena, G; Regis, J | 1 |
| Timmerman, MF; Van der Velden, U; Van der Weijden, GA; Van Winkelhoff, AJ; Winkel, EG | 1 |
| Weeda, LW | 1 |
| McNulty, CA; Warburton-Timms, VJ | 1 |
| Konorev, MR | 1 |
| Eickholz, P; Kugel, B; Näher, H; Pohl, S; Staehle, HJ | 1 |
| Chuang, CH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Axon, AT; Barrowclough, S; Crocombe, W; Moayyedi, P; Neville, PM; Wrangstadh, M | 1 |
| Hellström, MK; Lindhe, J; Ramberg, P; Rosling, B; Serino, G; Socransky, SS | 1 |
| Bravo, JC; Bravo, LE; Casabon, AL; Collazos, T; Correa, P; Fischbach, LA; Ramirez, H; Realpe, JL; Ruiz, B; Schmidt, BA | 1 |
| Nguyen, HN | 1 |
| Hopkins, RJ | 1 |
| Delves, HT; Doig, LA; Phillips, RH; Powell, JJ; Sieniawska, CE; Thompson, RP; Whitehead, MW | 1 |
| Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 2 |
| Moayyedi, P; Murphy, B | 1 |
| Kuipers, EJ; Kusters, JG | 1 |
| Allard, K; Feres, M; Haffajee, AD; Socransky, SS; Som, S | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Ohkura, R; Sato, K; Sato, N; Yamada, T | 1 |
| Chan, KL; Ng, DK; Tam, PK; Zhou, H | 1 |
| Ell, C; Moser, W; Ridl, W; Schoerner, C; Solbach, W; Stolte, M; Vieth, M | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Sato, N | 1 |
| Ashorn, M; Mäkipernaa, A; Ruuska, T | 1 |
| Barton, R; Campbell, M; Eccles, M; Hall, L; Steen, N | 1 |
| Aoyama, N; Hohda, T; Kasuga, M; Kita, T; Komada, F; Okumura, K; Saijoh, Y; Sakaeda, T; Sakai, T; Tanigawara, Y | 1 |
| Conejo Gonzalo, C; Hergueta Delgado, P; Herrerías Gutiérrez, JM; Rojas Feria, M; Romero Castro, R; Suárez Barrenechea, AI | 1 |
| Cutler, RH; Freedman, AL; Mellado, JR; Salkin, LM; Schneider, DB; Stein, MD | 1 |
| Amini, M; Kamalian, N; Kaviani, MJ; Malekzadeh, R; Massarrat, S; Sotoudeh, M; Vahedi, H | 1 |
| Daroch, F; García, A; González, C; Kawaguchi, F; Rivera, N; Solar, H; Vega, E | 1 |
| Antonenko, OM; Dicheva, DT; Lebedev, EG; Maev, IV; Ovsiannikova, EV; Shchekina, MI; V'iuchnova, ES | 1 |
| Mahachai, V; Vilaichone, RK | 1 |
| Gisbert, JP; Pajares, JM | 2 |
| Burm, M; Faigel, D; Fennerty, MB; Kelly, C; Magaret, N; Peterson, W | 1 |
| Bayerdörffer, E; Müller, H; Rappel, S; Stolte, M; Wündisch, T | 1 |
| Hsu, CT; Kuo, CF; Wang, CS; Wang, TH; Yang, JC; Yang, KC | 1 |
| Ismailova, MZ; Maev, IV; Ovchinnikova, NI; Samsonov, A; Val'tova, ED | 1 |
| Ahmad, MM; Arefin, MS; Bardhan, P; Bauerfeind, P; Beglinger, C; Glatz-Krieger, K; Gyr, N; Hasan, M; Hildebrand, P; Khan, AK; Parvin, S; Rahman, A; Rossi, L; Terracciano, L | 1 |
| Delchier, JC; Lamarque, D; Lascols, C; Soussy, CJ; Tankovic, J | 1 |
| Barthélemy, P; Caekaert, A; Fléjou, JF; Laurent, J; Mégraud, F | 1 |
| Andersen, LP; Gernow, A; Hansen, JP; Krasilnikoff, PA; Matzen, P; Paerregaard, A; Wewer, V | 1 |
| Beertsen, W; Everts, V; Piscaer, M; Van Winkelhoff, AJ | 1 |
| Veldhuyzen van Zanten, SJ | 1 |
| Farkkilä, M; Koskenpato, J; Sipponen, P | 2 |
| Alarcón, T; Baquero, M; Carbó, J; García-Samaniego, J; Iñiguez, A; López-Brea, M; Toro, C | 1 |
| Chen, CL; Chen, LT; Cheng, AL; Chiang, IP; Jan, CM; Lin, JT; Liu, SM; Shyu, RY; Su, IJ | 1 |
| Esaki, M; Fukuda, T; Kurahara, K; Kusano, Y; Matsumoto, T; Nakamura, S | 1 |
| Berglundh, T; Lindhe, J; Persson, LG; Sennerby, L | 1 |
| Akao, T; He, JX; Nishino, T; Tani, T | 1 |
| Bhattacharyya, H; Hopkins, RJ; King, EC; Meyer, JM; Morris, D; Siepman, NY; Silliman, NP; Sugg, JE; Wang, W; Zhang, J | 1 |
| Andersen, LP; Glupczynski, Y; Lopez-Brea, M; Mégraud, F | 1 |
| Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J | 1 |
| Brou, E; Coulibaly, NT; Kamagate, A; Kone, D; Sixou, M | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Fujimura, S; Iinuma, K; Kato, S; Maisawa, S; Ozawa, K; Shimizu, T; Udagawa, H | 1 |
| Fujino, M; Miyagaw, K; Nakano, Y; Nakao, M; Nishimura, O; Sakane, T; Tada, M | 1 |
| Bruers, JJ; König, KG; Mikx, FH; van Rossum, GM | 1 |
| Asgari, AA; Dariani, NE; Malekzadeh, R; Massarrat, S; Sotoudehmanesh, R; Vahedi, H | 1 |
| Araj, GF; Barada, KA; Chedid, M; Mourad, FH; Sharara, AI | 1 |
| Alampi, G; Bazzoli, F; Berretti, D; De Luca, L; Di Pietro, C; Fossi, S; Morelli, P; Nicolini, G; Pozzato, P; Ricciardiello, L; Roda, E; Zagari, RM | 1 |
| Chang, CS; Chen, GH; Lai, CH; Poon, SK; Su, J; Wang, WC; Yang, CC | 1 |
| Fujimura, S; Kato, S; Kawamura, T; Watanabe, A | 1 |
| Brousse, N; Copie-Bergman, C; de Mascarel, A; Delchier, JC; Flejou, JF; Gaulard, P; Hemery, F; Lavergne-Slove, A; Levy, M; Traulle, C | 1 |
| Haapiainen, R; Härkönen, M; Kokkola, A; Kosunen, TU; Puolakkainen, P; Rautelin, H; Sipponen, P | 1 |
| Fallah, MS; Mansour-Ghanaei, F; Shafaghi, A | 1 |
| Grove, DI; Koutsouridis, G | 1 |
| Barbier, C; Benhamou, PH; Bergeret, M; Dupont, C; Gottrand, F; Husson, MO; Kalach, N; Raymond, J | 1 |
| Addy, M; Newcombe, RG; Rooney, J; Sprague, SV; Wade, WG | 1 |
| Coelho, C; Contreras, A; Pacheco, JJ; Salazar, F; Slots, J; Velazco, CH | 1 |
| Fukuda, Y; Sakagami, T; Shimoyama, T; Yamamoto, N | 1 |
| Murakami, K; Nasu, M | 1 |
| Kato, S | 1 |
| Takahashi, S; Tanaka, A | 1 |
| Fu, HY; Kawano, S; Tanimura, H | 1 |
| Ohkusa, T; Sato, N | 1 |
| Miwa, H; Miyazaki, A; Nagahara, A; Sato, N | 1 |
| Takahashi, S; Tokunaga, K | 1 |
| Inoue, K; Sugano, K | 1 |
| Sugano, K | 1 |
| Kiriyama, Y; Koizumi, K; Kuwayama, H; Ohara, T; Suga, M; Suzuki, K; Takahashi, M; Takata, H | 1 |
| Isomoto, H; Kohno, S | 1 |
| Cuchí Burgos, E; Forné Bardera, M; Garau Alemany, J; Lite Lite, J; Quintana Riera, S | 1 |
| Kapp, A; Wedi, B | 1 |
| Calvet, X; Gisbert, JP; Vallve, M; Vergara, M | 1 |
| Dolan, PM; Fahey, JW; Haristoy, X; Kensler, TW; Lozniewski, A; Scholtus, I; Stephenson, KK; Talalay, P | 1 |
| Bachor, J; Dinari, G; Fishman, M; Gal, E; Geler, A; Niv, Y; Passaro, DJ; Samra, Z; Shmuely, H; Yahav, J | 1 |
| Akamatsu, T; Gotoh, A; Ikeno, T; Ishida, K; Kaneko, T; Katsuyama, T; Kawakami, Y; Kiyosawa, K; Ota, H; Shimizu, T; Shimodaira, K; Sugiyama, A | 1 |
| Anand, P; Hardee, P; Holmes, S | 1 |
| Bal, B; Baloş, K; Bodur, A; Bodur, H | 1 |
| Buchmann, R; Lange, DE; Nunn, ME; Van Dyke, TE | 1 |
| Andreu, V; Bory, F; Calvet, X; Ducons, J; Guardiola, J; Guirao, R; Tito, L | 1 |
| Amat, C; Ancelin-Malbreil, E; Becquart, JP; Faulques, B; Michault, A; Picot, S; Sapin, G; Simac, C | 1 |
| Wallace, MR | 1 |
| Alarcon, T; Andersen, LP; Broutet, N; Cantagrel, A; Glupczynski, Y; López-Brea, M; Mégraud, F | 1 |
| Kopański, Z; Piekoszewski, W; Puto, T; Schlegel-Zawadzka, M; Szuszko, R; Tabak, J; Trebacz, P; Witkowska, B | 1 |
| Atherton, JC; Barrett, DA; Jenkins, D; Jordan, N; Shaw, PN; Sherwood, PV; Spiller, RC; Wibawa, JI | 1 |
| Vasil'ev, IuV | 1 |
| Larsen, T | 1 |
| Slots, J | 3 |
| Bondarenko, OY; Fedchenko, VI; Grigoriev, PY; Gulyaev, PV; Ivashkin, VT; Lapina, TL; Sklanskaya, OA; Vasiliev, YV; Yakovenko, EP | 1 |
| Bevanda, M; Falisevac, V; Korać, B; Pilas, V; Rosandić, M | 1 |
| Chuang, CH; Huang, AH; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Allard, K; Feres, M; Goodson, JM; Haffajee, AD; Socransky, SS; Som, S | 1 |
| Lang, NP; Mombelli, A; Rutar, A; Schmid, B | 1 |
| Fang, L; Huang, S; Jiang, K; Jiang, X; Lin, N; Pan, W; Wan, Y; Xu, R | 1 |
| Karpinia, K; Walker, C | 1 |
| Alanís-Aguilar, O; Bosques-Padilla, FJ; Garza-González, E; Maldonado-Garza, HJ; Pérez-Pérez, GI; Tijerina-Menchaca, R | 1 |
| Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M | 1 |
| Cui, M; Hu, F; Jiang, H; Zheng, X | 1 |
| Amberiadis, P; Archavlis, E; Chiotakakou, E; Christoforidis, P; Kourtessas, D; Mantzaris, GJ; Petraki, K; Triantafyllou, G | 1 |
| Burger, W; Gilijamse, M; Hart, AA; Loos, BG; Louwerse, PH; van der Velden, U; Van Winkelhoff, AJ | 1 |
| Chan, CK; Fung, FM; Ho, VY; Hu, WH; Hung, WK; Lai, KC; Lam, SK; Szeto, ML; Tong, TS; Wong, BC; Wong, GS; Wong, WM; Xia, HH; Yip, AW; Yuen, MF | 1 |
| Baumgartner, JC; Khemaleelakul, S; Pruksakorn, S | 1 |
| Fujioka, T; Kagawa, J; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R | 1 |
| Kniazeva, BG; Vakhrushev, IaM | 1 |
| Schuster, MJ | 1 |
| Baumgartner, JC; Xia, T | 1 |
| Bougouma, A; Cisse, R; Niakara, A | 1 |
| Celińska-Cedro, D; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Jóźwiak, P; Madaliński, K; Rozynek, E | 1 |
| Amann, G; Binder, C; Crone, J; Granditsch, G; Hirschl, AM; Huber, WD; Innerhofer, A | 1 |
| Sano, T; Urakami, Y | 1 |
| Berg, DE; Dailidiene, D; Gu, Q; Lai, KC; Lam, SK; Wang, WH; Wong, BC; Wong, WM | 1 |
| Hu, WH; Hui, WM; Ip, WY; Lai, KC; Lam, SK; Lau, CS; Wong, BC; Wong, RW | 1 |
| El-Zimaity, H; Hunt, R; Laine, L; Nguyen, B; Osato, M; Spénard, J | 1 |
| Dupas, JL | 1 |
| Bruley des Varannes, S | 1 |
| Akao, T; He, JX; Tani, T | 2 |
| Itoh, T; Kai, A; Matsuda, M; Shingaki, M; Takahashi, S; Wada, S | 1 |
| Bohuschke, M; Gatz, G; Kirchner, T; Kist, M; Leodolter, A; Malfertheiner, P; Peitz, U; Strobel, S | 1 |
| Azagra, R; Calvet, X; Gené, E; Gisbert, JP | 1 |
| Bonnaure-Mallet, M; Cormier, M; Jolivet-Gougeon, A; Magaud, C; Sixou, JL | 1 |
| Ekström, P; Hellblom, M; Kihira, K; Kimura, K; Ohlin, B; Satoh, K; Sipponen, P; Stubberöd, A; Unge, P; Yoshida, Y; Yube, T | 1 |
| Kolesnikow, T; Lee, A; Leung, V; O'Rourke, JL; van Zanten, SJ | 1 |
| Fischbach, L; Nash, C; Veldhuyzen van Zanten, S | 1 |
| Enjoji, A; Fujimoto, C; Furusu, H; Hirakata, Y; Inoue, K; Isomoto, H; Kohno, S; Mizuta, Y; Murase, K; Murata, I; Omagari, K; Shimada, S; Yamakawa, M | 1 |
| Hardikar, W; Midolo, PD; Rerksuppaphol, S; Ward, P | 1 |
| Prónai, L; Tulassay, Z | 1 |
| Correa, P; Feldman, M; Fischbach, LA; Fontham, E; Goodman, KJ; Jain, R; Priest, E | 1 |
| Ermolaev, IA; Nazarov, VE; Rukhliada, NV | 1 |
| Bakumov, PA; Dugina, YL; Epstein, OI; Sergeeva, SA; Shchepotkin, IV | 1 |
| Bästlein, E; Bayerdörffer, E; Haferland, C; Jacobs, E; Kirsch, C; Lehn, N; Miehlke, S; Neumeyer, M; Papke, J; Schneider-Brachert, W; Stolte, M; Vieth, M | 1 |
| Campeau, NG; Heaney, CJ; Lindell, EP | 1 |
| Cisneros, G; Gurney, M; Jarjoura, D; Lara, LF; Moauro, B; Polen, A; Rutecki, G; Van Ness, M; Whittier, F | 1 |
| Hansen, LB; Malaty, W; Stigleman, S | 1 |
| Barthelemy, P; Bretagne, JF; Courillon-Mallet, A; De Korwin, JD; Delchier, JC; Fauchère, JL; Fléjou, JF; Labigne, A; Lamouliatte, H; Mégraud, F | 1 |
| Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
| Bauerfeind, P; Gubler, C; Ossola, N; Zinkernagel, A | 1 |
| Bianchi Porro, G; Cucino, C; Parente, F | 1 |
| Hara, Y; Shimamura, T; Yamamoto, Y; Yanagawa, Y | 1 |
| Burroughs, A; Fisher, N; Hastings, M; Kibbler, C; Mutimer, D; O'Grady, J; Patch, D; Philpott-Howard, J; Rolando, N; Wade, J; Wendon, J | 1 |
| Ahuja, A; Ali, J; Chaudhry, R; Rahman, S | 1 |
| Carpenter, CF; Neuhann, HF; Shao, O; Swai, B | 1 |
| Herszényi, L | 1 |
| Bochenek, WJ; Davis, KD; El-Zimaity, HM; Fraga, PD; Graham, DY; Mack, ME; Osato, MS; Peters, S; Wang, W | 1 |
| Barbato, A; Landi, L; Panizzolo, C; Rugge, M; Semenzato, R | 1 |
| Berchiche, C; Floret, D; Valla, F | 1 |
| Il'chenko, LIu; Nazarenko, IV; Parfenov, AI; Ruchkina, IN; Zvenogorodskaia, LA | 1 |
| Ayyagari, A; Bhasin, D; Das, BK; Dharmalingam, S; Habibullah, CM; Khan, AA; Naik, SR; Rajasambandam, P; Ramathilagam, B; Rao, UA; Ray, P; Sharma, MP; Thyagarajan, SP | 1 |
| Dragosics, B; Fischbach, W; Goebeler-Kolve, ME; Greiner, A; Stolte, M | 1 |
| Vithayasai, N | 1 |
| Cerda, O; Toledo, H; Valenzuela, M; Vallejos, C | 1 |
| Abdullaeva, DA; Abduzhbarova, ZM; Kamilova, AT; Pazylova, SA | 1 |
| Gunsolley, JC; Haffajee, AD; Socransky, SS | 1 |
| Boyacioglu, S; Cosar, AM; Gumurdulu, Y; Gur, G; Gursoy, M; Kayaselcuk, F; Ozer, B; Ozsahin, K; Serin, E; Yilmaz, U | 1 |
| Cuomo, A; De Simone, T; Del Vecchio Blanco, C; Iovene, MR; Marmo, R; Montella, F; Mucherino, C; Nardone, G; Romano, M; Tufano, MA | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Okimoto, T; Sato, R | 1 |
| Howden, CW; Sharma, VK | 1 |
| Färkkilä, M; Sarna, S; Sipponen, P; Valtonen, V | 1 |
| Baldwin, L; Bell, GD; Cameron, EAB; Jones, P; Powell, KU; Williams, SGJ | 1 |
| Ahuja, V; Bal, C; Bhatia, V; Das, B; Sharma, MP | 1 |
| Bonito, AJ; Evensen, C; Jackman, A; Lohr, KN; Lux, L; Sutton, S; Whitener, L | 1 |
| de Boer, WA; Kuipers, EJ; Kusters, JG | 1 |
| Burroughs, R; Lane, E; Lobetti, R | 1 |
| Beikler, T; Ehmke, B; Flemmig, T; Göbel, U; Moter, A; Riep, B | 1 |
| Gościniak, G; Grabińska, J; Iwańczak, B; Iwańczak, F; Przondo-Mordarska, A | 1 |
| Wollner, T | 1 |
| Chen, XX; Ou, BY; Qü, YP; Shang, SQ; Tang, HF; Wu, XY; Zhou, XL | 1 |
| Doherty, GM; Farrell, S; McCallion, WA; Milliken, I; Murphy, JL; Wootton, SA | 1 |
| Ando, T; El-Omar, E; Goto, H; Ichiyama, S; Iinuma, Y; Ina, K; Kusugami, K; Minami, M; Nada, T; Nobata, K; Ohta, M; Tsuzuki, T | 1 |
| Adib, SM; Al-Mutawa, S; Rotimi, VO; Salako, NO | 1 |
| Arslan, N; Bekem, O; Buyukgebiz, B; Hizli, S; Ozer, E; Ozturk, Y | 1 |
| Schluter, PJ; Wallace, RA; Webb, PM | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| Lundgren, T; Renvert, S | 1 |
| Bax, DA; de Jong, A; Gerrits, MM; Kuipers, EJ; Kusters, JG; Thijs, JC; van der Wouden, EJ; van Vliet, AH; van Zwet, AA | 1 |
| Cieśla, J; Kaczmarski, M; Kondej-Muszyńska, K; Kowalczuk, J; Maciorkowska, E; Musaibili, S; Roszko, I; Zielińska, A | 1 |
| Fukuda, S; Fukushi, M; Mikami, T; Munakata, A; Shimoyama, T | 1 |
| Accornero, L; Bilardi, C; Dulbecco, P; Iiritano, E; Mamone, M; Mansi, C; Parodi, A; Reglioni, S; Savarino, E; Savarino, V; Vigneri, S; Zentilin, P | 1 |
| García, F; Lang, L | 1 |
| Iinuma, K; Kato, S; Konno, M; Maisawa, S; Nakayama, Y; Shimizu, T; Tajiri, H; Toyoda, S; Yoshimura, N | 1 |
| Hirashima, N; Ito, K; Kato, A; Kato, H; Kondo, H; Matsunaga, S; Nukaya, H; Sakakibara, K; Sakamoto, T; Tanaka, Y | 1 |
| Asaoka, D; Hojo, M; Iijima, K; Kawabe, M; Kurosawa, A; Miwa, H; Miyazaki, A; Nagahara, A; Ohkusa, T; Sato, N; Terai, T | 1 |
| Casanovas, N; Elizalde, JI; Escolar, G; González, J; Heras, M; Lozano, M; Martorell, T; Pérez-Pujol, S; Piqué, JM; Sanz, G; Sionis, A | 1 |
| Chan, CK; Chen, MH; Cui, Y; Gu, Q; Hu, PJ; Hu, WH; Huang, JQ; Lai, KC; Lam, SK; Li, CJ; Wang, WH; Wong, BC; Wong, WM; Wu, SM; Xia, HH; Xiao, SD | 1 |
| Schuster, M | 1 |
| Bory, F; Calvet, X; Ducons, J; Guardiola, J; Marko, D; Tito, L | 1 |
| Ballesteros, A; González de Cárdenas, M; Plovins, J; Sáez-Nieto, JA; Serra, T; Vindel, A | 1 |
| Johansen, JK; Krogfelt, KA; Ladefoged, K; Myrhøj, T; Sehested, A | 1 |
| Chang, FY; Chen, CY; Lee, SD; Lu, CL; Lu, RH; Luo, JC | 1 |
| Maaroos, HI; Oona, M; Rägo, T | 1 |
| Aalam, A; Jorgensen, MG; Slots, J | 1 |
| Chey, WD; Saad, R | 1 |
| Kawai, T; Matsumoto, Y; Noguchi, N; Rimbara, E; Sasatsu, M; Tanabe, M | 1 |
| Brochut, P; Casagni, F; Giannopoulou, C; Mombelli, A; Plagnat, D | 1 |
| Färkkilä, MA; Heikkinen, MT; Koivisto, TT; Koskenpato, JP; Rautelin, HI; Voutilainen, ME | 1 |
| Benno, Y; Hayashi, H; Hirai, S; Hojo, M; Kobayashi, O; Miwa, H; Nomura, T; Ogihara, T; Ohkusa, T; Okayasu, I; Sakamoto, M; Sato, N; Takei, Y; Terai, T; Yoshida, T | 1 |
| Bauerfeind, P; Bernardi, M; Fried, M; Yuen, B; Zbinden, R | 1 |
| Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF | 1 |
| Shao, Y; Wang, YS; Yang, H; Yu, ZL; Zhang, L; Zhang, ST | 1 |
| Bar-Meir, M; Benenson, S; Faber, J; Halle, D; Rachman, E; Rudensky, B; Schlesinger, Y; Sirota, G; Stankiewic, H; Wilschanski, M | 1 |
| Beikler, T; Ehmke, B; Flemmig, TF; Milian, E; Moter, A | 1 |
| Das, S; Huengsberg, M; Shahmanesh, M | 1 |
| Apfalter, P; Blacky, A; Hirschl, AM; Makristathis, A; Rotter, ML; Willinger, B | 1 |
| Shao, Y; Yu, ZL; Zhang, L; Zhang, ST | 1 |
| Chan, AO; Chan, CK; Cheung, KL; Fung, FM; Ho, VY; Huang, J; Hui, CK; Lai, KC; Lam, SK; Tong, TS; Wong, BC; Wong, WM; Xia, HH | 1 |
| Bernabucci, V; Cavina, M; De Francesco, V; Gatta, L; Hassan, C; Ierardi, E; Morini, S; Perna, F; Ricci, C; Tampieri, A; Vaira, D; Zullo, A | 1 |
| Berg, DE; Bhattacharya, SK; Chattopadhyay, S; Chowdhury, A; Datta, S; De, R; Hembram, J; Mukhopadhyay, AK; Nair, GB; Patra, R; Ramamurthy, T | 1 |
| Chiba, N; Fischbach, L; Khurana, R; Veldhuyzen van Zanten, S | 1 |
| Bonner, RA; Delaney, KH; Gee, LC; Jury, J; Perdue, MH | 1 |
| Abasiyanik, MF; Huten, O; Salih, BA; Sander, E; Saribasak, H | 1 |
| Dmitrović, B; Horvat, D; Ivezić, Z; Kraljik, N; Misević, T; Soldo, I; Timarac, J; Vcev, A | 1 |
| Budzyńska, A; Celińska-Cedro, D; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Jarosz, M; Jóźwiak, P; Nowak, J; Pawłowska, J; Prosiecki, R; Romańczuk, W; Rozynek, E; Szadkowski, A | 1 |
| Griffiths, GS; Guerrero, A; Laurell, L; Moles, DR; Nibali, L; Suvan, J; Tonetti, MS | 1 |
| Chen, CL; Chen, GH; Chen, LT; Cheng, AL; Jan, CM; Kuo, SH; Lin, JT; Sheu, BS; Su, IJ; Tai, JJ; Wang, HP; Wang, TE; Wang, WM; Whang-Peng, J; Wu, CW; Yang, SS; Yeh, HZ | 1 |
| Baggett, HC; Bruce, MG; Dunaway, E; Gessner, BD; Gold, BD; Muth, PT; Parkinson, AJ | 1 |
| Chen, FB; Chen, J; Chen, XJ; Li, ZY; Yu, JD; Zhang, XP | 1 |
| Biron, F; Depagne, C; Guerin, JC; Louerat, C; Nesme, P | 1 |
| Kamagate, A; Kone, D | 1 |
| Pan, Y; Xiao, SD; Zhang, L; Zheng, Q | 1 |
| Foucar, MK; Pai, RK; Snider, WK; Starkey, CR; Viswanatha, D; Wilson, CS | 1 |
| Ahuja, V; Mudgil, A; Nanda, V; Schoor, R; Shin, RH | 1 |
| Amoruso, A; Boscarelli, G; Castellaneta, SP; Cavallo, L; Di Leo, A; Francavilla, A; Francavilla, R; Ierardi, E; Lionetti, E; Magistà, AM; Miniello, VL; Piscitelli, D | 1 |
| Häni, A; Klainguti, A; Mihailovic, M; Soldini, G | 1 |
| Cheng, H; Hu, FL | 1 |
| Cagli, NA; Dursun, R; Gokalp, A; Hakki, SS; Hart, PS; Hart, TC; Ryu, OH; Toy, H | 1 |
| Hirai, S; Hojo, M; Kobayashi, O; Miwa, H; Nomura, T; Ogihara, T; Ohkusa, T; Okayasu, I; Sato, N; Takei, Y; Terai, T | 1 |
| Asaka, M | 1 |
| Fujioka, T | 1 |
| Fujioka, T; Murakami, K | 1 |
| Katsuyama, T; Kawakami, Y; Oana, K; Okimura, Y; Ota, H | 1 |
| Imase, K; Sugano, H; Takahashi, S | 1 |
| Nagahara, A; Sato, N | 1 |
| Fujioka, T; Murakami, K; Okimoto, T | 1 |
| Furuta, T; Nakamura, A; Shirai, N; Sugimoto, M | 1 |
| Bray, R; Hiratsuka, H; Hiratsuka, T; Kimura, K; Suzuki, T; Tamura, K | 1 |
| Fujishiro, M; Kobayashi, K; Oka, M; Omata, M | 1 |
| Konno, M | 1 |
| Katoh, H; Kuwano, H; Miyazaki, T; Tsukada, K | 1 |
| Abe, C; Hikichi, T; Irisawa, A; Obara, K; Sato, Y | 1 |
| Barsaoui, S; Boukthir, S; Fdhila, F; Fendri, C; Mrad, SM | 1 |
| Berini-Aytés, L; Brescó-Salinas, M; Costa-Riu, N; Gay-Escoda, C | 1 |
| Palmer, NO | 1 |
| Chan, AO; Chan, CK; Chu, KM; Fung, FM; Gu, Q; Lai, KC; Tong, TS; Wong, BC; Wong, WM; Yee, YK | 1 |
| Antos, D; Bästlein, E; Bayerdörffer, E; Buchner, M; Haferland, C; Hänel, C; Lehn, N; Meier, E; Schneider-Brachert, W; Stolte, M; Trump, F | 1 |
| Cheon, JH; Jung, HC; Kim, JM; Kim, JS; Kim, N; Lee, DH; Song, IS | 1 |
| Bahcall, JK; Hoelscher, AA; Maki, JS | 1 |
| Borody, TJ; Clancy, R; Herdman, K; Llorente, R; Ng, C; Pang, G; Surace, R; Wettstein, AR | 1 |
| Ahuja, A; Ali, J; Rahman, S | 1 |
| Benito, LM; Bermejo, F; Bory, F; Castro-Fernández, M; Cosme, A; Ducons, J; Fernández-Bermejo, M; Gisbert, JP; Lamas, E; López-Rivas, L; Olivares, D; Pabón, M; Pérez-Aisa, A | 1 |
| Deguchi, R; Kobayashi, I; Kobayashi, K; Kurumada, T; Masui, A; Matsushima, M; Mine, T; Muraoka, H; Shirai, T; Suzuki, T; Takagi, A; Watanabe, K; Watanabe, S | 1 |
| Abe, T; Arita, T; Fujioka, T; Kodama, M; Murakami, K; Nasu, M; Okimoto, T; Sato, R; Sato, S; Watanabe, K | 1 |
| Hirakawa, K; Ishikawa, T; Katsuragi, K; Maeda, K; Mino, A; Ohira, M; Onoda, N; Sawada, T; Wakasa, K | 1 |
| Postavnyĭ, VE | 1 |
| Butorov, IV; Butorov, SI; Maksimov, VV; Osoianu, IuP | 1 |
| Bernard, P; Conscience, I; Le Berruyer, PY; Perceau, G | 1 |
| Chey, WD; Kim, HM; Saad, RJ; Schoenfeld, P | 1 |
| Baka, A; Konstantinidis, A; Sakellari, D; Slini, T; Xajigeorgiou, C | 1 |
| Castro-Fernández, M; Cosme, A; Gisbert, JP; Gómez, B; Herrerías, JM; Luna, M; Monés, J; Olivares, D; Pajares, JM; Sánchez-Pobre, P | 1 |
| Andersen, E; Brochut, P; Giannopoulou, C; Mombelli, A; Plagnat, D | 1 |
| Kerton, A; Warden, P | 1 |
| Ashorn, M; Bodanszky, H; Bontems, P; Casswall, T; Celinska-Cedro, D; Crone, J; Gottrand, F; Kalach, N; Kolacek, S; Koletzko, S; Martínez-Gómez, MJ; Mégraud, F; Monteiro, ML; Orderda, G; Richy, F; Roma-Giannikou, E; Urruzuno, P | 1 |
| Aghakhani, S; Bahremand, S; Fourutan, H; Mir, E; Nematollahi, LR; Nouripour, S; Tirgari, F | 1 |
| Amayo, EO; Kariuki, S; Lwai-Lume, L; Ogutu, EO | 1 |
| Ito, M; Kawai, T; Kawamura, Y; Masaoka, T; Matsuhisa, T; Mine, T; Sakaki, N; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K | 1 |
| Alarcón, T; Díaz-Reganon, J; Domingo, D; López-Brea, M | 1 |
| Graham, DY; Lu, H | 1 |
| Quandalle, P; Tran, TT | 1 |
| Hatao, K; Takahashi, T; Yamada, K | 1 |
| Bosboom, R; de Boer, SY; de Boer, WA; Hendrikse, L; Jansen, JB; Janssen, MJ; Laheij, RJ | 1 |
| Classen, M; Li, J; Lin, SR; Liu, WD; Ma, JL; Pan, KF; Shen, L; Xiao, SD; You, WC; Zhang, L | 1 |
| Altintaş, E; Sezgin, O; Tataroğlu, C; Uçbilek, E | 1 |
| Bästlein, E; Bayerdörffer, E; Hansky, K; Jacobs, E; Kirsch, C; Kuhlisch, E; Lehn, N; Madisch, A; Miehlke, S; Morgner, A; Schneider-Brachert, W; Stolte, M | 1 |
| Da Silva, I; Haffajee, AD; Japlit, MR; López, NJ; Socransky, SS | 1 |
| Dorkoosh, F; Tavakoli, N; Varshosaz, J; Zargarzadeh, MR | 1 |
| Mousavi, S; Toussy, J; Yaghmaie, S; Zahmatkesh, M | 1 |
| Alberer, M; Antos, D; Arenz, T; Buderus, S; Kappler, M; Koletzko, S; Rüssmann, H | 1 |
| Droździk, M; Gawrońska-Szklarz, B; Kurzawski, M; Siuda, A; Starzyńska, T; Wrześniewska, J | 1 |
| Mombelli, A | 3 |
| Pistiolas, D; Robotis, J; Rokkas, T; Sechopoulos, P | 1 |
| Abouzari, M; Hasibi, M; Mirbagheri, SA; Rashidi, A | 1 |
| Anzai, K; Kamiya, S; Kamoda, O; Mizoguchi, J; Nishino, T; Shiojiri, M; Yanagi, T | 1 |
| Fujioka, T; Inoue, K; Kodama, M; Miyajima, H; Murakami, K; Okimoto, T; Ono, M; Otsu, S; Sato, R; Watanabe, K | 1 |
| Baron, F; Eickholz, P; Ludwig, B; Noack, B; Schacher, B; Valesky, E | 1 |
| Goić-Barisić, I; Jukić, I; Punda-Polić, V; Simunić, M; Tonkić, A; Tonkić, M | 1 |
| Chen, A; Hsu, PI; Lai, KH; Lo, GH; Tsay, FW; Tseng, HH; Wang, WM; Wu, CJ; Wu, DC; Wu, IC; Wu, JY | 1 |
| Ziemniak, W | 1 |
| Dzieniszewski, J; Jarosz, M | 1 |
| Ben Ayed, M; Ben Khelifa, H; Chedly-Debbiche, A; Gargouri, D; Ghorbel, AJ; Kharrat, J; Khayat, O; Kilani, A; Souissi, A; Zeddini, A | 1 |
| Cheon, JH; Choi, YS; Jung, HC; Kim, JM; Kim, JS; Kim, N; Kim, SG; Lee, DH; Lee, JY; Song, IS | 1 |
| Crosbie, O; Dempsey, C; Hooton, C; Keohane, J; Lucey, B; O'Mahony, S | 1 |
| Doratotaj, D; Fallahi, GH; Khatami, GR; Mirnaseri, MM; Safari, F; Siavoshi, F | 1 |
| Apikoglu-Rabus, S; Besisik, F; Dulger, G; Izzettin, FV; Sancar, M; Tozun, N | 1 |
| Bella, A; Caracciolo, F; Crispino, P; Gurnari, M; Iacopini, F; Nardi, F; Paoluzi, P; Pica, R; Rivera, M; Rossi, P; Zippi, M | 1 |
| Berg, DE; Bruce, MG; Bruden, DL; Hennessy, TW; Hurlburt, DA; Martinez, P; McMahon, BJ; Morris, J; Parkinson, AJ; Parks, D; Peters, H; Reasonover, A; Sacco, F; Swenson, M | 1 |
| Choe, YH; Choi, J; Jang, JY; Kim, JS; Kim, KM; Park, HY | 1 |
| Fukuda, S; Fukushi, M; Munakata, A; Nakasato, F; Shimoyama, T; Tanaka, M | 1 |
| Koppel, T; Loivukene, K; Naaber, P; Pahkla, ER; Saag, M | 1 |
| Kumala, W; Rani, A | 1 |
| Tepes, B | 1 |
| Dorchy, H; Khalil, T; Melot, C; Scaillon, M | 1 |
| Agah, S; Ajvadi, Y; Ali-Asgari, A; Ebrahimi-Dariani, N; Khatibian, M; Malekzadeh, R; Massarrat, S; Mikaeli, J; Nasseri-Moghaddam, S; Pourshams, A; Sotoudehmanesh, R; Vahedi, H; Zendehdel, N | 1 |
| Bélanger, M; LeCorn, DW; Progulske-Fox, A; Rojas, MF; Vertucci, FJ | 1 |
| Cheng, CC; Hu, CT; Lin, CY; Lin, NT; Su, SC; Tseng, YH; Wu, CC | 1 |
| Kadayifçi, A | 1 |
| Aslan, M; Bagci, S; Erdil, A; Gunhan, O; Ozel, AM; Uygun, A; Yesilova, Z; Yildiz, O | 1 |
| Furuta, T; Hishida, A; Ikuma, M; Ishizaki, T; Kajimura, M; Kodaira, C; Nishino, M; Ohashi, K; Shirai, N; Sugimoto, M | 1 |
| Demirci, H; Ersoy, O; Ersoy, R; Tatlican, S; Yayar, O | 1 |
| Bernimoulin, JP; Christan, C; Dietrich, T; Friedmann, A; Kaner, D; Kleber, BM | 1 |
| Fahami, N; Fallahzadeh, H; Haerian-ardakani, A; Moeintaghavi, A; Pakzad, A; Taghipour, S; Talebi-ardakani, MR; Zandi, H | 1 |
| Cabrera, E; Castro, M; Fernández, N; Méndez, I; Moreno, JL; Navarro-Jarabo, JM; Perea-Milla, E; Ramírez, LM; Rivas-Ruiz, F; Rivera, R; Sousa, FL; Ubiña, E; Vera, F | 1 |
| Asmar, E; Bergeret, M; Campeotto, F; Charkaluk, ML; Decoster, A; Dehecq, E; Dupont, C; Kalach, N; Raymond, J; Serhal, L; Spyckerelle, C | 1 |
| Dannewitz, B; Eickholz, P; Kim, TS; Pohl, S | 1 |
| Conrads, G; Horz, HP | 1 |
| Echeverría, JJ; Guerrero, A; Tonetti, MS | 1 |
| Feres-Filho, EJ; Moreira, RM | 1 |
| Alvarez, M; Diz, P; Limeres, J; Potel, C; Tomás, I; Tomás, M; Velasco, D | 1 |
| Sedlacek, MJ; Walker, C | 1 |
| Bernimoulin, JP; Friedmann, A; Hopfenmüller, W; Kaner, D; Kleber, BM | 1 |
| Chen, LH; Luo, HS | 1 |
| Bazzoli, F; Fuccio, L; Grilli, D; Magrini, N; Minardi, ME; Zagari, RM | 1 |
| Azuma, T; Fujioka, T; Fukuda, Y; Haruma, K; Kato, M; Kato, S; Katsuyama, T; Kobayashi, I; Murakami, K; Nasu, M; Takahashi, S; Uemura, N | 1 |
| Ernst, ME; Philbrick, AM | 1 |
| Bagci, S; Ilgan, S; Kadayifci, A; Safali, M; Uygun, A | 1 |
| Fariña, N; Kasamatsu, E; Laspina, F; Morán, M; Samudio, M; Sanabria, R | 1 |
| Gisbert, JL; Gisbert, JP; Jimenez-Alonso, I; Marcos, S; Moreno-Otero, R; Pajares, JM | 1 |
| Jung, HC; Kang, JM; Kim, JS; Kim, N; Kim, YR; Lee, DH; Park, YS; Song, IS | 1 |
| Altintaş, E; Nayir, E; Sezgin, O; Uçbilek, E | 1 |
| Chen, J; Hu, HJ; Huang, XL; Li, ZY; Yan, WH; Yu, JD | 1 |
| Gigliotti, F; Morini, S; Ricci, C; Vaira, D; Zullo, A | 1 |
| Abu-Hammad, OA; Dar-Odeh, NS; El Maaytah, MA; Khraisat, AS; Shehabi, A | 1 |
| Chan, FK; Lee, CC; Lee, VW; Ling, TK | 1 |
| Ahn, SB; Bang, SY; Eun, CS; Han, DS; Jeon, YC; Kang, JO; Kim, JE; Sohn, JH | 1 |
| Hibi, T; Iwasaki, E; Masaoka, T; Nishizawa, T; Suzuki, H | 1 |
| Fujioka, T; Kodama, M; Murakami, K; Okimoto, T; Sato, R; Watanabe, K | 2 |
| Hirata, Y; Kawabe, T; Maeda, S; Mitsuno, Y; Ogura, K; Ohmae, T; Okamoto, M; Omata, M; Shibata, W; Watabe, H; Yamaji, Y; Yanai, A; Yoshida, H | 1 |
| Bergeret, M; Dupont, C; Kalach, N; Raymond, J; Serhal, L; Spyckerelle, C | 1 |
| Bravo, JC; Bravo, LE; Camargo, MC; Ceron, C; Correa, P; Delgado, AG; Fontham, ET; Mera, RM; Piazuelo, MB; Yepez, MC | 1 |
| Chung, MH; Hwang, JB; Kang, YN; Kim, AS; Kim, JY; Lee, HJ; Park, JH | 1 |
| Akoachere, JF; Luma, HN; MacMillan, M; Malange Takang, AE; Malongue, A; Ndip, LM; Ndip, RN; Ojongokpoko, JE; Weaver, LT | 1 |
| Ilgan, S; Kadayifci, A; Karaeren, N; Safali, M; Uygun, A; Yesilova, Z | 1 |
| Cobb, TG | 1 |
| Hallas, J; Hansen, JM; Schaffalitzky de Muckadell, OB; Wildner-Christensen, M | 1 |
| Nijawan, S; Rishi, JP; Yadav, MK | 1 |
| Baek, YH; Cho, YK; Choi, WH; Hong, CH; Hong, EJ; Jeon, WK; Kim, BI; Kim, HJ; Oh, SJ; Park, DI; Park, JH; Park, SK; Sohn, CI; Song, MJ | 1 |
| Bujanda, L; Calvet, X; Castro, M; Gisbert, JP; Sánchez-Delgado, J; Titó, L | 1 |
| Akincibay, H; Orsal, SO; Sengün, D; Tözüm, TF | 1 |
| Ching, SS; Jenkinson, LR; Sabanathan, S | 1 |
| Egan, BJ; O'Connor, HJ; O'Morain, CA | 1 |
| Cruz, SE; Faveri, M; Feres, M; Figueiredo, LC; Matarazzo, F | 1 |
| Cozzolino, D; Iovene, MR; Nardone, G; Pilloni, AP; Rocco, A; Romano, M; Russo, MI; Salerno, R; Tufano, MA; Vaira, D | 1 |
| Alves, A; Delerue-Matos, C; Santos, L; Teixeira, S | 1 |
| Bijlsma, JW; Bloemena, E; Boers, M; De Leest, HT; Dijkmans, BA; Houben, HH; Janssen, M; Kostense, PJ; Kuipers, EJ; Lems, WF; Steen, KS; Van de Laar, MA | 1 |
| Benno, Y; Kudo, T; Nishikawa, J; Sakata, S; Sugiyama, T | 1 |
| Dehghani, SM; Erjaee, A; Haghighat, M; Imanieh, MH | 1 |
| Chen, R; Hinrichs, JE; Johnson, JD; Lenton, PA; Rudney, JD; Zhang, G | 1 |
| Machtei, EE; Younis, MN | 1 |
| Diop, M; Diouf, ML; Fall, I; Fall, M; Konaté, I; Ndoye, M; Ngom, G; Sankalé, AA | 1 |
| Hibi, T; Iwasaki, E; Masaoka, T; Nakagawa, I; Nishizawa, T; Suzuki, H | 1 |
| Aoki, T; Itoi, T; Kataoka, M; Kawai, T; Kawakami, K; Moriyasu, F; Noguchi, N; Osaka, Y; Rimbara, E; Sakai, Y; Sasatsu, M; Sofuni, A; Takagi, Y; Yagi, K; Yamagishi, T | 1 |
| Aladag, I; Erkokmaz, U; Eyibilen, A; Guven, M | 1 |
| Abd El-Hamed, TM; El Awady, S; El-Nakeeb, A; Farid, M; Fikry, A; Fouda, el Y; Sherief, D; Youssef, T | 1 |
| Bengtsson, C; Granström, M; Hoang, TT; Nguyen, GK; Nguyen, TV; Phung, DC; Sörberg, M | 1 |
| Sánchez-Delgado, J | 1 |
| Abdullahi, M; Annibale, B; Capoccia, D; Leonetti, F; Marcheggiano, A; Osborn, J; Severi, C; Tari, R; Vannella, L | 1 |
| Filipec Kanizaj, T; Kalenic, S; Katicic, M; Plecko, V; Skurla, B; Ticak, M | 1 |
| André, C; Halbwax, M; Mahamba, CK; Ngalula, AM | 1 |
| Bernimoulin, JP; Friedmann, A; Kaner, D; Kleber, BM | 1 |
| Chang, LL; Chen, A; Hsu, PI; Hu, HM; Jan, CM; Kuo, CH; Kuo, FC; Li, CJ; Tsai, PY; Wang, SW; Wang, WM; Weng, BC; Wu, DC; Wu, IC; Yu, FJ | 1 |
| Cionca, N; Giannopoulou, C; Mombelli, A; Ugolotti, G | 2 |
| Bhola, M; Steiger, J; Zeevi, A | 1 |
| Azizi, T; Lotfi, A; Moshref, M; Motamedi, MH | 1 |
| Gu, CP; Huang, LP; Zhuang, ML | 1 |
| Futagami, S; Inagaki, H; Kawagoe, T; Kusunoki, M; Miyake, K; Sakamoto, C; Shindo, T; Tsukui, T; Ueki, N | 1 |
| Bravo, JC; Bravo, LE; Casabon, AL; Casabon, LA; Collazos, T; Correa, P; Fischbach, LA; Guerrero, LZ; Ojha, PR; Ojha, RP; Priest, EL; Singh, KP; Singh, PK; Zarama, GR | 1 |
| Arigbabu, AO; Coker, AO; Oyedeji, KS; Smith, SI | 1 |
| Ellison, SJ | 2 |
| Abdou, AG; Elnaidany, NF; Elshayeb, EI; Farag, AG | 1 |
| Peplies, J; Roldan-Pareja, Mdel C; Schlagenhauf, U; Tichy, D; Valenza, G; Veihelmann, S; Vogel, U | 1 |
| Deguchi, R; Fukuda, R; Matsushima, M; Mine, T; Nishina, M; Ozawa, H; Suzuki, T; Takagi, A | 1 |
| Balkarli, A; Baştürk, A; Cerçi, S; Senol, A; Songür, Y | 1 |
| Chang, WL; Cheng, HC; Sheu, BS; Wu, JJ; Yang, HB; Yang, YJ | 1 |
| Derakhshan, F; Haghazali, M; Mirsattari, D; Mohsenian, N; Molaei, M; Talaie, R; Zali, MR; Zojaji, H | 1 |
| Agudo, S; Alarcón, T; Cibrelus, L; López-Brea, M; Martínez, MJ; Urruzuno, P | 1 |
| Alvarez, A; Corredor, LF; Moncayo, JI; Reinosa, E; Santacoloma, M; Santacruz, JJ | 1 |
| García, A; González, CL; Soto, A | 1 |
| Fujimura, S; Kato, S | 1 |
| Bittencourt, S; Bovi Ambrosano, GM; Casati, MZ; Gonçalves, RB; Nociti, FH; Ribeiro, Edel P; Sallum, EA; Zanin, IC | 1 |
| Katelaris, PH | 1 |
| Kandulski, A; Malfertheiner, P; Selgrad, M | 1 |
| Boches, SK; Colombo, AP; Cotton, SL; Dewhirst, F; Goodson, JM; Haffajee, AD; Hasturk, H; Kent, R; Paster, BJ; Socransky, SS; Van Dyke, TE | 1 |
| Dixit, VK; Gulati, AK; Jain, AK; Maurya, P; Mishra, S; Nath, G; Rao, G; Singh, V | 1 |
| Boye, CS; Diouf, L; Gassama-Sow, A; Ka, MM; Mbengue, M; Seck, A | 1 |
| Chey, WD; Higgins, PD; Luther, J; Moayyedi, P; Schoenfeld, PS; Vakil, N | 1 |
| Amini, M; Tajik, A | 1 |
| Di Mario, F; Gatta, L; Leandro, G; Vaira, D; Vakil, N | 1 |
| Choe, YH; Chung, IS; Kim, HS; Kim, JI; Kim, JJ; Kim, N | 1 |
| Malfertheiner, P; Moayyedi, P | 1 |
| Murakami, K; Okimoto, T | 1 |
| Mahachai, V; Sirimontaporn, N; Thong-Ngam, D; Tumwasorn, S | 1 |
| Angelini, R; Pontone, P; Pontone, S; Standoli, M | 1 |
| Ataseven, H; Demir, M; Gen, R | 2 |
| Abadia, EG; Dueñas, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Perez-Gallardo, B; Vinagre, G | 1 |
| Levy, I; Samra, Z; Shmuely, H; Yahav, J; Zevit, N | 1 |
| Cintan, S; Issever, H; Kantarci, A; Kulekci, G; Topcuoglu, N; Yek, EC | 1 |
| Chiba, T; Kato, K; Mabe, K; Mizokami, Y; Murakami, K; Ohkusa, T; Okayasu, I; Sato, N; Sugiyama, T; Tajiri, H; Takeuchi, Y; Terao, S; Watanabe, S; Yamato, S; Yanaka, A; Yokoyama, T | 1 |
| Buchmann, R; Conrads, G; Sculean, A | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H | 1 |
| Bielicki, D; Droździk, M; Gawrońska-Szklarz, B; Kurzawski, M; Marlicz, W; Siuda, A | 1 |
| Ardila, CM; Guzmán, IC; López, MA | 1 |
| Cetinkaya, ZA; Coşgun, S; Düzgün, S; Güzelbulut, F; Kurdaş, OO; Sezikli, M | 1 |
| Hwang, JH; Jeong, SH; Jung, HC; Kim, JJ; Kim, JW; Kim, N; Kwon, JH; Lee, DH; Lee, JW; Lee, SH; Park, YS; Song, BJ; Song, IS | 1 |
| Demir, M; Göktürk, S; Oztürk, NA; Serin, E; Yilmaz, U | 1 |
| Feliciano, O; Fernández, H; Gala, A; Gutiérrez, O; Guzmán, D; Kobayashi, N; Llanes, R; Llop, A; Nagashima, S; Soria, C; Valdés, L; Wada, A | 1 |
| Clarke, AM; Green, E; Mkwetshana, N; Naidoo, N; Ndip, LM; Ndip, RN; Okeleye, BI; Tanih, NF | 1 |
| Devani, S; Kariuki, S; Kimang'a, AN; Revathi, G; Sayed, S | 1 |
| Latifi-Navid, S; Massarrat, S; Saniee, P; Sheykholeslami, A; Siavoshi, F | 1 |
| Changsom, D; Chawansuntati, K; Koosirirat, C; Linpisarn, S; Wipasa, J | 1 |
| Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Lira, EA; Mestnik, MJ | 1 |
| Ardila, CM; Granada, MI; Guzmán, IC | 1 |
| Ishii, Y; Kato, K; Moriyama, M; Nemoto, N; Ohkusa, T; Sugitani, M; Uehara, T | 1 |
| Beck, SE; Brayton, C; Del Carmen Martino-Cardona, M; Watson, J | 1 |
| Aguayo, P; Andrews, WS; Fraser, JD; Holcomb, GW; Keckler, SJ; Leys, CM; Murphy, JP; Newland, JG; Ostlie, DJ; Sharp, RJ; Sharp, SW; Snyder, CL; St Peter, SD | 1 |
| Hsueh, PR; Lee, PI; Yang, JC | 1 |
| Ayadi, A; Ben Mansour, K; Boubaker, J; Burucoa, C; Cheikh, I; Chouaib, S; Fekih, M; Fendri, C; Filali, A; Hriz, MB; Kallel, L; Karoui, S; Labbene, M; Maherzi, A; Mami, NB; Masmoudi, A; Matri, S; Najjar, T; Sfar, MT; Siala, N; Zarrouk, S; Zribi, M | 1 |
| Ae, T; Azuma, M; Higuchi, K; Ishido, K; Katada, C; Koizumi, W; Nakatani, K; Nakayama, N; Nishimura, K; Saigenji, K; Sasaki, T; Tanabe, S | 1 |
| Fischbach, L; Graham, DY | 1 |
| Bomers, MK; Peerbooms, P; van Bunderen, CC; Veenstra, J; Wesdorp, E | 1 |
| Chen, WJ; Lu, H; Sun, QJ; Xiao, SD; Zheng, Q | 1 |
| Bahar, K; Çinar, K; Özden, A; Seven, G; Yakut, M | 1 |
| Jonaitis, L; Kiudelis, G; Kupčinskas, J; Kupčinskas, L | 1 |
| Sugano, H; Takahashi, Si; Tanaka, A; Tokunaga, K | 1 |
| Ayob, R; Griffiths, GS; Guerrero, A; Moles, DR; Nibali, L; Suvan, J; Tonetti, MS | 1 |
| Mobarez, AM; Taghvaei, T; Talebi Bezmin Abadi, A; Wolfram, L | 1 |
| Deli, G; di Prisco, MO; Hoffmann, O; Kasaj, A; Zafiropoulos, GG | 1 |
| Kahler, B; Thomson, A | 1 |
| Almaghlouth, A; Cionca, N; Mombelli, A | 1 |
| Berning, M; Krasz, S; Labenz, J; Miehlke, S | 1 |
| Jamshidi, S; Khoshnegah, J; Mohammadi, M; Sasani, F | 1 |
| Eden, A; Le Falher, G; Le Moing, V; Lesnik, A; Makinson, A; Reynes, J | 1 |
| Lin, L; Tang, XL | 1 |
| Kilic, ZM; Nadir, I; Ozin, Y; Sezgin, O; Yonem, O | 1 |
| Colombo, AP; Feres-Filho, EJ; Heller, D; Silva-Senem, MX; Torres, MC; Varela, VM | 3 |
| Hirano, T; Kato, K; Ohkusa, T; Tamura, I; Terao, S; Yamashiro, K | 1 |
| Fischbach, LA; Graham, DY; Rimbara, E | 1 |
| Abbas, Z; Abid, S; Jafri, SN; Yakoob, J | 1 |
| Almaghlouth, A; Cionca, N; Décaillet, F; Mombelli, A; Wick, P | 1 |
| Bazzoli, F; Celiñski, K; Delchier, JC; Giguère, M; Malfertheiner, P; Mégraud, F; Rivière, M | 1 |
| Asaka, M; Furukawa, K; Furuta, T; Inaba, T; Ishii, N; Kamoshida, T; Kato, M; Konda, Y; Nomura, H; Sasaki, M; Shirai, T; Sugimoto, M; Tomita, T | 1 |
| Kulik, EM; Walter, C; Waltimo, T; Weiger, R; Zitzmann, NU | 1 |
| Buonavolontà, R; Miele, E; Russo, D; Staiano, A; Vecchione, R | 1 |
| Alexander, M; Pasupathy, S | 1 |
| Al-Nawas, B; d'Hoedt, B; Karbach, J; Mouratidou, A | 1 |
| Bontem, P; Buderus, S; Iwańczak, B; Kalach, N; Koletzko, S; Liptay, S; Martínez-Gómez, MZ; Roma-Giannikou, E; Schwarzer, A; Urruzuno, P; Wenzl, TG | 1 |
| Albayrak, B; Altuntas, Y; Bayraktar, B; Bugdaci, MS; Sokmen, M; Toksoy, B; Zuhur, SS | 1 |
| Graham, DY; Hsu, PI; Wu, DC; Wu, JY | 2 |
| Benouda, A; El Quessar, A; Jeddi, D; Ouriemchi, W; Ziane, Y | 1 |
| Anacleto, TP; Andreollo, NA; Bernis Filho, WO; Lopes, LR; Macedo, A; Resck, MC | 1 |
| Bytzer, P; Dahlerup, JF; Eriksen, JR; Jarbøl, DE; Rosenstock, S; Wildt, S | 1 |
| Bernimoulin, JP; Dietrich, T; Friedmann, A; Kaner, D; Kleber, BM | 1 |
| Chen, A; Hsu, PI; Kuo, CH; Lai, KH; Tsay, FW; Tseng, HH; Wang, SW; Wu, DC | 1 |
| Baik, GH; Jung, HC; Kim, GH; Kim, HB; Kim, JM; Kim, JY; Kim, NY; Kim, SJ; Lee, DH; Nam, RH; Song, IS | 1 |
| Ince, AT; Kesici, B; Polat, Z; Saglam, M; Toros, AB; Uygun, A | 1 |
| Hori, K; Matsumoto, T; Miwa, H | 1 |
| Goto, Y; Hamajima, N; Inoue, S; Kamiya, Y; Kawai, S; Kondo, T; Kurata, M; Tamura, T | 1 |
| Bono, A; Brunotto, M | 1 |
| Astegiano, M; Cisarò, F; De Angelis, C; Pellicano, R; Rizzetto, M; Saracco, G | 1 |
| Akadiri, AO; Arotiba, JT; Fasola, OA; Olusanya, AA | 1 |
| Bontems, P; Cadranel, S; Kalach, N; Miendje, DY; Muyshont, L; Oderda, G; Raymond, J; Salame, A; Scaillon, M | 1 |
| Bauerfeind, P; Kaiser, P; Misselwitz, B; Vavricka, SR | 1 |
| Baelum, V; Casanova, PA; Ibieta, CI; López, NJ; López, R; Quintero, A | 1 |
| Faveri, M; Feres, M; Figueiredo, LC; Mendes, JA; Silva, MP; Sirotto, TA; Soares, GM | 1 |
| Benoliel, J; Cabral, J; Lemos, PS; Lopes, AI; Oleastro, M; Paixão, E; Ramalho, PM; Santos, A | 1 |
| Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Torres, J; Valdivieso, M | 1 |
| Francesconi, CF; Mazzoleni, LE; Sander, GB | 1 |
| Bessong, PO; Ndip, RN; Okeleye, BI | 1 |
| Choi, KD; Chung, JW; Jeong, JY; Jung, HY; Jung, JH; Kim, JH; Lee, GH; Lee, SM; Song, HJ | 1 |
| Chiu, YC; Chuah, SK; Hsu, PI; Hu, ML; Hu, TH; Kuo, CM; Tai, WC; Wu, DC; Wu, KL | 1 |
| Aslan, M; Baltacioglu, E; Saraç, Ö; Saybak, A; Yuva, P | 1 |
| Budak, A; Karczewska, E; Sito, E; Wojtas-Bonior, I; Zwolińska-Wcisło, M | 1 |
| Bornschein, J; Malfertheiner, P; Selgrad, M | 1 |
| Cho, HJ; Cho, YR; Hwang, JH; Jeoung, SH; Jung, HC; Kim, JW; Kim, N; Lee, DH; Lee, SH; Oh, HS; Park, YS; Seo, JY; Shin, CM; Song, IS | 1 |
| Baik, GH; Kim, DJ; Kim, DY; Kim, HY; Kim, JB; Kim, KH; Kim, SJ; Kim, YS; Min, HJ; Park, SH; Shin, WG; Suk, KT; Yoon, JH | 1 |
| Dobashi, Y; Fukunishi, M; Matsumoto, S; Miyatani, H; Takamatsu, T; Ugajin, T; Yoshida, Y | 1 |
| Sun, C; Wang, J; Wu, L; Xia, W; Zhang, X | 1 |
| Jide, AA; Ndip, RN; Njume, C | 1 |
| Geng, QM; Han, YJ; Tian, XL; Zhang, JZ; Zhou, LY | 1 |
| Chuah, SK; Hsu, PI; Tsay, FW; Wu, DC | 1 |
| Gatto, R; Monaco, A; Petrucci, A; Sgolastra, F | 2 |
| De Micheli, G; Hirata, MH; Hirata, RD; Lima Neto, LG; Lotufo, RF; Lourenção, DS; Pannuti, CM; Rodrigues, AS | 1 |
| Cho, KB; Jeon, SW; Jung, JT; Jung, MK; Kim, ES; Kim, EY; Kim, KO; Kwon, JG; Lee, JH; Lee, SH; Park, HG; Park, KS; Seo, HE; Yang, CH | 1 |
| Faddy, M; Heitz-Mayfield, LJA; Lang, NP; Mombelli, A; Salvi, GE | 1 |
| de Faveri, M; de Lima Oliveira, AP; Feres, M; Gursky, LC; Haffajee, AD; Mestnik, MJ; Socransky, SS; Teles, RP | 1 |
| Aimetti, M; Carnevale, G; Guzzi, N; Romano, F | 1 |
| Kolber, MR; Korownyk, C | 1 |
| Casarin, RC; Casati, MZ; Gonçalves, RB; Nociti, FH; Peloso Ribeiro, ED; Sallum, EA | 1 |
| Ford, AC; Slater, CM | 1 |
| Gatta, L; Vaira, D; Vakil, N | 1 |
| Graham, DY; Trespalacios, AA | 1 |
| Bdioui, F; Ben Chaabane, N; Bouhlel, W; Hellara, O; Loghmari, H; Melki, W; Safer, L; Saffar, H; Zakhama, A | 1 |
| Bennet, S; Colombo, AP; Cotton, SL; Dewhirst, FE; Goodson, JM; Haffajee, AD; Hasturk, H; Kent, R; Paster, BJ; Socransky, SS; Van Dyke, TE | 1 |
| Duarte, PM; Feres, M; Lima, JA; Mendonça, AC; Miranda, TS; Ribeiro, FV; Santos, VR | 1 |
| Dumančić, J; Hojsak, I; Jadrešin, O; Jaklin Kekez, A; Kolaček, S; Kos, T; Lukić Grlić, A; Mišak, Z | 1 |
| Chang, LL; Chen, YH; Huang, YK; Kuo, CH; Kuo, FC; Lee, YC; Wang, SS; Wang, TH; Wang, WM; Wu, DC; Wu, MC | 1 |
| Başer, O; Emer, O; Kadayifci, A; Kantarcioğlu, M; Kılcıler, G; Ozcan, A; Polat, Z; Uygun, A | 1 |
| Wang, Z; Wu, S | 1 |
| Bogren, A; Goodson, JM; Haffajee, AD; Hasturk, H; Kent, R; Lindhe, J; Socransky, SS; Teles, R; Van Dyke, T; Wennstrom, J | 1 |
| Chacra, NB; DeStefano, AJ; Hauck, WW; Löbenberg, R; Shah, VP; Stippler, ES; Williams, RL | 1 |
| Barenys, M; Bory, F; Bujanda, L; Calvet, X; Calvo, MM; Castro-Fernández, M; García-Iglesias, P; Gisbert, JP; Lisozain, J; Sánchez-Delgado, J; Torra, S | 1 |
| Cobb, CM; Slot, DE; Van der Weijden, FA; Zandbergen, D | 2 |
| Choi, JH; Chun, HJ; Hyun, JJ; Jung, SW; Kim, SY; Koo, JS; Lee, SW; Park, JJ; Yim, HJ | 1 |
| Bhakuni, RS; Chinniah, A; Das, PK; Goswami, S; Kar, SK; Pal, A | 1 |
| Amid, R; Kadkhodazadeh, M; Mehdizadeh, AR; Tabeie, MB; Youssefi, N | 1 |
| Boyanova, L; Gergova, G; Mateev, G; Mitev, A; Mitov, I | 1 |
| Dueñas-Sadornil, C; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Garcia, G; Hernandez-Alonso, M; Mateos-Rodriguez, JM; Molina-Infante, J; Pazos-Pacheco, C; Perez-Gallardo, B; Vinagre-Rodriguez, G | 1 |
| Ando, T; Fujinami, H; Hosokawa, A; Kudo, T; Murakami, J; Nishikawa, J; Ogawa, K; Orihara, T; Sugiyama, T; Takahara, T | 1 |
| Amornsawadwattana, S; Kongchayanun, C; Mahachai, V; Pornthisarn, B; Vilaichone, RK | 1 |
| Figura, N; Giordano, N; Langone, F; Moretti, E; Vaglio, L; Vernillo, R; Vindigni, C | 1 |
| Chung, JW; Hahm, KB; Jeong, JY; Jung, YK; Kim, JH; Kim, YJ; Kwon, KA; Lee, JJ; Lee, SM; Yun, SC | 1 |
| Agah, S; Ekhlasi, G; Ghourchian, S; Salehpour, A; Shidfar, F | 1 |
| Georgopoulos, S; Karatapanis, S; Laoudi, F; Lisgos, P; Papantoniou, N; Papastergiou, V; Spiliadi, C; Xirouchakis, E | 1 |
| Almaghlouth, A; Cionca, N; Courvoisier, DS; Décaillet, F; Giannopoulou, C; Mombelli, A | 1 |
| Duarte, PM; Faveri, M; Feres, M; Fermiano, D; Figueiredo, LC; Mestnik, MJ; Soares, G; Teles, RP | 1 |
| Aukhil, I; Beliveau, D; Bidwell, JA; Magnusson, I; Shaddox, LM; Wallet, SM; Zapert, EF | 1 |
| Chen, DW; Chen, JK; Hsiao, CY; Lee, FY; Liao, JY; Liu, SJ | 1 |
| Crielaard, W; Irshad, M; Laine, ML; van der Reijden, WA | 1 |
| Faveri, M; Feres, M; Figueiredo, LC; Mendes, JA; Silva, MP; Soares, GM; Socransky, SS; Teles, R | 1 |
| Ashida, C; Higashida, A; Kuwada, T; Mamori, S; Mitsuoka, T; Senda, E; Suga, Y; Taki, M; Yamada, H | 1 |
| Gizani, S; Madianos, P; Seremidi, K | 1 |
| Kareem, T | 1 |
| Andersen, LP; Berg, D; Jonaitis, L; Jørgensen, M; Kadusevicius, E; Kiudelis, G; Kupcinskas, J; Kupcinskas, L; Miciuleviciene, J; Rasmussen, L; Tamosiunas, V; Urbonaviciene, N | 1 |
| Arai, T; Furuhata, Y; Iinuma, N; Sakata, Y; Sugizaki, K; Suzuki, H | 1 |
| Chen, PY; Geng, LL; Gong, ST; He, WE; Huang, H; Huang, J; Liu, LY; Ou, WJ; Pan, RF; Zhou, LY | 1 |
| Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsu, SJ; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tseng, CH; Tseng, PH; Wang, HP; Wu, MS; Yang, UC | 1 |
| Alaoui, S; Amarti, A; Benajah, DA; Bennani, B; El Abkari, M; El Rhazi, K; Ibrahimi, A; Lahbabi, M; Mahmoud, M; Nejjari, C | 1 |
| Degener, JE; Rams, TE; van Winkelhoff, AJ | 3 |
| Adegbola, RA; Antonio, M; Berg, DE; Corrah, T; Galano, JJ; Sancho, J; Secka, O; Tapgun, M; Thomas, JE; Thomas, V; Walton, R | 1 |
| Breurec, S; Burucoa, C; Dia, D; Mbengue, M; Onambele, M; Raymond, J; Seck, A | 1 |
| Feng, XH; Lu, RF; Meng, HX; Xu, L | 1 |
| Choi, C; Hwang, JH; Jang, ES; Jeong, SH; Jo, HJ; Jung, HC; Kim, JW; Kim, N; Lee, DH; Lee, SH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, Is | 1 |
| Carter, LM; Singh, RP; Whitfield, PH | 1 |
| da Silva Patricio, FR; Godoy, AP; Kawakami, E; Ogata, SK | 1 |
| Anderson, GL; Baker, LH; Bravo, LE; Chey, WD; Correa, P; Crowley, JJ; Dominguez, RL; Ferreccio, C; Goodman, GE; Greenberg, ER; Herrero, R; Lazcano-Ponce, EC; Martínez, ME; Meza-Montenegro, MM; Morgan, DR; Peña, EM; Peña, R; Salazar-Martínez, E; Sexton, R; Torres, J; Valdivieso, M | 1 |
| Amin, M; Anwar, F; Mehmood, T; Naz, F; Saari, N | 1 |
| Arweiler, NB; Haririan, H; Kierstein, S; Polonyi, M; Prenninger, N; Winklehner, P | 1 |
| Malfertheiner, P | 1 |
| Alfant, B; Aukhil, I; Gonçalves, PF; Harrison, P; Huang, H; McAninley, S; Shaddox, LM; Walker, C | 1 |
| Gisbert, JP; Marin, AC; McNicholl, AG | 1 |
| Barrio, J; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Vinagre, G | 1 |
| Alaoui, S; Amarti, A; Benajah, DA; Bennani, B; El Abkari, M; El Rhazi, K; Ibrahimi, SA; Lahbabi, M; Mahmoud, M; Nejjari, C | 1 |
| Füessl, HS | 1 |
| Astasov-Frauenhoffer, M; Braissant, O; Hauser-Gerspach, I; Walter, C; Waltimo, T; Weiger, R; Zitzmann, NU | 1 |
| Almasi, S; Mirsattari, D; Seyedmajidi, S; Seyyedmajidi, M; Zali, M; Zanganeh, E; Zojaji, H | 1 |
| Botero, ML; Cárdenas, A; Forero, JD; Rey, M; Sierra, F | 1 |
| Belibasakis, GN; Thurnheer, T | 1 |
| Chen, J; He, J; Miao, X; Wu, X; Xie, Y; Xu, B; Xu, M; Yu, L; Zhang, W | 1 |
| Barrio, J; Bory, F; Calvet, X; Castro, M; de la Coba, C; Ducons, J; Forné, M; Gisbert, JP; Marin, AC; McNicholl, AG; Molina-Infante, J; Montoro, M; Perez-Aisa, A | 1 |
| Hibi, T; Nishizawa, T; Suzuki, H; Suzuki, M; Takahashi, M | 1 |
| Bogren, A; Goodson, JM; Haffajee, AD; Hasturk, H; Lindhe, J; Socransky, SS; Teles, R; van Dyke, T; Wang, X; Wennstrom, JL | 1 |
| Georgopoulos, SD; Laoudi, F; Martinez-Gonzalez, B; Mentis, AF; Sgouras, DN; Spiliadi, C; Xirouchakis, E | 1 |
| Powell, LV | 1 |
| Graham, DY; Lee, YC; Wu, MS | 1 |
| Asaoka, D; Ito, M; Kawai, T; Kawakami, K; Kurihara, N; Matsuhisa, T; Mine, T; Mizuno, S; Nagahara, A; Nishizawa, T; Ohkusa, T; Omata, F; Sakaki, N; Sasaki, H; Suzuki, H; Suzuki, M; Takahashi, S; Tokunaga, K; Torii, A | 1 |
| Albandar, JM | 1 |
| Allin, N; Aukhil, I; Gonçalves, PF; Hou, W; Huang, H; Shaddox, LM; Vovk, A; Wallet, SM | 1 |
| Benzer, E; Bilir, G; Gokcan, H; Onal, IK; Oztas, E | 1 |
| Cheung, DY; Chung, WC; Jun, EJ; Kim, BW; Kim, JI; Kim, JK; Kim, SS; Kim, TH; Lee, HJ; Oh, JH; Park, SH | 1 |
| Borges-Junior, I; de Oliveira Dias, R; Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Rebello, A | 1 |
| Arweiler, NB; Auschill, TM; Bläs, M; Dolińska, E; Pietruska, M; Pietruski, JK; Sculean, A; Skurska, A | 1 |
| Almasi, V; Moradimoghadam, F; Zendedel, A; Zivarifar, H | 1 |
| Einck, L; Makobongo, MO; Merrell, DS; Peek, RM | 1 |
| Jang, JY; Jung, HK; Kim, CG; Kim, SG; Lee, H; Lee, HL; Lee, YC; Shin, ES; Shin, WG | 1 |
| Adriani, A; Astegiano, M; Pellicano, R; Rizzetto, M; Smedile, A | 1 |
| Jo, HJ; Kim, MS; Kim, N; Kim, SE; Lee, DH; Park, YS; Shin, CM | 1 |
| Ding, ZL; Geng, L; Gong, ST; Huang, J; Li, DY; Li, ZL; Mao, M; Wang, ZL; Xu, XW; Yang, M; Zhou, L | 1 |
| Chung, JW; Jang, DK; Kang, KK; Kim, N; Lee, DH; Oh, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Furuta, T; Ichikawa, H; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
| Algaba, A; Antón, R; Barrio, J; Bermejo, F; Castro-Fernández, M; Cosme, A; Fernandez-Bermejo, M; Gisbert, JP; Gonzalez-Barcenas, M; Harb, Y; Marín, AC; McNicholl, AG; Modolell, I; Molina-Infante, J; Perez-Aisa, A; Rodrigo, L; Sacristán, B | 1 |
| Furuta, T; Ichikawa, H; Kodaira, C; Nishino, M; Osawa, S; Sahara, S; Sugimoto, K; Sugimoto, M; Umemura, K; Uotani, T; Watanabe, H; Yamada, T; Yamade, M | 1 |
| But, DY; Hsu, AS; Hung, IF; Lam, FY; Leung, WK; Liu, KS; Seto, WK; Tong, T; Wong, SY | 1 |
| Kamenwa, R; Kimang'a, AN; Laving, A; Revathi, G; Sayed, S | 1 |
| Chiarelli, FM; Dias, RR; Faveri, M; Feres, M; Figueiredo, LC; Lira, EA; Ramiro, FS | 1 |
| Chang, HJ; Geary, J; Goodman, KJ; Keelan, M; Morse, AL; Morse, JW; Munday, R; Sander, Vv | 1 |
| Asaoka, D; Hojo, M; Matsumoto, K; Nagahara, A; Osada, T; Sasaki, H; Watanabe, S | 1 |
| Almaghlouth, AA; Cancela, JA; Cionca, N; Courvoisier, DS; Décaillet, F; Giannopoulou, C; Mombelli, A | 1 |
| Arakawa, H; Kajihara, M; Kajiura, T; Koido, S; Mitobe, J; Odahara, S; Ohkusa, T; Saito, K; Shinozaki, J; Suzuki, M; Tajiri, H; Takakura, K; Tsukinaga, S; Uchiyama, K; Yukawa, T | 1 |
| Arweiler, NB; Auschill, TM; Dolińska, E; Heumann, C; Pietruska, M; Pietruski, J; Sculean, A; Skurska, A | 1 |
| Almeida, N; Cardoso, O; Cipriano, MA; Donato, MM; Luxo, C; Marinho, C; Romãozinho, JM; Sofia, C | 1 |
| Case, P; Holcombe, T; Kahler, B; Mistry, S; Moule, A; Ringsmuth, AK; Thomson, A | 1 |
| Baelum, V; Preus, HR; Scheie, AA | 1 |
| Graham, DY; Hsu, PI; Wang, WM; Wu, DC; Wu, JY | 1 |
| Chiba, T; Ishii, Y; Kato, K; Murakami, K; Ohkusa, T; Soma, M; Tajiri, H; Terao, S; Uehara, T; Yanaka, A | 1 |
| Bagenda, D; Bbosa, GS; Bwanga, F; Obua, C; Ocan, M; Ogwal-Okeng, J; Waako, P | 1 |
| Rurenga, P; Singadji, Z; van Winkelhoff, AJ; Wekema-Mulder, G | 1 |
| Furuta, T; Ichikawa, H; Sahara, S; Sugimoto, K; Sugimoto, M; Uotani, T; Yamade, M | 1 |
| Kulik Kunz, EM; Lenkeit, K; Walter, C; Waltimo, T; Weiger, R | 1 |
| Brodsky, D; Glyatman, T; Nasser, O; On, A; Paritsky, M; Peretz, A; Segal, S | 1 |
| Faveri, M; Feres, M; Figueiredo, LC; Mendes, JA; Silva, MP; Soares, GM; Socransky, SS; Teles, R; Wang, X | 1 |
| Löbenberg, R; Stuart, AV; Zuo, J | 1 |
| Bou-Chacra, N; Gao, Y; Löbenberg, R; Zuo, J | 1 |
| Kanfer, I; Löbenberg, R; Patnala, S; Reddy, NH | 1 |
| Jeon, HK; Kim, GH | 1 |
| Ahn, JY; Choi, KD; Choi, KS; Gong, EJ; Jung, HY; Kim, DH; Kim, JH; Lee, GH; Lee, JH; Lim, H; Song, HJ; Yun, SC | 1 |
| Akcay, M; Arslan, H; Kavrık, F; Yasa, B; Yasa, E | 1 |
| Barrett, K; Corcoran, M; Inglis, S; Martin, P; Pierce, D; Preston, P; Thompson, TN; Willsie, SK | 1 |
| Fakharian, T; Ghanei, H; Hosseini, SM; Nazemian, F; Sharifipoor, F; Zivarifar, HR | 1 |
| Ameerally, PJ; Farmahan, S; Tuopar, D | 1 |
| Ameerally, PJ; Farmahan, S; Kotecha, R; Sisodia, B; Tuopar, D | 1 |
| Kato, M | 1 |
| Harada, N; Hosoda, Y; Inoue, S; Katayama, S; Kimura, T; Kuwai, T; Maekawa, T; Masuda, E; Miyabayashi, H; Nishizawa, T; Nishizawa, Y; Ohta, H; Saito, H; Suzuki, H; Takahashi, M; Toyokawa, T; Watanabe, N; Yamashita, H; Yoshinaga, M; Yoshio, T | 1 |
| Bastos, MF; Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Miranda, TS; Perez-Chaparro, PJ; Tamashiro, NS | 1 |
| Hwang, JH; Jang, ES; Jeoung, SH; Jung, HC; Kang, KK; Kim, JW; Kim, N; Lee, DH; Oh, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Kolho, KL; Ledder, O; Levine, A; Shaoul, R; Turner, D | 1 |
| Akdoğan, RA; Bedir, R; Copur, A; Rakici, H; Yilmaz, A | 1 |
| Jung, HC; Kim, JM; Kim, JY; Kim, N; Lee, DH; Lee, JW; Lee, JY; Nam, RH | 1 |
| Lundborg, CS; Marrone, G; Tanwir, F; Tariq, A | 1 |
| Degener, JE; Hawley, CE; Rams, TE; van Winkelhoff, AJ; Whitaker, EJ | 1 |
| Jo, HJ; Kim, N; Lee, DH; Lee, ST; Lim, JH; Park, YS; Shin, CM; Song, IS | 1 |
| Abdulrahman, GO; Gateley, CA | 1 |
| Degener, JE; Feik, D; Mortensen, JE; Rams, TE; van Winkelhoff, AJ | 1 |
| Cho, KB; Ha, CY; Heo, J; Jang, BI; Jeon, SW; Jung, JT; Kim, ES; Kim, EY; Kim, HJ; Kwon, JG; Lee, DW; Lee, SH; Park, KS; Seo, HE | 1 |
| Griffiths, GS; Guerrero, A; Lambertenghi, R; Nibali, L; Ready, D; Suvan, J; Tonetti, MS; Wilson, M | 1 |
| de Boer, EM; de Boer, WA; Schneeberger, PM | 1 |
| Akyon, Y; Bayrak, A; Celikel, C; Ertem, D; Kutluk, G; Tutar, E; Volkan, B | 1 |
| Aukhil, I; Bidwell, J; Harrison, P; Hovencamp, N; Kalash, D; Merchant, SN; Shaddox, LM; Varnado, P; Vovk, A; Zapert, E | 1 |
| Gillam, DG; Turner, W | 1 |
| Kwok, J; O'Connell, S; Yeaton, K | 1 |
| Cho, Y; Chung, KH; Hwang, JH; Jeong, SH; Jin, E; Kim, JW; Kim, N; Lee, DH; Seo, JY; Shin, CM | 1 |
| Lv, ZF; Wang, B; Wang, H; Wang, YH; Xie, Y; Xiong, HF; Yang, Y | 1 |
| Delgado, M; Eizaguirre, FJ; Fernández-Reyes, M; Montes, M; Muñoz-Seca, IM; Pérez-Trallero, E; Villalon, FN | 1 |
| Almaghlouth, A; Cionca, N; Courvoisier, DS; Giannopoulou, C; Mombelli, A | 1 |
| Chung, JW; Kim, KO; Kim, SY; Kim, YJ; Kwon, KA; Park, DK | 1 |
| Hong, SN; Kim, JJ; Lee, H; Lee, JH; Lee, YC; Min, BH; Rhee, PL | 1 |
| Chan, HH; Cheng, JS; Hsu, PI; Kao, SS; Lai, KH; Peng, NJ; Tsai, TJ; Tsai, WL; Tsay, FW; Tseng, HH; Wang, HM; Wu, DC | 1 |
| Coucke, W; Grosjean, I; Keestra, JA; Quirynen, M; Teughels, W | 1 |
| Dziedzic, A; Wojtyczka, RD | 1 |
| Held, U; Kolakovic, M; Sahrmann, P; Schmidlin, PR | 1 |
| Akcay, M; Arslan, H; Çakir, M; Dalli, M; Gok, A; Yasa, B | 1 |
| Dlugosz, J; Dzierzanowska, D; Dzierzanowska-Fangrat, K; Gosciniak, G; Iwanczak, B; Iwanczak, F; Laszewicz, W; Rozynek, M | 1 |
| Cheung, DY; Chung, WC; Jun, EJ; Kim, BW; Kim, JI; Kim, SS; Lee, HJ; Lee, JS; Oh, JH | 1 |
| Ang, D; Ang, TL; Dhamodaran, S; Fock, KM; Kwek, AB; Ong, J; Song, M; Tan, J; Teo, EK | 1 |
| Esfahani, HM; Kargosha, K; Rashvand, M; Salemi, A; Vosough, M | 1 |
| An, YB; Li, Y; Lu, RF; Meng, HX; Song, WL; Wang, XE; Xu, L | 1 |
| Al-Adhba, HS; Ben Chaabane, N | 1 |
| Feres, M; Martin, L; Patel, M; Soares, GM; Starr, JR; Teles, F; Teles, R | 1 |
| Angueira, T; Ariño, I; Balboa, A; Barrio, J; Bermejo, F; Botargues-Bote, JM; Gisbert, JP; Gomez-Camarero, J; Gomez-Rodriguez, BJ; Herranz-Bachiller, MT; Huerta, A; Lucendo, AJ; Martin-Noguerol, E; McNicholl, AG; Modolell, I; Molina-Infante, J; O'Morain, C; Perez-Aisa, A; Rodriguez-Tellez, M | 1 |
| Kotsiubniak, LA; Koval', VIu; Moskal', OM | 1 |
| Andrianov, M; Azzam, R; Rivera, E | 1 |
| BaniŢă, IM; Bătăiosu, M; Dăguci, C; Dăguci, L; Pascu, EI; Pisoschi, CG; Taisescu, CI; Ţuculină, MJ | 1 |
| Cho, KB; Heo, J; Jang, BI; Jeon, SW; Jung, JT; Kim, HS; Kwon, JG; Lee, DW; Lee, SH; Park, JB; Park, KS; Yang, CH | 1 |
| Kim, BW; Kim, JS; Park, SM | 1 |
| Cao, Z; Chen, Q; Liang, X; Liao, J; Liu, W; Lu, H; Xiao, S; Zhang, W | 1 |
| Aktaş, B; Başyiğit, S; Kefeli, A; Nazlıgül, Y; Uzman, M; Yeniova, AÖ | 1 |
| Akkan, T; Aktaş, B; Atbaşı, ST; Başyiğit, S; Nazlıgül, Y; Şimşek, G; Uzman, M; Yılmaz, B; Yüksel, O | 1 |
| Hauser, G; JajacKnez, A; Salkic, N; Stimac, D; Vukelic, K | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Lee, JY; Lin, JT; Liou, JM; Liou, TC; Luo, JC; Sheu, BS; Tseng, CH; Wang, HP; Wu, CY; Wu, JY; Wu, MS; Yang, TH | 1 |
| Adyani-Fard, S; Beikler, T; Flemmig, TF; Klocke, A; Neering, SH; Rüttermann, S | 1 |
| Azodo, CC; Ojehanon, PI | 1 |
| Roy, BK; Shukla, HS; Srivastava, AK; Tewari, M | 1 |
| Arweiler, NB; Dolinska, E; Dymicka, V; Kemona, H; Milewsk, R; Pietruska, M; Pietruski, JK; Sculean, A; Skurska, A | 1 |
| Abdel-Hay, MH; Belal, TS; Mahgoub, AA; Sabry, SM | 1 |
| Gurgan, CA; Guzeldemir-Akcakanat, E | 1 |
| Cirano, FR; Pimentel, SP; Ribeiro, FV; Siqueira, SJ; Villalpando, KT | 1 |
| Altun, B; Ozturk, K | 1 |
| Chambrone, L; Faveri, M; Feres, M; Figueiredo, LC; Gonçalves, C; Rabelo, CC; Tu, YK | 1 |
| Bair, MJ; Hsu, PI; Hsu, WH; Hu, CT; Hu, HM; Jheng, GH; Kuo, CH; Kuo, FC; Liu, CJ; Shih, HY; Wu, DC; Wu, IC; Wu, MC | 1 |
| Chiou, SS; Chiu, CH; Chiu, YC; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, KL; Yen, YH | 1 |
| Nejat, M; Werno, A | 1 |
| Dechsukhum, C; Kaewpitoon, N; Kaewpitoon, S; Leeanansaksiri, W; Loyd, RA; Matrakool, L; Panpimanmas, S; Tongtawee, T | 1 |
| Grgov, S; Katić, V; Krstić, M; Nagorni, A; Radovanović-Dinić, B; Tasić, T | 1 |
| Doering, S; Ehmke, B; Eickholz, P; Gravemeier, M; Harks, I; Harmsen, D; Hoffmann, T; Holtfreter, B; Kaner, D; Kim, TS; Koch, R; Kocher, T; Meyle, J; Schlagenhauf, U | 1 |
| Annibale, B; Calabrese, C; Caselli, M; Di Mario, F; Farinati, F; Gasbarrini, G; Gullini, S; Ierardi, E; Luzza, F; Maconi, G; Ojetti, V; Pretolani, S; Romano, M; Rugge, M; Savio, A; Stockbrugger, R; Zagari, RM | 1 |
| Colombo, AP; do Souto, RM; Feres-Filho, EJ; Heller, D; Lourenço, TG; Silva-Senem, MX; Torres, MC; Varela, VM | 1 |
| Brennan, DE; Breslin, N; Haider, RB; Hall, B; Holleran, G; McNamara, D; O'Connor, HJ; O'Morain, C; Omorogbe, J; Smith, SM | 1 |
| Guo, B; Li, BZ; Li, P; Mao, C; Threapleton, DE; Wang, JY; Xu, JM; Ye, DQ; Ye, QL; Yuan, JQ; Zhang, C | 1 |
| Braden, B | 1 |
| Kosar, S; Ors, CH; Ozisik Karaman, HI; Ozkan, A | 1 |
| Akhtar, N; Asif, HM; Sugiyama, T; Usmanghani, K; Zaidi, SF | 1 |
| Belzer, C; de Vos, WM; den Dunnen, JT; Devilee, P; Dingemanse, C; Günthel, M; Kuijper, EJ; Robanus-Maandag, EC; Salvatori, D; van Hijum, SA; van Ommen, GB | 1 |
| Chen, Q; Graham, DY; Liang, X; Liu, W; Lu, H; Xiao, S; Zhang, W | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chang, WH; Chen, CC; Chen, MJ; Fang, YJ; Hsieh, CF; Hsu, YC; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Liou, TC; Liu, TY; Luo, JC; Shun, CT; Tsao, FY; Tseng, CH; Wu, JY; Wu, MS; Yang, TH | 1 |
| Casarin, RC; Casati, MZ; Nociti Júnior, FH; Ribeiro, Édel P; Sallum, EA; Taiete, T | 1 |
| Hwang, JH; Jang, ES; Jeong, SH; Kim, J; Kim, JW; Kim, N; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Chen, KY; Lee, HC; Lin, CL; Lin, TJ; Wang, CK; Wu, DC | 1 |
| Alexandrakis, G; Apostolopoulos, P; Dogantzis, P; Ekmektzoglou, K; Kalantzis, C; Koumoutsos, I; Tsibouris, P; Vlachou, E | 1 |
| Anssari Moin, D; Jepsen, K; Jepsen, S; Laine, ML; Ortiz-Vigon, A; Pilloni, A; Renvert, S; Roos-Jansåker, AM; Sanz, M; Zeza, B | 1 |
| Choi, YJ; Kim, N; Kwon, YH; Lee, DH; Lee, JW; Lee, JY; Nam, RH; Suh, JH; Yoon, K | 1 |
| Boyanova, L; Evstatiev, I; Gergova, G; Mitov, I; Yaneva, P | 1 |
| Chiang, YS; Chien, CC; Chiou, SS; Chou, YP; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, IT; Yang, SC; Yen, YH | 1 |
| Agarwal, K; Agrawal, N; Jain, V; Kallury, A; Khurana, R | 1 |
| Cerqueira, RM; Correia, MR; Manso, MC; Vilar, H | 1 |
| Hawke, KL; McGuire, TM; Ranmuthugala, G; van Driel, ML | 1 |
| Ahmed, MR; Mel-Hennawi, D | 1 |
| Al Kaabi, S; Babu, R; Chandra, P; Derbala, M; Doiphode, S; John, A; Sharma, M; Yacoub, R | 1 |
| Andrzejewska, E; Eder, P; Karpiński, TM; Linke, K; Szkaradkiewicz, A | 1 |
| Cataldi, V; Cellini, L; Ciccaglione, AF; Di Bartolomeo, S; Di Campli, E; Di Giulio, M; Grossi, L; Marzio, L; Nostro, A | 1 |
| Almaghlouth, A; Cancela, J; Cionca, N; Courvoisier, DS; Giannopoulou, C; Mombelli, A | 2 |
| Asilturk, Z; Basyigit, S; Hokkaomeroglu, M; Kefeli, A; Nazligul, Y; Sapmaz, F; Uzman, M; Yeniova, AO | 1 |
| Chen, A; Chen, WC; Cheng, JS; Chuah, SK; Hsu, PI; Kao, SS; Lai, KH; Peng, NJ; Tsay, FW; Wang, HM; Wu, DC; Yu, HC | 1 |
| Almaghlouth, A; Cherkaoui, A; Cionca, N; Giannopoulou, C; Mombelli, A; Schrenzel, J | 1 |
| Buchmann, A; Eick, S; Friedrich, A; Jentsch, HF | 1 |
| Berchová, K; Hassan, ST; Majerová, M; Pokorná, M; Švajdlenka, E | 1 |
| Aslan, M; Basyigit, S; Kefeli, A; Kefeli, TT; Tanas, O; Yeniova, AO | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chang, WH; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Fang, YJ; Hsu, WF; Hung, HW; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Tseng, CH; Wu, JY; Wu, MS; Yang, TH | 1 |
| Firth, M; Rincon, J; Saleh, A; Tan, A | 1 |
| Bai, P; He, L; Song, Z; Xue, Y; Zhang, J; Zhou, L | 1 |
| Niv, Y | 1 |
| Forte, A; Jeverica, S; Šeruga, M; Stefanovič, M; Tepeš, B; Vujasinović, M | 1 |
| Ji, C; Kong, C; Liu, G; Meng, X; Wu, J; Yang, L; Zhao, L; Zhu, X | 1 |
| Bao, ZY; He, C; Lin, Q; Meng, YH; Peng, X; Su, JZ | 1 |
| Arnold, CA; Coss, E; Cryer, B; Doern, CD; Dunbar, KB; Lam-Himlin, DM; Mitui, M; Okwara, C; Park, JY; Thung, I; Valasek, MA | 1 |
| Niederman, R; Slot, DE; Van der Weijden, FA; Zandbergen, D | 1 |
| Asaka, M; Funao, N; Murakami, K; Nishimura, A; Sakurai, Y; Shiino, M | 1 |
| Han, F; Ji, Z; Meng, F; Tu, M; Yang, N; Zhang, J | 1 |
| Fukayama, M; Hayakawa, Y; Hirata, Y; Koike, K; Niikura, R; Shichijo, S; Ushiku, T; Yamada, A | 1 |
| Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Maciel, SS; Miranda, TS; Tamashiro, NS | 1 |
| Arweiler, N; Cosgarea, R; Heumann, C; Juncar, R; Lascu, L; Sculean, A; Stavropoulos, A; Tristiu, R | 1 |
| Dore, MP; Graham, DY | 1 |
| Amorena, E; Campillo, A; Kutz, M; LaIglesia, M; Ostiz, M | 1 |
| Chiba, N; Fallone, CA; Fischbach, L; Gisbert, JP; Hunt, RH; Jones, NL; Leontiadis, GI; Marshall, JK; Moayyedi, P; Render, C; van Zanten, SV | 1 |
| Baik, GH; Hong, SJ; Kim, BW; Kim, JH; Kim, JI; Kim, JS; Kim, SW; Shim, KN; Song, HJ | 1 |
| Georgopoulos, SD; Grivas, E; Kasapidis, P; Laoudi, F; Martinez-Gonzales, B; Mentis, A; Michopoulos, S; Petraki, K; Sgouras, D; Sotiropoulou, M; Spiliadi, C; Xirouchakis, E; Zampeli, E; Zografos, K | 1 |
| Bizzarro, S; Loos, BG; Van der Velden, U | 1 |
| Chang, KC; Chiou, SS; Chiu, YC; Chou, YP; Chuah, SK; Hu, ML; Hu, TH; Kuo, CH; Kuo, CM; Lee, CH; Liang, CM; Lu, LS; Tai, WC; Wu, KL | 1 |
| Boudebesse, C; Etain, B; Henry, C; Legendre, T | 1 |
| Andoh, A; Ban, H; Furuta, T; Ichikawa, H; Kagami, T; Otsuka, T; Sahara, S; Sugimoto, M | 1 |
| Bhanthumkomol, P; Chonprasertsuk, S; Mahachai, V; Phiphatpatthamaamphan, K; Pornthisarn, B; Siramolpiwat, S; Tangaroonsanti, A; Vilaichone, RK | 1 |
| Fukuda, Y; Kamiya, S; Kato, M; Kikuchi, S; Mabe, K; Okuda, M; Osaki, T | 1 |
| Ida, A; Miyaki, A; Miyauchi, T; Yamaguchi, K | 1 |
| Ahmed, W; Arif, A; Bibi, S; Khan, A; Siddiqui, TR | 1 |
| Hsu, TH; Huang, KW; Lin, LC; Tam, KW | 1 |
| Baylina, M; Calvet, X; Cohen, H; Dacoll, C; García-Iglesias, P; Gisbert, JP; López-Gongora, S; Muñoz, N; Puig, I; Sánchez-Delgado, J; Suarez, D | 1 |
| Amorena, E; Campillo, A; Kutz, M; La Iglesia, M; Ostiz, M | 1 |
| Doering, S; Ehmke, B; Eickholz, P; Gravemeier, M; Harks, I; Hoffmann, T; Kaner, D; Kim, TS; Koch, R; Kocher, T; Meyle, J; Nickles, K; Schlagenhauf, U | 1 |
| Hasegawa, S; Nakamura, K; Nishimura, A; Okamoto, H; Sakurai, Y; Shiino, M | 1 |
| Cutović, T; Daković, D; Dukić, S; Matijević, S | 1 |
| Choi, H; Ji, JS; Kim, BW; Kim, JS; Park, SM | 1 |
| Hayakawa, Y; Hirata, Y; Koike, K; Sakitani, K; Serizawa, T; Shichijo, S; Suzuki, N; Yamada, A | 1 |
| Abuhammour, A; Dajani, A; Nounou, M; Zakaria, M | 1 |
| Chen, Q; Fu, Q; Liang, X; Liu, W; Lu, H; Xiao, S; Zhang, W | 1 |
| Canet, E; Donay, JL; Kerhuel, L; Valade, S | 1 |
| Adetoye, JO; Dipo-Fagbemi, IM; Ebigwei, S; Gbotolorun, OM; Olojede, AO | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Hu, WH; Lee, JY; Lee, YC; Lin, JT; Liou, JM; Luo, JC; Sheu, BS; Shun, CT; Tseng, CH; Wu, JY; Wu, MS; Yang, TH | 1 |
| Barone, M; Di Leo, A; Giorgio, F; Iannone, A; Ierardi, E; Losurdo, G; Principi, M | 1 |
| Kajihara, Y; Mizuki, I; Shimoyama, T | 1 |
| Miftahussurur, M; Sharma, RP; Shrestha, PK; Subsomwong, P; Yamaoka, Y | 1 |
| Haga, K; Hiramatsu, K; Ishikawa, D; Kuwahara-Arai, K; Osada, T; Sasaki, T; Shibuya, T; Watanabe, S | 1 |
| Cruz-Correa, M; López-Román, O; Tirado Montijo, R; Toro, DH; Urbina, R; Warrington, E | 1 |
| Lin, JT; Liou, JM; Wu, MS | 1 |
| Adi, P; Akada, J; Akil, F; Maimunah, U; Makmun, D; Maulahela, H; Miftahussurur, M; Mustika, S; Nusi, IA; Rahardjo, D; Rezkitha, YA; Saudale, AM; Simanjuntak, D; Subsomwong, P; Suzuki, R; Syam, AF; Uwan, WB; Waleleng, JB; Waskito, LA; Wibawa, ID; Yamaoka, Y; Yusuf, F; Zein, LH | 1 |
| Dahlen, G; Preus, HR | 1 |
| Akbay Harmandar, F; Çekin, AH; Çekin, Y; Şahintürk, Y; Uyar, S; Yolcular, BO | 1 |
| Eguchi, T; Fujita, M; Fukuchi, T; Hashimura, H; Kanamori, A; Kano, C; Koizumi, A; Matsumoto, K; Momose, K; Okada, A; Shimoyama, K; Tsujimae, M; Yamashita, H | 1 |
| Chey, WD; Howden, CW; Leontiadis, GI; Moss, SF | 1 |
| Chang, JY; Jung, HK; Jung, SA; Kim, SE; Lee, J; Lee, KE; Lee, KH; Moon, CM; Shim, KN; Tae, CH | 1 |
| Almeida, N; Branquinho, D; Cabral, JE; Casela, A; Donato, MM; Gregório, C; Tomé, L | 1 |
| Dolińska, E; Dymicka-Piekarska, V; Milewski, R; Pietruska, M; Pietruski, J; Sculean, A; Skurska, A | 1 |
| Hasuda, K; Hattori, M; Ido, Y; Okuda, A; Sakurai, K; Suda, H; Takeichi, T | 1 |
| Oh, TJ | 1 |
| Chang, WL; Chen, WY; Cheng, HC; Lin, CH; Lu, CC; Ou, HY; Sheu, BS; Wu, CT; Yang, HB; Yang, YJ | 1 |
| Attaran, B; Falsafi, T; Ghorbanmehr, N | 1 |
| Borges, I; Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Montenegro, SCL; Retamal-Valdes, B | 1 |
| de Albera, ER; Menso, J; Sembaj, A; Tabares, SM; Usin, MM | 1 |
| Fattahi, G; Safarnejad, S; Shafahi Tilaki, S; Talebi Bezmin Abadi, A | 1 |
| Hu, Y; Lu, NH; Zhu, Y | 2 |
| Akay, S; Akpinar, Z; Unsal, B | 1 |
| Boal Carvalho, P; Cotter, J; Dias de Castro, F; Magalhães, J; Rosa, B | 1 |
| Astegiano, M; Pellicano, R; Ribaldone, DG; Saracco, G | 1 |
| Colak, Y; Doganay, L; Ozdil, K; Ozturk, O; Tuncer, I; Ulasoglu, C; Yilmaz Enc, F | 1 |
| Arweiler, NB; Cosgarea, R; Heumann, C; Juncar, R; Lascu, L; Salvi, GE; Sculean, A; Tristiu, R | 1 |
| Ando, K; Fujinaga, A; Fujiya, M; Goto, M; Ichiishi, E; Ito, T; Kashima, S; Kawamoto, T; Kohgo, Y; Moriichi, K; Nomura, Y; Okumura, T; Otake, T; Sato, K; Sato, T; Sugano, H; Tanabe, H; Ueno, N; Utsumi, T; Yanagawa, N | 1 |
| Alarcón, T; Alba, C; Blanco, A | 1 |
| Chowers, Y; Geffen, Y; Khoury, J; Saadi, T; Shaul, R; Sholy, H | 1 |
| Ang, TL; Aung, MM; Chakravuth, O; Chotivitayatarakorn, P; Fock, KM; Goh, KL; Graham, D; Harnsomburana, P; Kositchaiwat, C; Lee, YC; Leelakusolvong, S; Leow, A; Mahachai, V; Mairiang, P; Maneerattanaporn, M; Mya, SM; Pisespongsa, P; Pittayanon, R; Rani, A; Rasachak, B; Rojborwonwitaya, J; Sansak, I; Sollano, JD; Sugano, K; Syam, AF; Treeprasertsuk, S; Trong Quach, D; Vannarath, S; Vilaichone, RK; Wiwattanachang, O; Yamaoka, Y | 1 |
| Das, R; El-Omar, EM; Goh, KL; Kuo, YT; Leow, AHR; Lin, JT; Liou, JM; Lu, H; Tu, YK; Wu, JY; Wu, MS; Yamaoka, Y | 1 |
| Fujibayashi, S; Fujiya, M; Goto, T; Kashima, S; Moriichi, K; Nomura, Y; Okumura, T; Sakatani, A; Sasajima, J; Tanaka, K; Ueno, N | 1 |
| Chen, WC; Cheng, JS; Hsu, PI; Kao, SS; Lin, KH; Sun, WC; Tsai, KW; Tsay, FW; Wang, HM; Wu, DC; Yu, HC | 1 |
| Aukhil, I; Burgess, DK; Harrison, P; Huang, H; Kompotiati, T; Shaddox, LM | 1 |
| Choi, YJ; Kang, JB; Kim, N; Kwon, S; Lee, DH; Park, YS; Shin, CM; Yoon, H | 1 |
| Alves, MLF; Cláudio, MM; Duque, C; Garcia, VG; Lopes, AB; Miessi, DMJ; Mombelli, A; Nuernberg, MAA; Theodoro, LH | 1 |
| Avila-Campos, MJ; Chukwu, EE; Coker, AO; Nwaokorie, FO; Ogunsola, FT | 1 |
| Algaba, A; Barrio, J; Calvet, X; Castro, M; Gisbert, JP; González-Santiago, JM; Herranz, MT; Molina-Infante, J; Puig, I | 1 |
| Costa, S; Gonçalves, R; Soares, JB | 1 |
| Ivanovski, S; McGowan, K; McGowan, T | 1 |
| Azrad, M; Brodsky, D; Isakovich, N; On, A; Pastukh, N; Peretz, A | 1 |
| Chiba, D; Chinda, D; Fukuda, S; Kikuchi, H; Mikami, T; Nakagawa, S; Nakamura, M; Sawaya, M; Shimoyama, T | 1 |
| Göktaş, Z; Kahramanoğlu Aksoy, E; Nazlıgül, Y; Pirinçci Sapmaz, F; Uzman, M | 1 |
| Ba-Thein, W; Pan, H | 1 |
| Choi, IJ; Kim, BJ; Kim, JG; Kim, JI; Kim, JJ; Kim, SG; Lee, H; Lee, YC | 1 |
| Cho, IK; Jung, JH; Lee, CH; Lim, JH; Song, GG | 1 |
| Chen, Q; Li, H; Liang, X; Lu, H; Zhang, W | 1 |
| Brignardello-Petersen, R | 1 |
| Adachi, T; Asakuma, Y; Kamata, K; Kashida, H; Komeda, Y; Kono, M; Kudo, M; Matsui, S; Minaga, K; Nagai, T; Nishida, N; Okamoto, A; Okamoto, K; Sakurai, T; Takenaka, M; Watanabe, T; Yamada, M; Yamao, K | 1 |
| Morgando, A; Younes, R | 1 |
| Choe, JW; Hyun, JJ; Jung, SW; Jung, YK; Kim, SY; Koo, JS; Lee, SW; Yim, HJ | 1 |
| Fiorini, G; Gatta, L; Pavoni, M; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Chambrone, L; Ganhito, JA; Holzhausen, M; Pannuti, CM; Rovai, ES; Souto, MLS | 1 |
| Belsey, J; Fiorini, G; Gatta, L; Ricci, C; Saracino, IM; Scarpignato, C; Vaira, D | 1 |
| de Figueiredo, LC; de Franco Rodrigues, M; Duarte, PM; Faustino, E; Faveri, M; Feres, M; Fritoli, A; Giudicissi, M; Mestnik, MJ; Nogueira, BCL; Pannuti, CM; Retamal-Valdes, B; Romito, GA; Saraiva, L; Souto, MLS | 1 |
| Chen, Y; Du, Y; Li, Y; Liu, D; Lv, N; Pan, X; Wang, H; Wang, J; Wu, K; Xie, Y; Xu, J; Zeng, Z; Zhang, G | 1 |
| Amagai, K; Asaka, M; Kato, M; Kikuchi, S; Mabe, K; Okuda, M; Sakamoto, N; Yoshimura, R | 1 |
| Alves, MLF; Assem, NZ; Duque, C; Garcia, VG; Longo, M; Stipp, RN; Theodoro, LH; Vizoto, NL | 1 |
| Çakici, F; Fundaoğlu Küçükekenci, F; Küçükekenci, AS | 1 |
| Ehmke, B; Eickholz, P; Hagenfeld, D; Harks, I; Harmsen, D; Hoffmann, T; Jünemann, S; Kaner, D; Kim, TS; Koch, R; Kocher, T; Meyle, J; Prior, K; Schlagenhauf, U | 1 |
| Carli, T; Kaliterna, N; Pintar, T | 1 |
| Aldrovandi, GM; Cunningham, NJ; Kordy, K; Lee, DJ; Li, F; Romeo, AC; Saavedra, M; Tobin, N; Zabih, S | 1 |
| Al-Tannak, N; da Silva Neto, MJJ; Kathriarachchi, UL; Thomson, AH; Vidhate, SS; Watson, DG | 1 |
| de Lira, E; Faveri, M; Feres, M; Figueiredo, LC; Ramiro, FS; Retamal-Valdes, B; Soares, G | 1 |
| Baghbanian, M; Mirvakili, M; Salmanroghani, H; Salmanroghani, R; Sanati, G; Yazdian, P | 1 |
| An, Z; Bie, M; Huang, H; Tang, C; Wan, L; Wang, B; Zhou, Y | 1 |
| Robotis, J; Rokkas, T; Tsiodras, S | 1 |
| Bair, MJ; Chang, CC; Chang, CY; Chen, CC; Chen, MJ; Chen, PY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Luo, JC; Shun, CT; Wu, MS; Yang, TH | 1 |
| Jeffery, N | 1 |
| Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Miranda, TS; Retamal-Valdes, B; Soares, GMS; Yassine, LLS | 1 |
| Wang, JC | 1 |
| Gonçalves, JP; Lima, R; Nascimento, J; Pereira, F; Silva, GM; Silva, HM | 1 |
| Jones, L; Kelsburg, G; Safranek, S; Ta, J | 1 |
| Cai, T; Tang, D; Wang, F; Yao, Y; Yuan, L; Yue, C | 1 |
| Haga, K; Hiramatsu, K; Ishikawa, D; Ito, S; Kuwahara-Arai, K; Nagahara, A; Nakajima, A; Okahara, K; Osada, T; Sasaki, T; Shibuya, T; Takahashi, M; Watanabe, S | 1 |
| Aldeguer, X; Badiola, C; Calafat, M; Calleja, JL; Callejo, Á; Comino, L; Gisbert, JP; Lucendo, AJ; McNicholl, AG; Modolell, I; Molina-Infante, J; Pérez-Aisa, Á; Ramas, M; Serra, J | 1 |
| Irie, K; Kaneko, H; Kondo, M; Maeda, S; Sasaki, T; Shibata, W; Sue, S | 1 |
| Bayingana, C; Dusabejambo, V; Hale, D; Hategeka, C; Kabakambira, JD; Ndoli, J; Ngabonziza, F; Ntirenganya, C; Page, C; Walker, T | 1 |
| Chen, CC; Chen, MJ; Chen, YN; Fang, YJ; Lin, JT; Liou, JM; Wu, MS | 1 |
| Malekzadeh, R; Saniee, P; Siavoshi, F | 1 |
| Ennkaa, A; Mohammad, RM; Salam, A; Shaath, N | 1 |
| Alimov, A; Dekhnich, N; Ivanchik, N; Kirsov, P; Kozlov, R; Pandav, K; Steshits, A | 1 |
| Baik, GH; Bang, CS; Choi, JH; Hong, JT; Kang, HS; Kim, DJ; Lee, JJ; Lim, H; Shin, SP; Shin, WG; Soh, JS; Suk, KT; Yang, YJ | 1 |
| Albuquerque-Souza, E; Giudicissi, M; Mayer, MPA; Paulino da Silva, M; Rebeis, ES; Saraiva, L | 1 |
| Bird, L; Landes, D; Ling, J; Ojelabi, A; Robson, T; Sturrock, A | 1 |
| Bizzarri, B; De' Angelis, GL; Di Mario, F; Gaiani, F; Iuliano, S; Kayali, S; Leandro, G; Manfredi, M; Minelli, R | 1 |
| Aral, CA; Aral, K; Kapila, Y | 1 |
| Liaw, A; Miller, C; Nimmo, A | 2 |
| Kim, JG; Park, JY | 1 |
| Albuquerque-Souza, E; César-Neto, JB; Holzhausen, M; Martins, ES; Mayer, MPA; Pannuti, CM; Rebeis, ES; Saraiva, L | 1 |
| Heo, JJ; Jung, K; Kim, JH; Kim, SE; Moon, W; Park, MI; Park, SJ; Roh, JH | 1 |
| Benkirane, A; Berrag, S; Berraida, R; Boutallaka, H; Elkoti, I; Loubaris, K; Nejjari, F; Seddik, H; Sentissi, S | 1 |
| Andreev, DN; Dicheva, DT; Maiev, IV; Partzvania-Vinogradova, EV; Yurenev, GL | 1 |
| Fukuba, N; Ishitobi, H; Kinoshita, Y; Kobayashi, Y; Komazawa, Y; Kusunoki, M; Nagaoka, M; Shizuku, T; Takahashi, Y; Yuki, M | 1 |
| Chu, CH; Liao, PH; Lin, YC; Liou, TC; Shih, SC | 1 |
| Fu, CC; Juang, RS; Tran, ML | 1 |
| Ehmke, B; Eickholz, P; Harks, I; Harmsen, D; Hoffmann, T; Kaner, D; Kim, TS; Koch, R; Kocher, T; Meyle, J; Schlagenhauf, U | 1 |
| Kim, N; Yoon, K | 1 |
| De Francesco, V | 1 |
| Huck, O; Martín-Cabezas, R | 1 |
| Cholleti, SM; Jodesty, Y; Li, D; Pham, HV; Tseng, DS; Wei, JC | 1 |
| Arce, RM; Cutler, CW; El-Awady, AR; Elashiry, M; Looney, S; Meghil, MM; Rajendran, M; Singh, N; Susin, C; Tawfik, O | 1 |
| Jeon, SW; Kwon, YH; Lee, HS; Nam, SY; Park, JH | 1 |
| Baylina, M; Calvet, X; López-Góngora, S; Muñoz, N; Puig, I; Sánchez-Delgado, J | 1 |
| Abe, Y; Hirashima, H; Kobayashi, Y; Koyanagi, R; Lefor, AK; Nabeta, H; Nakamichi, T; Shinozaki, S | 1 |
| Fallone, CA; Malfertheiner, P; Moss, SF | 1 |
| Chen, Q; Chen, Y; Gao, H; Graham, DY; Ji, Y; Li, D; Liang, X; Liu, M; Liu, W; Long, X; Lu, H; Song, Y; Sun, Y; Xu, B; Xu, G; Yu, L; Zhang, W; Zhao, Y | 1 |
| Hojo, F; Kamiya, S; Osaki, T; Yonezawa, H | 1 |
| Ahn, JY; Baik, GH; Cheung, DY; Cho, SJ; Choi, KD; Choi, YJ; Chung, JW; Jung, HK; Jung, HY; Kim, BW; Kim, JH; Kim, JJ; Kim, JM; Kim, SY; Lee, H; Lee, JH; Lee, SH; Lee, WS; Min, YW; Park, JC; Shin, CM; Sung, JK | 1 |
| Bertoni, DM; Brownson, KE; Cohen, PJ; Lannin, DR; Pronovost, MT | 1 |
| Jacqz-Aigrain, E; Leroux, S; Magréault, S; Storme, T; Touati, J | 1 |
| Donos, N; Hamborg, T; Koidou, VP; Nibali, L | 1 |
| Andere, NMRB; Araujo, CF; Casarin, RCV; Castro Dos Santos, NC; de Oliveira, LD; Jardini, MAN; Mathias-Santamaria, IF; Reis, AA; Santamaria, MP | 1 |
| Baddour, LM; Dayer, MJ; Durkin, MJ; Lockhart, PB; Thornhill, MH | 1 |
| de Andrés, E; Gómez Hernando, C; Gómez Rodríguez, R; Muñoz Gómez, P; Sierra Bernal, C; Valle Muñoz, J | 1 |
| Attia, TZ; Derayea, SM; Tsujino, H; Tsutsumi, Y; Uno, T; Yamashita, T | 1 |
| Baik, GH; Choi, IJ; Jeon, SW; Kim, BJ; Kim, GH; Kim, HS; Kim, HU; Kim, J; Kim, JG; Kim, JI; Kim, JJ; Kim, SG; Kim, SW; Lee, DH; Lee, H; Lee, J; Lee, JY; Lee, YC; Park, MI; Sung, JK; Yoon, SM | 1 |
| Jha, P; Jha, SK; Mishra, MK; Purkayastha, S; Ranjan, R; Saharawat, K | 1 |
| Arévalo, A; Otero, WA; Trespalacios, AA | 1 |
| Bergenholtz, G; Hoon Yu, VS; Quah, SY; Rosa, V; Tan, EE; Tan, KS | 1 |
| Bair, MJ; Chang, CM; Chang, CY; Chen, CC; Chen, CY; Chen, MJ; Chen, PY; Chen, YN; Chuang, EY; El-Omar, EM; Fang, YJ; Hsu, WF; Hsu, YC; Lee, JY; Lin, JT; Liou, JM; Lu, TP; Luo, JC; Wu, JY; Wu, MS; Yang, TH | 1 |
| Faveri, M; Feres, M; Ferrari, DS; Figueiredo, LC; Shibli, JA; Siroma, RS | 1 |
| van der Weijden, GA | 1 |
| Bergonzi, M; Corazza, GR; Di Sabatino, A; Di Stefano, M; Figura, N; Pagani, E; Pesatori, EV | 1 |
| Apostolopoulos, P; Doulberis, M; Galanopoulos, M; Georgopoulos, SD; Giakoumis, M; Katsinelos, P; Kountouras, J; Kyriakos, N; Liatsos, C; Papadomichelakis, M; Papaefthymiou, A; Rokkas, T | 1 |
| Goss, A; Kaur, S; Sambrook, P | 1 |
| Balta, MG; Bizzarro, S; Buurma, KG; Faruque, MR; Liefferink, E; Loos, BG; Moonen, CG; Nicu, EA | 1 |
| Ahmed, F; Le Bihan, A; O'Driscoll, J | 1 |
| El-Makaky, Y; Shalaby, HK | 1 |
| Ezzat, SE; Farhoud, NS; Ibrahim, OM | 1 |
| Jin, Z; Li, Y; Lin, D; Lin, L; Meng, F; Pan, J; Shi, Z; Wu, J; Yang, N; Zhang, J; Zhou, Q | 1 |
| Bernardino, JI; Martín Carbonero, L; Montejano, R; Moreno, V; Serrano, L; Valencia, ME | 1 |
| Chen, WC; Chen, YH; Hsu, PI; Kao, SS; Lin, TF; Peng, NJ; Tsai, KW; Tsai, TJ; Tsay, FW; Wu, DC | 1 |
| Attin, T; Kaufmann, ME; Schmidlin, PR; Solderer, A; Wiedemeier, DB; Zellweger, U | 1 |
| Huang, Y; Jiang, Y; Tang, Z; Wang, Y; Yan, W; Ye, Z; Zhang, Y; Zhou, Y | 1 |
| Espinel-Bermudez, MC; Gómez-Sandoval, JR; Hernández-González, SO; Mariaud-Schmidt, R; Martínez-Rodríguez, V; Mercado-Sesma, AR; Morgado-Castillo, KC; Robles-Cervantes, JA | 1 |
| Feres, M; Herrera, D; Martín, C; Matesanz, P; Oud, V; Teughels, W | 1 |
| Graham, DY; Huang, Y; Ji, Y; Liang, X; Lu, H; Luo, L; Yu, L | 1 |
| Alexandrakis, G; Apostolopoulos, P; Chounta, E; Ekmektzoglou, K; Georgopoulos, S; Kalantzis, C; Theofanopoulou, A; Tsibouris, P; Vlachou, E | 1 |
| Fang, EH; Li, HJ; Tong, QS; Wang, JQ; Zheng, LD | 1 |
| Chen, YH; Hsu, PI; Kao, JY; Kao, SS; Kuo, CH; Peng, NJ; Shie, CB; Tsai, KW; Tsai, TJ; Tsay, FW; Wang, HM; Wu, DC | 1 |
| Cogdill, AG; Guevara, B | 1 |
| Baik, GH; Bang, CS; Choi, JH; Hong, JT; Jeong, HM; Kang, HS; Kim, DJ; Lee, JJ; Lim, H; Shin, SP; Shin, WG; Soh, JS; Suk, KT; Yang, YJ | 1 |
| Ando, T; Handa, O; Horie, R; Imamoto, E; Itoh, Y; Murakami, T; Ose, T; Sendo, R; Suzuki, N | 1 |
| Alshareef, A; Bach Dat, B; Duc, NT; Nam, NH; Ngoc, NM; Nguyen, JG; Reda, A; Thieu, H; Tien Huy, N | 1 |
| Aumpan, N; Mahachai, V; Ratanachu-Ek, T; Tshering, L; Uchida, T; Vilaichone, RK; Yamaoka, Y | 1 |
| Ehmke, B; Eickholz, P; Hagenfeld, D; Harks, I; Harmsen, D; Kaner, D; Kim, TS; Kocher, T; Lorenz, K; Matern, J; Meyle, J; Prior, K; Schlagenhauf, U | 1 |
| Ardila, CM; Bedoya-García, JA; Castañeda-Parra, LD; Flórez-Flórez, J; Guzmán, IC | 1 |
| Attin, T; Kaufmann, ME; Lenherr, P; Schmidlin, PR; Walter, C; Wiedemeier, DB | 1 |
| Bontems, P; Cabral, J; Casswall, T; Chong, S; Cilleruelo Pascual, ML; Cseh, Á; Dolinsek, J; Homan, M; Iwanczak, B; Kalach, N; Kindermann, A; Koletzko, S; Kori, M; Le Thi, TG; Lopes, AI; Martinez Gomez, MJ; Miele, E; Misak, Z; Oleastro, M; Papadopoulou, A; Pehlivanoglu, E; Rea, F; Rogalidou, M; Roma, E; Sustmann, A; Urbonas, V; Urruzuno, P; Werkstetter, K | 1 |
| Al-Haroni, M; Al-Mahdi, R; Dahlen, G; Malcolm, W; Palmer, N; Smith, A | 1 |
| Beer, A; Gruber, S; Hader, M; Hirschl, AM; Hudler, H; Hudler, S; Kain, R; Kundi, M; Makristathis, A; Schachner, H; Täuber, V | 1 |
| Eriksen, J; Kalyango, JN; Katureebe, A; Lanyero, H; Nanzigu, S; Obua, C; Ocan, M; Stålsby Lundborg, C | 1 |
| Chen, ZB; Feng, XH; Lu, RF; Meng, HX; Xu, L; Zhang, L | 1 |
| Antonelli, G; Borghi, C; Cavallo, R; Fiorini, G; Lazzarotto, T; Pavoni, M; Saccomanno, L; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Kiguchi, T; Kono, Y; Kusumoto, C; Okada, H | 1 |
| Merrell, DS; Windham, IH | 2 |
| Ardila, CM; Bedoya-García, JA; Hernández-Casas, C | 1 |
| Calvo, PL; Cisarò, F; Pizzol, A | 1 |
| Fridmanis, D; Gorskis, H; Gudra, D; Leja, M; Pupola, D; Radovica-Spalvina, I; Skenders, G; Vangravs, R | 1 |
| Cheung, KS; Guo, H; Guo, J; Leung, WK; Li, Y; Lyu, T; Lyu, Z; Mu, P; Ni, L; Seto, WK; Wu, J; Yang, Q; Yu, X | 1 |
| Abbas, Z; Asim, M; Baqai, K; Laique, N; Samejo, SA | 1 |
| Hu, JN; Ji, CR; Ji, R; Li, LX; Li, YQ; Li, YY; Lin, MJ; Liu, J; Qiao, C; Qu, JY; Zuo, XL | 1 |
| Bittinger, K; Faveri, M; Feres, M; Fermiano, D; Figueiredo, LC; Lee, JJ; Mayer, MPA; Retamal-Valdes, B; Teles, F | 1 |
| Cruz, DFD; da Silva, HDP; Duarte, PM; Feres, M; Figueiredo, LC; Miranda, TS; Retamal-Valdes, B | 1 |
| Kang, JK; Kim, JH; Lee, GH; Lee, KM; Lim, SG; Noh, CK; Shin, SJ | 1 |
| Arslan, M; Balamtekin, N; Günal, A | 1 |
| Pan, L; Tang, G; Tang, Y; Wei, Z; Zhou, S; Zhu, H | 1 |
| Arweiler, NB; Cosgarea, R; Eick, S; Heumann, C; Jepsen, S; Juncar, R; Salvi, GE; Sculean, A; Tristiu, R | 1 |
| Alix, C; Bénéjat, L; Bessède, E; Charron, P; Ducournau, A; Lehours, P; Mégraud, F | 1 |
| Cho, SJ; Choi, J; Chung, H; Chung, SJ; Kim, JL; Kim, SG; Lee, A | 1 |
| Brglez Jurecic, N; Espada Sanchez, M; Gisbert, J; Mégraud, F; O'Morain, C; Perez Nyssen, O; Tepes, B; Tepes, K | 1 |
| Ahn, JY; Choi, KD; Gong, EJ; Jung, HY; Jung, KW; Kim, DH; Lee, GH; Lee, JH; Na, HK; Pih, GY; Song, HJ | 1 |
| Georgopoulos, S; Papastergiou, V | 1 |
| Bryant, RV; Costello, S; Gehlert, J; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP | 1 |
| Ahumarán, G; Gollo, P; González, P; Khoury, M; Laudanno, O; Thomé, M | 1 |
| Berjeaud, JM; Crapart, S; Crépin, A; Ecale, F; El Houari, A; Laparre, J; Ramnath, M; Rodier, MH | 1 |
| Graham, DY; Howden, CW | 1 |
| Bozic, J; Kardum, G; Mestrovic, A; Pavicic Ivelja, M; Perkovic, N; Puljiz, Z; Tonkic, A; Vukovic, J | 1 |
| Abdulkhakov, R; Barrio, J; Bordin, D; Bujanda, L; Castro-Fernández, M; Fernandez-Salazar, L; Garre, A; Gasbarrini, A; Gisbert, JP; Huguet, JM; Jurecic, NB; Kupcinskas, L; Lucendo, A; Mégraud, F; Nyssen, OP; O'Morain, C; Pérez-Aisa, Á; Perez-Lasala, J; Rodrigo-Sáez, L; Romero, PM; Tepes, B; Vaira, D; Vologzhanina, L; Voynovan, I; Vujasinovic, M | 1 |
| Guentsch, A | 1 |
| Hu, Y; Lu, NH; Ouyang, Y; Zhu, Y | 1 |
| Harada, K; Ikoshi, H; Koizumi, J; Nakaminami, H; Nakanishi-Yamasaki, M; Nakase, K; Noguchi, N; Yamada, T | 1 |
| Choi, IJ; Kim, CG; Kim, YI; Lee, JY; Park, B; Park, JY | 1 |
| Fukuda, K; Fukuda, M; Hirashita, Y; Kawahara, Y; Kodama, M; Kudo, Y; Matsunari, O; Mizukami, K; Murakami, K; Ogawa, R; Okamoto, K; Okimoto, T; Wada, Y | 1 |
| De Francesco, V; Fiorini, G; Gatta, L; Manta, R; Saracino, IM; Vaira, D; Zullo, A | 1 |
| Hu, J; Zhao, H; Zhao, L | 1 |
| Lee, YC; Liou, JM; Wu, MS | 1 |
| Maeda, S; Sue, S | 1 |
| da Silva, RN; Doyle, H; Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Fritoli, A; Furquim, CP; Gomes, P; Oliveira, LM; Retamal-Valdes, B; Soares, GMS; Temporão, N; Teughels, W | 1 |
| Cheng, H; Dai, Y; Dong, XH; Gao, W; Li, J; Li, SY; Teng, GG; Wang, WH; Zhang, W; Zhang, XH | 1 |
| Bhat, KG; Ingalagi, P; Patil, S; Pattar, G | 1 |
| Ford, PJ; Hollingworth, SA; McGuire, T; van Driel, M; Walsh, LJ | 1 |
| Hassan, SU; Khooharo, TS; Shaikh, AH | 1 |
| Holmes, JA; Khan, SF; Perera, C; Prendergast, L; Teng, JC; Waring, L | 1 |
| Bontems, P; Cadranel, S; Kotilea, K; Mahler, T; Miendje Deyi, VY; Nguyen, J; Salame, A; Verset, L | 1 |
| Faller, WJ; Garcia, TM; Koelink, PJ; Koster, J; Meisner, S; Muncan, V; Renes, IB; Silva, J; Smit, WL; van Elburg, RM; van Roest, M; Vermeulen, JLM; Wildenberg, ME | 1 |
| Anand Paramadhas, BD; Ebruke, BE; Godman, B; Kalada Richard, A; Kalejaye, F; Kurdi, A; Odunuga, PT; Ogundele, SO; Ogunleye, OO; Olalekan, A; Oyawole, MR; Seaton, A; Sneddon, J; Yinka-Ogunleye, AF | 1 |
| Bang, MTL; Duc, NM; Khoi, HH; Nghi, BTD; Ngoc, TLC; Tien, VNT; Van Bach, N; Van Thieu, H | 1 |
| He, L; Jin, D; Lu, H; Meng, H; Zhu, Y | 1 |
| Choi, Y; Jang, JY; Kim, N; Lee, DH; Lee, JW; Nam, RH | 1 |
| Chen, YH; Chuah, SK; Hsu, PI; Kao, JY; Kao, SS; Kuo, CH; Peng, NJ; Shie, CB; Tang, SY; Tsay, FW; Wang, HM; Wu, DC; Wu, IT | 1 |
| Bonilla, S; Mansuri, I; Mitchell, PD | 1 |
| Hickel, R; Huth, KC; Kollmuss, M; Wuersching, SN | 1 |
| Agaram, R; da Silva Neto, MJJ; MacKay, G; MacLeod, M; Thomson, AH; Watson, DG | 1 |
| Ang, D; Ang, TL; Lim, KW; Tan, M; Wong, YJ; Yih Wong, AS | 1 |
| Alcedo, J; Amador, J; Bujanda, L; Calvet, X; Castro-Fernández, M; Fernández-Salazar, L; Gené, E; Gisbert, JP; Lanas, Á; Lucendo, AJ; Molina-Infante, J; Nyssen, OP; Pérez-Aisa, A; Puig, I | 2 |
| Buszewski, B; Król-Górniak, A; Pauter, K; Pomastowski, P; Szultka-Młyńska, M; Szumski, M | 1 |
| Akpan, RM; Akpan, SE; Ozuluoha, CC; Udoh, EI | 1 |
| Cao, P; Li, P; Liu, J; Luan, Q; Zou, P | 1 |
| Echeverría, M; Navarrete, H; Paz Y Miño, A; Peñaherrera, V; Sevillano, G; Zurita, J; Zurita-Salinas, C | 1 |
| Bryant, RV; Costello, S; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS | 1 |
| Hu, M; Pang, X; Wang, L; Zhang, J | 1 |
| Cho, JH; Jin, SY; Park, S | 1 |
| He, C; Kong, F; Liu, Y; Wang, K; Zhao, W; Zhu, X | 1 |
| Dutta, AK; Phull, PS | 1 |
| Hassib, ST; Mostafa, EA; Sharf, MG; Taha, EA | 1 |
| Aw, MM; Huang, JG; Lim, SYS; Quak, SH | 1 |
| Chen, M; Kuang, S; Lu, X; Shi, F; Xu, J; Zhang, Y | 1 |
| Collins, JR; Figuero, E; González, R; Herrera, D; Marín, MJ; Ogando, G; Sanz, M | 1 |
| Baik, GH; Bang, CS; Jang, HJ; Kae, SH; Kim, HY; Kim, J; Lee, SP; Lim, H; Seo, SI; Shin, WG; Yang, YJ | 1 |
| Andrade, C; Castro, AB; Quirynen, M; Siawasch, SAM; Temmerman, A; Teughels, W | 1 |
| Mabiki, F; Malebo, HM; Mariki, EE; Mdegela, R; Mwankuna, CJ; Styrishave, B; Uwamaliya, GA | 1 |
| Hayashi, S; Kamiya, S; Kato, M; Murakami, K; Ojima, H; Osaki, T; Rimbara, E; Sato, T; Shibayama, K; Sugiyama, T; Takeuchi, H; Tokunaga, K; Yokota, K; Yokota, SI; Yonezawa, H | 1 |
| Chou, YP; Chuah, SK; Huang, TH; Kuo, CM; Kuo, YH; Lee, CH; Liang, CM; Tai, WC; Wu, CK; Wu, KL; Yang, SC; Yao, CC | 1 |
| Bryant, RV; Costello, SP; Mangoni, AA; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS; Woodman, RJ | 1 |
| Continisio, A; D'Abramo, FS; Di Leo, A; Ierardi, E; Losurdo, G; Piazzolla, M; Pricci, M; Rima, R | 1 |
| Al-Samadani, KH; Alharbi, AM; Alsaidalani, HM; Gazal, G; Karbouji, GA | 1 |
| Cheung, KS; Guo, CG; Jiang, F; Law, SYK; Leung, WK; Li, B | 1 |
| Florholmen, JR; Goll, R; Halvorsen, FA; Johnsen, KM; Melby, KK; Moayeri, B; Nestegard, O; Paulssen, E; Sørbye, SW; Tønnesen, T | 1 |
| An, Z; Kang, L; Li, J; Ru, C; Tian, L; Wang, L; Yao, Y; Yin, L | 1 |
| Abouwarda, AM; Abu El-Wafa, WM; Faraag, AHI; Ismail, TA | 1 |
| de Boer, MGJ; Kuijper, EJ; Molendijk, I; Schoffelen, AF; van den Brink, G; Veenendaal, RA; Woudt, SHS | 1 |
| Elfanagely, Y; Ho, JJC; Moss, SF; Navarro, M; Sawyer, K | 1 |
| Al-Moraissi, EA; de Souza, GM; Falci, SGM; Fernandes, IA; Galvão, EL; Souza, MRF | 1 |
| Abd-Elsalam, SM; Bahaa, MM; Baiomy, N; Elnaggar, MH; Elsawy, AA; Gamal, RM; Habba, E; Salamah, AM; Shawky, D | 1 |
| Amiriani, T; Ghafourian, S; Khadiv, A; Kouhsari, E; Krutova, M; Sadeghifard, N; Sayadi, H; Valadbeigi, H | 1 |
| Bai, F; Bo, Y; Chen, X; Deng, Y; Hao, Q; Hu, S; Li, X; Liu, J; Sang, T; Tang, Y; Wang, J; Zhong, Z; Zhou, Y | 1 |
| Fu, Y; Liu, D; Wang, L; Wang, Y; Wu, S; Xie, Y | 1 |
| Baghani, Z; Basir Shabestari, S; Karrabi, M | 1 |
| Karbalaei, M; Keikha, M; Talebi Bezmin Abadi, A | 1 |
| Arweiler, NB; Batori-Andronescu, I; Bora, R; Cosgarea, R; Eick, S; Heumann, C; Jepsen, S; Rosu, A; Sculean, A | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Hadzhiyski, P; Kandilarov, N; Markovska, R | 1 |
| Borges, I; Castro Dos Santos, N; Duarte, PM; Faveri, M; Feres, M; Figueiredo, LC; Giudicissi, M; Graças, YTD; Mestnik, MJ; Miranda, TS; Monique, S; Pannuti, CM; Pereira da Silva, HD; Retamal-Valdes, B; Romito, GA; Saraiva, L; Soares, GMS; Souto, MLS; Tavares, APL | 1 |
| Barão, VAR; de Figueiredo, LC; Duarte, PM; Faveri, M; Feres, M; Mestnik, MJ; Retamal-Valdes, B; Souza, JGS | 1 |
| Lin, Y; Miao, M; Shao, Y; Wang, B; Ye, G | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Wang, Z | 1 |
| Jang, JS; Jee, SR; Jung, K; Kim, GH; Kim, SJ; Koh, M; Lee, J; Lee, MW; Park, MI | 1 |
| Wadia, R | 1 |
| Badre, W; Benomar, H; Bounder, G; Boura, H; Elyounsi, I; Essaidi, I; Jouimyi, RM; Kheir, FZ; Maachi, F; Zerouali, K | 1 |
| Casarin, RCV; Casati, MZ; Corrêa, MG; da Silva, RVC; de Freitas Monteiro, M; Rangel, TP; Ruiz, KG; Sallum, AW; Sallum, EA | 1 |
| Bakshi, S; Banerjee, S; Chandra Karmakar, B; Chaudhuri, S; Chawla, M; Das, B; Kumar, S; Kumari Pragasam, A; Kumari, S; Mehrotra, T; Mukhopadyay, AK; Mutreja, A; Paul, S; Porey Karmakar, S; Purohit, A; Ramamurthy, T; Ray, A; Talukdar, D; Verma, J | 1 |
| Agay-Shay, K; Azrad, M; On, A; Paritski, M; Peretz, A; Rohana, H; Roshrosh, H; Vazana, D | 1 |
| Chan, MTV; Chen, H; Liu, X; Wu, WKK; Xie, C; Zeng, J; Zhang, L | 1 |
| Adil, M; Ajmal, M; Ali, MM; Aqib, AI; Cui, K; Khan, A; Liang, Q; Liu, Q; Pan, H; Qin, C; Saleem, A; Sarwar, Z; Shafique, L | 1 |
| Akhlaghi, M; Ghasemi, E; Mahaki, B; Malekpour, MR; Mansourian, M; Tabesh, H | 1 |
| Almeida, N; Bastos, I; Branquinho, D; Calhau, C; Correia, C; Fernandes, A; Figueiredo, P; Gravito-Soares, E; Leal, C; Vasconcelos, H | 1 |
| Chey, WD; Graham, DY; Howden, CW; Hunt, B; Leifke, E; Mégraud, F; Smith, N; Trevino, E; Weissfeld, A | 1 |
| Cao, Y; Dong, L; Iheozor-Ejiofor, Z; Li, C; Liu, W; Lv, Z; Miao, C; Ye, Z | 1 |
| Li, T; Zhou, Y | 1 |
| Hu, C; Jiang, M; Li, H; Peng, K; Shu, X; Ye, D; Zhao, H | 1 |
| Celiberto, F; D'attoma, B; De Bellis, M; Di Leo, A; Iannone, A; Ierardi, E; Losurdo, G; Pricci, M; Rendina, M; Riezzo, G; Russo, F | 1 |
| Barrio, J; Bontems, P; Cabral, J; Cilleruelo Pascual, ML; Homan, M; Kalach, N; Koletzko, S; Kori, M; Kotilea, K; Le Thi, TG; Lima, R; Misak, Z; Tavares, M; Urbonas, V; Urruzuno, P; Werkstetter, K | 1 |
| Mugri, MH | 1 |
| Li, CL; Lu, HP; Ren, XL; Song, ZQ; Suo, BJ; Tian, XL; Yao, XY; Zhang, H; Zhang, YX; Zhou, LY | 1 |
| Cao, P; Li, P; Liu, J; Luan, Q; Wang, Y; Zou, P | 1 |
| Bontems, P; Burette, A; Delhaye, M; Gossum, MV; Kahegeshe, NL; Kotilea, K; Louis, H; Miendje Deyi, VY; Nkuize, M; Ntounda, R | 1 |
| Choi, SI; Jang, JY; Kim, N; Lee, DH; Lee, JW; Nam, RH; Song, CH | 1 |
| Chu, N; Gu, Y; Luo, H; Wang, Q; Xiao, Y; Yang, J; Zhang, J | 1 |
| Ardila, CM; Vivares-Builes, AM | 1 |
| Maher, HM; Mahgoub, H; Ragab, MAA; Tarek, S | 1 |
| Abraham, P; Desai, D; Dhoble, P; Doctor, S; Gupta, T; Joshi, A | 1 |
| Adachi, K; Ebi, M; Funaki, Y; Izawa, S; Kasugai, K; Kato, S; Koshino, A; Nagao, K; Ogasawara, N; Ohashi, W; Sasaki, M; Sugiyama, T; Yamaguchi, Y; Yoshimine, T | 1 |
| Gotoda, T; Ishibashi, F; Suzuki, S | 1 |
| Chen, J; Gui, Q; Liang, X; Lu, H; Su, W; Yu, D; Zhang, W; Zhu, C | 1 |
| Boyanova, L; Gergova, G; Gergova, R; Kandilarov, N; Markovska, R; Yordanov, D | 1 |
| Niu, Z; Ren, X; Song, Z; Suo, B; Tian, X; Xue, Y; Zhou, L | 1 |
| Braendli, T; Braun, DL; Hente, JM; Murray, FR; Pohl, D; Schindler, V | 1 |
| Hoang, VT; Tran, TNQ; Tran, TQA; Vu, DL; Vu, TB | 1 |
| Chen, JN; Ding, ZH; Huang, Y; Liang, X; Lu, H; Luo, LS; Zhang, W | 1 |
| Ayaş, M; Gürol, Y | 1 |
| Li, C; Lu, H; Ren, X; Song, Z; Suo, B; Tian, X; Yao, X; Zhang, H; Zhang, Y; Zhou, L | 2 |
| Kakiuchi, T | 1 |
| Akyön, Y; Örsten, S; Yılmaz, E | 1 |
| Balasubramaniam, R; Beneragama, H; Navaratinaraja, TS; Sri Ranganathan, S | 1 |
| Boal Carvalho, P; Cotter, J; Freitas, M; Lima Capela, T; Macedo Silva, V; Magalhães, J | 1 |
| Dewan, M; Goyal, L; Gupta, S; Singla, M | 1 |
| Attin, T; Bensland, S; Eick, S; Karygianni, L; Kulik, EM; Thurnheer, T | 1 |
| Bo, Y; Cao, Y; Cao, Z; Chen, X; Cui, T; Deng, Y; Fu, L; Gao, H; Gao, R; Guo, J; Hao, Q; Hou, Z; Hu, J; Hu, S; Jin, L; Li, F; Li, H; Li, X; Li, Y; Liu, J; Ma, B; Ma, L; Ma, S; Ma, Z; Mu, R; Niu, M; Qi, H; Shi, R; Su, X; Tang, N; Tang, Y; Wang, P; Wang, X; Xin, R; Yang, B; Yang, W; Yao, L; Yong, H; You, Y; Yu, X; Yu, Y; Zhang, X; Zhao, W; Zhou, Y | 1 |
| Chen, J; Chen, X; Ding, Z; Han, Y; Huang, Y; Liang, X; Lu, H; Xu, F; Zeng, X | 1 |
| Chen, J; Ding, Z; Guo, Y; Han, Y; Huang, Y; Liang, X; Lu, H; Wang, J; Xu, P | 1 |
| Blanco, J; Dopico, J; Liñares, A; Molina, A; Montero, E; Sanz-Sánchez, I | 1 |
| Ehmke, B; Eickholz, P; Hagenfeld, D; Harks, I; Harmsen, D; Kaner, D; Kim, TS; Kleine Bardenhorst, S; Kocher, T; Lorenz, K; Matern, J; Meyle, J; Prior, K; Schlagenhauf, U | 1 |
| Chouhan, MI; Hallur, VK; Kumar, C; Makashir, MS; Nayak, HK; Padhy, BM; Panigrahi, MK; Samal, SC; Sethi, S | 1 |
| Chen, M; Dong, Y; Gong, Y; Li, Y; Sun, J; Wang, Y | 1 |
| Babic, I; Gisbert, J; Kekic, D; Krstic, M; Mégraud, F; Milivojevic, V; Milosavljevic, T; Moreira, L; Nyssen, OP; O' Morain, C; Panic, N; Rankovic, I; Sagdati, S; Spasic, IS | 1 |
| Abbott, P; Nakhaei, N; Parirokh, M; Saffarzadeh, A | 1 |
| Abdallah, H; Abdel-Samiee, M; Abdelfattah, A; Abdelsameea, E; Ansari, S; Asaad, AM; Awad, SM; El-Azab, G; El-Refaie, A; Elbahr, O; Ghanem, SE; Kamal, A; Maher, D | 1 |
| Ehmke, B; Eickholz, P; Göde, M; Harks, I; Kaner, D; Kim, TS; Koch, R; Kocher, T; Lorenz, K; Meyle, J; Nickles, K; Schlagenhauf, U | 1 |
| Kim, JH; Lee, SY; Park, HS; Sung, IK | 1 |
| Cerezo, C; Herzlinger, M; Moss, SF; Riaz, MS; Shapiro, JM | 1 |
| Bae, HJ; Jeon, SW; Kwon, YH; Lee, DW; Nam, SY; Park, JH | 1 |
| Barão, VAR; Bertolini, M; Feres, M; Martins, R; Shibli, JA; Souza, JGS | 1 |
| Bontems, P; Iliadis, E; Kotilea, K; Mahler, T; Miendje Deyi, VY; Nguyen, J; Salame, A | 1 |
| Chen, Q; Chen, Y; Huang, X; Ji, X; Lin, Z; Suo, B; Wu, B; Zheng, X; Zhou, X | 1 |
| Bontems, P; Che, TH; Le, GKN; Nguyen, HT; Nguyen, LTH; Nguyen, PNV; Nguyen, TC; Pham, BV; Pham, DTH; Robert, A; Truong, DQ | 1 |
| Benghezal, M; Li, H; Marshall, BJ; Shen, Y; Song, X; Tang, H; Tang, X; Yang, T | 1 |
| Bonilla, S; Bousvaros, A; Goldsmith, J; Mitchell, P | 1 |
| Ang, TL; Aye, TT; Basir, DN; Lee, YY; Luu, MN; Mahachai, V; Miftahussurur, M; Quach, DT; Sollano, JD; Vannarath, S; Vilaichone, RK; Vutha, K | 1 |
| Huang, L; Li, A; Li, K; Lin, K; Wang, Y; Yang, S; Ye, Y | 1 |
| Bucki, R; Daniluk, T; Daniluk, U; Kucharska, M; Lebensztejn, DM; Zdanowicz, K | 1 |
| Choi, SI; Jung, SY; Kim, BJ; Kim, JG; Kim, JS; Lee, J; Lee, JW; Park, CH; Seo, SI; Yang, HJ | 1 |
| Bryant, RV; Costello, SP; Ingram, PR; Rayner, CK; Roberts-Thomson, IC; Schubert, JP; Warner, MS | 1 |
| Armange, L; Bayeh, B; Chauvin, P; Goter, T; Jouneau, S; Lalanne, S; Lefèvre, CR; Luque-Paz, D; Tattevin, P; Verdier, MC | 1 |
| Atherton, J; Bakshi, N; Garvey, E; Letley, D; Mahmood, F; Rhead, J; Robinson, K; Suffian, S; Whiley, D; White, J; Winter, JA | 1 |
| Aumpan, N; Graham, D; Issariyakulkarn, N; Mahachai, V; Vilaichone, RK; Yamaoka, Y | 1 |
190 review(s) available for metronidazole and amoxicillin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Thieno[2,3-d]pyrimidine as a promising scaffold in medicinal chemistry: Recent advances.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemistry, Pharmaceutical; Humans; Inflammation; Neoplasms; Pyrimidines; Structure-Activity Relationship | 2019 |
Metronidazole-conjugates: A comprehensive review of recent developments towards synthesis and medicinal perspective.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Antiprotozoal Agents; Drug Development; Humans; Hypoglycemic Agents; Metronidazole | 2021 |
Recent advances in antimicrobial therapy.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Clindamycin; Humans; Metronidazole; Sisomicin; Spectinomycin; Sulfamethoxazole; Ticarcillin; Tobramycin; Trimethoprim | 1977 |
Review article: the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Organometallic Compounds | 1992 |
The use of antimicrobials in dentistry.
Topics: Adolescent; Adult; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Child; Dental Care; Doxycycline; Drug Interactions; Erythromycin; Female; Humans; Male; Metronidazole; Mouth Diseases; Penicillin V; Pregnancy | 1989 |
Lower genitourinary infections in women.
Topics: Amoxicillin; Anti-Infective Agents, Urinary; Cystitis; Diagnosis, Differential; Drug Combinations; Family Practice; Female; Humans; Metronidazole; Pregnancy; Pregnancy Complications, Infectious; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; Urethritis; Urinary Tract Infections; Uterine Cervicitis; Vaginitis | 1986 |
[Classification, diagnosis and therapy of pneumonia].
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibody Specificity; Biopsy; Cefoxitin; Cephalosporins; Clindamycin; Cross Infection; Erythromycin; Humans; Legionnaires' Disease; Lung; Metronidazole; Penicillin G; Pneumonia; Radiography, Thoracic; Serologic Tests; Sputum; Tetracycline | 1985 |
New drugs in respiratory disorders: II.
Topics: Adult; Aged; Amantadine; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cephalosporins; Cyclophosphamide; Drug Combinations; Erythromycin; Ethambutol; Humans; Metronidazole; Pyrazinamide; Respiratory Tract Diseases; Respiratory Tract Infections; Rifampin; Trimethoprim; Tuberculosis, Pulmonary | 1983 |
Gardnerella vaginalis and its clinical syndrome.
Topics: Amoxicillin; Ampicillin; Culture Media; Female; Gardnerella vaginalis; Gentian Violet; Haemophilus; Haemophilus Infections; Humans; Hydrogen-Ion Concentration; Leukorrhea; Male; Metronidazole; Phenazines; Recurrence; Syndrome; Vagina; Vaginal Diseases | 1982 |
The best therapy for Helicobacter pylori infection: should efficacy or side-effect profile determine our choice?
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; United States | 1994 |
Endoscopic and histologic resolution of gastric pseudolymphoma (reactive lymphoid hyperplasia) following treatment with bismuth and oral antibiotics.
Topics: Aged; Amoxicillin; Biopsy; Bismuth; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hyperplasia; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Male; Metronidazole; Organometallic Compounds; Ranitidine; Salicylates; Stomach; Stomach Neoplasms | 1994 |
The role of acid inhibition in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Depression, Chemical; Drug Administration Schedule; Drug Therapy, Combination; Gastric Acid; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1994 |
Duodenal ulcer treatment: progress from pH to HP.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Tetracycline | 1994 |
Antimicrobial therapy in periodontics.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clinical Protocols; Dental Prophylaxis; Drug Delivery Systems; Drug Therapy, Combination; Humans; Metronidazole; Opportunistic Infections; Patient Care Planning; Periodontal Diseases; Periodontitis; Tetracyclines | 1993 |
Triple therapy and Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Stomach Neoplasms; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Critical evaluation of the treatment of peptic ulcer diseases associated with Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracyclines; Tinidazole | 1996 |
[Helicobacter pylori eradication: triple therapy versus dual therapy].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Tetracycline; Tinidazole; Treatment Outcome | 1996 |
The role of antisecretory drugs in the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Treatment strategies for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Salicylates; Tetracycline | 1997 |
Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. European Helicobacter Pylori Study Group.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Tinidazole | 1997 |
Treatment of Helicobacter pylori infection: a review of the world literature.
Topics: Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome | 1996 |
Amoxycillin dual therapy against Helicobacter pylori--the final nail in the coffin?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole | 1997 |
[Helicobacter pylori infection and ulcer].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Treatment Outcome; Virulence | 1998 |
[Treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Tetracycline; Time Factors | 1998 |
[Problems following antibiotic therapy for eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Esophagitis, Peptic; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 1998 |
Systemic antibiotic therapy in severe periodontitis.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Metronidazole; Patient Care Planning; Periodontitis; Tetracycline | 1997 |
Clinical relevance of resistant strains of Helicobacter pylori: a review of current data.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Proton Pump Inhibitors | 1998 |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 1998 |
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Gastric Acid; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 1999 |
[Importance of drug selection and the use of sensitivity tests for the eradication therapy for Helicobacter pylori].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1999 |
[Antibiotic-resistant H. pylori strains in the last ten years in Japan].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Penicillin Resistance; Penicillins; Peptic Ulcer; Time Factors | 1999 |
[Eradication rate and side effect from a point of view of Helicobacter pylori eradication of peptic ulcer disease in dual therapy or new triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors | 1999 |
The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 1999 |
Microbial ecology and treatment of Helicobacter pylori infections: review.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastric Mucosa; Gastritis; Genetic Variation; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Stomach Neoplasms | 2000 |
A meta-analysis of short versus long therapy with a proton pump inhibitor, clarithromycin and either metronidazole or amoxycillin for treating Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2000 |
[How to eradicate Helicobacter pylori?].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins | 1999 |
Strategy for treatment of Helicobacter pylori infection in adults. II. Practical policy in 2000.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Metronidazole; Proton Pump Inhibitors | 2000 |
[Selection of antibiotics and planning of eradication for H. pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2001 |
[A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Patient Compliance; Polymorphism, Genetic; Proton Pump Inhibitors; Treatment Failure | 2001 |
Management of brain stem abscess.
Topics: Amoxicillin; Brain Abscess; Brain Stem; Bronchi; Cefotaxime; Child, Preschool; Drainage; Drug Therapy, Combination; Female; Foreign Bodies; Humans; Metronidazole; Tomography, X-Ray Computed; Treatment Outcome | 2001 |
Helicobacter pylori: a clinical update.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Protein Synthesis Inhibitors; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2001 |
Antibiotic resistance of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitroimidazoles; Penicillins; Peptic Ulcer; Tetracycline | 2001 |
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Topics: Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Research Design; Tetracycline; Treatment Outcome | 2001 |
[Experience in the use of losek (omeprazole) in gastroenterology].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Metronidazole; Omeprazole; Penicillins; Placebos; Randomized Controlled Trials as Topic; Stomach Diseases; Stomach Ulcer; Tablets; Time Factors; Zollinger-Ellison Syndrome | 2001 |
Current management of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prognosis; Stomach Diseases; Thailand; Treatment Outcome | 2001 |
Helicobacter pylori therapy: first-line options and rescue regimen.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Salvage Therapy; Treatment Outcome | 2001 |
Risk factors for Helicobacter pylori resistance in the United States: the surveillance of H. pylori antimicrobial resistance partnership (SHARP) study, 1993-1999.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Ethnicity; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Penicillins; Population Surveillance; Prevalence; Risk Factors; Sex Factors; Stomach Ulcer; United States | 2002 |
[Development of Helicobacter pylori eradication therapy].
Topics: Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2002 |
[Drug sensitivity test for Helicobacter pylori].
Topics: Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Insurance, Health, Reimbursement; Metronidazole; Microbial Sensitivity Tests | 2002 |
[Guidelines of Helicobacter pylori eradication in children].
Topics: Amoxicillin; Breath Tests; Child; Clarithromycin; Drug Therapy, Combination; Europe; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; North America; Omeprazole; Pediatrics; Practice Guidelines as Topic | 2002 |
[New triple therapy for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2002 |
[Classic triple therapy for Helicobacter pylori infection].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Salicylates; Tetracycline | 2002 |
[Dual therapy for Helicobacter pylori resistance to anti microbial agents].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole | 2002 |
[Proton pump inhibitor-based quadruple therapy regimen for Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Tetracycline | 2002 |
[Effect of PPI/AM re-treatment regimen for the patients with Helicobacter pylori infection after failure of first line eradication therapy by PPI/AC regimens].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure; Treatment Outcome | 2002 |
[Second line treatment regimen of PPI + AMPC + MNZ for patients with clarithromycin-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2002 |
[Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Failure | 2002 |
[Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2002 |
[Proton pump inhibitors: Omeprazole].
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Depression, Chemical; Drug Therapy, Combination; Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Treatment Outcome | 2002 |
[Polaprezinc].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Anti-Ulcer Agents; Carnosine; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Urease; Zinc Compounds | 2002 |
[Helicobacter heilmannii-associated gastritis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Animals; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter heilmannii; Helicobacter Infections; Humans; Lansoprazole; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2002 |
Helicobacter pylori infection in skin diseases: a critical appraisal.
Topics: Amoxicillin; Clarithromycin; Clinical Trials as Topic; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Omeprazole; Prognosis; Risk Factors; Severity of Illness Index; Skin Diseases, Bacterial; Urticaria | 2002 |
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Histamine H2 Antagonists; Humans; Metronidazole; Patient Care Planning; Penicillins; Proton Pumps; Ranitidine; Recurrence | 2002 |
Single vs. double dose of a proton pump inhibitor in triple therapy for Helicobacter pylori eradication: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole; Sulfoxides; Treatment Outcome | 2002 |
Selection of antimicrobial agents in periodontal therapy.
Topics: Administration, Topical; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Ciprofloxacin; Delayed-Action Preparations; Drug Combinations; Humans; Metronidazole; Penicillins; Periodontal Diseases; Periodontitis; Povidone-Iodine; Sodium Hypochlorite; Therapeutic Irrigation; Treatment Outcome | 2002 |
Rationale for use of antibiotics in periodontics.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chemotherapy, Adjuvant; Child; Clavulanic Acid; Dental Scaling; Drug Delivery Systems; Drug Therapy, Combination; Gram-Negative Anaerobic Bacteria; Humans; Metronidazole; Periodontitis; Tetracycline | 2002 |
[Helicobacter pylori. Update 2002].
Topics: Adenocarcinoma; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Follow-Up Studies; Gastritis, Atrophic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Recurrence; Risk; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Time Factors | 2002 |
[First line therapy for Helicobacter pylori eradication in France].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; France; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Practice Guidelines as Topic; Recurrence | 2003 |
[How to treat after Helicobacter pylori eradication failure?].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Recurrence; Rifabutin | 2003 |
Triple vs. quadruple therapy for treating Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Ditiocarb; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2003 |
What are the global response rates to Helicobacter pylori eradication therapy?
Topics: Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Global Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2003 |
Is it time for quadruple therapy to be first line?
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Time Factors | 2003 |
Clinical inquiries. What regimens eradicate Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2003 |
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine | 2003 |
[Eradication of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole | 2003 |
[Antimicrobial resistance of Helicobacter pylori: clinical and molecular aspects].
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracyclines | 2003 |
Systemic anti-infective periodontal therapy. A systematic review.
Topics: Administration, Oral; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clindamycin; Consensus; Dental Scaling; Doxycycline; Humans; Metronidazole; Penicillins; Periodontal Attachment Loss; Periodontal Index; Periodontitis; Spiramycin; Tetracycline | 2003 |
[Second-line eradication therapy for H. pylori infection].
Topics: Amoxicillin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2004 |
Sequential therapy; a new treatment for Helicobacter pylori infection. But is it ready for general use?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline | 2004 |
Eradicate H. pylori with effective treatment regimens.
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Proton Pump Inhibitors; Salicylates; Tetracycline; Treatment Outcome | 2004 |
[Evaluation of the efficacy of an Helicobacter pylori eradication treatment for idiopathic thrombocytopenic purpura patients].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Purpura, Thrombocytopenic, Idiopathic | 2004 |
[Helicobacter pylori: reasons for eradication].
Topics: Adenocarcinoma; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Risk Factors; Secondary Prevention; Stomach Neoplasms | 2004 |
A clinician's guide to managing Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diagnosis, Differential; Endoscopy; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer | 2005 |
An update on anti-Helicobacter pylori treatment in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Stomach Diseases | 2005 |
[Guidelines in the management of H. pylori infection in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2005 |
[Establishment of 2nd line treatment regimen for H. pylori infection--future prospect for the application for national health insurance system in Japan].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; National Health Programs; Omeprazole; Proton Pump Inhibitors; Rabeprazole | 2005 |
[Drug resistant H. pylori in Japan: general remarks].
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Sex Factors | 2005 |
[Yearly change in occurrence of antibiotic-resistant Helicobacter pylori isolates in Shinshu University Hospital during 1998-2002].
Topics: Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter pylori; Hospitals, University; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 23S; Time Factors | 2005 |
[Drug sensitivity test for Helicobacter pylori].
Topics: Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Proton Pump Inhibitors; Specimen Handling | 2005 |
[Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Second-line eradication therapy for H. pylori infection--PPI+AMPC+MNZ triple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2005 |
[High dose dual PPI/AMPC therapy for the treatment of Helicobacter pylori infection after failure of usual standard triple PPI/AMPC/CAM therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Rabeprazole; Treatment Failure | 2005 |
[Comparison between one-week and two-week regimens of new triple therapy in H. pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Time Factors; Treatment Outcome | 2005 |
[Helicobacter pylori eradication therapy for children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2005 |
[Eradication of Helicobacter pylori in patients with end-stage renal disease undergoing dialysis treatment].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dialysis; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Kidney Failure, Chronic; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2005 |
[Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Pharmacogenetics; Polymorphism, Single Nucleotide; Proton Pump Inhibitors; Treatment Outcome | 2005 |
Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2006 |
Diagnosis and anti-infective therapy of periodontitis.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Chlorhexidine; Clindamycin; Humans; Metronidazole; Microscopy; Penicillins; Periodontitis; Polymerase Chain Reaction; Serologic Tests; Tetracyclines | 2007 |
Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2007 |
[Treatment for Helicobacter pylori: current criteria].
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Quinolones; Tinidazole; Treatment Outcome | 2007 |
What is new in the management of Helicobacter pylori?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Practice Guidelines as Topic; Probiotics; Proton Pump Inhibitors; Rifabutin; Tetracycline | 2008 |
The role of phenoxymethylpenicillin, amoxicillin, metronidazole and clindamycin in the management of acute dentoalveolar abscesses--a review.
Topics: Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Clindamycin; Drainage; Drug Resistance, Bacterial; Drug Utilization; Evidence-Based Dentistry; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillin V; Periapical Abscess; Periodontal Abscess; Practice Guidelines as Topic | 2009 |
Helicobacter pylori: diagnosis and treatment.
Topics: Amoxicillin; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Treatment Failure | 2009 |
Empiric quadruple vs. triple therapy for primary treatment of Helicobacter pylori infection: Systematic review and meta-analysis of efficacy and tolerability.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Outcome Assessment, Health Care; Patient Compliance; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline | 2010 |
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole | 2009 |
[Acquisition of the drug resistance and Helicobacter pylori gene mutation].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter pylori; Metronidazole; Mutation | 2009 |
Helicobacter pylori eradication therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Guidelines as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Ranitidine; Tetracycline; Treatment Failure; Treatment Outcome | 2010 |
Clostridium perfringens septicaemia with massive intravascular haemolysis: a case report and review of the literature.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cholangitis; Clostridium Infections; Clostridium perfringens; Drug Therapy, Combination; Gentamicins; Hemolysis; Humans; Male; Metronidazole; Sepsis; Ultrasonography | 2010 |
Regenerative endodontics--biologically-based treatment for immature permanent teeth: a case report and review of the literature.
Topics: Amoxicillin; Anti-Bacterial Agents; Bicuspid; Blood Coagulation; Child; Ciprofloxacin; Dental Pulp; Dental Pulp Necrosis; Drug Combinations; Female; Humans; Metronidazole; Neovascularization, Physiologic; Periapical Abscess; Regeneration; Root Canal Irrigants; Root Canal Obturation; Sodium Hypochlorite; Tooth Apex | 2010 |
Does adjunctive antimicrobial therapy reduce the perceived need for periodontal surgery?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chemotherapy, Adjuvant; Drug Combinations; Drug Hypersensitivity; Humans; Metronidazole; Patient Selection; Periodontal Debridement; Periodontitis | 2011 |
[Modern Helicobacter pylori therapies in times of increasing anti biotic resistance].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Gastroscopy; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Medication Adherence; Metronidazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Proton Pump Inhibitors; Treatment Failure | 2010 |
Optimal therapy for Helicobacter pylori infections.
Topics: Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2011 |
[Efficient, minimally invasive periodontal therapy. An evidence based treatment concept].
Topics: Administration, Oral; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Cost-Benefit Analysis; Dental Scaling; Double-Blind Method; Evidence-Based Dentistry; Female; Humans; Metronidazole; Periodontal Debridement; Porphyromonas gingivalis | 2011 |
Diagnosis and treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Clarithromycin; Denmark; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Stomach Neoplasms; Tetracycline | 2011 |
Amoxicillin/metronidazole or scaling and root planing in the treatment of chronic periodontitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Periodontitis; Dental Plaque Index; Dental Scaling; Drug Administration Schedule; Gingival Hemorrhage; Humans; Metronidazole; Oral Hygiene; Periodontal Attachment Loss; Periodontal Pocket; Randomized Controlled Trials as Topic; Research Design; Root Planing; Sample Size | 2010 |
[New options for helicobacter pylori antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ofloxacin; Precision Medicine; Proton Pump Inhibitors; Retreatment; Stomach Diseases; Treatment Failure | 2011 |
[Helicobacter pylori: an infection with local complications and systemic effects].
Topics: Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Asthma; Clarithromycin; Cross-Sectional Studies; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Metronidazole; Obesity; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic; Risk Factors; Stomach Neoplasms; Virulence | 2011 |
A new look at anti-Helicobacter pylori therapy.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Tetracycline | 2011 |
Effectiveness of systemic amoxicillin/metronidazole as an adjunctive therapy to full-mouth scaling and root planing in the treatment of aggressive periodontitis: a systematic review and meta-analysis.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Dental Scaling; Drug Combinations; Humans; Metronidazole; Root Planing; Safety; Treatment Outcome | 2012 |
Antimicrobial advances in treating periodontal diseases.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Humans; Metronidazole; Periodontal Diseases; Porphyromonas gingivalis; Time Factors; Virulence Factors | 2012 |
Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to scaling and root planing in the treatment of chronic periodontitis: a systematic review and meta-analysis.
Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Chemotherapy, Adjuvant; Chi-Square Distribution; Chronic Periodontitis; Confidence Intervals; Dental Scaling; Drug Combinations; Humans; Likelihood Functions; Metronidazole; Patient Safety; Periodontal Index; Publication Bias; Quality Assurance, Health Care; Randomized Controlled Trials as Topic; Treatment Outcome | 2012 |
The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Infective Agents; Chemotherapy, Adjuvant; Chronic Periodontitis; Dental Scaling; Drug Combinations; Humans; Metronidazole | 2013 |
A review of rescue regimens after clarithromycin-containing triple therapy failure (for Helicobacter pylori eradication).
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Proton Pump Inhibitors; Treatment Failure | 2013 |
Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Meta-analysis of first-line triple therapy for helicobacter pylori eradication in Korea: is it time to change?
Topics: Alkylating Agents; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Communicable Disease Control; Cytochrome P-450 CYP3A Inhibitors; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Republic of Korea; Tinidazole | 2014 |
[Expanded indication of National Health Insurance for H. pylori associated gastritis].
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Metronidazole; National Health Programs; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2014 |
Review: efficacy and safety of hybrid therapy for Helicobacter pylori infection: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2015 |
Non-surgical periodontal therapy with systemic antibiotics in patients with untreated aggressive periodontitis: a systematic review and meta-analysis.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Humans; Metronidazole; Treatment Outcome | 2015 |
An estimate of pocket closure and avoided needs of surgery after scaling and root planing with systemic antibiotics: a systematic review.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Combined Modality Therapy; Dental Scaling; Drug Combinations; Humans; Metronidazole; Periodontal Pocket; Root Planing | 2014 |
Sequential or concomitant therapy for eradication of Helicobacter pylori infection: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Databases, Bibliographic; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Rho Guanine Nucleotide Exchange Factors; Treatment Outcome | 2015 |
Systemic antibiotics in the treatment of aggressive periodontitis. A systematic review and a Bayesian Network meta-analysis.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Bayes Theorem; Combined Modality Therapy; Dental Scaling; Humans; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Root Planing | 2015 |
Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Nitroimidazoles; Probiotics; Proton Pump Inhibitors | 2015 |
Doxycycline in Eradication Therapy of Helicobacter pylori--a Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Proton Pump Inhibitors; Ranitidine; Tetracycline | 2016 |
The concomitant administration of systemic amoxicillin and metronidazole compared to scaling and root planing alone in treating periodontitis: =a systematic review=.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Humans; Metronidazole; Periodontal Pocket; Periodontitis; Root Planing; Treatment Outcome | 2016 |
Helicobacter pylori therapy: a paradigm shift.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Standard of Care; Treatment Outcome | 2016 |
The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Canada; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2016 |
[Antibiomania: Think of the manic syndrome secondary to antibiotic therapy].
Topics: Amoxicillin; Anti-Bacterial Agents; Bipolar Disorder; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Peptic Ulcer | 2017 |
Nonbismuth concomitant quadruple therapy for Helicobacter pylori eradication in Chinese regions: A meta-analysis of randomized controlled trials.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Metronidazole; Patient Compliance; Peptic Ulcer; Prevalence; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Singapore; Taiwan | 2016 |
Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole for Helicobacter pylori first-line treatment.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2016 |
Novel and Effective Therapeutic Regimens for
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Mutation; Prevalence; Probiotics; Proton Pump Inhibitors; Pyrroles; Rifabutin; Sulfonamides; Tetracycline; Tetracycline Resistance | 2017 |
Efficacy of Vonoprazan-Based Triple Therapy for Helicobacter pylori Eradication: A Multicenter Study and a Review of the Literature.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Remission Induction; Retrospective Studies; Sulfonamides; Time Factors; Treatment Outcome | 2017 |
Antibiotic resistance in Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2017 |
Helicobacter pylori management in ASEAN: The Bangkok consensus report.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Consensus; Drug Resistance, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Proton Pump Inhibitors; Taiwan; Tetracycline; Thailand; Treatment Outcome; United States | 2018 |
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Asia; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Pacific Islands; Prevalence; Tetracycline | 2017 |
Optimal dose and duration of amoxicillin-plus-metronidazole as an adjunct to non-surgical periodontal therapy: A systematic review and meta-analysis of randomized, placebo-controlled trials.
Topics: Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Drug Therapy, Combination; Humans; Metronidazole; Periodontitis; Placebos; Randomized Controlled Trials as Topic; Time Factors | 2018 |
Microbial colonization of the periodontal pocket and its significance for periodontal therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Physiological Phenomena; Biodiversity; Dental Scaling; Humans; Metronidazole; Microbiota; Oral Hygiene; Periodontal Diseases; Periodontal Pocket; Periodontitis; Root Planing | 2018 |
Efficacy of systemic antibiotics in nonsurgical periodontal therapy for diabetic subjects: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Diabetes Mellitus; Doxycycline; Drug Therapy, Combination; Humans; Metronidazole; Periodontal Diseases; Periodontal Pocket | 2018 |
The Use of Amoxicillin (500 Mg) Plus Metronidazole (500 Mg) for 7 Days Adds Adjunctive Benefits for Nonsurgical Periodontal Therapy, but Limited Evidence Supports Higher/Longer Dose.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Humans; Metronidazole | 2018 |
Clinical Inquiries: What's the best secondary treatment for patients who fail initial triple therapy for H pylori?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Practice Guidelines as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2018 |
Systematic Review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole; Treatment Outcome | 2018 |
[New
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Helicobacter Infections; Humans; Metronidazole; Precision Medicine; Proton Pump Inhibitors; Salicylates | 2018 |
Systematic review: Would susceptibility-guided treatment achieve acceptable cure rates for second-line Helicobacter pylori therapy as currently practiced?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Endoscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Treatment Outcome | 2019 |
Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Canada; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Practice Guidelines as Topic; Proton Pump Inhibitors; Rifabutin; Tetracycline; United States | 2019 |
Empirical or microbiologically guided systemic antimicrobials as adjuncts to non-surgical periodontal therapy? A systematic review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Dental Scaling; Humans; Metronidazole | 2019 |
Recent progress in Helicobacter pylori treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Probiotics; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Vitamins | 2020 |
Gingival recession after scaling and root planing with or without systemic metronidazole and amoxicillin: a re-review.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Gingival Recession; Humans; Metronidazole; Root Planing | 2020 |
Adjunctive effect of systemic antimicrobials in periodontitis therapy: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Dental Scaling; Humans; Metronidazole; Periodontitis; Root Planing | 2020 |
Helicobacter pylori: A Review of Current Diagnostic and Management Strategies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Biopsy; Bismuth; Breath Tests; Clarithromycin; Culture Techniques; Doxycycline; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Feces; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Nitro Compounds; Organometallic Compounds; Peptic Ulcer; Polymerase Chain Reaction; Proton Pump Inhibitors; Rifabutin; Salicylates; Salvage Therapy; Serologic Tests; Stomach Neoplasms; Tetracycline; Thiazoles; Treatment Outcome; Urea | 2020 |
Primer on etiology and treatment of progressive/severe periodontitis: A systemic health perspective.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Dental Scaling; Humans; Metronidazole; Periodontitis | 2020 |
Systemically administered amoxicillin/ metronidazole versus azithromycin as adjuncts to subgingival instrumentation during non-surgical periodontal therapy. A systematic review.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Dental Scaling; Humans; Metronidazole; Root Planing | 2020 |
Gastrointestinal: Rapid emergence of double-expressor lymphoma after Helicobacter pylori eradication therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Digestive System; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Metronidazole; Middle Aged; Rabeprazole; Stomach Neoplasms | 2021 |
An update on current and advancing pharmacotherapy options for the treatment of H. pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2021 |
Antibiotic resistance of Helicobacter pylori in Australia and New Zealand: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; New Zealand; Tetracycline | 2021 |
Antibiotics against Periodontal Biofilms.
Topics: Amoxicillin; Anti-Bacterial Agents; Biofilms; Doxycycline; Humans; Metronidazole | 2021 |
Reverse hybrid therapy for Helicobacter pylori eradication: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Helicobacter pylori eradication following first-line treatment failure in Europe: What, how and when chose among different standard regimens? A systematic review.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Rifabutin; Tetracycline; Treatment Failure | 2021 |
The effect of drug dose and duration of adjuvant Amoxicillin-plus-Metronidazole to full-mouth scaling and root planing in periodontitis: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Dental Scaling; Humans; Metronidazole; Periodontitis; Pharmaceutical Preparations; Root Planing | 2021 |
Treatment of Refractory
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2022 |
Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Potassium; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Helicobacter pylori antimicrobial resistance in Melbourne, Australia. Time to review therapeutic guidelines?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Observational Studies as Topic; Retrospective Studies; Young Adult | 2021 |
V Spanish Consensus Conference on Helicobacter pylori infection treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors | 2021 |
V Spanish Consensus Conference on Helicobacter pylori infection treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2022 |
Treatment of
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Hypersensitivity; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2021 |
The influence of pretreatment with PPI on Helicobacter pylori eradication: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Treatment Outcome | 2021 |
Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Rifabutin; Tetracycline; United States | 2022 |
Do antibiotics prevent infection after third molar surgery? A network meta-analysis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antibiotic Prophylaxis; Dry Socket; Humans; Metronidazole; Molar, Third; Network Meta-Analysis | 2022 |
Heteroresistance to clarithromycin and metronidazole in patients with a Helicobacter pylori infection: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
Clinical attachment loss in the use of adjunctive antimicrobial photodynamic therapy in Stages II-IV Grade C molar-incisor periodontitis: A systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Periodontitis; Humans; Incisor; Metronidazole; Photochemotherapy | 2022 |
Clinical relevance of the cagA and vacA s1m1 status and antibiotic resistance in Helicobacter pylori: a systematic review and meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Resistance, Microbial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2022 |
Host Cell Antimicrobial Responses against
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline; Virulence Factors | 2022 |
Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Cardiovascular Diseases; Chronic Periodontitis; Humans; Metabolic Syndrome; Metronidazole; Primary Prevention; Randomized Controlled Trials as Topic; Secondary Prevention | 2022 |
Efficacy of Systemic Amoxicillin-Metronidazole in Periodontitis Patients with Diabetes Mellitus: A Systematic Review of Randomized Clinical Trials.
Topics: Amoxicillin; Anti-Bacterial Agents; Clindamycin; Diabetes Mellitus, Type 2; Humans; Metronidazole; Periodontitis; Randomized Controlled Trials as Topic | 2022 |
Antibiotic Resistance in Patients with Peri-Implantitis: A Systematic Scoping Review.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Fusobacterium nucleatum; Humans; Metronidazole; Peri-Implantitis; Porphyromonas gingivalis | 2022 |
Antibiotic Resistance of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Turkey | 2023 |
Is periodontal therapy an effective treatment modality for preventing or managing cardiovascular disease in patients with periodontitis?
Topics: Amoxicillin; Cardiovascular Diseases; Chronic Periodontitis; Female; Humans; Lactation; Metronidazole; Pilot Projects; Randomized Controlled Trials as Topic; United States | 2023 |
Efficacy of adjunctive measures in the non-surgical treatment of peri-implantitis: A systematic review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Dental Implants; Humans; Metronidazole; Minocycline; Peri-Implantitis | 2023 |
Unraveling the effectiveness of antibiotics for peri-implantitis treatment: A scoping review.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Implants; Humans; Metronidazole; Peri-Implantitis; Periodontitis | 2023 |
Efficacy of genotypic susceptibility-guided tailored therapy for Helicobacter pylori infection: A systematic review and single arm meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2023 |
595 trial(s) available for metronidazole and amoxicillin
| Article | Year |
|---|---|
Eradicating Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter pylori; Humans; Metronidazole; Time Factors | 1992 |
The use of the Body Mass Index in studies of abdominal wound infection.
Topics: Abdomen; Amoxicillin; Body Mass Index; Cefazolin; Clavulanic Acids; Drug Therapy, Combination; Humans; Metronidazole; Risk Factors; Surgical Wound Infection | 1992 |
Surface hydrophobicity of gastric mucosa in Helicobacter pylori infection: effect of clearance and eradication.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Bismuth; Duodenal Ulcer; Endoscopy, Digestive System; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Ranitidine; Recurrence; Regression Analysis; Water | 1992 |
Effect of Helicobacter pylori on parietal cell sensitivity to pentagastrin in duodenal ulcer subjects.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acidity Determination; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Parietal Cells, Gastric; Pentagastrin; Stomach Diseases | 1992 |
[Comparative analysis of mezlocillin/metronidazole and amoxicillin/clavulanic acid as "one shot" preventive antibiotic administration in colorectal interventions].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Colectomy; Colorectal Neoplasms; Female; Humans; Infusions, Intravenous; Male; Metronidazole; Mezlocillin; Middle Aged; Surgical Wound Infection | 1992 |
[Treatment of acute salpingitis with tetracycline/metronidazole with or without additional balneotherapy, Augmentin or ciprofloxacin/metronidazole: a second-look laparoscopy study].
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Balneology; Clavulanic Acids; Combined Modality Therapy; Drug Therapy, Combination; Female; Humans; Laparoscopy; Metronidazole; Pelvic Inflammatory Disease; Prospective Studies; Recurrence; Reoperation; Salpingitis; Tetracycline | 1992 |
Duodenal ulcer recurrence and Helicobacter pylori.
Topics: Amoxicillin; Duodenal Ulcer; Follow-Up Studies; Helicobacter pylori; Humans; Metronidazole; Recurrence | 1991 |
One week eradication regimen for Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Amoxicillin; Anti-Ulcer Agents; Drug Administration Schedule; Drug Combinations; Drug Resistance, Microbial; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Pyloric Antrum; Time Factors | 1991 |
Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies | 1991 |
The role of omeprazole (40 mg) in the treatment of gastric Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates | 1991 |
[Randomized study of amoxicillin-clavulanic acid versus amoxicillin-metronidazole combinations in pyogenic infections of dental origin].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Peptostreptococcus; Pulpitis; Streptococcus; Tooth Diseases | 1991 |
Cure of duodenal ulcer associated with eradication of Helicobacter pylori.
Topics: Administration, Oral; Amoxicillin; Anti-Ulcer Agents; Campylobacter; Campylobacter Infections; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Gastric Mucosa; Humans; Metronidazole; Organometallic Compounds; Prospective Studies; Randomized Controlled Trials as Topic; Recurrence | 1990 |
Effect of short-term intermittent antibiotic treatment on growth of Burmese (Myanmar) village children.
Topics: Age Factors; Amoxicillin; Bacterial Infections; Body Height; Body Weight; Breath Tests; Child, Preschool; Drug Administration Schedule; Evaluation Studies as Topic; Factor Analysis, Statistical; Gastrointestinal Contents; Growth; Humans; Hydrogen; Infant; Intestinal Absorption; Malabsorption Syndromes; Metronidazole; Myanmar; Nutritional Status; Oryza; Time Factors | 1990 |
Duodenal ulcer disease--to heal or to cure?
Topics: Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Ranitidine; Recurrence | 1991 |
Triple therapy for Helicobacter pylori in nonulcer dyspepsia.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged | 1991 |
Chronic alcoholic gastritis. Roles of alcohol and Helicobacter pylori.
Topics: Adult; Alcoholism; Aluminum Hydroxide; Amoxicillin; Bismuth; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Salicylates; Temperance | 1991 |
Chest infection following head and neck surgery: a pilot study.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Clavulanic Acids; Drug Therapy, Combination; Floxacillin; Humans; Metronidazole; Middle Aged; Otorhinolaryngologic Diseases; Pilot Projects; Postoperative Complications; Premedication; Respiratory Tract Infections | 1990 |
Amoxycillin/clavulanic acid ('Augmentin') compared with a combination of aminopenicillin, aminoglycoside and metronidazole in the treatment of pelvic inflammatory disease.
Topics: Adult; Aminoglycosides; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Metronidazole; Pelvic Inflammatory Disease; Penicillins; Random Allocation | 1989 |
[Treatment and surgery of abdominal septic states: comparison of two antibiotic therapies].
Topics: Abdomen; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefadroxil; Cefazolin; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Prospective Studies; Random Allocation | 1989 |
[Treatment of upper genital infections in women. Multicenter study of the comparative efficacy and tolerance of an amoxicillin-clavulanic acid combination and of a triple antibiotic combination].
Topics: Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Metronidazole; Middle Aged; Multicenter Studies as Topic; Paromomycin; Penicillins; Prospective Studies; Random Allocation; Salpingitis | 1989 |
Antibiotic therapy of perforated appendicitis in children: a comparison of amoxycillin/clavulanate with a combination of benzylpenicillin, netilmicin and metronidazole.
Topics: Amoxicillin; Appendicitis; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Metronidazole; Netilmicin; Penicillin G; Peritonitis; Postoperative Period; Randomized Controlled Trials as Topic | 1989 |
A randomized trial to compare amoxycillin/clavulanate with metronidazole plus gentamicin in prophylaxis in elective colorectal surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Colon; Drug Therapy, Combination; Female; Gentamicins; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Randomized Controlled Trials as Topic; Rectum; Surgical Wound Infection | 1989 |
Prophylaxis in gynaecological surgery: a prospective randomized comparison between single dose prophylaxis with amoxycillin/clavulanate and the combination of cefuroxime and metronidazole.
Topics: Adult; Amoxicillin; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Genitalia, Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Laparotomy; Metronidazole; Middle Aged; Premedication; Prospective Studies; Randomized Controlled Trials as Topic; Surgical Wound Infection; Urinary Tract Infections | 1989 |
Effectiveness of two therapeutic antibiotic regimens in the treatment of serious post-operative infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Postoperative Complications; Prospective Studies; Randomized Controlled Trials as Topic | 1989 |
Factors predicting abnormal hysterosalpingographic findings in patients treated for acute pelvic inflammatory disease.
Topics: Acute Disease; Adolescent; Adult; Amoxicillin; Chlamydia Infections; Clinical Trials as Topic; Doxycycline; Drug Therapy, Combination; Female; Humans; Hysterosalpingography; Infertility, Female; Intrauterine Devices; Metronidazole; Pelvic Inflammatory Disease; Penicillin G; Pregnancy; Prognosis; Random Allocation | 1985 |
[Treatment of acute non-chlamydial salpingitis. Study of the efficacy and tolerance of a single-therapy antibiotic: Augmentin].
Topics: Acute Disease; Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acids; Drug Therapy, Combination; Female; Gentamicins; Humans; Metronidazole; Penicillins; Salpingitis | 1988 |
Amoxycillin-clavulanic acid (Augmentin) versus metronidazole as prophylaxis in hysterectomy: a prospective, randomized clinical trial.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Humans; Hysterectomy; Metronidazole; Middle Aged; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection | 1988 |
Single-dose prophylaxis in gynaecological surgery: amoxycillin/clavulanic acid versus the combination of cefuroxim and metronidazole in a randomized prospective comparison.
Topics: Adult; Aged; Amoxicillin; Cefuroxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Genital Diseases, Female; Humans; Metronidazole; Middle Aged; Premedication; Prospective Studies; Random Allocation; Surgical Wound Infection; Urinary Tract Infections | 1988 |
[The drug combination amoxicillin-clavulanic acid compared to the triple combination ampicillin-gentamicin-metronidazole in the treatment of severe adnexal infections].
Topics: Amoxicillin; Ampicillin; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Clinical Trials as Topic; Drug Combinations; Female; Gentamicins; Humans; Metronidazole; Pelvic Inflammatory Disease; Random Allocation | 1986 |
[Comparative clinical study between Rocephin (Roche) and doxycycline, amoxycillin, erythromycin and amoxycillin + metronidazole combination in gynecology].
Topics: Abscess; Adult; Aged; Amoxicillin; Breast Diseases; Cefotaxime; Ceftriaxone; Clinical Trials as Topic; Doxycycline; Drug Combinations; Endometritis; Erythromycin; Female; Genital Diseases, Female; Humans; Metronidazole; Middle Aged; Postoperative Complications; Pregnancy; Puerperal Infection; Salpingitis; Urinary Tract Infections | 1985 |
Metronidazole and Augmentin in the prevention of sepsis after appendicectomy.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Appendectomy; Appendicitis; Bacteria, Aerobic; Bacteria, Anaerobic; Clavulanic Acids; Drug Combinations; Female; Humans; Male; Metronidazole; Surgical Wound Infection | 1985 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
[Comparison of 2 treatment schemes to eradicate Helicobacter pylori].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Recurrence | 1995 |
Cure of peptic gastric ulcer associated with eradication of Helicobacter pylori. Finnish Gastric Ulcer Study Group.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Ranitidine; Recurrence; Stomach Ulcer | 1995 |
Recrudescence of Helicobacter pylori infection in patients with healed duodenal ulcer after treatment with different regimens.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Prospective Studies; Recurrence; Tetracycline; Time Factors | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Efficacy of omeprazole combined with antibiotics for Helicobacter pylori eradication and duodenal ulcer recurrence.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Recurrence | 1995 |
Helicobacter pylori clearance and eradication with triple therapy in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds | 1995 |
Pharmacological effects of metronidazole+tetracycline+bismuth subcitrate versus omeprazole+amoxycillin+bismuth subcitrate in Helicobacter pylori-related gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Stomach Ulcer; Tetracycline; Treatment Outcome | 1994 |
Rapid eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Chi-Square Distribution; Cost-Benefit Analysis; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Drug Tolerance; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1995 |
Successful Helicobacter pylori eradication incorporating a one-week antibiotic regimen.
Topics: Adult; Amoxicillin; Drug Synergism; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer | 1995 |
A 1-h topical therapy for the treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Antacids; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Instillation, Drug; Male; Metronidazole; Middle Aged; Pronase; Time Factors; Treatment Outcome | 1995 |
Long-term prospective study of Helicobacter pylori in nonulcer dyspepsia.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies | 1995 |
The effect of eradication of Helicobacter pylori upon the duodenal ulcer recurrence--a 24 month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Recurrence | 1994 |
An observer blind trial of co-amoxiclav versus cefuroxime plus metronidazole in the prevention of postoperative wound infection after general surgery.
Topics: Abdomen; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefuroxime; Child; Clavulanic Acids; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Surgical Wound Infection | 1994 |
Prospective, randomized study of H2-blocker and triple therapy for duodenal ulcer treatment and the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Recurrence | 1994 |
Causal role of Helicobacter pylori in peptic ulcer relapse.
Topics: Aged; Amoxicillin; Bismuth; Chi-Square Distribution; Drug Therapy, Combination; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Leukocytes; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Proton Pumps; Recurrence | 1994 |
Selection of patients for treatment of duodenal ulcer infected with Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Selection; Ranitidine; Recurrence; Retrospective Studies; Time Factors | 1994 |
Omeprazole 40 mg o.m. combined with amoxycillin alone or with amoxycillin and metronidazole in the eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies | 1994 |
[H. pylori and chronic duodenal ulcer: eradication therapy with ranitidine-antibiotic combination and follow-up of ulcer disease].
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Ranitidine; Recurrence | 1994 |
[Antibiotic therapy of perforated appendicitis in children: comparison between the amoxicillin-clavulanic acid and the benzylpenicillin-netilmicin-metronidazole combinations].
Topics: Adolescent; Amoxicillin; Appendicitis; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Intestinal Perforation; Male; Metronidazole; Netilmicin; Penicillin G; Rupture, Spontaneous; Time Factors | 1993 |
Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate.
Topics: Amoxicillin; Anti-Ulcer Agents; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Stomach Ulcer | 1994 |
Effects of eradication of Helicobacter pylori on gastritis in duodenal ulcer patients.
Topics: Amoxicillin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metaplasia; Metronidazole; Omeprazole | 1994 |
Evaluation of two therapeutic regimens for the treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Time Factors | 1994 |
Helicobacter pylori and refractory duodenal ulcers: cross-over comparison of continued cimetidine with cimetidine plus antimicrobials.
Topics: Adult; Amoxicillin; Cimetidine; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Time Factors | 1994 |
[Eradication of metronidazole-resistant Helicobacter pylori: is omeprazole/amoxicillin a therapeutic alternative?].
Topics: Adult; Aged; Amoxicillin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1994 |
Microbiological and clinical effects of metronidazole and amoxicillin in Actinobacillus actinomycetemcomitans-associated periodontitis. A 2-year evaluation.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Bacteroides; Dental Plaque; Dental Plaque Index; Dental Scaling; Drug Therapy, Combination; Humans; Metronidazole; Periodontal Index; Periodontitis; Porphyromonas gingivalis; Root Planing | 1994 |
Eradicating Helicobacter pylori infection lowers gastrin mediated acid secretion by two thirds in patients with duodenal ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Basal Metabolism; Breath Tests; Carbon Radioisotopes; Duodenal Ulcer; Female; Gastric Acid; Gastrin-Releasing Peptide; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Infusions, Intravenous; Male; Metronidazole; Organometallic Compounds; Pepsin A; Peptides; Time Factors; Urea | 1993 |
Helicobacter pylori eradication: efficacy and side effect profile of a combination of omeprazole, amoxycillin and metronidazole compared with four alternative regimens.
Topics: Aged; Amoxicillin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1993 |
Optimizing antimicrobial prophylaxis in reconstructive vascular surgery.
Topics: Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Aorta, Abdominal; Arterial Occlusive Diseases; Blood Vessel Prosthesis; Cefuroxime; Clavulanic Acids; Drug Therapy, Combination; Female; Femoral Artery; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Metronidazole; Middle Aged; Popliteal Artery; Premedication; Surgical Wound Infection | 1993 |
Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy.
Topics: Amoxicillin; Antibodies, Bacterial; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Kinetics; Metronidazole; Ranitidine; Sensitivity and Specificity; Treatment Outcome | 1993 |
A prospective randomized study comparing amoxycillin/clavulanate with cefuroxime plus metronidazole for perioperative prophylaxis in gynaecological surgery.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacterial Infections; Cefuroxime; Cesarean Section; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Hysterectomy; Intraoperative Complications; Metronidazole; Middle Aged; Postoperative Complications; Pregnancy; Prospective Studies | 1993 |
Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline | 1993 |
Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Prospective Studies; Ranitidine; Recurrence | 1993 |
Short report: a non-metronidazole triple therapy for eradication of Helicobacter pylori infection--tetracycline, amoxicillin, bismuth.
Topics: Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Stomach Ulcer; Tetracycline | 1993 |
Triple therapy vs. amoxicillin plus omeprazole for treatment of Helicobacter pylori infection: a multicenter, prospective, randomized, controlled study of efficacy and side effects.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colloids; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance; Penicillins; Prospective Studies; Tetracycline; Time Factors | 1996 |
[Ulcer healing through the elimination of Helicobacter pylori: is a week of therapy enough?].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Remission Induction; Stomach Ulcer; Tetracycline; Time Factors | 1996 |
Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Duodenum; Female; Gastric Acid; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins | 1996 |
Addition of metronidazole to omeprazole/amoxycillin dual therapy increases the rate of Helicobacter pylori eradication: a double-blind, randomized trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Double-Blind Method; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1995 |
Dual therapy versus triple therapy for Helicobacter pylori-associated duodenal ulcers.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Single-Blind Method; Tetracycline; Time Factors | 1996 |
Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Antibodies, Bacterial; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Prospective Studies | 1996 |
Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence; Time Factors | 1996 |
Low H. pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Chile; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Salicylates; Single-Blind Method; Time Factors | 1996 |
Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: randomized controlled study in Japan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cimetidine; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Prognosis; Recurrence; Treatment Outcome; Wound Healing | 1996 |
Effect of omeprazole on the distribution of metronidazole, amoxicillin, and clarithromycin in human gastric juice.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Double-Blind Method; Gastric Acid; Gastric Juice; Gastric Mucosa; Humans; Male; Metronidazole; Omeprazole; Penicillins; Saliva; Tissue Distribution | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Stomach Ulcer; Time Factors | 1996 |
One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Helicobacter pylori infection in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Tinidazole | 1996 |
Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: results of a randomized prospective single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Tetracycline | 1995 |
Prospective evaluation of the macrolide antibiotic dirithromycin for the treatment of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Combinations; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies; Urea | 1996 |
Helicobacter pylori eradication--evaluation of triple therapy containing omeprazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Prospective Studies; Time Factors | 1996 |
Symptomatic and endoscopic duodenal ulcer relapse rates 12 months following Helicobacter pylori eradication treatment with omeprazole and amoxycillin with or without metronidazole.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Recurrence | 1996 |
One-week therapy for Helicobacter pylori. A randomized trial of two treatment regimens.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Salicylates | 1996 |
Chemoprevention trial on precancerous lesions of the stomach in Venezuela: summary of study design and baseline data.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anticarcinogenic Agents; Antioxidants; Clarithromycin; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Placebos; Precancerous Conditions; Stomach Neoplasms; Vitamins | 1996 |
Therapeutic options after failed Helicobacter pylori eradication therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Retreatment; Treatment Failure | 1996 |
Omeprazole plus amoxicillin versus triple therapy eradicates Helicobacter pylori in the Chinese with peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Salicylates; Salicylic Acid | 1996 |
Reinfection and duodenal ulcer relapse in south-east Asian patients following successful Helicobacter pylori eradication: results of a 2-year follow-up.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Recurrence; Time Factors | 1996 |
A twelve-month follow-up after Helicobacter pylori eradication. A clinical and histological evaluation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Ranitidine; Tetracycline | 1996 |
Highly effective twice-daily triple therapies for Helicobacter pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Norway; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Stomach Ulcer | 1997 |
A comparison between omeprazole-based triple therapy and bismuth-based triple therapy for the treatment of Helicobacter pylori infection: a prospective randomized 1-yr follow-up study.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Oxytetracycline; Penicillins; Prospective Studies; Recurrence; Time Factors | 1997 |
Immediate repeat course of amoxycillin, metronidazole and omeprazole to eradicate Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 1997 |
Does pretreatment with omeprazole decrease the chance of eradication of Helicobacter pylori in peptic ulcer patients?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies; Treatment Outcome | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Another therapeutic schedule in eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Ulcer Agents; Clavulanic Acids; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole | 1997 |
Efficacy of ebrotidine and ranitidine combined with amoxicillin and metronidazole in the eradication of Helicobacter pylori in patients with duodenal ulcer.
Topics: Adult; Amoxicillin; Benzenesulfonates; Double-Blind Method; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Ranitidine; Thiazoles | 1997 |
Helicobacter pylori eradication for the treatment of low-grade gastric MALT lymphoma: follow-up together with sequential molecular studies.
Topics: Aged; Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastrointestinal Neoplasms; Genes, Immunoglobulin; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction; Prospective Studies | 1997 |
Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomised double blind placebo controlled study.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged | 1997 |
Helicobacter pylori eradication--comparison of three drug regimens and symptomatic assessment in duodenitis and antral gastritis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 1997 |
Endoscopic ultrasonography for the initial staging and follow-up in patients with low-grade gastric lymphoma of mucosa-associated lymphoid tissue treated medically.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Antineoplastic Agents, Alkylating; Clarithromycin; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Endosonography; Female; Follow-Up Studies; Gastric Mucosa; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Staging; Omeprazole; Sensitivity and Specificity; Treatment Outcome | 1997 |
A United States multicentre trial of dual and proton pump inhibitor-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; United States | 1997 |
Two omeprazole-based Helicobacter pylori eradication regimens for the treatment of duodenal ulcer disease in general practice.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quality of Life | 1997 |
Short-course therapy with amoxycillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Canada; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 1997 |
Double-blind, multicenter evaluation of lansoprazole and amoxicillin dual therapy for the cure of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Double-Blind Method; Drug Eruptions; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hypertension; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prevalence; Proton Pump Inhibitors; Research Design; Treatment Outcome | 1996 |
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study.
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1996 |
Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Combinations; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Salicylates; Tetracycline; Urea | 1997 |
Rapid recurrence of Helicobacter pylori infection in Peruvian patients after successful eradication. Gastrointestinal Physiology Working Group of the Universidad Peruana Cayetano Heredia and The Johns Hopkins University.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peru; Recurrence; Salicylates; Tetracycline; Tinidazole | 1997 |
Ranitidine versus colloidal bismuth subcitrate in combination with amoxicillin and metronidazole for eradicating Helicobacter pylori in patients with duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Ranitidine; Recurrence | 1997 |
[Hormonal changes and secretion and stomach mucosal microstructure in the course of H. pylori in patients with duodenal ulcer].
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Somatostatin | 1997 |
[Endocrine and exocrine gastric mucosal secretion in the course of H. pylori eradication in patients with non-ulcer dyspepsia].
Topics: Amoxicillin; Bismuth; Dyspepsia; Epidermal Growth Factor; Gastric Juice; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Somatostatin; Stomach Ulcer | 1997 |
Carbon 13-labeled urea breath test for the diagnosis of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Radioisotopes; Child; Child, Preschool; Fasting; Female; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity; Urea | 1997 |
Combination amoxycillin and metronidazole with famotidine in the eradication of Helicobacter pylori--a randomized, double-blind comparison of a three times daily and twice daily regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antitrichomonal Agents; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Treatment Outcome | 1997 |
Highly effective second-line anti-Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Oxytetracycline; Prospective Studies | 1997 |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline | 1998 |
Adding once-daily omeprazole 20 mg to metronidazole/amoxicillin treatment for Helicobacter pylori gastritis: a randomized, double-blind trial showing the importance of metronidazole resistance.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Chronic Disease; Confidence Intervals; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Placebos; Stomach; Time Factors | 1998 |
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method | 1997 |
Differential effects of systemic metronidazole and amoxicillin on Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in intraoral habitats.
Topics: Administration, Oral; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chlorhexidine; Colony Count, Microbial; Dental Plaque; Dental Scaling; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Mouth Mucosa; Mouthwashes; Palatine Tonsil; Penicillins; Periodontitis; Porphyromonas gingivalis; Tablets; Therapeutic Irrigation; Tongue | 1998 |
[new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1998 |
[Effects of the triple therapy in the eradication of Helicobacter pylori: comparison of 3 different antibiotics].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Time Factors | 1997 |
Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.
Topics: Adult; Alginates; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Ulcer Agents; Drug Combinations; Drug Therapy, Combination; Esophagitis; Female; Gastrins; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Silicic Acid; Sodium Bicarbonate | 1998 |
Short duration therapy for Helicobacter pylori in Western Australia: the impact of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Tetracycline; Western Australia | 1998 |
Amoxicillin/metronidazole/omeprazole/clarithromycin: a new, short quadruple therapy for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Prospective Studies | 1998 |
Utility of serology in determining Helicobacter pylori eradication after therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Enzyme-Linked Immunosorbent Assay; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Immunoglobulin A; Immunoglobulin G; Male; Metronidazole; Organometallic Compounds; Predictive Value of Tests; Sensitivity and Specificity | 1998 |
A prospective randomized study of amoxycillin and omeprazole with and without metronidazole in the eradication treatment of Helicobacter pylori.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Ulcer; Treatment Outcome | 1998 |
Two-day quadruple therapy for cure of Helicobacter pylori infection: a comparative, randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Treatment Outcome | 1998 |
The use of metronidazole and amoxicillin in the treatment of advanced periodontal disease. A prospective, controlled clinical trial.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Biopsy; Combined Modality Therapy; Dental Scaling; Female; Follow-Up Studies; Gingival Hemorrhage; Humans; Male; Metronidazole; Middle Aged; Penicillins; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Pocket; Periodontitis; Placebos; Porphyromonas gingivalis; Prevotella intermedia; Prospective Studies; Radiography; Root Planing | 1998 |
Differential clinical treatment outcome after systemic metronidazole and amoxicillin in patients harboring Actinobacillus actinomycetemcomitans and/or Porphyromonas gingivalis.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chlorhexidine; Dental Scaling; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Penicillins; Periodontal Attachment Loss; Periodontitis; Porphyromonas gingivalis; Therapeutic Irrigation; Treatment Outcome | 1998 |
Omeprazole, azithromycin and either amoxycillin or metronidazole in eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1998 |
Comparison of two 1-week low-dose omeprazole triple therapies--optimal treatment for Helicobacter pylori infection?
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method; Treatment Outcome | 1997 |
Susceptibility of Helicobacter pylori isolates to metronidazole, clarithromycin and amoxycillin in vitro and in clinical treatment in Japan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; Disease Susceptibility; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter pylori; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 1997 |
Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Stomach Ulcer; Tetracycline; Treatment Outcome | 1998 |
Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pefloxacin; Proton Pump Inhibitors | 1998 |
Spiramycin as an alternative to amoxicillin treatment associated with lansoprazole/metronidazole for Helicobacter pylori infection in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Spiramycin | 1998 |
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase; Ranitidine | 1998 |
Incidence of duodenal ulcer healing after 1 week of proton pump inhibitor triple therapy for eradication of Helicobacter pylori. The Lansoprazole Helicobacter Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Treatment Outcome | 1998 |
Cure of H. pylori infection using a 7-day triple therapy combining pantoprazole with two antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Patient Compliance; Penicillins; Peptic Ulcer; Sulfoxides; Treatment Outcome | 1998 |
Reversal of fundic atrophy after eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Female; Follow-Up Studies; Gastric Acid; Gastric Emptying; Gastric Fundus; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds | 1998 |
Safety and efficacy of rabeprazole in combination with four antibiotic regimens for the eradication of Helicobacter pylori in patients with chronic gastritis with or without peptic ulceration.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton-Translocating ATPases; Rabeprazole; Time Factors; Treatment Outcome | 1998 |
A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Roxithromycin; Treatment Outcome | 1998 |
Continuous and more effective duodenal ulcer healing under therapy with bismuth and two antibiotics than with dual therapy comprising omeprazole and amoxicillin.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Female; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1998 |
Additional clinical and microbiological effects of amoxicillin and metronidazole after initial periodontal therapy.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Bacteroides; Bacteroides Infections; Drug Therapy, Combination; Feces; Female; Humans; Male; Metronidazole; Middle Aged; Penicillins; Periodontal Pocket; Porphyromonas gingivalis; Prevotella intermedia; Statistics, Nonparametric | 1998 |
Effects of metronidazole plus amoxicillin in progressive untreated adult periodontitis: results of a single 1-week course after 2 and 4 months.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Colony Count, Microbial; Double-Blind Method; Drug Combinations; Female; Humans; Male; Metronidazole; Middle Aged; Penicillins; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Statistics, Nonparametric | 1998 |
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline | 1998 |
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Odds Ratio; Omeprazole; Penicillins; Prognosis; Prospective Studies; Time Factors | 1998 |
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 1999 |
Clinical and microbiological effects of adjunctive antibiotics in treatment of localized juvenile periodontitis. A controlled clinical trial.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Process; Amoxicillin; Anti-Bacterial Agents; Child; Combined Modality Therapy; Dental Plaque Index; Dental Scaling; Double-Blind Method; Follow-Up Studies; Humans; Metronidazole; Mouth; Penicillins; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Radiography; Root Planing; Subgingival Curettage | 1998 |
[Recurrence rate of H. pylori after successful eradication and second eradication therapy after initial failure of treatment].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Recurrence; Time Factors; Treatment Failure | 1999 |
[Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 1999 |
Enhancing compliance not a prerequisite for effective eradication of Helicobacter pylori: the HelP Study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Single-Blind Method | 1999 |
[The treatment of chronic duodenal ulcer with accompanying Helicobacter pylori infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Clinical Protocols; Duodenal Ulcer; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Retrospective Studies; Treatment Outcome | 1998 |
The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
Topics: Acute Disease; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1999 |
The influence of metronidazole resistance on the efficacy of ranitidine bismuth citrate triple therapy regimens for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Ranitidine; Stomach Ulcer | 1999 |
Once-daily therapy for H. pylori infection: a randomized comparison of four regimens.
Topics: Adult; Amoxicillin; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pilot Projects | 1999 |
Rapid elimination of Helicobacter pylori and reduction of histocompatibility leucocyte antigen-DR expression 12 h after a single dose of omeprazole, amoxycillin and metronidazole triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; HLA-DR Antigens; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Time Factors | 1999 |
Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 1999 |
The optimal antibiotic combination in a 5-day Helicobacter pylori eradication regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Single-Blind Method; Treatment Outcome | 1999 |
Comparison of enamel matrix proteins and bioabsorbable membranes in the treatment of intrabony periodontal defects. A split-mouth study.
Topics: Absorbable Implants; Alveolar Bone Loss; Amoxicillin; Anti-Infective Agents; Dental Enamel Proteins; Dental Plaque Index; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Recession; Guided Tissue Regeneration, Periodontal; Humans; Male; Membranes, Artificial; Metronidazole; Penicillins; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Single-Blind Method; Treatment Outcome | 1999 |
[Antral biopsy is sufficient to confirm Helicobacter pylori eradication with the "new" one-week long triple treatments].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach Ulcer; Time Factors | 1999 |
Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments.
Topics: Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 1999 |
Efficacy of 7 day lansoprazole-based triple therapy for Helicobacter pylori infection in elderly patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Treatment Outcome | 1999 |
Helicobacter pylori eradication: comparison of three treatment regimens in India.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Treatment Outcome | 1999 |
Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Doxycycline; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Tetracycline; Treatment Failure | 1999 |
Colloidal bismuth pectin: an alternative to bismuth subcitrate for the treatment of Helicobacter pylori--positive duodenal ulcer.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; China; Colloids; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pectins | 1999 |
Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Child; Double-Blind Method; Drug Therapy, Combination; Female; Ferrous Compounds; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Intestinal Absorption; Male; Metronidazole; Nutritional Status; Organometallic Compounds; Placebos; Pyloric Antrum | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
Randomized trial of omeprazole and clarithromycin combined with either metronidazole or amoxycillin in patients with metronidazole-resistant or -susceptible Helicobacter pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Single-Blind Method | 1999 |
Eradication of Helicobacter pylori infection with proton pump-based triple therapy in patients in whom bismuth-based triple therapy failed.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Proton Pump Inhibitors; Salicylates; Treatment Outcome | 1999 |
One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 1999 |
Prevalence of resistance to clarithromycin and its clinical impact on the efficacy of Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Peptic Ulcer; Prospective Studies; Statistics, Nonparametric; Sulfoxides; Treatment Failure | 1999 |
The OAC and OMC options.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Treatment Outcome | 1999 |
Clonal infection with Actinobacillus actinomycetemcomitans following periodontal therapy.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Bacterial Typing Techniques; Chronic Disease; Clone Cells; Dental Plaque; Disease Progression; DNA Fingerprinting; DNA, Bacterial; Exotoxins; Female; Genetic Variation; Humans; Male; Metronidazole; Middle Aged; Penicillins; Periodontal Pocket; Periodontitis; Random Amplified Polymorphic DNA Technique; Survival Analysis; Virulence | 1999 |
Assessment of decisions in the treatment of Helicobacter pylori-related duodenal ulcer: a cost-effectiveness study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; China; Cimetidine; Cost-Benefit Analysis; Disease Management; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Treatment Outcome | 1999 |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 1999 |
Protective effect of serum antibodies against a 110-kilodalton protein of Actinobacillus actinomycetemcomitans following periodontal therapy.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Bacterial Outer Membrane Proteins; Chlorhexidine; Dental Scaling; Female; Humans; Immunoglobulin A; Immunoglobulin G; Male; Metronidazole; Middle Aged; Molecular Weight; Penicillins; Periodontitis | 1999 |
Comparative effects of omeprazole, amoxycillin plus metronidazole versus omeprazole, clarithromycin plus metronidazole on the oral, gastric and intestinal microflora in Helicobacter pylori-infected patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Male; Metronidazole; Middle Aged; Mouth; Omeprazole; Penicillins; Stomach | 1999 |
The outcome of a 2-week treatment of Helicobacter pylori-positive duodenal ulcer with omeprazole-based antibiotic regimen in a region with high metronidazole resistance rate.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Contraindications; Drug Resistance, Microbial; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Outcome | 1999 |
[Reinfection with Helicobacter pylori in patients with duodenal ulcer after successful eradication].
Topics: Adult; Amoxicillin; Bismuth; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Wound Healing | 1999 |
Predictors of failure of Helicobacter pylori eradication and predictors of ulcer recurrence: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Duodenal Ulcer; Endoscopy; Female; Follow-Up Studies; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Penicillins; Predictive Value of Tests; Quebec; Recurrence; Treatment Failure | 1999 |
Efficacy of two different dosage regimens of omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Resistance; Drug Therapy, Combination; Endoscopy; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum; Pylorus; Time Factors; Urea | 1999 |
Eradication of Helicobacter pylori using 30 mg or 60 mg lansoprazole combined with amoxicillin and metronidazole: one and two weeks of a new triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Isotopes; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Time Factors; Treatment Outcome; Urea | 1999 |
Comparison of lansoprazole-based triple and dual therapy for treatment of Helicobacter pylori-related duodenal ulcer: an Asian multicentre double-blind randomized placebo controlled study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Asia; Breath Tests; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Risk Factors; Urea | 2000 |
Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asia, Southeastern; Biopsy; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Single-Blind Method | 2000 |
Four-day, twice daily, quadruple therapy with amoxicillin, clarithromycin, tinidazole and omeprazole to cure Helicobacter pylori infection: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nausea; Omeprazole; Organometallic Compounds; Patient Compliance; Pilot Projects; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2000 |
[The MACH2 Study: value of inhibiting gastric acid secretion in eradication of Helicobacter pylori with a one week triple therapy protocol].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Treatment Outcome | 2000 |
Repeated metronidazole and amoxicillin treatment of periodontitis. A follow-up study.
Topics: Adult; Aged; Amoxicillin; Analysis of Variance; Anti-Infective Agents; Chronic Disease; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Gingival Hemorrhage; Humans; Male; Metronidazole; Middle Aged; Penicillins; Periodontal Abscess; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Placebos | 2000 |
Effect of triple therapy on eradication of canine gastric helicobacters and gastric disease.
Topics: Amoxicillin; Animals; Antacids; Anti-Bacterial Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Helicobacter; Helicobacter Infections; Male; Metronidazole; Organometallic Compounds; Penicillins; Stomach Diseases | 2000 |
Is Helicobacter pylori eradication associated with gastroesophageal reflux disease?
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis, Peptic; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Failure | 2000 |
Patients with dyspepsia benefit from eradication of Helicobacter pylori if other organic causes for dyspepsia were carefully ruled out.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Salicylates; Tetracycline; Treatment Outcome | 2000 |
Randomized trial of omeprazole and metronidazole with amoxycillin or clarithromycin for Helicobacter pylori eradication, in a region of high primary metronidazole resistance: the HERO study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2000 |
Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome | 2000 |
[Effect of pantoprazole, amoxicillin and metronidazole treatment on the level of H. pylori eradication and the histological image of antral gastritis in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Pyloric Antrum; Sulfoxides | 2000 |
[Cost-effectiveness analysis of 2 strategies of Helicobacter pylori eradication: results of a prospective and randomized study in primary care].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Primary Health Care; Prospective Studies; Stomach Ulcer; Tetracycline; Time Factors | 2000 |
Eradication of Helicobacter pylori with pantoprazole and two antibiotics: a comparison of two short-term regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Pantoprazole; Sulfoxides | 2000 |
Impact of Helicobacter pylori antimicrobial resistance on the outcome of 1-week lansoprazole-based triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Treatment Outcome | 2000 |
Treatment of Helicobacter pylori in patients with duodenal ulcer hemorrhage--a long-term randomized, controlled study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Peptic Ulcer Hemorrhage; Prognosis; Secondary Prevention | 2000 |
Eradication of Helicobacter pylori compared with long-term acid suppression in duodenal ulcer disease. A randomized trial with 2-year follow-up. The Danish Ulcer Study Group.
Topics: Amoxicillin; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Quality of Life | 2000 |
A multicentre study on eradication of Helicobacter pylori using four 1-week triple therapies in China.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Furazolidone; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 2001 |
Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Agents; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2000 |
The HOMER Study: the effect of increasing the dose of metronidazole when given with omeprazole and amoxicillin to cure Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Infant, Newborn; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2000 |
Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy, Needle; Confidence Intervals; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pantoprazole; Probability; Prospective Studies; Rifabutin; Sulfoxides; Tetracycline; Treatment Failure | 2001 |
Clarithromycin vs. furazolidone in quadruple therapy regimens for the treatment of Helicobacter pylori in a population with a high metronidazole resistance rate.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Anti-Ulcer Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Treatment Outcome | 2001 |
Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Rabeprazole; Treatment Outcome | 2001 |
Prevalence of Helicobacter pylori resistance to antibiotics in Northeast Italy: a multicentre study. GISU. Interdisciplinary Group for the Study of Ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Clarithromycin; Confidence Intervals; Culture Techniques; Drug Resistance, Microbial; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Prevalence; Probability; Risk Factors; Sex Distribution; Statistics, Nonparametric | 2000 |
The effect of postsurgical antibiotics on the healing of intrabony defects following treatment with enamel matrix proteins.
Topics: Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bone Substitutes; Dental Enamel Proteins; Dental Plaque Index; Double-Blind Method; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Recession; Humans; Male; Metronidazole; Penicillins; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Smoking; Statistics as Topic; Wound Healing | 2001 |
The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Organometallic Compounds; Patient Selection; Penicillins; Peptic Ulcer; Time Factors; Treatment Failure | 2001 |
Amoxicillin plus metronidazole in the treatment of adult periodontitis patients. A double-blind placebo-controlled study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteroides; Dental Plaque; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Gingival Hemorrhage; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptostreptococcus; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Placebos; Porphyromonas gingivalis; Prevotella intermedia; Smoking; Statistics as Topic; Statistics, Nonparametric; Subgingival Curettage | 2001 |
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.
Topics: Adult; Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probability; Ranitidine; Reference Values; Treatment Outcome | 2001 |
Randomised study of the efficacy of omeprazole and clarithromycin with either amoxycillin or metronidazole in the eradication of Helicobacter pylori in screened primary care patients.
Topics: Adult; Amoxicillin; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Probability; Reference Values; Treatment Outcome | 2001 |
Anti-inflammatory and tissue-protectant drug effects: results from a randomized placebo-controlled trial of gastritis patients at high risk for gastric cancer.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Epithelium; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Male; Metronidazole; Middle Aged; Organometallic Compounds; Penicillins; Placebos; Risk Factors; Salicylates; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2001 |
Is eradication of Helicobacter pylori with colloidal bismuth subcitrate quadruple therapy safe?
Topics: Adult; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Safety | 2001 |
High efficacy of ranitidine bismuth citrate, amoxicillin, clarithromycin and metronidazole twice daily for only five days in Helicobacter pylori Eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 2001 |
The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori.
Topics: Adolescent; Aged; Aged, 80 and over; Amoxicillin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2001 |
Helicobacter pylori and iron deficiency anaemia in children.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Chronic Disease; Clarithromycin; Drug Therapy, Combination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Urea | 2001 |
Is untargeted outreach visiting in primary care effective? A pragmatic randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Community Pharmacy Services; Community-Institutional Relations; Drug Prescriptions; Drug Therapy, Combination; Drug Utilization Review; Education, Medical, Continuing; England; Family Practice; Female; Guideline Adherence; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medical Audit; Metronidazole; Omeprazole; Penicillins; Practice Guidelines as Topic; Practice Patterns, Physicians'; Primary Health Care; Program Evaluation; Proton Pump Inhibitors | 2001 |
Various durations of a standard regimen (amoxycillin, metronidazole, colloidal bismuth sub-citrate for 2 weeks or with additional ranitidine for 1 or 2 weeks) on eradication of Helicobacter pylori in Iranian peptic ulcer patients. A randomized controlled
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy, Needle; Bismuth; Breath Tests; Drug Administration Schedule; Drug Therapy, Combination; Esophagoscopy; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Urea | 2001 |
A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors | 2001 |
A multicenter study on eradication of Helicobacter pylori infection in patients with duodenal ulcer by lansoprazole-antibiotics combined therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies | 1999 |
[Efficiency of quamatel in combination with device sound stimulation of the gastroduodenal zone in ulcer patients].
Topics: Acoustic Stimulation; Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Antifungal Agents; Combined Modality Therapy; Drug Therapy, Combination; Famotidine; Female; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Sound | 2001 |
A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia.
Topics: Administration, Oral; Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Penicillins; Treatment Outcome; Urea | 2001 |
Treatment of Helicobacter pylori in children with recurrent abdominal pain.
Topics: Abdominal Pain; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Double-Blind Method; Drug Therapy, Combination; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Recurrence | 2001 |
Helicobacter pylori eradication therapy is more effective in peptic ulcer than in non-ulcer dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Penicillins; Peptic Ulcer; Ranitidine; Retrospective Studies | 2001 |
Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Sickness Impact Profile | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome | 2002 |
Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Taiwan | 2002 |
Conservative treatment of primary gastric low-grade B-cell lymphoma of mucosa-associated lymphoid tissue: predictive factors of response and outcome.
Topics: Adult; Aged; Amoxicillin; Antineoplastic Agents, Alkylating; Biopsy, Needle; Chlorambucil; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Predictive Value of Tests; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2002 |
Eradication of Helicobacter pylori in duodenal ulcer disease tetracycline & furazolidone vs. metronidazole & amoxicillin in omeprazole based triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Duodenal Ulcer; Furazolidone; Helicobacter pylori; Humans; Metronidazole; Tetracycline | 2002 |
Adjunctive effects to non-surgical periodontal therapy of systemic metronidazole and amoxycillin alone and combined. A placebo controlled study.
Topics: Adult; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Capsules; Chronic Disease; Colony Count, Microbial; Combined Modality Therapy; Dental Plaque; Dental Scaling; Double-Blind Method; Drug Combinations; Follow-Up Studies; Gingival Hemorrhage; Humans; Linear Models; Metronidazole; Middle Aged; Penicillins; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Pocket; Placebos; Prevotella intermedia; Root Planing; Suppuration; Tablets; Treatment Outcome | 2002 |
Additive effect of pronase on the efficacy of eradication therapy against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pronase; Treatment Outcome | 2002 |
Aggressive periodontitis: 5-year follow-up of treatment.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Dental Plaque; Dental Scaling; Disease Progression; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontitis; Recurrence; Statistics, Nonparametric; Subgingival Curettage; Surgical Flaps; Treatment Outcome | 2002 |
One-week triple vs. quadruple therapy for Helicobacter pylori infection - a randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Tetracycline; Treatment Outcome | 2002 |
Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Urease | 2002 |
Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Azithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Treatment Outcome | 2002 |
Vitamin C and E supplements to lansoprazole-amoxicillin-metronidazole triple therapy may reduce the eradication rate of metronidazole-susceptible Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Lansoprazole; Male; Metronidazole; Omeprazole; Severity of Illness Index; Stomach Diseases; Treatment Outcome; Vitamin E | 2002 |
Antibiotic resistance of subgingival species during and after antibiotic therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Colony Count, Microbial; Dental Plaque; Doxycycline; Drug Resistance, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillin Resistance; Periodontitis; Random Allocation; Saliva; Tetracycline Resistance | 2002 |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2002 |
[Comparison of pantoprazole and omeprazole-based triple therapy regimens in the treatment of Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Sulfoxides; Time Factors; Treatment Outcome | 2002 |
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection: a 24-month follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Tetracycline; Wound Healing | 2002 |
Use of barrier membranes and systemic antibiotics in the treatment of intraosseous defects.
Topics: Abscess; Absorbable Implants; Adult; Alveolar Bone Loss; Amoxicillin; Biocompatible Materials; Bone Regeneration; Citrates; Colony Count, Microbial; Drug Therapy, Combination; Female; Guided Tissue Regeneration, Periodontal; Humans; Male; Membranes, Artificial; Metronidazole; Mouth Floor; Oral Surgical Procedures; Periodontal Index; Polyesters; Smoking; Surgical Wound Infection | 2002 |
One-week ranitidine bismuth citrate, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Ranitidine; Treatment Outcome | 2002 |
Efficacy of triple therapy comprising rabeprazole, amoxicillin and metronidazole for second-line Helicobacter pylori eradication in Japan, and the influence of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Rabeprazole | 2003 |
[Conservative treatment of patients with stomach polyps].
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Gastric Acid; Helicobacter Infections; Histamine H2 Antagonists; Hormones; Humans; Male; Metronidazole; Middle Aged; Polyps; Ranitidine; Stomach Neoplasms | 2002 |
Effect of treatment of Helicobacter pylori on the prevention of gastroduodenal ulcers in patients receiving long-term NSAIDs: a double-blind, placebo-controlled trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Stomach Ulcer | 2003 |
Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Capsules; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; North America; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2003 |
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Stomach Ulcer; Sulfoxides | 2003 |
Do Japanese and Swedish peptic ulcer patients respond differently to Helicobacter pylori eradication therapies and what are their histological features?
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Sweden; White People | 2003 |
High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Rabeprazole; Treatment Outcome | 2003 |
Increased reflux symptoms after calcium carbonate supplementation and successful anti-Helicobacter pylori treatment.
Topics: Adult; Amoxicillin; Antacids; Bismuth; Calcium Carbonate; Drug Therapy, Combination; Dyspepsia; Female; Gastric Acidity Determination; Gastritis, Atrophic; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Retrospective Studies; Risk Factors; Salicylates; Tetracycline | 2003 |
Clinical efficiency of Epigam in patients with exacerbation of peptic ulcer disease of the stomach and duodenum.
Topics: Adolescent; Adult; Amoxicillin; Anti-Ulcer Agents; Antibodies; Dose-Response Relationship, Drug; Drug Administration Schedule; Duodenum; Female; Helicobacter Infections; Histamine; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Ranitidine; Stomach; Treatment Outcome; Young Adult | 2003 |
A prospective, randomized study of quadruple therapy and high-dose dual therapy for treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Tetracycline; Urea | 2003 |
One-day quadruple therapy compared with 7-day triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salicylates; Severity of Illness Index; Treatment Outcome | 2003 |
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Failure | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
Piperacillin-tazobactam versus ciprofloxacin plus amoxicillin in the treatment of infective episodes after liver transplantation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae; Female; Fever; Humans; Liver Transplantation; Male; Metronidazole; Middle Aged; Penicillanic Acid; Penicillins; Piperacillin; Piperacillin, Tazobactam Drug Combination; Postoperative Complications; Prospective Studies; Staphylococcus aureus | 2003 |
Efficacy of different antibiotic regimens for eradication treatment of Helicobacter pylori infection in peptic ulcer disease in Tanzanian patients.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Treatment Outcome | 2003 |
Eradication of Helicobacter pylori by 7-day triple-therapy regimens combining pantoprazole with clarithromycin, metronidazole, or amoxicillin in patients with peptic ulcer disease: results of two double-blind, randomized studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer; Sulfoxides; Treatment Outcome | 2003 |
Long term outcome of patients with gastric marginal zone B cell lymphoma of mucosa associated lymphoid tissue (MALT) following exclusive Helicobacter pylori eradication therapy: experience from a large prospective series.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2004 |
[Efficacy of omeprazole in the treatment of Helicobacter pylori-associated duodenal ulcers... in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Child; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Secondary Prevention; Time Factors | 2003 |
Low eradication rate of Helicobacter pylori with triple 7-14 days and quadriple therapy in Turkey.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach Ulcer; Tetracycline; Treatment Outcome; Turkey | 2004 |
Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost Savings; Cost-Benefit Analysis; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prevalence; Proton Pump Inhibitors; Proton Pumps; Statistics as Topic; Tetracycline; Treatment Outcome | 2003 |
Does the 'test-and-treat' strategy work in primary health care for management of uninvestigated dyspepsia? A prospective two-year follow-up study of 1552 patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Endoscopy, Gastrointestinal; Family Practice; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Outcome and Process Assessment, Health Care; Peptic Ulcer; Prospective Studies; Quality of Life; Referral and Consultation | 2004 |
Use of imidazole-based eradication regimens for Helicobacter pylori should be abandoned in North India regardless of in vitro antibiotic sensitivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; India; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Peptic Ulcer; Prospective Studies; Tinidazole; Treatment Outcome; Wound Healing | 2004 |
Intraoral dissemination of treponemes after periodontal therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Chronic Disease; Colony Count, Microbial; Debridement; Dental Plaque; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Periodontitis; Prospective Studies; Treponema; Treponema denticola; Treponemal Infections | 2004 |
[Long-term therapeutic effect of triple therapy consisted of omeperazole, clarithromycin and amoxycillin in children with Helicobacter pylori infection and approach to re-treatment after failure of the treatment].
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence; Time Factors; Treatment Outcome | 2004 |
Total family unit Helicobacter pylori eradication and pediatric re-infection rates.
Topics: Adolescent; Amoxicillin; Breath Tests; Child; Child, Preschool; Clarithromycin; Community-Acquired Infections; Family Health; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Recurrence; Urea | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study].
Topics: Amoxicillin; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Recurrence | 2004 |
Periodontal treatment of patients with Papillon-Lefèvre syndrome: a 3-year follow-up.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Dental Care for Chronically Ill; Dental Scaling; Humans; Male; Metronidazole; Papillon-Lefevre Disease; Patient Compliance; Periodontitis; Tetracycline; Treatment Outcome | 2004 |
A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Pantoprazole; Prospective Studies; Sulfoxides; Treatment Outcome | 2004 |
Effects of Helicobacter pylori eradication on platelet activation and disease recurrence in patients with acute coronary syndromes.
Topics: Acute Disease; Amoxicillin; Antigens, CD; Coronary Disease; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; P-Selectin; Platelet Activation; Platelet Membrane Glycoprotein IIb; Platelet Membrane Glycoproteins; Recurrence; Tetraspanin 30 | 2004 |
Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Protocols; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2005 |
Response of blood endothelin-1 and nitric oxide activity in duodenal ulcer patients undergoing Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Biomarkers; Drug Therapy, Combination; Duodenal Ulcer; Endothelin-1; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrates; Nitric Oxide; Nitrites; Omeprazole; Rabeprazole | 2005 |
Enamel matrix proteins and systemic antibiotics as adjuncts to non-surgical periodontal treatment: clinical effects.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bone Density; Chronic Disease; Combined Modality Therapy; Dental Enamel Proteins; Dental Scaling; Humans; Longitudinal Studies; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Placebos; Porphyromonas gingivalis; Root Planing | 2005 |
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Ranitidine; Risk Factors | 2005 |
Mucosa-associated bacteria in ulcerative colitis before and after antibiotic combination therapy.
Topics: Amoxicillin; Colitis, Ulcerative; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Humans; Intestinal Mucosa; Metronidazole; Tetracycline | 2005 |
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey | 2005 |
Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Treatment Outcome | 2005 |
Adjunctive antimicrobial therapy of periodontitis: long-term effects on disease progression and oral colonization.
Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Chemotherapy, Adjuvant; Chi-Square Distribution; Chlorhexidine; Dental Plaque; Dental Scaling; Female; Humans; Male; Metronidazole; Middle Aged; Periodontitis; Porphyromonas gingivalis; Time Factors | 2005 |
Low-dose rabeprazole, amoxicillin and metronidazole triple therapy for the treatment of Helicobacter pylori infection in Chinese patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Biopsy; Dose-Response Relationship, Drug; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Proton-Translocating ATPases; Pyloric Antrum; Rabeprazole; Retrospective Studies; Treatment Outcome | 2005 |
A follow-up study on the effect of Helicobacter pylori eradication on the severity of gastric histology.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Atrophy; Female; Follow-Up Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Intestines; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Stomach; Treatment Outcome | 2005 |
The results of Helicobacter pylori eradication on repeated bleeding in patients with stomach ulcer.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Recurrence; Stomach Ulcer; Treatment Outcome | 2005 |
Adjunctive benefits of systemic amoxicillin and metronidazole in non-surgical treatment of generalized aggressive periodontitis: a randomized placebo-controlled clinical trial.
Topics: Adolescent; Adult; Algorithms; Amoxicillin; Anti-Infective Agents; Epidemiologic Methods; Female; Humans; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis | 2005 |
A randomized trial of triple therapy for pediatric Helicobacter pylori infection and risk factors for treatment failure in a population with a high prevalence of infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prevalence; Prospective Studies; Risk Factors; Treatment Failure | 2005 |
Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors | 2005 |
Improved efficacy of 10-Day sequential treatment for Helicobacter pylori eradication in children: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Remission Induction; Tinidazole; Treatment Outcome | 2005 |
Effectiveness of antibiotic combination therapy in patients with active ulcerative colitis: a randomized, controlled pilot trial with long-term follow-up.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Fusobacterium; Fusobacterium Infections; Humans; Male; Metronidazole; Middle Aged; Probability; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 2005 |
[PPI plus bismuth-based quintuple therapy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Minocycline; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Treatment Outcome | 2005 |
[Children Helicobacter pylori infection: antibiogram results].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prospective Studies; Stomach | 2005 |
Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 2006 |
7-day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2006 |
Efficacy of moxifloxacin-based triple therapy as second-line treatment for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline; Treatment Outcome | 2006 |
Third-line rescue therapy with levofloxacin after two H. pylori treatment failures.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Prospective Studies; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
Effectiveness of minocycline-based triple therapy for eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Minocycline; Omeprazole; Peptic Ulcer; Rabeprazole; Treatment Outcome | 2006 |
[Lipid peroxidation and antioxidant system in treatment dynamics of patients with chronic gastritis].
Topics: Adult; Aged; alpha-Tocopherol; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antioxidants; Chronic Disease; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lipid Peroxidation; Lipid Peroxides; Male; Metronidazole; Middle Aged; Omeprazole; Tocopherols; Treatment Outcome | 2005 |
[Comparison of the effectiveness of tri- and quadricomponent eradication therapy in patients with peptic ulcer].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Costs; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Russia; Tetracycline; Treatment Outcome | 2005 |
Clinical and microbiological effects of different antimicrobials on generalized aggressive periodontitis.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides; Colony Count, Microbial; Dental Scaling; Doxycycline; Female; Follow-Up Studies; Gingival Hemorrhage; Humans; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Root Planing; Treponema denticola | 2006 |
Enamel matrix derivative and systemic antibiotics as adjuncts to non-surgical periodontal treatment: biologic response.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Dental Enamel Proteins; Dental Scaling; Female; Gingival Crevicular Fluid; Humans; Inflammation Mediators; Interleukin-1; Leukocyte L1 Antigen Complex; Linear Models; Male; Metronidazole; Middle Aged; Pancreatic Elastase; Periodontitis; Prospective Studies; Statistics, Nonparametric | 2006 |
Evaluation of triple and quadruple Helicobacter pylori eradication therapies in Iranian children: a randomized clinical trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Treatment Outcome | 2006 |
Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retreatment; Tokyo; Treatment Outcome | 2006 |
Eradication of H pylori infection in a rural population: one-day quadruple therapy versus 7-day triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Pilot Projects; Prospective Studies; Rural Population | 2006 |
Bismuth-based therapies for the first step eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Ranitidine; Tetracycline; Treatment Outcome; Urease; Young Adult | 2006 |
Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cross-Over Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Rifabutin; Treatment Outcome | 2006 |
Effects of metronidazole plus amoxicillin as the only therapy on the microbiological and clinical parameters of untreated chronic periodontitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Case-Control Studies; Chronic Disease; Dental Plaque; Dental Scaling; Drug Combinations; Female; Follow-Up Studies; Gingival Hemorrhage; Humans; Male; Metronidazole; Middle Aged; Patient Compliance; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Placebos; Root Planing; Smoking | 2006 |
Azithromycin in one week quadruple therapy for H pylori eradication in Iran.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Azithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Patient Compliance | 2006 |
Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds | 2006 |
Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Middle Aged; Proton Pump Inhibitors; Proton Pumps; Treatment Failure | 2006 |
Randomized comparison of two rescue therapies for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline | 2006 |
Efficacy of Helicobacter pylori eradication taking into account its resistance to antibiotics.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lactobacillus acidophilus; Male; Metronidazole; Middle Aged; Pantoprazole; Probiotics; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole; Treatment Outcome | 2006 |
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Melena; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Taste Disorders; Time Factors; Treatment Outcome | 2006 |
2-week triple therapy for Helicobacter pylori infection is better than 1-week in clinical practice: a large prospective single-center randomized study.
Topics: Administration, Oral; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton Pumps | 2006 |
Duration of the metronidazole-containing regimen for eradication of Helicobacter pylori infection in northern Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Time Factors | 2006 |
Furazolidone-based, metronidazole-based, or a combination regimen for eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Stomach Ulcer | 2007 |
Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline; Treatment Failure; Treatment Outcome; Turkey | 2008 |
Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Rabeprazole | 2007 |
H pylori infection in patients with Behcet's disease.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Behcet Syndrome; Biopsy; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Pyloric Antrum; Tetracycline | 2007 |
Adjunctive effects of systemic amoxicillin and metronidazole with scaling and root planing: a randomized, placebo controlled clinical trial.
Topics: Administration, Oral; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Analysis of Variance; Anti-Infective Agents; Chronic Disease; Dental Scaling; Double-Blind Method; Female; Humans; Male; Metronidazole; Middle Aged; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Statistics, Nonparametric | 2007 |
Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Rifabutin; Tetracycline; Treatment Outcome | 2007 |
Comparison between full-mouth scaling and root planing and quadrant-wise basic therapy of aggressive periodontitis: 6-month clinical results.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents, Local; Chlorhexidine; Dental Scaling; Drug Combinations; Facial Pain; Fever; Herpes Labialis; Humans; Linear Models; Metronidazole; Mouthwashes; Periodontal Index; Periodontitis | 2007 |
Controlled-delivery chlorhexidine chip versus amoxicillin/metronidazole as adjunctive antimicrobial therapy for generalized aggressive periodontitis: a randomized controlled clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chlorhexidine; Delayed-Action Preparations; Dental Scaling; Female; Humans; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Root Planing; Single-Blind Method; Smoking; Statistics, Nonparametric | 2007 |
Effects of H pylori therapy on erythrocytic and iron parameters in iron deficiency anemia patients with H pylori-positive chronic gastristis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anemia, Iron-Deficiency; Anti-Infective Agents; Chronic Disease; Drug Therapy, Combination; Erythrocyte Indices; Female; Ferritins; Ferrous Compounds; Gastritis; Helicobacter Infections; Helicobacter pylori; Hemoglobins; Humans; Iron; Male; Metronidazole; Middle Aged; Organometallic Compounds; Risk Factors | 2007 |
The efficacy of bismuth containing quadruple therapy as a first-line treatment option for Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Middle Aged; Single-Blind Method; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 2007 |
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Rifabutin; Tetracycline; Treatment Failure | 2008 |
Second-line treatment for Helicobacter pylori infection: 10-day moxifloxacin-based triple therapy versus 2-week quadruple therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Patient Compliance; Quinolines; Tetracycline | 2007 |
A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Patient Compliance; Pilot Projects; Tetracycline; Turkey | 2007 |
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retreatment; Treatment Outcome | 2008 |
Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2008 |
Effect of a community screening for Helicobacter pylori: a 5-Yr follow-up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Community Health Services; Cost-Benefit Analysis; Cross-Sectional Studies; Denmark; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer | 2008 |
[Effectiveness of 10 day-sequential therapy for Helicobacter pylori eradication in Korea].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Middle Aged; Omeprazole; Time Factors; Treatment Outcome | 2008 |
Systemic administration of doxycycline versus metronidazole plus amoxicillin in the treatment of localized aggressive periodontitis: a clinical and microbiologic study.
Topics: Administration, Oral; Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Capsules; Dental Plaque; Dental Plaque Index; Dental Scaling; Doxycycline; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Root Planing | 2008 |
Treatment of Helicobacter pylori in surgical practice: a randomised trial of triple versus quadruple therapy in a rural district general hospital.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, General; Hospitals, Rural; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Patient Compliance; Prospective Studies; Tetracycline; Treatment Outcome | 2008 |
Clinical and microbiological benefits of systemic metronidazole and amoxicillin in the treatment of smokers with chronic periodontitis: a randomized placebo-controlled study.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Bacteria; Chronic Periodontitis; Colony Count, Microbial; Combined Modality Therapy; Dental Deposits; Dental Scaling; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Periodontal Index; Smoking; Treatment Outcome | 2008 |
Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Efficacy of the standard quadruple therapy versus triple therapies containing proton pump inhibitor plus amoxicillin and clarithromycin or amoxicillin-clavulanic acid and metronidazole for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Clavulanic Acid; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Single-Blind Method; Treatment Outcome; Urea | 2009 |
The use of 2 antibiotic regimens in aggressive periodontitis: comparison of changes in clinical parameters and gingival crevicular fluid biomarkers.
Topics: Adolescent; Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Dental Plaque Index; Dental Scaling; Dinoprostone; Doxycycline; Drug Combinations; Female; Gingival Crevicular Fluid; Humans; Interleukin-1beta; Male; Metronidazole; Oral Hygiene; Periodontal Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2008 |
Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2008 |
Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Feces; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Patient Selection; Point Mutation; Proton Pump Inhibitors; Ribotyping; Treatment Outcome | 2008 |
Effect of Helicobacter pylori eradication on ulcer recurrence after simple closure of perforated duodenal ulcer.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Prevalence; Secondary Prevention | 2009 |
Evaluation of two triple-therapy regimens with metronidazole or clarithromycin for the eradication of H. pylori infection in Vietnamese children: a randomized, double-blind clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Antigens, Bacterial; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Stomach; Vietnam | 2008 |
High efficacy of bismuth subcitrate for Helicobacter pylori eradication in pangastritis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Young Adult | 2009 |
Helicobacter pylori eradication therapy success regarding different treatment period based on clarithromycin or metronidazole triple-therapy regimens.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 2009 |
Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Endoscopy, Gastrointestinal; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Organometallic Compounds; Prospective Studies; Salvage Therapy; Tetracycline; Treatment Outcome; Young Adult | 2009 |
Amoxicillin and metronidazole as an adjunct to full-mouth scaling and root planing of chronic periodontitis.
Topics: Adult; Aged; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Chronic Periodontitis; Dental Scaling; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Recession; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Mouthwashes; Periodontal Attachment Loss; Periodontal Pocket; Placebos; Root Planing; Treatment Outcome | 2009 |
Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Failure | 2009 |
A randomized clinical trial to determine the efficacy of regimens containing clarithromycin, metronidazole, and amoxicillin among histologic subgroups for Helicobacter pylori eradication in a developing country.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Colombia; Developing Countries; Drug Therapy, Combination; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Single-Blind Method; Treatment Outcome | 2009 |
Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antibodies, Monoclonal; Antigens, Bacterial; Clarithromycin; Feces; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Sensitivity and Specificity | 2009 |
Triple or quadruple tetracycline-based therapies versus standard triple treatment for Helicobacter pylori treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome; Young Adult | 2009 |
The efficacy of Helicobacter pylori eradication regimen with and without vitamin C supplementation.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Ascorbic Acid; Bismuth; Dietary Supplements; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Young Adult | 2009 |
Full-mouth ultrasonic debridement associated with amoxicillin and metronidazole in the treatment of severe chronic periodontitis.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Bacteroides; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque Index; Dental Scaling; Dinoprostone; Double-Blind Method; Female; Follow-Up Studies; Gingival Crevicular Fluid; Gingival Hemorrhage; Humans; Interferon-gamma; Interleukin-1beta; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Pocket; Placebos; Porphyromonas gingivalis; Subgingival Curettage; Treatment Outcome; Ultrasonic Therapy | 2009 |
Microbiologic testing and outcomes of full-mouth scaling and root planing with or without amoxicillin/metronidazole in chronic periodontitis.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria; Chronic Periodontitis; Colony Count, Microbial; Combined Modality Therapy; Dental Scaling; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Periodontal Pocket; Root Planing; Statistics, Nonparametric; Treatment Outcome | 2010 |
Efficacy of H. pylori eradication with a sequential regimen followed by rescue therapy in clinical practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2010 |
Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Treatment Outcome; Young Adult | 2010 |
Efficacy of amoxicillin and metronidazole combination for the management of generalized aggressive periodontitis.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides; Colony Count, Microbial; Combined Modality Therapy; Dental Plaque; Dental Scaling; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis; Prevotella; Prevotella intermedia; Prevotella nigrescens; Root Planing; Treatment Outcome; Treponema denticola; Young Adult | 2010 |
Newly developed antibiotic combination therapy for ulcerative colitis: a double-blind placebo-controlled multicenter trial.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Amoxicillin; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Fusobacterium Infections; Humans; Male; Metronidazole; Placebos; Statistics, Nonparametric; Tetracycline; Treatment Outcome | 2010 |
Short-term effects of systemic antibiotics during periodontal healing.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroidaceae Infections; Bacteroides; Bacteroides Infections; Chronic Periodontitis; Colony Count, Microbial; Combined Modality Therapy; Dental Scaling; Drug Combinations; Follow-Up Studies; Humans; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Placebos; Porphyromonas gingivalis; Prevotella intermedia; Root Planing | 2010 |
Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Animals; Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Tetracycline; Time Factors; Treatment Outcome; Turkey | 2010 |
Bismuth-based first-line therapy for Helicobacter pylori eradication in type 2 diabetes mellitus patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Statistics, Nonparametric; Surveys and Questionnaires; Tetracycline; Treatment Outcome | 2010 |
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Load; Curcumin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-8; Male; Metronidazole; Middle Aged; Omeprazole | 2010 |
Short-term benefits of the adjunctive use of metronidazole plus amoxicillin in the microbial profile and in the clinical parameters of subjects with generalized aggressive periodontitis.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Bacteria; Combined Modality Therapy; Dental Plaque; Dental Prophylaxis; DNA, Bacterial; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Metronidazole; Periodontal Index; Subgingival Curettage; Time Factors; Treatment Outcome; Young Adult | 2010 |
Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Colitis, Ulcerative; Colon; Colonoscopy; Drug Therapy, Combination; Female; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Recurrence; Remission Induction; Severity of Illness Index; Steroids; Tetracycline; Time Factors; Treatment Outcome; Young Adult | 2010 |
Eradication of Helicobacter spp. by using medicated diet in mice deficient in functional natural killer cells and complement factor D.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antigens, CD1; Clarithromycin; Complement Factor D; Drug Combinations; Female; Helicobacter; Helicobacter Infections; Immunocompromised Host; Male; Metronidazole; Mice; Mice, Inbred Strains; Mice, Knockout; Omeprazole; Rodent Diseases | 2010 |
A complete course of intravenous antibiotics vs a combination of intravenous and oral antibiotics for perforated appendicitis in children: a prospective, randomized trial.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Appendectomy; Appendicitis; Ceftriaxone; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injections, Intravenous; Laparoscopy; Male; Metronidazole; Preoperative Care; Prospective Studies; Rupture, Spontaneous; Treatment Outcome | 2010 |
Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Pilot Projects; Prospective Studies; Tetracycline | 2010 |
Comparison of the efficacy of triple versus quadruple therapy on the eradication of Helicobacter pylori and antibiotic resistance.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tetracycline | 2010 |
Amoxicillin and metronidazole as an adjunctive treatment in generalized aggressive periodontitis at initial therapy or re-treatment: a randomized controlled clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Aggressive Periodontitis; Amoxicillin; Analysis of Variance; Anti-Infective Agents; Chemotherapy, Adjuvant; Female; Humans; Linear Models; Male; Metronidazole; Periodontal Debridement; Retreatment; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome; Young Adult | 2011 |
Comparison of two different treatment protocols in Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Tetracycline; Turkey | 2011 |
Systemic antimicrobials adjunctive to a repeated mechanical and antiseptic therapy for aggressive periodontitis: a 6-month randomized controlled trial.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Combined Modality Therapy; Dental Plaque; Dental Scaling; Double-Blind Method; Drug Combinations; Female; Humans; Longitudinal Studies; Male; Metronidazole; Retreatment; Statistics, Nonparametric; Time Factors; Treatment Outcome; Young Adult | 2011 |
Antibiotic combination therapy for steroid withdrawal in steroid-dependent ulcerative colitis.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azathioprine; Colitis, Ulcerative; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Metronidazole; Middle Aged; Remission Induction; Tetracycline; Young Adult | 2011 |
Impact of systemic antimicrobials combined with anti-infective mechanical debridement on the microbiota of generalized aggressive periodontitis: a 6-month RCT.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Debridement; Dental Scaling; Double-Blind Method; Female; Follow-Up Studies; Fusobacterium necrophorum; Humans; Male; Metronidazole; Mouthwashes; Peptostreptococcus; Periodontal Attachment Loss; Periodontal Pocket; Placebos; Prevotella; Root Planing; Therapeutic Irrigation; Toothbrushing; Ultrasonic Therapy; Young Adult | 2011 |
[Efficient, minimally invasive periodontal therapy. An evidence based treatment concept].
Topics: Administration, Oral; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Cost-Benefit Analysis; Dental Scaling; Double-Blind Method; Evidence-Based Dentistry; Female; Humans; Metronidazole; Periodontal Debridement; Porphyromonas gingivalis | 2011 |
Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Tablets; Tetracycline; Young Adult | 2011 |
Triple therapy with ecabet sodium, amoxicillin and lansoprazole for 2 weeks as the rescue regimen for H. pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abietanes; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Failure | 2011 |
Helicobacter pylori chronic gastritis in children: to eradicate or not to eradicate?
Topics: Adolescent; Aluminum Hydroxide; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Humans; Magnesium Hydroxide; Male; Metronidazole; Omeprazole; Proton Pump Inhibitors; Severity of Illness Index; Urea | 2011 |
Antibiotic prophylaxis in third molar surgery.
Topics: Adolescent; Adult; Amoxicillin; Analysis of Variance; Antibiotic Prophylaxis; Chi-Square Distribution; Humans; Male; Metronidazole; Middle Aged; Molar, Third; Surgical Wound Infection; Tooth, Impacted; Treatment Outcome | 2011 |
New effective treatment regimen for children infected with a double-resistant Helicobacter pylori strain.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Europe; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lost to Follow-Up; Male; Medication Adherence; Metronidazole; Microbial Sensitivity Tests | 2011 |
The role of Helicobacter pylori in patients with hypothyroidism in whom could not be achieved normal thyrotropin levels despite treatment with high doses of thyroxine.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Hypothyroidism; Male; Metronidazole; Middle Aged; Tetracycline; Thyrotropin; Thyroxine; Triiodothyronine | 2011 |
Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2011 |
Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2011 |
Calprotectin levels in gingival crevicular fluid predict disease activity in patients treated for generalized aggressive periodontitis.
Topics: Administration, Topical; Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Area Under Curve; Biomarkers; Chlorhexidine; Dental Scaling; Disease Progression; Follow-Up Studies; Gingival Crevicular Fluid; Gingival Hemorrhage; Humans; Leukocyte L1 Antigen Complex; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Predictive Value of Tests; ROC Curve; Root Planing; Treatment Outcome; Young Adult | 2011 |
Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Polymorphism, Genetic; Tetracycline; Treatment Outcome | 2011 |
A new modified concomitant therapy for Helicobacter pylori eradication in Turkey.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Treatment Outcome; Young Adult | 2011 |
Efficacy of 2-week, second-line Helicobacter pylori eradication therapy using rabeprazole, amoxicillin, and metronidazole for the Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Asian People; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Rabeprazole; Treatment Outcome; Young Adult | 2011 |
Prophylaxis versus pre-emptive antibiotics in third molar surgery: a randomised control study.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Edema; Female; Hospitals, Teaching; Humans; Male; Metronidazole; Middle Aged; Molar, Third; Pain, Postoperative; Postoperative Complications; Risk Factors; Surgical Wound Infection; Tooth Extraction; Treatment Outcome; Trismus | 2011 |
Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Treatment Outcome | 2011 |
Effects of periodontal therapy on systemic markers of inflammation in patients with metabolic syndrome: a controlled clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atherosclerosis; Biomarkers; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol; Dental Plaque; Dental Scaling; Double-Blind Method; Female; Fibrinogen; Follow-Up Studies; Humans; Lipoproteins; Male; Metabolic Syndrome; Metronidazole; Middle Aged; Obesity; Periodontitis; Placebos; Risk Factors; Root Planing | 2012 |
Clinical and microbiological benefits of metronidazole alone or with amoxicillin as adjuncts in the treatment of chronic periodontitis: a randomized placebo-controlled clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Chemotherapy, Adjuvant; Chronic Periodontitis; Dental Plaque; Dental Scaling; DNA, Bacterial; Double-Blind Method; Drug Combinations; Female; Humans; Male; Metronidazole; Middle Aged; Numbers Needed To Treat; Observer Variation; Periodontal Pocket; Statistics, Nonparametric | 2011 |
14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Urea | 2011 |
Randomized comparison of two nonbismuth-containing rescue therapies for Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Treatment Outcome | 2011 |
Analysis of clinical results of systemic antimicrobials combined with nonsurgical periodontal treatment for generalized aggressive periodontitis: a pilot study.
Topics: Administration, Oral; Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chi-Square Distribution; Dental Plaque Index; Dental Scaling; Doxycycline; Drug Combinations; Female; Humans; Male; Metronidazole; Periodontal Index; Periodontal Pocket; Pilot Projects; Statistics, Nonparametric; Young Adult | 2011 |
Ten-day sequential therapy is more effective than proton pump inhibitor-based therapy in Korea: a prospective, randomized study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Republic of Korea | 2012 |
Randomised clinical trial: the efficacy of a 10-day sequential therapy vs. a 14-day standard proton pump inhibitor-based triple therapy for Helicobacter pylori in Korea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Data Interpretation, Statistical; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Time Factors; Treatment Outcome | 2011 |
Survey of anaemia and Helicobacter pylori infection in adolescent girls in Suihua, China and enhancement of iron intervention effects by H. pylori eradication.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; China; Dietary Supplements; Drug Therapy, Combination; Edetic Acid; Female; Ferric Compounds; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Mass Screening; Metronidazole; Organometallic Compounds; Prevalence; Suburban Health; Urban Health | 2012 |
Randomised clinical trial: a comparative study of 10-day sequential therapy with 7-day standard triple therapy for Helicobacter pylori infection in naïve patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Rabeprazole; Republic of Korea; Time Factors; Treatment Outcome | 2012 |
Effects of periodontal therapy on GCF cytokines in generalized aggressive periodontitis subjects.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Cytokines; Dental Scaling; Double-Blind Method; Female; Gingival Crevicular Fluid; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Interferon-gamma; Interleukin-10; Interleukin-1beta; Interleukin-2; Interleukin-6; Male; Metronidazole; Statistics, Nonparametric; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial.
Topics: Administration, Oral; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacteroides; Chi-Square Distribution; Chlorhexidine; Dental Plaque; Double-Blind Method; Female; Humans; Male; Metronidazole; Mouthwashes; Periodontal Index; Statistics, Nonparametric; Treponema denticola | 2012 |
The combination of amoxicillin and metronidazole improves clinical and microbiologic results of one-stage, full-mouth, ultrasonic debridement in aggressive periodontitis treatment.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Bacteroides; Dental Plaque Index; Drug Combinations; Female; Follow-Up Studies; Gingival Crevicular Fluid; Gingival Hemorrhage; Gingival Recession; Humans; Interleukin-10; Interleukin-1beta; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Debridement; Periodontal Index; Periodontal Pocket; Placebos; Porphyromonas gingivalis; Single-Blind Method; Treatment Outcome; Ultrasonic Therapy | 2012 |
Clarithromycin versus metronidazole in first-line Helicobacter pylori eradication. Prospective randomized study of 85 Tunisian adults.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Omeprazole; Prospective Studies | 2012 |
Surgical and non-surgical therapy with systemic antimicrobials for residual pockets in type 2 diabetics with chronic periodontitis: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Cytokines; Dental Scaling; Diabetes Mellitus, Type 2; Drug Combinations; Female; Glycated Hemoglobin; Humans; Interferon-gamma; Interleukin-17; Interleukin-23; Interleukin-4; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Debridement; Periodontal Index; Periodontal Pocket; Pilot Projects; Prospective Studies; Treatment Outcome | 2012 |
Lansoprazole-based sequential and concomitant therapy for the first-line Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2012 |
Comparison of bismuth-containing quadruple and concomitant therapies as a first-line treatment option for Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Antidiarrheals; Bismuth; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Salicylates; Tetracycline; Young Adult | 2012 |
Doxycycline-based quadruple regimen versus routine quadruple regimen for rescue eradication of Helicobacter pylori: an open-label control study in Chinese patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Doxycycline; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Tetracycline; Treatment Outcome; Young Adult | 2012 |
Control of periodontal infections: a randomized controlled trial I. The primary outcome attachment gain and pocket depth reduction at treated sites.
Topics: Amoxicillin; Analysis of Variance; Anti-Infective Agents; Cellulose; Chemotherapy, Adjuvant; Chlorhexidine; Dental Scaling; Drug Combinations; Drug Delivery Systems; Female; Humans; Male; Metronidazole; Middle Aged; Oral Surgical Procedures; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Index; Periodontal Pocket; Smoking; Tetracycline; Treatment Outcome | 2012 |
Comparative study of Helicobacter pylori eradication rates with 5-day quadruple "concomitant" therapy and 7-day standard triple therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Algorithms; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2013 |
Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Young Adult | 2012 |
Comparison of lafutidine and rabeprazole in 7-day second-line amoxicillin- and metronidazole-containing triple therapy for Helicobacter pylori: a pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Piperidines; Pyridines; Rabeprazole; Time Factors; Young Adult | 2012 |
Pilot studies to identify the optimum duration of concomitant Helicobacter pylori eradication therapy in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Prospective Studies; Rabeprazole; Thailand; Time Factors; Young Adult | 2012 |
Ten-day sequential versus triple therapy for Helicobacter pylori eradication: a prospective, open-label, randomized trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Lansoprazole; Male; Metronidazole; Middle Aged; Patient Compliance; Republic of Korea; Urea | 2012 |
Lycopene an adjunctive therapy for Helicobacter pylori eradication: a quasi-control trial.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antioxidants; Bismuth; Carotenoids; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lycopene; Male; Metronidazole; Middle Aged; Omeprazole; Treatment Outcome | 2012 |
Nonbismuth quadruple "concomitant" therapy versus standard triple therapy, both of the duration of 10 days, for first-line H. pylori eradication: a randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome; Urea | 2013 |
Are there specific benefits of amoxicillin plus metronidazole in Aggregatibacter actinomycetemcomitans-associated periodontitis? Double-masked, randomized clinical trial of efficacy and safety.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Dental Plaque Index; Dental Scaling; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Recession; Humans; Male; Metronidazole; Middle Aged; Molar; Pasteurellaceae Infections; Periodontal Pocket; Periodontitis; Placebos; Root Planing; Safety; Smoking; Treatment Outcome | 2013 |
The effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized aggressive periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Combined Modality Therapy; Dental Scaling; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Longitudinal Studies; Male; Metronidazole; Periodontal Attachment Loss; Treatment Outcome; Young Adult | 2012 |
Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a 1-year double-blinded, placebo-controlled, randomized clinical trial.
Topics: Adult; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Chemotherapy, Adjuvant; Chlorhexidine; Chronic Periodontitis; Dental Scaling; Double-Blind Method; Drug Combinations; Female; Humans; Logistic Models; Longitudinal Studies; Male; Metronidazole; Middle Aged; Mouthwashes; Periodontal Index; Periodontal Pocket; Statistics, Nonparametric; Treatment Outcome | 2012 |
A multicenter prospective observational study of triple therapy with rabeprazole, amoxicillin and metronidazole for Helicobacter pylori in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2012 |
[A 10-day sequential therapy for eradication of Helicobacter pylori infection in children].
Topics: Administration, Oral; Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Time Factors; Treatment Outcome | 2012 |
Sequential versus triple therapy for the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Ofloxacin | 2013 |
Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: result of the HPFEZ randomised study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Single-Blind Method; Young Adult | 2013 |
Clinical and microbiological effects of systemic antimicrobials combined to an anti-infective mechanical debridement for the management of aggressive periodontitis: a 12-month randomized controlled trial.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacterial Load; Chlorhexidine; Dental Scaling; Double-Blind Method; Drug Combinations; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Metronidazole; Mouthwashes; Periodontal Debridement; Periodontal Pocket; Placebos; Root Planing; Therapeutic Irrigation; Toothbrushing; Treatment Outcome; Ultrasonic Therapy | 2013 |
[Short term effect of combined use of amoxicillin and metronidazole at different time of non-surgical periodontal treatment for aggressive periodontitis].
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Dental Scaling; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Root Planing; Time Factors; Young Adult | 2012 |
Clinical outcomes of two-week sequential and concomitant therapies for Helicobacter pylori eradication: a randomized pilot study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome; Urea | 2013 |
Risk of recurrent Helicobacter pylori infection 1 year after initial eradication therapy in 7 Latin American communities.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Latin America; Male; Medication Adherence; Metronidazole; Middle Aged; Primary Prevention; Recurrence; Risk; Stomach Neoplasms; Young Adult | 2013 |
[Is sequential eradication of Helicobacter pylori effective? Sequential treatment more effective than triple therapy in patients with clarithromycin resistance].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Peptic Ulcer; Stomach Neoplasms; Taiwan | 2013 |
Periodontal treatment reduces matrix metalloproteinase levels in localized aggressive periodontitis.
Topics: Adolescent; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Black or African American; Child; Child, Preschool; Dental Scaling; Female; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Male; Matrix Metalloproteinase 1; Matrix Metalloproteinase 12; Matrix Metalloproteinase 13; Matrix Metalloproteinase 2; Matrix Metalloproteinase 3; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Metronidazole; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Root Planing; Young Adult | 2013 |
Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Failure | 2013 |
Penbactam for Helicobacter pylori eradication: a randomised comparison of quadruple and triple treatment schedules in an Iranian population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Analysis of Variance; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Combinations; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors; Sulbactam; Urea; Young Adult | 2013 |
Randomised clinical trial comparing sequential and concomitant therapies for Helicobacter pylori eradication in routine clinical practice.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome; Urea; Young Adult | 2014 |
Effect of periodontal therapy on the subgingival microbiota over a 2-year monitoring period. I. Overall effect and kinetics of change.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bacteroides; Biofilms; Capnocytophaga; Chronic Periodontitis; Dental Scaling; Drug Combinations; Eubacterium; Female; Follow-Up Studies; Fusobacterium; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Prevotella; Prospective Studies; Root Planing; Single-Blind Method; Streptococcus; Tetracycline; Treponema denticola | 2013 |
Clinical evaluation of a ten-day regimen with esomeprazole, metronidazole, amoxicillin, and clarithromycin for the eradication of Helicobacter pylori in a high clarithromycin resistance area.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Young Adult | 2013 |
LPS-induced inflammatory response after therapy of aggressive periodontitis.
Topics: Adolescent; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chemokine CCL2; Chemokine CCL3; Chemokine CXCL10; Chemokines, CC; Child; Child, Preschool; Escherichia coli; Female; Follow-Up Studies; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Inflammation Mediators; Interferon-gamma; Interleukin-10; Interleukin-12 Subunit p40; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Debridement; Periodontal Pocket; Porphyromonas gingivalis; Tumor Necrosis Factor-alpha; Young Adult | 2013 |
Eradication of Helicobacter pylori according to 23S ribosomal RNA point mutations associated with clarithromycin resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Point Mutation; Polymerase Chain Reaction; Proton Pump Inhibitors; Rabeprazole; RNA, Ribosomal, 23S; Treatment Outcome; Young Adult | 2013 |
Clinical and microbiologic effects of adjunctive metronidazole plus amoxicillin in the treatment of generalized chronic periodontitis: smokers versus non-smokers.
Topics: Actinomyces; Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Cohort Studies; Combined Modality Therapy; Dental Plaque; Dental Plaque Index; Dental Scaling; Disease Progression; Female; Follow-Up Studies; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Metronidazole; Middle Aged; Oral Hygiene; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Root Planing; Smoking | 2014 |
Nonsurgical treatment of aggressive periodontitis with photodynamic therapy or systemic antibiotics. Three-month results of a randomized, prospective, controlled clinical study.
Topics: Administration, Oral; Adult; Aggressive Periodontitis; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Dental Scaling; Female; Humans; Lasers, Semiconductor; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Phenothiazines; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Single-Blind Method; Statistics, Nonparametric; Young Adult | 2013 |
Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aza Compounds; Breath Tests; Disease-Free Survival; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Kaplan-Meier Estimate; Longitudinal Studies; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Quinolines; Recurrence; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2013 |
Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; China; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2013 |
Effect of dosing schemes of amoxicillin on eradication rates of Helicobacter pylori with amoxicillin-based triple therapy.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2014 |
Third-line rescue therapy with bismuth-containing quadruple regimen after failure of two treatments (with clarithromycin and levofloxacin) for H. pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Salvage Therapy; Spain; Surveys and Questionnaires; Tetracycline; Time Factors; Treatment Failure | 2014 |
Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Fluoroquinolones; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Time Factors; Treatment Outcome | 2014 |
Ten day sequential versus 10 day modified bismuth quadruple therapy as empirical firstline and secondline treatment for Helicobacter pylori in Chinese patients: an open label, randomised, crossover trial.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Asian People; Breath Tests; China; Clarithromycin; Cross-Over Studies; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Tetracycline; Treatment Outcome | 2014 |
Effectiveness of sequential v. standard triple therapy for treatment of Helicobacter pylori infection in children in Nairobi, Kenya.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Synergism; Drug Therapy, Combination; Dyspepsia; Feces; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Kenya; Male; Metronidazole; Treatment Outcome | 2013 |
Reduction in prevalence of Archaea after periodontal therapy in subjects with generalized aggressive periodontitis.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Archaea; Combined Modality Therapy; Dental Plaque; Dental Scaling; Double-Blind Method; Drug Therapy, Combination; Female; Gene Amplification; Humans; Male; Metronidazole; Middle Aged; RNA, Archaeal; RNA, Ribosomal, 16S; Root Planing; Treatment Outcome | 2013 |
A randomized controlled trial comparing sequential with triple therapy for Helicobacter pylori in an Aboriginal community in the Canadian North.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inuit; Male; Medication Adherence; Metronidazole; Middle Aged; Northwest Territories; Proton Pump Inhibitors; Rabeprazole | 2013 |
Long-term alteration of intestinal microbiota in patients with ulcerative colitis by antibiotic combination therapy.
Topics: Actins; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Double-Blind Method; Drug Therapy, Combination; Female; Fusobacterium; Fusobacterium Infections; Humans; Intestinal Mucosa; Male; Metronidazole; Microbiota; Middle Aged; Tetracycline | 2014 |
Six-month results following treatment of aggressive periodontitis with antimicrobial photodynamic therapy or amoxicillin and metronidazole.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Dental Scaling; Female; Humans; Male; Metronidazole; Photochemotherapy; Root Planing; Treatment Outcome | 2014 |
Feasibility of shortening 14-day hybrid therapy while maintaining an excellent Helicobacter pylori eradication rate.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Time Factors; Treatment Outcome; Young Adult | 2014 |
Adjunct antibiotic combination therapy for steroid-refractory or -dependent ulcerative colitis: an open-label multicentre study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colectomy; Colitis, Ulcerative; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Metronidazole; Middle Aged; Severity of Illness Index; Tetracycline; Time Factors; Treatment Outcome; Young Adult | 2014 |
Metronidazole alone or with amoxicillin as adjuncts to non-surgical treatment of chronic periodontitis: a secondary analysis of microbiological results from a randomized clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Bacteria; Bacterial Load; Chlorhexidine; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque; Dental Scaling; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Mouthwashes; Periodontal Attachment Loss; Periodontal Pocket; Placebos; Root Planing; Treatment Outcome | 2014 |
Effect of MMX® mesalamine coadministration on the pharmacokinetics of amoxicillin, ciprofloxacin XR, metronidazole, and sulfamethoxazole: results from four randomized clinical trials.
Topics: Adult; Amoxicillin; Ciprofloxacin; Colitis, Ulcerative; Cross-Over Studies; Drug Interactions; Female; Humans; Male; Mesalamine; Metronidazole; Middle Aged; Sulfamethoxazole | 2014 |
Helicobacter pylori eradication in renal recipient: triple or quadruple therapy?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunocompromised Host; Iran; Kidney Transplantation; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2014 |
Clarithromycin Versus Metronidazole as First-line Helicobacter pylori Eradication: A Multicenter, Prospective, Randomized Controlled Study in Japan.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Rabeprazole; Urea | 2015 |
Metronidazole and amoxicillin as adjuncts to scaling and root planing for the treatment of type 2 diabetic subjects with periodontitis: 1-year outcomes of a randomized placebo-controlled clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque; Dental Scaling; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Eubacterium; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontal Pocket; Placebos; Prevotella intermedia; Prospective Studies; Root Planing; Treatment Outcome | 2014 |
Efficacy of hybrid therapy as first-line regimen for Helicobacter pylori infection compared with sequential therapy.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Treatment Outcome | 2014 |
Comparison of standard triple therapy, sequential therapy and moxifloxacin-based triple therapy for Helicobacter pylori infection: Patients' compliance and bacterial eradication rates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2014 |
A comparison between 15-day sequential, 10-day sequential and proton pump inhibitor-based triple therapy for Helicobacter pylori infection in Korea.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome | 2014 |
A randomised clinical trial of 10-day concomitant therapy and standard triple therapy for Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Metronidazole; Middle Aged; Multivariate Analysis; Prospective Studies; Republic of Korea; Time Factors; Treatment Outcome | 2014 |
Impact of baseline microbiological status on clinical outcomes in generalized aggressive periodontitis patients treated with or without adjunctive amoxicillin and metronidazole: an exploratory analysis from a randomized controlled clinical trial.
Topics: Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Bacteroides; Combined Modality Therapy; Double-Blind Method; Drug Combinations; Drug Resistance, Bacterial; Follow-Up Studies; Humans; Metronidazole; Penicillin Resistance; Periodontal Attachment Loss; Periodontal Debridement; Periodontal Pocket; Placebos; Porphyromonas gingivalis; Treatment Outcome | 2014 |
Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Treatment Outcome | 2014 |
Localized aggressive periodontitis treatment response in primary and permanent dentitions.
Topics: Adolescent; Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Cohort Studies; Combined Modality Therapy; Dental Plaque; Dentition, Permanent; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Debridement; Periodontal Index; Periodontal Pocket; Tooth, Deciduous; Treatment Outcome; Young Adult | 2014 |
Differential benefits of amoxicillin-metronidazole in different phases of periodontal therapy in a randomized controlled crossover clinical trial.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Cross-Over Studies; Double-Blind Method; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Pasteurellaceae Infections; Periodontal Debridement; Periodontal Index; Periodontal Pocket; Periodontitis; Placebos; Surgical Flaps; Treatment Outcome | 2015 |
Comparison of efficacy and safety of levofloxacin-containing versus standard sequential therapy in eradication of Helicobacter pylori infection in Korea.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Treatment Outcome; Urea | 2015 |
Reverse sequential therapy achieves a similar eradication rate as standard sequential therapy for Helicobacter pylori eradication: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome; Young Adult | 2015 |
Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Rabeprazole; Republic of Korea; Stomach Ulcer; Time Factors; Treatment Outcome | 2015 |
Ten-day triple therapy versus sequential therapy versus concomitant therapy as first-line treatment for Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2015 |
[Clinical effect of different sequences of debridement-antibiotic therapy in treatment of severe chronic periodontitis].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Combined Modality Therapy; Debridement; Dental Scaling; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged | 2015 |
Ciprofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: A randomized trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Treatment Outcome; Young Adult | 2015 |
Optimised empiric triple and concomitant therapy for Helicobacter pylori eradication in clinical practice: the OPTRICON study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Young Adult | 2015 |
[Estimation of efficiency of anti-helicobacter therapy in patients with a chronic pancreatitis combined with an erosive gastropathy].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pancreatitis, Chronic; Pantoprazole; Synbiotics | 2014 |
Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Fourteen-day optimized levofloxacin-based therapy versus classical quadruple therapy for Helicobacter pylori treatment failures: a randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Amoxicillin; Biopsy, Needle; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Failure; Treatment Outcome; Young Adult | 2015 |
Different treatment choice for first-line treatment of Helicobacter pylori in an area with a high antibiotic resistance.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Turkey | 2014 |
The impact of amalgam dental fillings on the frequency of Helicobacter pylori infection and H. pylori eradication rates in patients treated with concomitant, quadruple, and levofloxacin-based therapies.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Dental Amalgam; Dental Restoration, Permanent; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Male; Metronidazole; Middle Aged; Outpatients; Prospective Studies; Rabeprazole; Tetracycline; Treatment Outcome; Turkey; Urea | 2015 |
Probiotics for standard triple Helicobacter pylori eradication: a randomized, double-blind, placebo-controlled trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bifidobacterium; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lacticaseibacillus rhamnosus; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Placebos; Probiotics; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2015 |
Effect of nonsurgical periodontal treatment in conjunction with either systemic administration of amoxicillin and metronidazole or additional photodynamic therapy on the concentration of matrix metalloproteinases 8 and 9 in gingival crevicular fluid in pa
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Dental Scaling; Female; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Lasers, Semiconductor; Male; Matrix Metalloproteinase 8; Matrix Metalloproteinase 9; Metronidazole; Periodontal Debridement; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Root Planing; Single-Blind Method | 2015 |
Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Drug Therapy, Combination; Female; Fluoroquinolones; Follow-Up Studies; Humans; Male; Metronidazole; Moxifloxacin; Young Adult | 2015 |
Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Rabeprazole; Tetracycline | 2015 |
Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade "A" Success Rate for First-Line Helicobacter pylori Eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged | 2015 |
Effect of Pretreatment with Lactobacillus delbrueckii and Streptococcus thermophillus on Tailored Triple Therapy for Helicobacter pylori Eradication: A Prospective Randomized Controlled Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus delbrueckii; Male; Metronidazole; Middle Aged; Probiotics; Prognosis; Prospective Studies; Streptococcus; Young Adult | 2015 |
Is progression of periodontitis relevantly influenced by systemic antibiotics? A clinical randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Germany; Humans; Male; Metronidazole; Middle Aged; Periodontal Attachment Loss; Periodontitis; Prevalence; Prognosis; Prospective Studies | 2015 |
Long-term evaluation of the antimicrobial susceptibility and microbial profile of subgingival biofilms in individuals with aggressive periodontitis.
Topics: Adolescent; Adult; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Bacteria; Biofilms; Chlorhexidine; Female; Humans; Longitudinal Studies; Male; Metronidazole; Microbial Sensitivity Tests; Placebos; Treatment Outcome; Young Adult | 2015 |
A randomized-controlled study to compare the efficacy of sequential therapy with standard triple therapy for Helicobacter pylori eradication in an Irish population.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Ireland; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Urea; Young Adult | 2015 |
Phytomedicine-based and Quadruple Therapies in Helicobacter pylori Infection: A Comparative, Randomized Trial.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Phytotherapy; Plant Extracts; Treatment Outcome; Young Adult | 2015 |
Bismuth, lansoprazole, amoxicillin and metronidazole or clarithromycin as first-line Helicobacter pylori therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Young Adult | 2015 |
Sequential therapy for 10 days versus triple therapy for 14 days in the eradication of
Topics: Adult; Ambulatory Care; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Hospitalization; Humans; Lansoprazole; Male; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Amoxicillin/metronidazole associated with nonsurgical therapy did not promote additional benefits in immunologic parameters in generalized aggressive periodontitis: A randomized controlled clinical trial.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Dental Scaling; Dinoprostone; Drug Therapy, Combination; Female; Gingival Crevicular Fluid; Humans; Interferon-gamma; Interleukin-6; Male; Metronidazole; Pain Measurement; Periodontal Index; Root Planing; Treatment Outcome | 2016 |
Effects of N-acetylcysteine on First-Line Sequential Therapy for Helicobacter pylori Infection: A Randomized Controlled Pilot Trial.
Topics: Acetylcysteine; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Pilot Projects; Rabeprazole; Treatment Outcome | 2016 |
Hybrid vs sequential therapy for eradication of Helicobacter pylori in Taiwan: A prospective randomized trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Taiwan; Time Factors; Treatment Outcome | 2015 |
Concomitant versus sequential therapy for the treatment of Helicobacter pylori infection: a Greek randomized prospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Reconstruction of Peri-implant Osseous Defects: A Multicenter Randomized Trial.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Biocompatible Materials; Bone Substitutes; Chlorhexidine; Combined Modality Therapy; Debridement; Dental Disinfectants; Female; Follow-Up Studies; Gingival Hemorrhage; Humans; Hydrogen Peroxide; Male; Metronidazole; Middle Aged; Peri-Implantitis; Periodontal Pocket; Plastic Surgery Procedures; Prospective Studies; Titanium; Treatment Outcome | 2016 |
Comparison of the efficacy of culture-based tailored therapy for Helicobacter pylori eradication with that of the traditional second-line rescue therapy in Korean patients: a prospective single tertiary center study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Tertiary Care Centers; Tetracycline; Young Adult | 2016 |
Outcome evaluation of clarithromycin, metronidazole and lansoprazole regimens in Helicobacter pylori positive or negative children with resistant otitis media with effusion.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Case-Control Studies; Child; Child, Preschool; Chronic Disease; Clarithromycin; Clavulanic Acid; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Otitis Media with Effusion; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Systemic Biomarkers in 2-Phase Antibiotic Periodontal Treatment: A Randomized Clinical Trial.
Topics: Acute-Phase Proteins; Adult; Aged; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Biomarkers; Calcitonin; Chronic Periodontitis; Combined Modality Therapy; Cytokines; Double-Blind Method; Female; Ferritins; Follow-Up Studies; Haptoglobins; Humans; Inflammation Mediators; Interleukin 1 Receptor Antagonist Protein; Interleukin-10; Male; Metronidazole; Middle Aged; Periodontal Debridement; Placebos; Protein Precursors; Serum Amyloid P-Component | 2016 |
A Randomized Controlled Study Comparing Reverse Hybrid Therapy and Standard Triple Therapy for Helicobacter pylori Infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Pantoprazole; Proton Pump Inhibitors; Single-Blind Method | 2015 |
Effect of Periodontal Therapy With Amoxicillin-Metronidazole on Pharyngeal Carriage of Penicillin- and Erythromycin-Resistant Viridans Streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Periodontitis; Pharynx; Streptococcal Infections; Viridans Streptococci | 2016 |
Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; Cross-Over Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Potassium Citrate; Prospective Studies; Rabeprazole; Tetracycline; Time Factors; Young Adult | 2016 |
Levofloxacin Sequential Therapy vs Levofloxacin Triple Therapy in the Second-Line Treatment of Helicobacter pylori: A Randomized Trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Levofloxacin; Male; Metronidazole; Middle Aged; Stomach Diseases; Treatment Outcome | 2016 |
Comparison of adjunctive azithromycin and amoxicillin/metronidazole for patients with chronic periodontitis: preliminary randomized control trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Chronic Periodontitis; Dental Scaling; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Periodontal Index; Root Planing; Treatment Outcome | 2016 |
Randomized clinical trial comparing 10-day sequential, 7-day concomitant and 7-day standard triple therapies for Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Stomach Ulcer; Treatment Outcome; Young Adult | 2016 |
Vonoprazan, a novel potassium-competitive acid blocker, as a component of first-line and second-line triple therapy for Helicobacter pylori eradication: a phase III, randomised, double-blind study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Double-Blind Method; Drug Administration Schedule; Drug Monitoring; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
Amoxicillin Plus Metronidazole Therapy for Patients with Periodontitis and Type 2 Diabetes: A 2-year Randomized Controlled Trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Dental Plaque; Dental Scaling; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Gingiva; Humans; Male; Metronidazole; Periodontitis | 2016 |
Non-surgical periodontal treatment in conjunction with 3 or 7 days systemic administration of amoxicillin and metronidazole in severe chronic periodontitis patients. A placebo-controlled randomized clinical study.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Dental Scaling; Humans; Metronidazole; Root Planing; Treatment Outcome | 2016 |
Sequential Therapy versus Triple Therapy for the First Line Treatment of Helicobacter pylori in Korea: A Nationwide Randomized Trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome | 2016 |
Randomized clinical trial comparing ten day concomitant and sequential therapies for Helicobacter pylori eradication in a high clarithromycin resistance area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Pyloric Antrum; Urea | 2016 |
Local disinfection with sodium hypochlorite as adjunct to basic periodontal therapy: a randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Disinfection; Follow-Up Studies; Humans; Metronidazole; Periodontal Diseases; Sodium Hypochlorite | 2016 |
A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospecti
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1; Male; Metronidazole; Middle Aged; Polymorphism, Genetic; Prognosis; Prospective Studies; Rabeprazole; Young Adult | 2016 |
Is furcation involvement affected by adjunctive systemic amoxicillin plus metronidazole? A clinical trials exploratory subanalysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Double-Blind Method; Follow-Up Studies; Humans; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Prospective Studies | 2016 |
Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Healthy Volunteers; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors; Pyrroles; Sulfonamides; Treatment Outcome | 2016 |
Comparison of cefixime and amoxicillin plus metronidazole in the treatment of chronic periodontitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Chronic Periodontitis; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Periodontal Index; Treatment Outcome | 2016 |
Randomized clinical trial comparing 10- or 14-day sequential therapy and 10- or 14-day concomitant therapy for the first line empirical treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Time Factors; Treatment Outcome | 2017 |
Standard triple therapy versus sequential therapy for eradication of Helicobacter pylori in treatment naïve and retreat patients.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Child; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retreatment; Young Adult | 2016 |
Rescue Therapy for Helicobacter pylori Eradication: A Randomized Non-Inferiority Trial of Amoxicillin or Tetracycline in Bismuth Quadruple Therapy.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline; Treatment Failure; Treatment Outcome; Young Adult | 2016 |
Are systemic antibiotics necessary in the prevention of wound healing complications after intra-alveolar dental extraction?
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Double-Blind Method; Dry Socket; Female; Humans; Male; Metronidazole; Middle Aged; Patient Compliance; Postoperative Complications; Surgical Wound; Tooth Extraction; Wound Healing | 2016 |
Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Proton Pump Inhibitors; Taiwan; Tetracycline; Urea | 2016 |
Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Colitis, Ulcerative; Colon; Colonoscopy; Combined Modality Therapy; Drug Therapy, Combination; Dysbiosis; Fecal Microbiota Transplantation; Female; Fosfomycin; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Prospective Studies; Severity of Illness Index; Treatment Outcome; Young Adult | 2017 |
Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Time Factors | 2016 |
Low antibiotic resistance among anaerobic Gram-negative bacteria in periodontitis 5 years following metronidazole therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Periodontitis; Clindamycin; Drug Resistance, Bacterial; Follow-Up Studies; Gingiva; Gram-Negative Anaerobic Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Microbiota; Norway; Penicillins | 2017 |
Use of probiotics as an adjuvant to sequential H. pylori eradication therapy: impact on eradication rates, treatment resistance, treatment-related side effects, and patient compliance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Amoxicillin; Anorexia; Anti-Bacterial Agents; Bifidobacterium animalis; Clarithromycin; Diarrhea; Dizziness; Drug Eruptions; Drug Resistance; Drug Therapy, Combination; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Nausea; Numbers Needed To Treat; Pantoprazole; Probiotics; Proton Pump Inhibitors; Symptom Assessment; Treatment Outcome | 2017 |
Ten days of levofloxacin-containing concomitant therapy can achieve effective Helicobacter pylori eradication in patients with type 2 diabetes.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Diabetes Mellitus, Type 2; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracycline; Treatment Outcome | 2017 |
Different antibiotic protocols in the treatment of severe chronic periodontitis: A 1-year randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Combined Modality Therapy; Dental Scaling; Double-Blind Method; Female; Humans; Male; Metronidazole; Middle Aged; Periodontal Index; Prospective Studies; Root Planing; Treatment Outcome | 2017 |
Improving the standard sequential treatment of Helicobacter pylori with either extended treatment or by adding bismuth.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors | 2017 |
Randomized Controlled Trial for Helicobacter pylori Eradication in a Naive Portuguese Population: Is Sequential Treatment Superior to Triple Therapy in Real World Clinical Setting?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Portugal; Prospective Studies; Proton Pump Inhibitors | 2017 |
Therapeutic success with bismuth-containing sequential and quadruple regimens in Helicobacter pylori eradication.
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Doxycycline; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Smoking; Tetracycline; Treatment Outcome; Young Adult | 2017 |
One year results of a randomized controlled clinical study evaluating the effects of non-surgical periodontal therapy of chronic periodontitis in conjunction with three or seven days systemic administration of amoxicillin/metronidazole.
Topics: Adult; Amoxicillin; Chronic Disease; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Periodontitis | 2017 |
A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pantoprazole; Prospective Studies; Tetracycline | 2017 |
Non-Surgical Therapy Reduces Presence of JP2 Clone in Localized Aggressive Periodontitis.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Dental Plaque; Dental Scaling; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Periodontal Debridement; Polymerase Chain Reaction; Root Planing; Ultrasonic Surgical Procedures; Young Adult | 2017 |
Comparison of repeated applications of aPDT with amoxicillin and metronidazole in the treatment of chronic periodontitis: A short-term study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Female; Humans; Male; Metronidazole; Middle Aged; Photochemotherapy | 2017 |
Fourteen-day high-dose esomeprazole, amoxicillin and metronidazole as third-line treatment for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2017 |
Comparison of Helicobacter pylori Eradication Rates of 2-Week Levofloxacin-Containing Triple Therapy, Levofloxacin-Containing Bismuth Quadruple Therapy, and Standard Bismuth Quadruple Therapy as a First-Line Regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Salicylates; Tetracycline; Young Adult | 2017 |
Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trial.
Topics: Amoxicillin; Clarithromycin; Clinical Protocols; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Sample Size | 2017 |
Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies | 2017 |
Comparative study of Helicobacter pylori eradication rates of concomitant therapy vs modified quadruple therapy comprising proton-pump inhibitor, bismuth, amoxicillin, and metronidazole in Korea.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Republic of Korea | 2018 |
The ideal time of systemic metronidazole and amoxicillin administration in the treatment of severe periodontitis: study protocol for a randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Brazil; Dental Scaling; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Multicenter Studies as Topic; Periodontitis; Randomized Controlled Trials as Topic; Root Planing; Severity of Illness Index; Time Factors; Treatment Outcome | 2018 |
New single capsule of bismuth, metronidazole and tetracycline given with omeprazole versus quadruple therapy consisting of bismuth, omeprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a Chinese pro
Topics: Adolescent; Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Capsules; China; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline; Young Adult | 2018 |
Randomized controlled trial: PPI-based triple therapy containing metronidazole versus clarithromycin as first-line treatment for Helicobacter pylori in adolescents and young adults in Japan.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Hospitals; Humans; Japan; Male; Metronidazole; Proton Pump Inhibitors | 2018 |
Treatment of periodontitis in smokers with multiple sessions of antimicrobial photodynamic therapy or systemic antibiotics: A randomized clinical trial.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Chronic Periodontitis; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Middle Aged; Periodontal Index; Photochemotherapy; Photosensitizing Agents; Prevotella intermedia; Smokers | 2018 |
Do we treat our patients or rather periodontal microbes with adjunctive antibiotics in periodontal therapy? A 16S rDNA microbial community analysis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; DNA, Ribosomal; Female; Gingiva; Humans; Male; Metronidazole; Microbiota; Middle Aged | 2018 |
Effects of different periodontal treatments in changing the prevalence and levels of Archaea present in the subgingival biofilm of subjects with periodontitis: A secondary analysis from a randomized controlled clinical trial.
Topics: Adult; Amoxicillin; Archaea; Biofilms; Chronic Periodontitis; Combined Modality Therapy; Dental Plaque; Dental Scaling; Drug Therapy, Combination; Female; Gingiva; Humans; Male; Metronidazole; Middle Aged; Root Planing; Time Factors; Treatment Outcome | 2018 |
Efficacy and Tolerability of Two Quadruple Regimens: Bismuth, Omeprazole, Metronidazole with Amoxicillin or Tetracycline as First-Line Treatment for Eradication of Helicobacter Pylori in Patients with Duodenal Ulcer: A Randomized Clinical Trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Tetracycline | 2018 |
Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Breath Tests; Clarithromycin; Clinical Decision-Making; Doxycycline; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Predictive Value of Tests; Proton Pump Inhibitors; Taiwan; Tetracycline; Time Factors; Treatment Outcome | 2018 |
Probiotic supplementation with Lactobacillus plantarum and Pediococcus acidilactici for Helicobacter pylori therapy: A randomized, double-blind, placebo-controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lactobacillus plantarum; Male; Metronidazole; Middle Aged; Pediococcus acidilactici; Probiotics | 2018 |
Randomized trial of vonoprazan-based versus proton-pump inhibitor-based third-line triple therapy with sitafloxacin for Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Gastritis; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Sulfonamides; Treatment Failure; Treatment Outcome | 2019 |
Efficacy of Helicobacter pylori eradication regimens in Rwanda: a randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Disease Eradication; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Rwanda; Treatment Failure | 2018 |
Comparison of 10 and 14 days of triple therapy versus 10 days of sequential therapy for Helicobacter pylori eradication: A prospective randomized study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Time Factors; Treatment Outcome | 2018 |
Comparing the periodontal tissue response to non-surgical scaling and root planing alone, adjunctive azithromycin, or adjunctive amoxicillin plus metronidazole in generalized chronic moderate-to-severe periodontitis: a preliminary randomized controlled tr
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Chronic Periodontitis; Dental Scaling; Female; Humans; Male; Metronidazole; Middle Aged; Root Planing; Treatment Outcome | 2019 |
Saccharomyces boulardii CNCM I-745 plus sequential therapy for Helicobacter pylori infections: a randomized, open-label trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probiotics; Prospective Studies; Proton Pump Inhibitors; Random Allocation; Saccharomyces boulardii | 2019 |
Evaluation of the efficacy and safety of the hybrid scheme for eradication therapy of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Peptic Ulcer; Prospective Studies; Treatment Outcome | 2018 |
Intraluminal therapy for Helicobacter pylori infection.
Topics: Acetylcysteine; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Expectorants; Female; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Powders; Prospective Studies; Proton Pump Inhibitors; Remission Induction; Therapeutic Irrigation; Time Factors; Treatment Outcome; Young Adult | 2019 |
Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis severity and patients' age: An exploratory sub-analysis of the ABPARO trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Humans; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis | 2019 |
Systemic Antibiotic Therapy Reduces Circulating Inflammatory Dendritic Cells and Treg-Th17 Plasticity in Periodontitis.
Topics: Amoxicillin; Bacteria; Bacterial Infections; Dendritic Cells; Female; Humans; Male; Metronidazole; Middle Aged; Periodontitis; T-Lymphocytes, Regulatory; Th17 Cells | 2019 |
Efficacy of tailored therapy for Helicobacter pylori eradication based on clarithromycin resistance and survey of previous antibiotic exposure: A single-center prospective pilot study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Prospective Studies | 2019 |
Randomised controlled trial: susceptibility-guided therapy versus empiric bismuth quadruple therapy for first-line Helicobacter pylori treatment.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2019 |
Two different antibiotic protocols as adjuncts to one-stage full-mouth ultrasonic debridement to treat generalized aggressive periodontitis: A pilot randomized controlled clinical trial.
Topics: Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Debridement; Humans; Metronidazole; Porphyromonas gingivalis; Ultrasonics | 2019 |
Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Medication Adherence; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Republic of Korea; Treatment Outcome | 2019 |
Comparison of concomitant therapy versus standard triple-drug therapy for eradication of Helicobacter pylori infection: A prospective open-label randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Treatment Outcome | 2019 |
Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Disease Eradication; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Escherichia coli; Female; Follow-Up Studies; Gastrointestinal Microbiome; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metabolic Syndrome; Metronidazole; Middle Aged; Organometallic Compounds; Prevalence; Tetracycline | 2019 |
Microbiological and clinical effects of adjunctive systemic metronidazole and amoxicillin in the non-surgical treatment of peri-implantitis: 1 year follow-up.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Peri-Implantitis; Periodontal Index; Reference Values; Reproducibility of Results; Statistics, Nonparametric; Time Factors; Treatment Outcome | 2019 |
The effects of non-surgical periodontal therapy on glycemic control in diabetic patients: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Blood Glucose; Chronic Periodontitis; Dental Scaling; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Metronidazole; Root Planing | 2020 |
Efficacy and Cost-effectiveness Comparison of 10-Day, 14-Day Sequential Versus 14-Day Triple Therapies for Treating Helicobacter pylori Infection in Egyptian Patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Egypt; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Outcome | 2020 |
Is tailored therapy based on antibiotic susceptibility effective ? a multicenter, open-label, randomized trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; China; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Efficacy of clindamycin compared with amoxicillin-metronidazole after a 7-day regimen in the treatment of periodontitis in patients with diabetes: a randomized clinical trial.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clindamycin; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Periodontitis; Prognosis; Young Adult | 2020 |
14-Day High-Dose Amoxicillin- and Metronidazole-Containing Triple Therapy With or Without Bismuth as First-Line Helicobacter pylori Treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Drug Monitoring; Drug Resistance; Drug Therapy, Combination; Female; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Treatment Outcome | 2020 |
10-Day Versus 14-Day Quadruple Concomitant Nonbismuth Therapy for the Treatment of Helicobacter pylori Infection: Results From a Randomized Prospective Study in a High Clarithromycin Resistance Country.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Treatment Outcome | 2020 |
Equivalent efficacies of reverse hybrid and concomitant therapies in first-line treatment of Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dexlansoprazole; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 2020 |
Amoxicillin or tetracycline in bismuth-containing quadruple therapy as first-line treatment for
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Patient Compliance; Penicillin Resistance; Rabeprazole; Tetracycline; Tetracycline Resistance | 2020 |
Moxifloxacin versus amoxicillin plus metronidazole as adjunctive therapy for generalized aggressive periodontitis: a pilot randomized controlled clinical trial.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Humans; Metronidazole; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis; Treatment Outcome | 2020 |
Effects on clinical outcomes of adjunctive moxifloxacin versus amoxicillin plus metronidazole in periodontitis patients harboring Aggregatibacter actinomycetemcomitans, Porphyromonas gingivalis, and Tannerella forsythia: exploratory analyses from a clinic
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Humans; Metronidazole; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Tannerella; Tannerella forsythia | 2021 |
Addition of bismuth to standard triple therapy for Helicobacter pylori eradication: a randomised controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole | 2020 |
Susceptibility-guided quadruple therapy is not superior to medication history-guided therapy for the rescue treatment of Helicobacter pylori infection: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Treatment Outcome | 2020 |
Metronidazole and amoxicillin for patients with periodontitis and diabetes mellitus: 5-year secondary analysis of a randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Diabetes Mellitus; Humans; Metronidazole; Periodontitis; Root Planing; Treatment Outcome | 2021 |
Microbiological and host-derived biomarker evaluation following non-surgical periodontal therapy with short-term administration of systemic antimicrobials: secondary outcomes of an RCT.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Infective Agents; Biomarkers; Drug Administration Schedule; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Metronidazole; Periodontitis; Porphyromonas gingivalis; Real-Time Polymerase Chain Reaction; Subgingival Curettage | 2020 |
Empiric Versus Clarithromycin Resistance-Guided Therapy for Helicobacter pylori Based on Polymerase Chain Reaction Results in Patients With Gastric Neoplasms or Gastric Mucosa-Associated Lymphoid Tissue Lymphoma: A Randomized Controlled Trial.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction; Prospective Studies; Republic of Korea; RNA, Ribosomal, 23S; Stomach Neoplasms; Tetracycline; Treatment Outcome | 2020 |
Randomised clinical trial comparing concomitant and hybrid therapy for eradication of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Croatia; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Ten-day bismuth-containing quadruple therapy versus 7-day proton pump inhibitor-clarithromycin containing triple therapy as first-line empirical therapy for the Helicobacter pylori infection in Korea: a randomized open-label trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Republic of Korea | 2021 |
Clinical, microbiological, and immunological effects of systemic probiotics in periodontal treatment: study protocol for a randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Dental Scaling; Double-Blind Method; Humans; Metronidazole; Probiotics; Randomized Controlled Trials as Topic; Root Planing | 2021 |
Prevention of dry socket in mandibular 3rd molars with single preoperative oral dose of metronidazole and amoxicillin compared to conventional therapy.
Topics: Amoxicillin; Dry Socket; Female; Humans; Male; Metronidazole; Molar; Molar, Third; Tooth Extraction; Tooth, Impacted | 2021 |
Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Treatment Outcome | 2021 |
Effect of adjunctive systemic antibiotics on microbial populations compared with scaling and root planing alone for the treatment of periodontitis: A pilot randomized clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Glucose; Humans; Metronidazole; Periodontitis; Pilot Projects; Root Planing | 2022 |
Tetracycline-levofloxacin versus amoxicillin-levofloxacin quadruple therapies in the second-line treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2021 |
Comparison of tailored
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Republic of Korea; Treatment Outcome | 2022 |
Adjunctive efficacy of systemic metronidazole in the surgical treatment of periodontitis: a double-blind parallel randomized clinical trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Double-Blind Method; Humans; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis | 2022 |
Bismuth-Based Quadruple Therapy versus Metronidazole-Intensified Triple Therapy as a First-Line Treatment for Clarithromycin-Resistant
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Outcome | 2022 |
A Comparison of Pre-Emptive Co-Amoxiclav, Postoperative Amoxicillin, and Metronidazole for Prevention of Postoperative Complications in Dentoalveolar Surgery: A Randomized Controlled Trial.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Dry Socket; Humans; Metronidazole; Molar, Third; Pain, Postoperative; Postoperative Complications | 2022 |
Nitazoxanide-based therapeutic regimen as a novel treatment for Helicobacter pylori infection in children and adolescents: a randomized trial.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Nitro Compounds; Proton Pump Inhibitors; Thiazoles; Treatment Outcome | 2022 |
Clinical, microbiological, and immunological effects of 3- or 7-day systemic antibiotics adjunctive to subgingival instrumentation in patients with aggressive (Stage III/IV Grade C) periodontitis: A randomized placebo-controlled clinical trial.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Humans; Metronidazole | 2022 |
Microbiological effects of amoxicillin plus metronidazole in the treatment of young patients with Stages III and IV periodontitis: A secondary analysis from a 1-year double-blinded placebo-controlled randomized clinical trial.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Dental Plaque; Dental Scaling; DNA; Humans; Metronidazole; Periodontitis; Root Planing; Treatment Outcome; Young Adult | 2023 |
A randomized controlled trial to compare Helicobacter pylori eradication rates between the empirical concomitant therapy and tailored therapy based on 23S rRNA point mutations.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Point Mutation; Proton Pump Inhibitors; Rabeprazole; RNA, Ribosomal, 23S | 2022 |
Bismuth, esomeprazole, metronidazole and amoxicillin or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tetracycline | 2023 |
Prevalence and trends of multiple antimicrobial resistance of Helicobacter pylori in one tertiary hospital for 20 years in Korea.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Prevalence; Republic of Korea; Tertiary Care Centers | 2023 |
Ten-day concomitant and sequential therapy for Helicobacter pylori effective in region with high antibiotic resistance rates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome; Urea | 2022 |
Intravenous metronidazole-, levofloxacin-containing triple therapy for treating patients with Helicobacter pylori-related active peptic ulcer complications: A pilot study.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Peptic Ulcer; Pilot Projects | 2023 |
Tailored triple plus bismuth therapy based on previous antibiotic medication history for first-line Helicobacter pylori eradication: A randomized trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Macrolides; Metronidazole; Proton Pump Inhibitors; Quinolones; Treatment Outcome | 2023 |
A randomized superiority clinical trial: metronidazole improved the efficacy of high-dose dual therapy in Helicobacter pylori rescue treatment.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2023 |
New regimens as first-line eradication therapy for Helicobacter pylori infection in patients allergic to penicillin: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Cefuroxime; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Medication Adherence; Metronidazole; Minocycline; Penicillins; Tetracycline; Treatment Outcome | 2023 |
A "new" option in Helicobacter pylori eradication: High-dose amoxicillin dual therapy outperforms bismuth quadruple therapy in a high dual resistance setting.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2023 |
Bismuth, esomeprazole, metronidazole, and minocycline or tetracycline as a first-line regimen for Helicobacter pylori eradication: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Potassium Citrate; Tetracycline | 2023 |
Minocycline vs. tetracycline in bismuth-containing quadruple therapy for Helicobacter pylori rescue treatment: a multicentre, randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Minocycline; Proton Pump Inhibitors; Tetracycline; Treatment Outcome | 2023 |
Rifabutin-Containing Triple Therapy Versus Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter, Randomized Controlled Trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Esomeprazole; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Rifabutin; Treatment Outcome | 2023 |
Long-term changes in the subgingival microbiota in patients with stage III-IV periodontitis treated by mechanical therapy and adjunctive systemic antibiotics: A secondary analysis of a randomized controlled trial.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Humans; Metronidazole; Microbiota; Periodontitis; Porphyromonas gingivalis; RNA, Ribosomal, 16S | 2023 |
Comparison of the efficacies of triple, quadruple and sequential antibiotic therapy in eradicating Helicobacter pylori infection: A randomized controlled trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole | 2023 |
Clinical benefits of systemic amoxicillin/metronidazole may depend on periodontitis stage and grade: An exploratory sub-analysis of the ABPARO trial.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Scaling; Humans; Male; Metronidazole; Periodontal Pocket; Periodontitis | 2023 |
868 other study(ies) available for metronidazole and amoxicillin
| Article | Year |
|---|---|
Anti-Helicobacter pylori agents. 2. Structure activity relationships in a new series of 2-alkylguanidino-4-furylthiazoles.
Topics: Animals; Anti-Bacterial Agents; Dogs; Gastric Acid; Guanidines; Guinea Pigs; Heart Atria; Helicobacter pylori; Histamine H2 Antagonists; In Vitro Techniques; Microbial Sensitivity Tests; Rats; Structure-Activity Relationship; Thiazoles | 1998 |
Anti-Helicobacter pylori agents. 3. 2-[(Arylalkyl)guanidino]-4-furylthiazoles.
Topics: Animals; Anti-Bacterial Agents; Atrial Function; Colony Count, Microbial; Gastric Acid; Guanidines; Guinea Pigs; Heart Atria; Helicobacter pylori; Histamine H2 Antagonists; In Vitro Techniques; Male; Rats; Rats, Sprague-Dawley; Receptors, Histamine H2; Structure-Activity Relationship; Thiazoles | 1999 |
Anti-Helicobacter pylori agents. 4. 2-(Substituted guanidino)-4-phenylthiazoles and some structurally rigid derivatives.
Topics: Animals; Anti-Bacterial Agents; Gastric Acid; Guanidines; Helicobacter pylori; Histamine H2 Antagonists; Male; Microbial Sensitivity Tests; Ranitidine; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles | 2000 |
Anti-Helicobacter pylori agents. 5. 2-(Substituted guanidino)-4-arylthiazoles and aryloxazole analogues.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Gastric Juice; Guanidines; Guinea Pigs; Helicobacter pylori; Histamine H2 Antagonists; In Vitro Techniques; Male; Microbial Sensitivity Tests; Myocardium; Oxazoles; Rats; Structure-Activity Relationship; Thiazoles; Thiophenes | 2002 |
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 1.
Topics: Anti-Bacterial Agents; Benzimidazoles; Helicobacter pylori; Microbial Sensitivity Tests; Structure-Activity Relationship | 2002 |
Novel structures derived from 2-[[(2-pyridyl)methyl]thio]-1H-benzimidazole as anti-Helicobacter pylori agents, Part 2.
Topics: Animals; Anti-Bacterial Agents; Benzimidazoles; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter pylori; Kinetics; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Structure-Activity Relationship | 2002 |
A specific anti-Helicobacter pylori agent NE2001: synthesis and its effect on the growth of H. pylori.
Topics: Anti-Bacterial Agents; Biphenyl Compounds; Guanidine; Helicobacter pylori; Microbial Sensitivity Tests; Structure-Activity Relationship; Time Factors | 2003 |
Studies on anti-Helicobacter pylori agents. Part 3: A novel, efficacious cephem derivative, FR193879.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cephalosporins; Dogs; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Stability; Guinea Pigs; Helicobacter pylori; Mice; Microbial Sensitivity Tests; Pharmacokinetics; Structure-Activity Relationship; Thiazoles; Treatment Outcome | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
In vitro inhibitory activity of boropinic acid against Helicobacter pylori.
Topics: Carboxylic Acids; Helicobacter pylori; Rutaceae | 2006 |
Efficacy of the de novo-derived antimicrobial peptide WLBU2 against oral bacteria.
Topics: Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Biofilms; Fusobacterium nucleatum; Humans; Microbial Sensitivity Tests; Peptides; Porphyromonas gingivalis; Streptococcus | 2007 |
Antimicrobial susceptibilities of Peptostreptococcus anaerobius and the newly described Peptostreptococcus stomatis isolated from various human sources.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteremia; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Peptostreptococcus; Species Specificity | 2007 |
Anti-Helicobacter pylori and thrombin inhibitory components from Chinese dragon's blood, Dracaena cochinchinensis.
Topics: Anti-Bacterial Agents; Dracaena; Drugs, Chinese Herbal; Flavonoids; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Plants, Medicinal; Thrombin | 2007 |
Antimicrobial susceptibilities and clinical sources of Dialister species.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Species Specificity; Veillonellaceae | 2007 |
Synthesis and in vitro anti-Helicobacter pylori activity of N-[5-(5-nitro-2-heteroaryl)-1,3,4-thiadiazol-2-yl]thiomorpholines and related compounds.
Topics: Antiviral Agents; Helicobacter pylori; Humans; Molecular Structure; Morpholines; Nitrogen Compounds; Structure-Activity Relationship; Thiadiazoles | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Synthesis and anti-Helicobacter pylori activity of 5-(nitroaryl)-1,3,4-thiadiazoles with certain sulfur containing alkyl side chain.
Topics: Anti-Bacterial Agents; Helicobacter pylori; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Thiadiazoles | 2008 |
Resistance trends of the Bacteroides fragilis group over a 10-year period, 1997 to 2006, in Madrid, Spain.
Topics: Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Bacteroides Infections; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Spain; Species Specificity; Time Factors | 2008 |
Increasing trends in antimicrobial resistance among clinically important anaerobes and Bacteroides fragilis isolates causing nosocomial infections: emerging resistance to carbapenems.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides fragilis; Bacteroides Infections; Blood; Carbapenems; Cross Infection; Drug Resistance, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Taiwan | 2008 |
In vitro activity of OPT-80 tested against clinical isolates of toxin-producing Clostridium difficile.
Topics: Anti-Bacterial Agents; Bacterial Toxins; Clostridioides difficile; Cross Infection; Enterocolitis, Pseudomembranous; Glycosides; Humans; In Vitro Techniques; Microbial Sensitivity Tests | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Antianaerobic activity of sulopenem compared to six other agents.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Gram-Negative Bacteria; Humans; Lactams; Microbial Sensitivity Tests; Prodrugs | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Identification of 3',4',5'-trimethoxychalcone analogues as potent inhibitors of Helicobacter pylori-induced inflammation in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Cell Line; Chalcones; Epithelial Cells; Gastritis; Helicobacter Infections; Helicobacter pylori; Host-Pathogen Interactions; Humans; Interleukin-8; NF-kappa B | 2010 |
Synthesis and antimicrobial activity of 2-substituted [4-(1,3,4-oxadiazol-2-yl methyl)] phthalazin-1(2H)-one derivatives.
Topics: Anti-Infective Agents; Bacteria; Fungi; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Phthalazines; Spectrophotometry, Infrared | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Synthesis and bioevaluation of novel 3,4,5-trimethoxybenzylbenzimidazole derivatives that inhibit Helicobacter pylori-induced pathogenesis in human gastric epithelial cells.
Topics: Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Benzimidazoles; Cell Adhesion; Cell Line; Epithelial Cells; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoblotting; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Molecular Structure; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bambermycins; Drug Design; Drug Resistance, Multiple, Bacterial; Duodenal Ulcer; Enzyme Inhibitors; Gastritis; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Microbial Sensitivity Tests; Molecular Conformation; Stomach Neoplasms; Stomach Ulcer | 2014 |
Microbiological and clinical results of metronidazole plus amoxicillin therapy in Actinobacillus actinomycetemcomitans-associated periodontitis.
Topics: Adult; Age Factors; Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Amoxicillin; Bacteroides; Colony Count, Microbial; Dental Scaling; Drug Combinations; Gingival Hemorrhage; Humans; Metronidazole; Oral Hygiene; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Recurrence; Subgingival Curettage | 1992 |
Eradicating Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Resistance, Microbial; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole | 1992 |
Eradicating Helicobacter pylori.
Topics: Amoxicillin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds | 1992 |
Amoxycillin/clavulanic acid (augmentin) compared with triple drug therapy for pelvic inflammatory disease.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Clavulanic Acids; Drug Administration Schedule; Drug Therapy, Combination; Female; Gentamicins; Humans; Metronidazole; Pelvic Inflammatory Disease | 1992 |
Mucosal peptic activity during Helicobacter pylori infection in pediatric patients.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Pepsin A; Pepsinogens | 1992 |
Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer | 1992 |
pH-dependent secretion of gastrin in duodenal ulcer disease: effect of suppressing Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Organometallic Compounds | 1992 |
Comparative in vitro activity of Ro 40-6890, Ro 41-3399, and other antimicrobial agents against anaerobic bacteria.
Topics: Amoxicillin; Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; Cephalosporins; Chloramphenicol; Clindamycin; Clostridium perfringens; Metronidazole; Microbial Sensitivity Tests | 1992 |
Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Studies with antral alkalinisation.
Topics: Adult; Amoxicillin; Antacids; Duodenal Ulcer; Female; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pyloric Antrum | 1992 |
Hydatidiform mole with coexisting twin pregnancy after gamete intra-fallopian transfer.
Topics: Adult; Amoxicillin; Female; Gamete Intrafallopian Transfer; Humans; Hydatidiform Mole; Male; Metronidazole; Obstetric Labor, Premature; Placenta; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy, Multiple; Ritodrine; Twins; Ultrasonography; Uterine Diseases; Uterine Neoplasms | 1992 |
Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study.
Topics: Amoxicillin; Brazil; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Recurrence | 1992 |
Antimicrobial susceptibility of anaerobic bacteria in Auckland 1987-90.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Drug Resistance, Microbial; Humans; Metronidazole; Microbial Sensitivity Tests; New Zealand | 1992 |
Role of metronidazole resistance in therapy of Helicobacter pylori infections.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Sex Factors | 1992 |
Transient protein-losing hypertrophic gastropathy associated with Mycoplasma pneumoniae infection in childhood.
Topics: Amoxicillin; Antacids; Antibodies, Bacterial; Child, Preschool; Enzyme-Linked Immunosorbent Assay; Gastritis, Hypertrophic; Humans; Male; Metronidazole; Mycoplasma pneumoniae; Organometallic Compounds; Pneumonia, Mycoplasma; Protein-Losing Enteropathies | 1992 |
[Helicobacter pylori: from harmless commensal to clinically significant disease factor].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Recurrence; Stomach Ulcer; Tetracycline | 1992 |
[Chronic conjunctivitis caused by oral anaerobic germs].
Topics: Adult; Amoxicillin; Bacteroides; Chronic Disease; Conjunctivitis; Drug Therapy, Combination; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptostreptococcus; Periodontitis | 1991 |
[Helicobacter pylori and duodenal ulcer. Long-term results of triple sucralfate antibiotic therapy].
Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Sucralfate | 1991 |
A prospective study on the perinatal outcome in Mozambican pregnant women with preterm rupture of membranes using two different methods of clinical management.
Topics: Adult; Amoxicillin; Chloroquine; Female; Fetal Membranes, Premature Rupture; Humans; Infant Mortality; Infant, Newborn; Labor, Induced; Metronidazole; Mozambique; Pregnancy; Pregnancy Outcome; Prospective Studies; Sexually Transmitted Diseases | 1991 |
Evaluation of a commercial latex test for serological diagnosis of Helicobacter pylori infection in treated and untreated patients.
Topics: Amoxicillin; Antibodies, Bacterial; Drug Therapy, Combination; Evaluation Studies as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Latex Fixation Tests; Metronidazole; Sensitivity and Specificity; Urease | 1991 |
Susceptibility of Helicobacter pylori to metronidazole.
Topics: Amoxicillin; Chronic Disease; Drug Resistance, Microbial; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 1991 |
Plasma gastrin, daytime intragastric pH, and nocturnal acid output before and at 1 and 7 months after eradication of Helicobacter pylori in duodenal ulcer subjects.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Circadian Rhythm; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Organometallic Compounds; Stomach; Time Factors | 1991 |
Bactericidal effect of amoxicillin on Helicobacter pylori in an in vitro model using epithelial cells.
Topics: Amoxicillin; Bacterial Adhesion; Cell Line; Epithelial Cells; Epithelium; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests | 1991 |
Synergistic effects between amoxicillin, metronidazole, and the hydroxymetabolite of metronidazole against Actinobacillus actinomycetemcomitans.
Topics: Actinobacillus; Amoxicillin; Drug Synergism; Metronidazole; Microbial Sensitivity Tests | 1991 |
Five-day bismuth-free triple therapy for the eradication of Helicobacter pylori and reduction of duodenal ulcer relapse.
Topics: Adult; Amoxicillin; Breath Tests; Carbon Radioisotopes; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Recurrence; Urea | 1991 |
Anaerobic vertebral osteomyelitis.
Topics: Aged; Amoxicillin; Bacteroides fragilis; Bacteroides Infections; Cefazolin; Clavulanic Acid; Clavulanic Acids; Humans; Male; Metronidazole; Osteomyelitis; Thoracic Vertebrae | 1991 |
Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects.
Topics: Adult; Amoxicillin; Circadian Rhythm; Duodenal Ulcer; Female; Gastric Acidity Determination; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds | 1991 |
Antimicrobials in periodontitis: a clinical approach.
Topics: Amoxicillin; Drug Combinations; Humans; Metronidazole; Periodontitis; Spiramycin; Tetracycline | 1991 |
Chronic conjunctivitis caused by oral anaerobes and effectively treated with systemic metronidazole plus amoxicillin.
Topics: Adult; Amoxicillin; Bacteria, Anaerobic; Bacterial Infections; Conjunctivitis, Bacterial; DNA Fingerprinting; DNA, Bacterial; Drug Therapy, Combination; Gingivitis; Humans; Male; Metronidazole; Peptostreptococcus; Restriction Mapping | 1991 |
Identification, and susceptibility to seven antimicrobial agents, of 61 gram-negative anaerobic rods from periodontal pockets.
Topics: Amoxicillin; Anaerobiosis; Anti-Bacterial Agents; Bacteriological Techniques; Bacteroides; Clavulanic Acid; Clavulanic Acids; Drug Resistance, Microbial; Erythromycin; Fusobacterium; Humans; Metronidazole; Minocycline; Penicillin Resistance; Penicillin V; Periodontal Pocket; Periodontitis; Tetracycline Resistance | 1991 |
Spiral shaped microorganisms in the human duodenal mucosa.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Duodenum; Gram-Negative Bacteria; Humans; Intestinal Mucosa; Male; Metronidazole; Organometallic Compounds | 1991 |
Therapy in Helicobacter pylori infection.
Topics: Amoxicillin; Drug Interactions; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Tetracycline | 1990 |
Evaluation of the activity of four antimicrobial agents using an in vitro rapid micromethod against oral streptococci and various bacterial strains implicated in periodontitis.
Topics: Actinobacillus; Actinomyces; Amoxicillin; Bacteria; Bacteroides; Capnocytophaga; Doxycycline; Drug Evaluation; Drug Resistance, Microbial; Eikenella corrodens; Humans; Josamycin; Metronidazole; Mouth; Periodontitis; Streptococcus | 1990 |
Microbiology in diagnosis and treatment of severe periodontitis. A report of four cases.
Topics: Actinobacillus; Adult; Amoxicillin; Colony Count, Microbial; Combined Modality Therapy; Dental Scaling; Drug Therapy, Combination; Humans; Metronidazole; Middle Aged; Minocycline; Periodontitis | 1990 |
Adjuvant antibiotic therapy in duodenal ulcers treated with colloidal bismuth subcitrate.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Campylobacter Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Humans; Metronidazole; Organometallic Compounds | 1990 |
Beta-lactamase production and susceptibilities to amoxicillin, amoxicillin-clavulanate, ticarcillin, ticarcillin-clavulanate, cefoxitin, imipenem, and metronidazole of 320 non-Bacteroides fragilis Bacteroides isolates and 129 fusobacteria from 28 U.S. cen
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroides; Bacteroides Infections; beta-Lactamase Inhibitors; beta-Lactamases; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Fusobacterium; Fusobacterium Infections; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ticarcillin; United States | 1990 |
Antibiotics and endodontics.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Humans; Metronidazole; Root Canal Therapy | 1990 |
Conservative approach to the management of pelvic inflammatory disease.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Humans; Metronidazole; Oxytetracycline; Pelvic Inflammatory Disease; Penicillin G; Prospective Studies; Tetracycline; Tobramycin | 1990 |
[Prevention of wound infection following abdominal surgery].
Topics: Abdomen; Amoxicillin; Drug Therapy, Combination; Humans; Metronidazole; Postoperative Care; Surgical Wound Infection; Tobramycin; Wound Healing | 1990 |
Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
Topics: Amoxicillin; Bacteroides fragilis; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Kinetics; Metronidazole; Microbial Sensitivity Tests | 1990 |
Susceptibility of Bacteroides non-fragilis and fusobacteria to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole.
Topics: Amoxicillin; Bacteroides; Cefoxitin; Clavulanic Acid; Clavulanic Acids; Drug Combinations; Fusobacterium; Imipenem; Metronidazole; Microbial Sensitivity Tests; Ticarcillin | 1990 |
Bactericidal concentrations of chlorhexidine-digluconate, amine fluoride gel and stannous fluoride gel for subgingival bacteria tested in serum at short contact times.
Topics: Actinobacillus; Actinomyces; Amines; Amoxicillin; Bacteria; Bacteroides; Capnocytophaga; Chlorhexidine; Diamines; Fluorides; Fusobacterium; Gels; Metronidazole; Time Factors; Tin Fluorides | 1989 |
Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
Topics: Amoxicillin; Animals; Bacteroides fragilis; Bacteroides Infections; beta-Lactamases; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Escherichia coli; Escherichia coli Infections; Female; Metronidazole; Mice; Microbial Sensitivity Tests | 1989 |
Antibiotic susceptibilities of bacteria isolated from acute dentoalveolar abscesses.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Bacteria; Clindamycin; Drug Resistance, Microbial; Erythromycin; Metronidazole; Microbial Sensitivity Tests; Penicillins; Periapical Abscess | 1989 |
Standard treatment of pelvic inflammatory disease.
Topics: Amoxicillin; Drug Therapy, Combination; Female; Humans; Metronidazole; Papua New Guinea; Pelvic Inflammatory Disease | 1989 |
Metronidazole plus amoxycillin in the treatment of Actinobacillus actinomycetemcomitans associated periodontitis.
Topics: Actinobacillus; Adolescent; Adult; Aggressive Periodontitis; Amoxicillin; Bacteroides; Drug Combinations; Female; Humans; Male; Metronidazole; Periodontal Diseases; Periodontal Pocket; Periodontitis | 1989 |
[Morphologic change in Campylobacter pylori associated gastritis in and following successful antibacterial therapy].
Topics: Amoxicillin; Bismuth; Campylobacter Infections; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Salicylates | 1989 |
[In vitro effect of piperacillin, amoxicillin, cefoxitin and metronidazole against obligate anaerobic bacteria].
Topics: Amoxicillin; Bacteria, Anaerobic; Cefoxitin; Humans; Metronidazole; Microbial Sensitivity Tests; Piperacillin | 1986 |
Amoxycillin-clavulanic acid (Augmentin) versus metronidazole as prophylaxis in hysterectomy: a prospective randomized clinical trial.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Hysterectomy; Metronidazole; Premedication; Surgical Wound Infection | 1988 |
Managing trichomonal vaginitis refractory to conventional treatment with metronidazole.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Clavulanic Acids; Clinical Protocols; Drug Administration Schedule; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Female; Humans; Metronidazole; Streptococcal Infections; Streptococcus agalactiae; Trichomonas vaginalis; Trichomonas Vaginitis | 1988 |
Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Animals; Anti-Bacterial Agents; Bacteroides fragilis; Bacteroides Infections; Cefuroxime; Clavulanic Acids; Drug Combinations; Escherichia coli; Escherichia coli Infections; Female; Gentamicins; Metronidazole; Mice | 1988 |
Amoxycillin, amoxycillin-clavulanic acid and metronidazole in the treatment of clue cell-positive discharge. A comparative clinical and laboratory study.
Topics: Adult; Amoxicillin; Bacterial Infections; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Metronidazole; Microbial Sensitivity Tests; Vaginitis | 1987 |
Amoxycillin, augmentin and metronidazole in bacterial vaginosis associated with Gardnerella vaginalis.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Clavulanic Acids; Drug Combinations; Female; Gardnerella vaginalis; Humans; Metronidazole; Vaginal Diseases | 1986 |
In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroides; Bacteroides fragilis; Chloramphenicol; Clavulanic Acids; Clindamycin; Drug Synergism; Metronidazole; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Ticarcillin | 1986 |
Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter; Cell Wall; Cephalexin; Cimetidine; Clindamycin; Erythromycin; Metronidazole; Microscopy, Electron; Organometallic Compounds; Penicillin G | 1987 |
Metronidazole use.
Topics: Adolescent; Amoxicillin; Child Abuse; Female; Humans; Metronidazole; Sexual Behavior; Vaginitis | 1986 |
Antibiotic-associated pseudomembranous colitis.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacitracin; Bacterial Proteins; Bacterial Toxins; Cephalosporins; Cholestyramine Resin; Clindamycin; Clostridium; Colestipol; Endoscopy; Enterocolitis, Pseudomembranous; Feces; Humans; Leukocyte Count; Metronidazole; Vancomycin | 1985 |
[In vitro activity of the amoxicillin-clavulanic acid combination on anaerobic bacteria. Comparison with amoxicillin, lamoxactam and metronidazole].
Topics: Amoxicillin; Bacteria, Anaerobic; Clavulanic Acids; Drug Combinations; Metronidazole; Microbial Sensitivity Tests; Moxalactam | 1984 |
Transfer of bioactive substances in breast milk.
Topics: Amoxicillin; Breast Feeding; Candidiasis; Dermatitis, Atopic; Female; Humans; Infant; Intestinal Diseases; Male; Metronidazole; Milk, Human | 1984 |
Septicemia due to Mycoplasma hominis.
Topics: Amoxicillin; Ampicillin; Clindamycin; Doxycycline; Female; Humans; Male; Metronidazole; Mycoplasma Infections; Pregnancy; Pregnancy Complications, Infectious; Sepsis | 1983 |
Use of antibiotics to prevent hepatitis and typhlitis in male scid mice spontaneously infected with Helicobacter hepaticus.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bismuth; Cecal Diseases; Cecum; Chronic Disease; Helicobacter; Helicobacter Infections; Hepatitis, Animal; Inflammation; Liver; Male; Metronidazole; Mice; Mice, SCID; Neomycin; Rodent Diseases; Tetracycline | 1995 |
Mitsuokella dentalis in human periodontitis.
Topics: Adolescent; Adult; Age Distribution; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteroides; Ciprofloxacin; Cross-Sectional Studies; DNA Probes; Drug Resistance, Microbial; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Periodontal Pocket; Periodontitis; Sex Factors; Tetracycline; Tetracycline Resistance | 1994 |
[The importance of obtaining biopsies of the gastric body in the follow-up after eradicating treatment of Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Biopsy; Bismuth; Clavulanic Acid; Clavulanic Acids; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline; Time Factors | 1995 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Influence of amoxicillin, erythromycin and metronidazole on adherence of Helicobacter pylori.
Topics: Amoxicillin; Bacterial Adhesion; Erythromycin; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 1995 |
Evaluation of antibiotic therapies for eradication of Helicobacter hepaticus.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Base Sequence; Bismuth; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Helicobacter Infections; Male; Metronidazole; Mice; Mice, Inbred Strains; Molecular Sequence Data; Random Allocation; Stomach Diseases; Tetracycline | 1995 |
High Helicobacter pylori numbers are associated with low eradication rate after triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Colony Count, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Urea; Urease | 1995 |
Helicobacter pylori infection in recurrent abdominal pain in childhood: comparison of diagnostic tests and therapy.
Topics: Abdominal Pain; Adolescent; Amoxicillin; Antibodies, Bacterial; Bismuth; Child; Child, Preschool; Duodenal Ulcer; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Organometallic Compounds; Polymerase Chain Reaction; Recurrence; Salicylates; Stomach Ulcer | 1995 |
Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Gastric Mucosa; Gastrin-Releasing Peptide; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Linear Models; Male; Metronidazole; Organometallic Compounds; Peptides; Reproducibility of Results | 1995 |
Resolution of Helicobacter pylori-associated gastric lymphoproliferative disease in a child.
Topics: Adolescent; Amoxicillin; Bismuth; Chronic Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Remission Induction; Stomach Neoplasms | 1995 |
90% cure: which anti-Helicobacter therapy can achieve this treatment goal?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer; Randomized Controlled Trials as Topic; Tetracycline | 1995 |
Additive effect of clarithromycin combined with 14-hydroxy clarithromycin, erythromycin, amoxycillin, metronidazole or omeprazole against Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Erythromycin; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Omeprazole | 1994 |
Amoxycillin causes an enhanced uptake of metronidazole in Actinobacillus actinomycetemcomitans: a mechanism of synergy.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Drug Synergism; Metronidazole | 1994 |
Drug resistance in Helicobacter pylori.
Topics: Amoxicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter pylori; Humans; Metronidazole; Quinolones | 1995 |
Simultaneous resistance to metronidazole, co-amoxiclav, and imipenem in clinical isolate of Bacteroides fragilis.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteremia; Bacteroides fragilis; Bacteroides Infections; Clavulanic Acids; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Empyema, Pleural; Female; Humans; Imipenem; Metronidazole | 1995 |
Susceptibility of Helicobacter pylori to antimicrobial agents: effect of sulglycotide.
Topics: Amoxicillin; Erythromycin; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Sialoglycoproteins; Tetracycline | 1995 |
Treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline | 1995 |
Fulminant pseudomembranous colitis (PMC) following triple therapy for Helicobacter pylori.
Topics: Amoxicillin; Drug Therapy, Combination; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Organometallic Compounds | 1994 |
[Low malignancy MALT lymphoma of the stomach: H. pyloric eradication as a therapeutic concept?].
Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Neoplasms | 1994 |
Antimicrobial susceptibility of periodontopathic bacteria associated with failing implants.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Clavulanic Acids; Dental Implants; Dental Plaque; Dental Plaque Index; Drug Combinations; Fusobacterium nucleatum; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillin G; Periodontal Index; Periodontitis; Periodontium; Porphyromonas gingivalis; Prevotella intermedia; Prosthesis Failure; Prosthesis-Related Infections | 1995 |
Treatment of low-grade gastric MALT lymphoma with Helicobacter pylori eradication.
Topics: Amoxicillin; Biopsy; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Omeprazole; Remission Induction; Stomach Neoplasms | 1995 |
Helicobacter pylori infection and gastric juice vitamin C levels. Impact of eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ascorbic Acid; Bismuth; Drug Therapy, Combination; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Stomach Neoplasms | 1995 |
Duodenal ulcer healing drugs.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Acid; Gastrin-Releasing Peptide; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptides | 1994 |
Effect of Helicobacter pylori eradication on G-cell and D-cell density in children.
Topics: Adolescent; Amoxicillin; Cell Count; Child; Drug Therapy, Combination; Female; Furazolidone; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Pyloric Antrum; Somatostatin | 1994 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
[Comparative pharmacokinetics of antibiotics in blood, csf and brain].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Blood; Brain; Brain Neoplasms; Cefamandole; Cerebrospinal Fluid; Female; Humans; Male; Metronidazole; Middle Aged; Pefloxacin | 1993 |
[A Norwegian conference on updating of the treatment of Helicobacter pylori in peptic ulcer. Interessegruppe for Gastroenterologi].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Norway; Omeprazole; Oxytetracycline; Peptic Ulcer | 1994 |
Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; DNA, Bacterial; DNA, Ribosomal; Drug Resistance, Microbial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer | 1994 |
Helicobacter pylori infection and serum pepsinogen A, pepsinogen C, and gastrin in gastritis and peptic ulcer: significance of inflammation and effect of bacterial eradication.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pepsinogens; Peptic Ulcer; Salicylates | 1994 |
Effect of eradication of Helicobacter pylori on serum pepsinogen I, gastrin, and insulin in duodenal ulcer patients: a 12-month follow-up study.
Topics: Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Insulin; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pepsinogens; Time Factors | 1994 |
Resolution of protein-losing hypertrophic lymphocytic gastritis with therapeutic eradication of Helicobacter pylori.
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis, Hypertrophic; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Protein-Losing Enteropathies; Salicylates | 1994 |
[Helicobacter pylori resistance against metronidazole in Switzerland: implications for eradication therapy?].
Topics: Adult; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Switzerland | 1994 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
Histology of the mucosa of gastric antrum and body before and after eradication of Helicobacter pylori.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Time Factors | 1993 |
Vitamin C concentration in gastric juice before and after anti-Helicobacter pylori treatment.
Topics: Amoxicillin; Ascorbic Acid; Bismuth; Female; Gastric Juice; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Nitrofurantoin; Organometallic Compounds; Salicylates; Smoking | 1994 |
[Antimicrobial sensitivity and treatment of Helicobacter pylori infections].
Topics: Amoxicillin; Anti-Bacterial Agents; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1994 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
Role of serology in monitoring treatment for Helicobacter pylori infection in elderly patients.
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Metronidazole; Organometallic Compounds | 1993 |
In vitro antimicrobial susceptibility to combinations of drugs on bacteria from carious and endodontic lesions of human deciduous teeth.
Topics: Amoxicillin; Bacteria, Anaerobic; Cefaclor; Child; Child, Preschool; Ciprofloxacin; Dental Caries; Dental Pulp Diseases; Drug Therapy, Combination; Fosfomycin; Humans; Metronidazole; Microbial Sensitivity Tests; Miocamycin; Tooth, Deciduous | 1993 |
Use and abuse of antibiotics in periodontal therapy.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Clavulanic Acids; Clindamycin; Drug Combinations; Drug Therapy, Combination; Drug Utilization; Humans; Metronidazole; Periodontal Diseases; Tetracyclines | 1993 |
[Helicobacter pylori infection and peptic ulcer].
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Tetracycline | 1993 |
Antibiotic therapy alone eradicates Helicobacter pylori and prevents duodenal ulcer recurrence.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter pylori; Humans; Metronidazole; Ranitidine; Recurrence | 1993 |
Histamine content of the oxyntic mucosa from duodenal ulcer patients: effect of Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Furazolidone; Gastric Mucosa; Gastrins; Helicobacter Infections; Helicobacter pylori; Histamine; Humans; Male; Metronidazole; Time Factors | 1993 |
Infections caused by beta-lactamase-producing Fusobacterium spp. in children.
Topics: Adolescent; Amoxicillin; beta-Lactamase Inhibitors; beta-Lactamases; Child; Clavulanic Acid; Clavulanic Acids; Clindamycin; Drug Combinations; Female; Fusobacterium; Fusobacterium Infections; Humans; Male; Metronidazole; Penicillins; Retrospective Studies; Ticarcillin | 1993 |
Eradication of Helicobacter pylori in recurrent duodenal ulcer.
Topics: Amoxicillin; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Recurrence | 1993 |
One-day therapy for treatment of Helicobacter pylori infection.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Treatment Outcome | 1993 |
The role of Helicobacter pylori in peptic ulcer disease.
Topics: Amoxicillin; Antacids; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Metronidazole; Neutrophils; Prospective Studies; Recurrence; Stomach Ulcer | 1993 |
Evaluation of new therapy for eradication of H. pylori infection in nude mouse model.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Diterpenes; Drug Evaluation, Preclinical; Drug Therapy, Combination; Fatty Alcohols; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Male; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Nude | 1993 |
Treatment of peptic ulcers caused by Helicobacter pylori.
Topics: Amoxicillin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Ranitidine; Recurrence | 1993 |
[42-year-old patient with fever and a palpable abdominal tumor].
Topics: Abscess; Actinomycosis; Adult; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fever of Unknown Origin; Humans; Inguinal Canal; Male; Metronidazole | 1993 |
Long-standing bacteremia caused by oral Actinobacillus actinomycetemcomitans in a patient with a pacemaker.
Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Bacteremia; Drug Therapy, Combination; Humans; Male; Metronidazole; Middle Aged; Mouth; Pacemaker, Artificial; Periodontitis; Time Factors | 1993 |
Two-week eradication regimen for metronidazole-resistant Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Breath Tests; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds | 1993 |
Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
Topics: Amoxicillin; Anti-Ulcer Agents; Drug Interactions; Helicobacter pylori; Humans; Hydroxamic Acids; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Organometallic Compounds; Tetracycline | 1993 |
In vitro susceptibility of Helicobacter pylori to several antimicrobial combinations.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Drug Synergism; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1993 |
Evaluation of a new bismuth-free triple therapy in nude mice and humans.
Topics: Amoxicillin; Animals; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Colony Count, Microbial; Contraindications; Disease Models, Animal; Diterpenes; Drug Therapy, Combination; Fatty Alcohols; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Nude; Penicillins; Peptic Ulcer; Recurrence; Severity of Illness Index; Treatment Outcome | 1995 |
Sucralfate affects the susceptibility of Helicobacter pylori to antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Interactions; Erythromycin; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Sucralfate; Tetracycline | 1995 |
Cost-effectiveness of treatment regimens for the eradication of Helicobacter pylori in duodenal ulcer.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Patient Compliance; Penicillins; Recurrence; Tetracycline; Time Factors | 1996 |
Factors affecting growth and antibiotic susceptibility of Helicobacter pylori: effect of pH and urea on the survival of a wild-type strain and a urease-deficient mutant.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzamides; Clarithromycin; Drug Interactions; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Mutation; Omeprazole; Penicillins; Urea; Urease | 1996 |
[What factors influence healing of duodenal ulcer when Helicobacter pylori eradication treatment is used?].
Topics: Adult; Age Factors; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Evaluation Studies as Topic; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Penicillins; Sex Factors; Smoking; Tetracycline; Time Factors; Wound Healing | 1996 |
[New guidelines from the Medical Products Agency: the triple regime against Helicobacter pylori is necessary. Treat only if the ulcer is verified].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Stomach Ulcer; Tetracycline | 1996 |
One-day combined therapy of children with Helicobacter pylori-associated peptic disease.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins | 1996 |
Gastric mucosal hepatocyte growth factor in Helicobacter pylori gastritis and peptic ulcer disease.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Hepatocyte Growth Factor; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Penicillins; Peptic Ulcer; Statistics, Nonparametric; Time Factors | 1996 |
[Comment on the Stolte/Domschke letter-discussion].
Topics: Amoxicillin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Ranitidine; Treatment Outcome | 1996 |
[Triple combination antimicrobial therapy of Helicobacter pylori and basal levels of serum gastrin].
Topics: Adult; Amoxicillin; Drug Therapy, Combination; Female; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged | 1996 |
Pharmacology of the gastric mucosa: a rational approach to Helicobacter polytherapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastric Acid; Gastric Juice; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins | 1996 |
Boomslang envenomation in a dog.
Topics: Amoxicillin; Animals; Antivenins; Dog Diseases; Dogs; Hemorrhage; Male; Metronidazole; Penicillins; Snake Bites; South Africa | 1995 |
Preparation and characterization of freeze-dried chitosan-poly(ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach.
Topics: Amoxicillin; Antitrichomonal Agents; Biocompatible Materials; Chitin; Chitosan; Drug Delivery Systems; Freeze Drying; Gastric Juice; Gastric Mucosa; Gels; Humans; Hydrogen-Ion Concentration; Intestinal Secretions; Metronidazole; Microscopy, Electron, Scanning; Penicillins; Polyethylene Glycols; Surface-Active Agents | 1996 |
Treatment of Helicobacter pylori infection by topical administration of antimicrobial agents.
Topics: Administration, Topical; Amoxicillin; Antacids; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Intubation, Gastrointestinal; Metronidazole; Penicillins | 1996 |
Evaluation of various oral antimicrobial formulations for eradication of Helicobacter hepaticus.
Topics: Administration, Oral; Amoxicillin; Animals; Anti-Bacterial Agents; Base Sequence; Bismuth; Diet; Drinking; Female; Helicobacter; Helicobacter Infections; Male; Metronidazole; Mice; Mice, Inbred A; Mice, Inbred DBA; Molecular Sequence Data; Polymerase Chain Reaction; Rodent Diseases; Tetracycline | 1996 |
Use of PCR and culture to detect Helicobacter pylori in naturally infected cats following triple antimicrobial therapy.
Topics: Amoxicillin; Animals; Bacteriological Techniques; Cats; Cells, Cultured; Drug Therapy, Combination; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Male; Metronidazole; Omeprazole; Polymerase Chain Reaction; Saliva | 1996 |
Triple therapy with sucralfate, amoxycillin and metronidazole for healing duodenal ulcer and eradicating Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antitrichomonal Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins; Sucralfate; Treatment Outcome | 1996 |
One-week triple therapy with omeprazole, amoxycillin and either clarithromycin or metronidazole for cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Prospective Studies | 1996 |
The role of screening for Helicobacter pylori in patients with duodenal ulceration in the primary health care setting.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Antibodies, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Primary Health Care; Prospective Studies; Serologic Tests | 1996 |
Metronidazole resistance: a predictor of failure of Helicobacter pylori eradication by triple therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Penicillins; Predictive Value of Tests; Treatment Failure | 1996 |
Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole | 1996 |
[Which factors influence the success of the classical triple therapy in the eradication of Helicobacter pylori?].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Pyloric Antrum; Stomach; Tetracycline | 1996 |
[Triple-therapy treatment during 1 month versus 2 weeks in gastroduodenal disease due to Helicobacter pylori in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Drug Evaluation; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Time Factors | 1996 |
Activity of amoxicillin, metronidazole, bismuth salicylate and six aminoglycosides against Helicobacter pylori.
Topics: Aminoglycosides; Amoxicillin; Antacids; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Salicylates; Salicylic Acid | 1996 |
Insulin-like growth factor-I in Helicobacter pylori gastritis and response to eradication using bismuth based triple therapy.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Case-Control Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastric Juice; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Insulin-Like Growth Factor I; Male; Metronidazole; Middle Aged | 1996 |
[Connection between Helicobacter pylori infection and chronic gastrointestinal urticaria].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Bismuth; Chronic Disease; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Penicillins; Urticaria | 1996 |
Relevance of the ferret model of Helicobacter-induced gastritis to evaluation of antibacterial therapies.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Drug Therapy, Combination; Female; Ferrets; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins; Time Factors | 1996 |
Triple therapy in duodenal ulcer healing--a follow up study.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Pakistan; Treatment Outcome; Wound Healing | 1996 |
Kill kinetics of antimicrobial agents against Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Helicobacter pylori; Humans; Kinetics; Logistic Models; Metronidazole; Microbial Sensitivity Tests; Organometallic Compounds | 1996 |
Microbiological and immunohistological findings in a patient with Papillon-Lefèvre syndrome.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Child; Dental Care for Chronically Ill; Dental Cementum; Dental Plaque; Drug Therapy, Combination; Family Health; Female; Humans; Immunohistochemistry; Metronidazole; Papillon-Lefevre Disease; Penicillins; Periodontitis; Tooth Extraction | 1996 |
Effect of lansoprazole in mono-, dual-, or triple therapy on Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors; Stomach Ulcer; Tinidazole | 1996 |
Endoscopic topical therapy for the treatment of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Topical; Amoxicillin; Antacids; Anti-Ulcer Agents; Bismuth; Drug Combinations; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Instillation, Drug; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase | 1996 |
Bacterial density of Helicobacter pylori predicts the success of triple therapy in bleeding duodenal ulcer.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer Hemorrhage; Predictive Value of Tests; Ranitidine; Treatment Failure | 1996 |
Audit on the use of prophylactic parenteral antimicrobial agents and the use of co-amoxiclav and metronidazole.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antitrichomonal Agents; Clavulanic Acids; Cross Infection; Drug Therapy, Combination; Drug Utilization; Humans; Medical Audit; Metronidazole | 1996 |
Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Bismuth; Cost of Illness; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Pilot Projects; Salicylates; Tetracycline | 1996 |
Drugs for treatment of peptic ulcers.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diarrhea; Drug Interactions; Drug Resistance, Microbial; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Misoprostol; Peptic Ulcer; Proton Pump Inhibitors; Salicylates; Salicylic Acid; Sucralfate; Tetracycline | 1997 |
Localized prepubertal periodontitis--nonsurgical treatment of an adolescent patient: a case report.
Topics: Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Child; Clavulanic Acids; Dental Scaling; Drug Therapy, Combination; Humans; Male; Metronidazole | 1995 |
[Breath test in the diagnosis of Helicobacter pylori infection: concordance with histological methods and correlation with anatomopathological lesions of the gastric mucosa].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Tetracycline | 1996 |
"Mediterranean lymphoma" treated with antibiotics.
Topics: Aged; Amoxicillin; Drug Therapy, Combination; Duodenoscopy; Duodenum; Female; Humans; Immunoproliferative Small Intestinal Disease; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Tetracycline | 1996 |
[The treatment of children with Helicobarter pylory by triple therapy can be shortened without the risk of losing it eradicating efficacy. Letter].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Child; Child, Preschool; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Penicillins; Time Factors | 1996 |
The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Buffers; Chromatography, High Pressure Liquid; Clarithromycin; Gastric Juice; Half-Life; Helicobacter; Helicobacter Infections; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Metronidazole; Omeprazole; Penicillins; Solutions | 1997 |
Effect of eradication of Helicobacter pylori in patients with fundic atrophic gastritis.
Topics: Amoxicillin; Bismuth; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged | 1997 |
Putative periodontal pathogens, antibody titres and avidities to them in a longitudinal study of patients with resistant periodontitis.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Antibodies, Bacterial; Antibody Affinity; Antitrichomonal Agents; Chronic Disease; Disease Progression; Female; Gingival Pocket; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Penicillins; Periodontitis; Porphyromonas gingivalis; Statistics, Nonparametric | 1996 |
[Triple ranitidine therapy in Helicobacter pylori infection. Recommendation for effective, safe and cost effective combination for Helicobacter pylori eradication].
Topics: Amoxicillin; Anti-Ulcer Agents; Cost-Benefit Analysis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Ranitidine; Treatment Outcome | 1996 |
[Helicobacter pylori eradication: finally clarity].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Peptic Ulcer | 1996 |
Resolution of protein-losing hypertrophic gastropathy by eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child, Preschool; Drug Therapy, Combination; Gastric Mucosa; Gastritis, Hypertrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillins; Protein-Losing Enteropathies | 1997 |
Susceptibility of Helicobacter pylori isolates against agents commonly administered for eradication therapy and the efficacy of chemotherapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole | 1997 |
Antibiotic prophylaxis in gastrointestinal endoscopy: a report by a Working Party for the British Society of Gastroenterology Endoscopy Committee.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Cephalosporins; Cholangiopancreatography, Endoscopic Retrograde; Cholestasis; Ciprofloxacin; Drug Hypersensitivity; Endocarditis, Bacterial; Endoscopy, Gastrointestinal; Gentamicins; Humans; Immunocompromised Host; Metronidazole; Neutropenia; Pancreatic Pseudocyst; Penicillins; Risk Factors; Teicoplanin; Vancomycin | 1997 |
Regression of a large gastric MALT lymphoma with antibiotic treatment to eradicate Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Stomach Neoplasms | 1997 |
[Early results of treating Helicobacter pylori infections in patients with gastric ulcer and gastritis].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Stomach Ulcer; Treatment Outcome | 1996 |
Gastric metaplasia and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Penicillins; Stomach; Treatment Outcome | 1997 |
The effect of antimicrobial therapy on periimplantitis lesions. An experimental study in the dog.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Dental Implants; Dental Plaque; Dogs; Equipment Contamination; Metronidazole; Morpholines; Penicillins; Periodontitis; Periodontium; Prosthesis-Related Infections; Subgingival Curettage; Surface-Active Agents; Wound Healing | 1996 |
[Helicobacter pylori: pretherapeutic resistance status in Germany (Ruhr area)].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple; Female; Gastritis; Germany; Helicobacter Infections; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 1997 |
In vitro assessment of gastric mucosal transfer of anti-Helicobacter therapeutic agents.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antitrichomonal Agents; Biological Transport; Carbachol; Electric Conductivity; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine; Hydrogen-Ion Concentration; Male; Metronidazole; Penicillins; Rats; Rats, Wistar | 1997 |
Ranitidine in a twice daily triple therapy regimen for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Antitrichomonal Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Penicillins; Ranitidine; Recurrence; Treatment Outcome | 1997 |
In vitro anti-Helicobacter pylori activity of ebrotidine.
Topics: Amoxicillin; Benzenesulfonates; Clarithromycin; Drug Synergism; Erythromycin; Helicobacter pylori; Histamine H2 Antagonists; Metronidazole; Microbial Sensitivity Tests; Ranitidine; Tetracycline; Thiazoles | 1997 |
Serum 13C-bicarbonate assay for the diagnosis of gastric Helicobacter pylori infection and response to treatment.
Topics: Amoxicillin; Bicarbonates; Bismuth; Carbon Isotopes; Clarithromycin; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Spectrometry; Metronidazole; Middle Aged; Omeprazole; Sensitivity and Specificity; Tetracycline | 1997 |
Successful low-dose amoxycillin, metronidazole and omeprazole combination therapy in a population with a high frequency of metronidazole-resistant Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 1997 |
Identification and eradication of Helicobacter pylori in an isolated patient population.
Topics: Amoxicillin; Bismuth; Cost Savings; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Military Personnel; Organometallic Compounds; Peptic Ulcer; Salicylates; Tetracycline; United States; Utah | 1997 |
Unhealed duodenal ulcers despite Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Case-Control Studies; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Risk Factors; Tetracyclines; Time Factors; Treatment Outcome; Wound Healing | 1997 |
Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biopsy; Clarithromycin; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Neoplasm Recurrence, Local; Omeprazole; Precancerous Conditions; Stomach Neoplasms | 1997 |
Short-term eradication therapy for Helicobacter pylori does not reduce the incidence of gastric metaplasia in duodenal ulcer patients.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Stomach | 1997 |
Evolution of resistance to metronidazole and clarithromycin in Helicobacter pylori clinical isolates from Spain.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter pylori; Humans; Male; Metronidazole; Spain; Tetracycline | 1997 |
One-day high-dose combined therapy of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Evaluation; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Time Factors | 1997 |
Treatment of Helicobacter pylori infection: summary of a meeting at the Fourth United European Gastroenterology Week, September 20, 1995.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Bismuth; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Enzyme Inhibitors; Europe; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tetracycline; Tinidazole | 1996 |
Natural and experimental Helicobacter mustelae reinfection following successful antimicrobial eradication in ferrets.
Topics: Amoxicillin; Animals; Antacids; Bacterial Proteins; Biopsy; Bismuth; DNA, Bacterial; Drug Therapy, Combination; Ferrets; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter; Helicobacter Infections; Metronidazole; Organometallic Compounds; Recurrence; Salicylates; Time Factors; Urease | 1996 |
Characterization and therapy for experimental infection by Helicobacter mustelae in ferrets.
Topics: Amoxicillin; Animals; Antacids; Antibodies, Bacterial; Bismuth; Drug Therapy, Combination; Female; Ferrets; Gastritis; Helicobacter; Helicobacter Infections; Male; Metronidazole; Organometallic Compounds; Salicylates; Specific Pathogen-Free Organisms | 1996 |
Appearance of a metronidazole-resistant Helicobacter pylori strain in an infected-ICR-mouse model and difference in eradication of metronidazole-resistant and -sensitive strains.
Topics: Amoxicillin; Animals; Antitrichomonal Agents; Disease Models, Animal; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Male; Metronidazole; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Penicillins | 1997 |
Antimicrobial resistance testing of Helicobacter pylori: a comparison of Etest and disk diffusion methods.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Erythromycin; Female; Helicobacter pylori; Humans; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Microbiological Techniques; Middle Aged; Nitroimidazoles; Tetracycline | 1997 |
Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Resistance, Microbial; Drug Synergism; Helicobacter Infections; Helicobacter pylori; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Penicillins | 1997 |
Anti-Helicobacter pylori specific antibody immunohistochemistry improves the diagnostic accuracy of Helicobacter pylori in biopsy specimen from patients treated with triple therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Biopsy; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pyloric Antrum | 1998 |
Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin--influence on treatment outcome.
Topics: Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Treatment Outcome | 1998 |
Eradication of Actinobacillus actinomycetemcomitans from the oral cavity in adult periodontitis.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Colony Count, Microbial; Combined Modality Therapy; Dental Scaling; Female; Follow-Up Studies; Gingiva; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Odds Ratio; Penicillins; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Regression Analysis; Subgingival Curettage; Tooth; Treatment Outcome | 1998 |
[Short-term triple therapy with pantoprazole, amoxicillin and metronidazole in Helicobacter pylori infection].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Stomach Ulcer; Sulfoxides; Treatment Outcome | 1998 |
[Helicobacter pylori infection and recurrent abdominal pain in children. A proved relationship?].
Topics: Abdominal Pain; Adolescent; Adult; Age Factors; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antibodies, Bacterial; Child; Chronic Disease; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Recurrence; Risk Factors; Stomach Ulcer | 1998 |
Risk of development of in vitro resistance to amoxicillin, clarithromycin, and metronidazole in Helicobacter pylori.
Topics: Adenosine Triphosphate; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Resistance, Multiple; Helicobacter pylori; Metronidazole | 1998 |
[Complications of sinusitis].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Ceftriaxone; Cephalosporins; Clavulanic Acid; Drug Therapy, Combination; Expectorants; Female; Humans; Male; Methylprednisolone; Metronidazole; Middle Aged; Penicillins; Primary Health Care; Sinusitis; Time Factors; Vasoconstrictor Agents | 1998 |
Doppler flow characteristics in patients with pelvic inflammatory disease: responders versus nonresponders to therapy.
Topics: Adnexa Uteri; Adult; Amoxicillin; Case-Control Studies; Clavulanic Acid; Drug Therapy, Combination; Female; Gentamicins; Humans; Metronidazole; Pelvic Inflammatory Disease; Predictive Value of Tests; Retrospective Studies; Ultrasonography, Doppler, Color | 1998 |
Effect of metronidazole resistance on bacterial eradication of Helicobacter pylori in infected children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Child; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Omeprazole; Prospective Studies; Spiramycin | 1998 |
Use of a continuous-culture biofilm system to study the antimicrobial susceptibilities of Gardnerella vaginalis and Lactobacillus acidophilus.
Topics: Amoxicillin; Anti-Bacterial Agents; Biofilms; Clindamycin; Colony Count, Microbial; Erythromycin; Gardnerella vaginalis; Lactobacillus acidophilus; Metronidazole; Microbial Sensitivity Tests | 1998 |
Helicobacter pylori and peptic ulcer disease therapies: a survey of gastroenterologists in Israel.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Health Care Surveys; Helicobacter pylori; Humans; Israel; Metronidazole; Penicillins; Peptic Ulcer; Proton Pump Inhibitors; Tinidazole | 1998 |
Comparison of culture, histopathology and urease testing for the diagnosis of Helicobacter pylori gastritis and susceptibility to amoxycillin, clarithromycin, metronidazole and tetracycline.
Topics: Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Biopsy; Clarithromycin; Gastritis; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Predictive Value of Tests; Sensitivity and Specificity; Stomach; Tetracycline; Urease | 1998 |
[Polyneuropathy caused by vitamin B12 deficiency secondary to chronic atrophic gastritis and giardiasis].
Topics: Amoxicillin; Anemia, Pernicious; Anti-Bacterial Agents; Antiprotozoal Agents; Bismuth; Duodenitis; Enzyme Inhibitors; Evoked Potentials, Somatosensory; Female; Gastritis, Atrophic; Giardiasis; Helicobacter Infections; Helicobacter pylori; Humans; Hydroxocobalamin; Malabsorption Syndromes; Metronidazole; Middle Aged; Neural Conduction; Omeprazole; Peripheral Nervous System Diseases; Remission Induction; Vitamin B 12 Deficiency | 1998 |
Assessment of symptomatic response as predictor of Helicobacter pylori status following eradication therapy in patients with ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Predictive Value of Tests; Treatment Outcome | 1998 |
Clostridium difficile colitis associated with treatment of Helicobacter pylori infection.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clostridioides difficile; Diarrhea; Enterocolitis, Pseudomembranous; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Penicillins; Salicylates; Stomach Diseases | 1998 |
Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Microbial; Duodenal Ulcer; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Polymerase Chain Reaction | 1998 |
Getting to the route of Helicobacter pylori treatment.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Delivery Systems; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Patient Compliance | 1998 |
Detection of Helicobacter pylori in stool specimens by PCR and antigen enzyme immunoassay.
Topics: Adult; Amoxicillin; Antigens, Bacterial; Child; DNA, Bacterial; Feces; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Immunoenzyme Techniques; Metronidazole; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Delayed healing of chronic gastric ulcer after Helicobacter pylori infection in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred BALB C; Mice, Nude; Stomach Ulcer; Wound Healing | 1998 |
Characterization of clinical isolates of Helicobacter pylori in Singapore.
Topics: Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Bacterial Typing Techniques; Biopsy; Clarithromycin; Cytotoxins; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Electrophoresis, Agar Gel; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Prevalence; Random Amplified Polymorphic DNA Technique; Singapore; Stomach; Tetracycline Resistance | 1998 |
Use of a [13C]urea breath test for detection of gastric infection with Helicobacter spp in dogs.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Carbon Isotopes; Dog Diseases; Dogs; Famotidine; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Male; Metronidazole; Reproducibility of Results; Specific Pathogen-Free Organisms; Stomach; Urea; Urease | 1998 |
Vancomycin-resistant enterococcal colonization in nonhospitalized HIV-infected patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anti-Bacterial Agents; Bisexuality; Black People; Cephalexin; Cephalosporins; Clarithromycin; Dicloxacillin; Doxycycline; Drug Resistance, Microbial; Enterococcus; Feces; Female; Gram-Positive Bacterial Infections; Homosexuality, Male; Humans; Male; Metronidazole; Middle Aged; Ofloxacin; Penicillins; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin; White People | 1998 |
Long-term follow-up of duodenal ulcer in children before and after eradication of Helicobacter pylori.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Bismuth; Child; Disease Progression; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole | 1999 |
[Triple treatment for the eradication of Helicobacter pylori infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Recurrence; Time Factors | 1998 |
Optimal treatment for duodenal ulcer disease: a cost-decision analysis in Malaysian patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Cost-Benefit Analysis; Decision Support Techniques; Drug Therapy, Combination; Duodenal Ulcer; Humans; Malaysia; Metronidazole; Models, Economic; Omeprazole; Tetracycline | 1999 |
Helicobacter pylori eradication treatment reduces the severity of rosacea.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Antibodies, Bacterial; Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A; Immunoglobulin G; Male; Metronidazole; Middle Aged; Organometallic Compounds; Rosacea; Treatment Outcome | 1999 |
Treatment considerations in rapidly progressive periodontitis: a case report.
Topics: Adult; Age of Onset; Amoxicillin; Anti-Bacterial Agents; Antitrichomonal Agents; Colony Count, Microbial; Dental Scaling; Disease Progression; Humans; Male; Metronidazole; Periodontal Index; Periodontitis; Radiography; Root Planing | 1998 |
Effect of Helicobacter pylori eradication on the natural history of duodenal ulcer disease.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Organometallic Compounds; Tetracycline; Treatment Outcome | 1998 |
The effect of antibiotic resistance on the outcome of three 1-week triple therapies against Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Sulfoxides | 1999 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Utilization; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Naphthyridines; Netherlands; Tetracycline | 1999 |
Metronidazole resistance and virulence factors in Helicobacter pylori as markers for treatment failure in a paediatric population.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Child; Child, Preschool; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Organometallic Compounds; Penicillins; Treatment Failure; Virulence | 1999 |
In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteroides fragilis; beta-Lactamase Inhibitors; Cefoxitin; Ceftizoxime; Chloramphenicol; Clavulanic Acid; Clindamycin; Drug Therapy, Combination; Enzyme Inhibitors; Imipenem; Metronidazole; Mezlocillin; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Species Specificity; Sulbactam; Tazobactam; Thienamycins; Ticarcillin | 1999 |
A new quadruple therapy for Helicobacter pylori: influence of resistant strains on treatment outcome.
Topics: Adult; Aged; Amoxicillin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Roxithromycin | 1999 |
Two- to four-year histological follow-up of gastric mucosa after Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Organometallic Compounds; Prospective Studies; Statistics, Nonparametric | 1999 |
Primary peritonitis due to nonenteric salmonellae.
Topics: Adolescent; Aged; Amoxicillin; Cefotaxime; Ciprofloxacin; Clavulanic Acid; Fatal Outcome; Humans; Male; Metronidazole; Peritonitis; Salmonella; Salmonella Infections; Salmonella typhimurium; Treatment Outcome | 1999 |
My approach to Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Proton Pump Inhibitors | 1999 |
Evaluation of the factors influencing stomach-specific delivery of antibacterial agents for Helicobacter pylori infection.
Topics: Amoxicillin; Chitin; Chitosan; Drug Stability; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Metronidazole; Microspheres; Permeability | 1999 |
Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Ciprofloxacin; Drug Resistance, Microbial; Erythromycin; Humans; Metronidazole; Microbial Sensitivity Tests; Ornidazole; Periodontal Pocket; Periodontitis; Species Specificity; Spiramycin; Tetracycline; Virginiamycin | 1999 |
[Symptomatic improvement of patients with nonulcer dyspepsia after Helicobacter pylori eradication].
Topics: Amoxicillin; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Tetracycline; Treatment Outcome | 1999 |
[Circumscribed mandibular osteitis in children due to hematogenous dissemination. Apropos of 5 clinical cases].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacteremia; Child; Curettage; Focal Infection; Folliculitis; Humans; Mandibular Diseases; Metronidazole; Osteitis; Osteolysis; Otitis; Penicillins; Pharyngitis; Radiography, Panoramic; Spiramycin; Tomography, X-Ray Computed | 1999 |
Omeprazole, amoxycillin and metronidazole for the cure of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Treatment Outcome | 1999 |
Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Remission, Spontaneous; Treatment Outcome | 1999 |
Simultaneous quantification of amoxycillin and metronidazole in plasma using high-performance liquid chromatography with photodiode array detection.
Topics: Amoxicillin; Chromatography, High Pressure Liquid; Helicobacter Infections; Humans; Metronidazole; Spectrophotometry, Ultraviolet | 1999 |
Resolution of peri-implantitis following treatment. An experimental study in the dog.
Topics: Administration, Oral; Administration, Topical; Alveolar Bone Loss; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bone Regeneration; Dental Implants; Dental Plaque; Dogs; Implants, Experimental; Metronidazole; Osseointegration; Periodontitis | 1999 |
A survey of gastroenterologists' perceptions and practices related to Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Attitude of Health Personnel; Breath Tests; Carbon Isotopes; Carbon Radioisotopes; Clarithromycin; Drug Resistance, Microbial; Enzyme Inhibitors; Gastroenterology; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Practice Patterns, Physicians'; Proton Pump Inhibitors; Radiopharmaceuticals; Surveys and Questionnaires; Urea | 1999 |
CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Therapy, Combination; Enzyme Inhibitors; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Mixed Function Oxygenases; Omeprazole; Penicillins; Peptic Ulcer; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Protein Synthesis Inhibitors; Treatment Outcome | 1999 |
Salmonella meningitis and multiple cerebral abscesses in an infant.
Topics: Amoxicillin; Ampicillin; Brain Abscess; Cefotaxime; Chloramphenicol; Ciprofloxacin; Drug Therapy, Combination; Female; Humans; Infant; Meningitis, Bacterial; Metronidazole; Salmonella enteritidis; Salmonella Infections | 1999 |
Duodenal ulcer relapse is not always associated with recurrence of H. pylori infection: a prospective three-year follow-up study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Recurrence | 1999 |
[Resolution of an autoimmune thrombocytopenic purpura after eradicating treatment of Helicobacter pylori].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Bismuth; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; L-Lactate Dehydrogenase; Metronidazole; Omeprazole; Organometallic Compounds; Purpura, Thrombocytopenic, Idiopathic; Salicylates; Tetracycline | 1999 |
Regression of high-grade gastric mucosa-associated lymphoid tissue lymphoma with Helicobacter pylori after triple antibiotic therapy.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Omeprazole; Penicillins; Stomach Neoplasms | 2000 |
Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Proton Pump Inhibitors | 2000 |
The long-term reinfection rate and the course of duodenal ulcer disease after eradication of Helicobacter pylori in a developing country.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Chile; Developing Countries; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Recurrence; Tinidazole | 2000 |
Symptomatic benefit 1-3 years after H. pylori eradication in ulcer patients: impact of gastroesophageal reflux disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer | 2000 |
Unsuccessful treatment results in survival of less virulent genotypes of Helicobacter pylori in Colombian patients.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Chemoprevention; Colombia; Follow-Up Studies; Gastritis, Atrophic; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Penicillins; Precancerous Conditions; Salicylates; Stomach Neoplasms; Treatment Failure; Virulence | 2000 |
Inflammatory fibroid polyp and Helicobacter pylori. Aetiology or coincidence?
Topics: Amoxicillin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Metronidazole; Middle Aged; Polyps; Retrospective Studies; Stomach Neoplasms; Time Factors | 2000 |
Helicobacter pylori: related to rosacea?
Topics: Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Rosacea; Severity of Illness Index; Stomach Ulcer | 2000 |
[24-hour monitoring of gastric juice pH in assessment of anti-ulcer treatment].
Topics: Adult; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Circadian Rhythm; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Digestive System; Famotidine; Female; Gastric Juice; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged; Ranitidine; Treatment Outcome | 2000 |
Mucosal change of the stomach with low-grade mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori: follow-up study of 48 cases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction; Stomach; Stomach Neoplasms | 2000 |
Helicobacter pylori: cultivability and antibiotic susceptibility of coccoid forms.
Topics: Amoxicillin; Anti-Bacterial Agents; Colony Count, Microbial; Drug Resistance, Microbial; Erythromycin; Gentamicins; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests | 2000 |
Early-onset periodontitis in a patient with Ehlers-Danlos syndrome type III.
Topics: Adolescent; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Ehlers-Danlos Syndrome; Humans; Immunophenotyping; Male; Metronidazole; Penicillins; Subgingival Curettage | 1999 |
Actinobacillus actinomycetemcomitans in destructive periodontal disease. Three-year follow-up results.
Topics: Actinobacillus Infections; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Colony Count, Microbial; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Metronidazole; Middle Aged; Penicillins; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Index; Periodontal Pocket; Recurrence; Risk Factors; Treatment Outcome | 2000 |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Creatinine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Ranitidine | 2000 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxicillin, tetracycline, and furazolidone in Brazil.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Brazil; Drug Resistance, Microbial; Drug Resistance, Multiple; Dyspepsia; Female; Furazolidone; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Penicillins | 2000 |
In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.
Topics: Acetamides; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Helicobacter pylori; Humans; Linezolid; Metronidazole; Microbial Sensitivity Tests; Oxazoles; Oxazolidinones; Penicillins | 2000 |
[IgG and IgA immunoglobulins in helicobacter pylori infections of children with chronic dyspepsia before and after two week triple drug therapy].
Topics: Adolescent; Amoxicillin; Bismuth; Blotting, Western; Child; Chronic Disease; Drug Therapy, Combination; Dyspepsia; Enzyme-Linked Immunosorbent Assay; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Monitoring, Physiologic; Ranitidine; Serologic Tests | 1999 |
A study of therapeutic antibiotic prescribing in National Health Service general dental practice in England.
Topics: Abscess; Acute Disease; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Chronic Disease; Dentist-Patient Relations; Drainage; Drug Prescriptions; Drug Utilization; Dry Socket; England; Female; General Practice, Dental; Gingivitis; Gingivitis, Necrotizing Ulcerative; Humans; Male; Metronidazole; Penicillins; Pericoronitis; Pulpitis; State Medicine; Surveys and Questionnaires | 2000 |
Resistance of helicobacter pylori to metronidazole, tetracycline and amoxycillin.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Helicobacter pylori; Humans; Metronidazole; Tetracycline | 2000 |
Management of brain abscesses with sequential intravenous/oral antibiotic therapy.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amoxicillin; Brain Abscess; Ciprofloxacin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Metronidazole; Middle Aged; Treatment Outcome | 2000 |
[Quamatel application in three-drug eradication therapy of duodenal ulcer and gastroduodenal ulcerations associated with helicobacter pylori infection].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Duodenal Ulcer; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Penicillins; Stomach Ulcer | 2000 |
Liver abscesses due to Fusobacterium species.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clavulanic Acid; Drug Therapy, Combination; Fusobacterium; Fusobacterium Infections; Humans; Liver Abscess; Male; Metronidazole; Piperacillin; Tomography, X-Ray Computed | 2000 |
OAM for cure of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Costs; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Omeprazole; Penicillins | 2000 |
[The role of omeprazole in the eradication of Helicobacter pylori in patients with duodenal ulcers].
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 2000 |
An unusual case of pulmonary abscess.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Brain Abscess; Cefaclor; Cephalosporins; Diagnosis, Differential; Erythromycin; Gram-Positive Bacterial Infections; Gram-Positive Cocci; Humans; Lung Abscess; Male; Metronidazole; Penicillins; Periodontal Abscess; Thoracic Vertebrae; Tomography, X-Ray Computed | 2000 |
In vitro activities of a new ketolide, ABT-773, alone and in combination with amoxicillin, metronidazole, or tetracycline against Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Interactions; Drug Therapy, Combination; Erythromycin; Helicobacter pylori; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2000 |
[Helicobacter pylori eradication in gastroduodenal ulcer: good, fine and not expensive].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Primary Health Care; Tetracycline | 2000 |
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy.
Topics: Amoxicillin; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2000 |
Efficacy of a 1-week pantoprazole triple therapy in eradicating Helicobacter pylori in Asian patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Malaysia; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Sulfoxides; Treatment Outcome | 2000 |
Factors affecting the variation in antibiotic resistance of Helicobacter pylori over a 3-year period.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Gastritis; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer | 2000 |
Endoscopic characteristics of low-grade gastric mucosa-associated lymphoid tissue lymphoma after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; B-Lymphocytes; Base Sequence; Biopsy; Clone Cells; Data Interpretation, Statistical; DNA, Complementary; DNA, Neoplasm; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Molecular Sequence Data; Omeprazole; Penicillins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Time Factors | 2000 |
Efficacy of omeprazole plus two antimicrobials for the eradication of Helicobacter pylori in a Turkish population.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Proton Pump Inhibitors | 2000 |
Strategies to treat patients with antibiotic resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Resistance, Microbial; Drug Therapy; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2000 |
[High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy].
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Treatment Failure | 2000 |
Prevalence of Helicobacter pylori resistant strains in the southern part of Switzerland.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Prevalence; Switzerland | 2000 |
The use of AP-PCR and flaA-RFLP typing to investigate treatment failure in Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; Drug Therapy, Combination; Flagellin; Genotype; Helicobacter Infections; Helicobacter pylori; Metronidazole; Omeprazole; Penicillins; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Recurrence; Treatment Failure; Virulence | 2000 |
Antibiotic-resistance patterns of Helicobacter pylori in Croatia: cohort study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Benzimidazoles; Cohort Studies; Croatia; Drug Resistance; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Male; Metronidazole; Middle Aged; Omeprazole; Pantoprazole; Risk Factors; Sulfoxides | 2001 |
Mutations of the Helicobacter pylori genes rdxA and pbp1 cause resistance against metronidazole and amoxicillin.
Topics: Amino Acid Sequence; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Carrier Proteins; Drug Resistance, Microbial; Helicobacter pylori; Hexosyltransferases; Humans; Membrane Proteins; Metronidazole; Molecular Sequence Data; Multienzyme Complexes; Muramoylpentapeptide Carboxypeptidase; Mutation; Penicillin-Binding Proteins; Peptidyl Transferases; Sequence Homology, Amino Acid | 2001 |
A multidisciplinary approach to the diagnosis and treatment of early-onset periodontitis: a case report.
Topics: Adolescent; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Dental Scaling; Disease Progression; Female; Follow-Up Studies; Furcation Defects; Humans; Metronidazole; Patient Care Team; Penicillins; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis; Prevotella intermedia; Root Canal Therapy; Root Planing; Tooth Root; Treatment Outcome | 2001 |
Antibiotic susceptibilities of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter pylori; Humans; Male; Metronidazole | 2001 |
[Principles of managing Helicobacter pylori infections. Guidelines of the European Society of Gastroenterology in Primary Health Care].
Topics: Amoxicillin; Biopsy; Clarithromycin; Drug Resistance, Microbial; Duodenoscopy; Enzyme-Linked Immunosorbent Assay; Europe; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Primary Health Care; Proton Pump Inhibitors; Serologic Tests; Societies, Medical | 2000 |
Erythromycin and amoxicillin?
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Cephalosporins; Clindamycin; Erythromycin; Focal Infection, Dental; Humans; Metronidazole; Mouth Diseases; Penicillins; Streptococcus | 2001 |
Role of screening agar plates for in vitro susceptibility testing of Helicobacter pylori in a routine laboratory setting.
Topics: Adult; Agar; Amoxicillin; Clarithromycin; Culture Media; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Stomach | 2001 |
Eradication of Helicobacter pylori from the stomach and duodenum of patients with duodenal ulcers.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Duodenal Ulcer; Duodenum; Enzyme-Linked Immunosorbent Assay; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Stomach | 2001 |
Combined mechanical and antibiotic periodontal therapy in a case of Papillon-Lefèvre syndrome.
Topics: Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Child; Colony Count, Microbial; Dental Plaque; Dental Scaling; Follow-Up Studies; Humans; Male; Metronidazole; Papillon-Lefevre Disease; Penicillins; Periodontal Attachment Loss; Periodontal Pocket; Puberty; Root Planing; Subgingival Curettage | 2001 |
The effect of systemic antibiotics in the treatment of patients with recurrent periodontitis.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Biofilms; Dental Plaque; Dental Plaque Index; Dental Scaling; Disease Progression; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Penicillins; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Recurrence; Reproducibility of Results; Retreatment; Root Planing; Statistics as Topic | 2001 |
[Eradication therapy of Helicobacter pylori in antibiotic resistance].
Topics: Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Stomach Ulcer | 2001 |
In search of the Holy Grail of Heliocobacter pylori remedies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Helicobacter Infections; Humans; Metronidazole; Pilot Projects; Ranitidine; Spain | 2001 |
Change in subgingival microbial profiles in adult periodontitis subjects receiving either systemically-administered amoxicillin or metronidazole.
Topics: Actinomyces; Adult; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Bacteria; Bacteroides; Colony Count, Microbial; Combined Modality Therapy; Dental Plaque; Dental Scaling; Follow-Up Studies; Gingiva; Gingival Hemorrhage; Gingivitis; Humans; Metronidazole; Middle Aged; Nucleic Acid Hybridization; Penicillins; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Root Planing; Statistics as Topic; Suppuration; Treponema | 2001 |
Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Recurrence; Retrospective Studies; Treatment Failure | 2001 |
A prospective study of a one-week nonbismuth quadruple therapy for childhood Helicobacter pylori infection.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Penicillins; Prospective Studies; Stomach Diseases | 2001 |
CYP2C19 genotype related effect of omeprazole on intragastric pH and antimicrobial stability.
Topics: Amoxicillin; Anti-Ulcer Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Drug Combinations; Drug Stability; Gastric Acidity Determination; Genotype; Helicobacter pylori; Hydrogen-Ion Concentration; Metronidazole; Mixed Function Oxygenases; Omeprazole; Reverse Transcriptase Polymerase Chain Reaction | 2001 |
Resistance of Helicobacter pylori to antimicrobial treatment in a Seville hospital catchment area.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Catchment Area, Health; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter pylori; Hospitals; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillins; Prospective Studies; Spain; Tetracycline | 2000 |
The clinical relevance of microbiologic testing: a comparative analysis of microbiologic samples secured from the same sites and cultured in two independent laboratories.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacteriological Techniques; Bacteroides; Campylobacter; Cost-Benefit Analysis; Drug Combinations; Drug Resistance, Microbial; Humans; Laboratories, Dental; Metronidazole; Middle Aged; Penicillin Resistance; Penicillins; Peptostreptococcus; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Reproducibility of Results; Tetracycline; Tetracycline Resistance | 2001 |
[In vitro antimicrobial susceptibility of Helicobacter pylori strains: isolation of strains resistant to clarithromycin].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins | 2001 |
Healing of active, non-atrophic autoimmune gastritis by H. pylori eradication.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome; Wound Healing | 2001 |
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bangladesh; Body Mass Index; Breath Tests; Carbon Isotopes; Developing Countries; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Ranitidine; Recurrence; Tinidazole; Urea | 2001 |
Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Biopsy; Clarithromycin; DNA, Bacterial; Drug Resistance; Drug Resistance, Multiple; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Gastric Fundus; Gastric Mucosa; Gastritis; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pyloric Antrum; Retrospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
Generalized cervical root resorption associated with periodontal disease.
Topics: Acids; Adult; Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Colony Count, Microbial; Debridement; Dental Cementum; Dental Plaque; Dentin; Diet; Drug Combinations; Gingivitis; Humans; Male; Metronidazole; Penicillins; Periodontal Diseases; Periodontitis; Porphyromonas gingivalis; Root Resorption; Tooth Cervix; Tooth Crown; Wound Healing | 2001 |
The role of treatment with proton pump inhibitors and anti-Helicobacter therapy in functional dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors | 2001 |
[Prevalence of primary Helicobacter pylori resistance to eight antimicrobial agents in a hospital in Madrid].
Topics: Adult; Aged; Amoxicillin; Azithromycin; Cefotaxime; Ciprofloxacin; Clarithromycin; Clindamycin; Cross Infection; Drug Resistance; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Pyloric Antrum; Spain; Tetracycline | 2001 |
Prospective study of Helicobacter pylori eradication therapy in stage I(E) high-grade mucosa-associated lymphoid tissue lymphoma of the stomach.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Staging; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Stomach Neoplasms; Treatment Outcome | 2001 |
Duodenal mucosa-associated lymphoid tissue lymphoma treated by eradication of Helicobacter pylori: report of 2 cases including EUS findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Benzimidazoles; Biopsy, Needle; Clarithromycin; Drug Therapy, Combination; Duodenal Neoplasms; Duodenoscopy; Endosonography; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Mucosa; Lymphoma, B-Cell, Marginal Zone; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Treatment Outcome | 2001 |
Re-osseointegration after treatment of peri-implantitis at different implant surfaces. An experimental study in the dog.
Topics: Alveolar Bone Loss; Amoxicillin; Animals; Anti-Bacterial Agents; Bone Regeneration; Dental Implantation, Endosseous; Dental Implants; Dental Prosthesis Design; Dogs; Implants, Experimental; Metronidazole; Osseointegration; Periodontitis; Retreatment; Subgingival Curettage; Surface Properties | 2001 |
The influence of commonly prescribed synthetic drugs for peptic ulcer on the pharmacokinetic fate of glycyrrhizin from Shaoyao-Gancao-tang.
Topics: Amoxicillin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Area Under Curve; Butylscopolammonium Bromide; Chromatography, High Pressure Liquid; Cimetidine; Drug Combinations; Drug Therapy, Combination; Drugs, Chinese Herbal; Feces; Glycyrrhiza; Glycyrrhizic Acid; Hydrolysis; Male; Metronidazole; Muscarinic Antagonists; Omeprazole; Paeonia; Peptic Ulcer; Phytotherapy; Rats; Rats, Wistar | 2001 |
European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori.
Topics: Amoxicillin; Clarithromycin; Confidence Intervals; Drug Resistance, Microbial; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Probability; Sensitivity and Specificity | 2001 |
Summaries for patients. Factors associated with Helicobacter pylori infections in the United States that are resistant to usual antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Penicillins; Population Surveillance; Prevalence; Risk Factors; Stomach Ulcer; United States | 2002 |
[A comparative study of various evaluation methods of the antibiotic sensitivity of strict anaerobic bacteria of the subgingival flora].
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Campylobacter; Chronic Disease; Diffusion; Drug Resistance, Bacterial; Erythromycin; Fusobacterium nucleatum; Gingiva; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins; Peptostreptococcus; Periodontitis; Porphyromonas gingivalis; Prevotella intermedia; Recurrence; Tetracycline; Time Factors | 2001 |
Drug combinations with amoxycillin reduce selection of clarithromycin resistance during Helicobacter pylori eradication therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2002 |
Antibiotic resistance of Helicobacter pylori strains in Japanese children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Microbial Sensitivity Tests; Nitroreductases; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S | 2002 |
Pyloricidins, novel anti-helicobacterpylori antibiotics produced by Bacillus sp. I. Taxonomy, fermentation and biological activity.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacillus; Biological Assay; Clarithromycin; Fermentation; Gerbillinae; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Peptides | 2001 |
[Prescription of antibiotics for periodontitis patients by dental practitioners in the Netherlands].
Topics: Amoxicillin; Anti-Infective Agents; Attitude of Health Personnel; Dental Health Surveys; Drug Prescriptions; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Netherlands; Penicillins; Periodontitis; Surveys and Questionnaires | 1995 |
Second-line Helicobacter pylori eradication with a furazolidone-based regimen in patients who have failed a metronidazole-based regimen.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Drug Therapy, Combination; Enzyme Inhibitors; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Medical Records; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Retrospective Studies; Tetracycline; Treatment Failure; Treatment Outcome | 2001 |
Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter pylori; Lebanon; Metronidazole; Microbial Sensitivity Tests; Penicillins; Prevalence; Tetracycline | 2002 |
In vitro activity of rifampicin against Helicobacter pylori isolated from children and adults.
Topics: Adolescent; Adult; Amoxicillin; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2002 |
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Combinations; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Serologic Tests | 2002 |
Increasing resistance of Helicobacter pylori to clarithromycin: is the horse bolting?
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Biopsy; Clarithromycin; Drug Resistance, Microbial; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Stomach; Tetracycline | 2002 |
[Acquisition of secondary resistance after failure of a first treatment of Helicobacter pylori infection in children].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Data Interpretation, Statistical; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Lansoprazole; Male; Metronidazole; Omeprazole; Penicillin Resistance; Penicillins; Retrospective Studies | 2002 |
Treatment of Papillon-Lefèvre syndrome periodontitis.
Topics: Aggregatibacter actinomycetemcomitans; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Cytomegalovirus; Dental Scaling; Female; Follow-Up Studies; Fusobacterium nucleatum; Gingivitis; Herpesvirus 4, Human; Humans; Metronidazole; Oral Hygiene; Papillon-Lefevre Disease; Penicillins; Peptostreptococcus; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Prevotella; Prognosis; Root Planing | 2002 |
[Evolution of the sensitivity of 235 strains of Helicobacter pylori from 1995 to 1998 and impact of antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Proton Pump Inhibitors; Retrospective Studies; Spain; Tetracycline | 2002 |
Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors.
Topics: Agaricales; Amoxicillin; Animals; Anticarcinogenic Agents; Benzo(a)pyrene; Brassica; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter pylori; Humans; Isothiocyanates; Metronidazole; Mice; Mice, Inbred ICR; Phytotherapy; Stomach Neoplasms; Sulfoxides; Thiocyanates | 2002 |
Resistance of Helicobacter pylori isolated in Israel to metronidazole, clarithromycin, tetracycline, amoxicillin and cefixime.
Topics: Amoxicillin; Cefixime; Chi-Square Distribution; Clarithromycin; Confidence Intervals; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2002 |
Use of an orthopaedic fixator for external fixation of the mandible.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bone Plates; Bone Transplantation; Chronic Disease; Equipment Design; External Fixators; Follow-Up Studies; Fractures, Ununited; Gentamicins; Humans; Male; Mandibular Fractures; Metronidazole; Orthopedic Fixation Devices; Osteonecrosis; Penicillins; Surgical Wound Infection; Treatment Outcome | 2002 |
Generalized aggressive periodontitis in a prepubertal patient: a case report.
Topics: Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Child; Combined Modality Therapy; Debridement; Dental Cementum; Follow-Up Studies; Gingivitis; Humans; Male; Metronidazole; Microscopy, Electron, Scanning; Penicillins; Root Planing; Subgingival Curettage; Tooth Extraction; Tooth Mobility | 2001 |
[Antibiotic resistance of Helicobacter pylori in Reunion Island: therapeutic consequences].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chi-Square Distribution; Ciprofloxacin; Clarithromycin; Confidence Intervals; DNA, Bacterial; Drug Resistance, Bacterial; Erythromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Random Amplified Polymorphic DNA Technique; Reunion; Stomach Ulcer; Tetracycline; Treatment Failure | 2002 |
Risk factors for Helicobacter pylori resistance.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Risk Assessment; United States | 2002 |
Comparison of the E test and agar dilution method for antimicrobial suceptibility testing of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Reproducibility of Results | 2002 |
[The efficacy of the Helicobacter pylori eradication in people of an advanced age].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Penicillins; Stomach Ulcer | 2002 |
Impact of acid secretion, gastritis, and mucus thickness on gastric transfer of antibiotics in rats.
Topics: Amoxicillin; Animals; Anti-Infective Agents, Local; Clarithromycin; Gastric Acid; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Hydrogen-Ion Concentration; Male; Metronidazole; Mucus; Rats; Rats, Wistar | 2002 |
[Zantac (ranitidine) in treating duodenal ulcers].
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Ranitidine | 2002 |
Susceptibility of Porphyromonas gingivalis in biofilms to amoxicillin, doxycycline and metronidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Biofilms; Colony Count, Microbial; Doxycycline; Drug Resistance, Bacterial; Filtration; Gingiva; Humans; Membranes, Artificial; Metronidazole; Microbial Sensitivity Tests; Penicillins; Porphyromonas gingivalis | 2002 |
Quantification of Helicobacter pylori resistance in functional and organic dyspepsia.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins | 2002 |
Local antibiotic therapy guided by microbiological diagnosis.
Topics: Administration, Topical; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Cellulose; Colony Count, Microbial; Humans; Logistic Models; Metronidazole; Periodontitis; Porphyromonas gingivalis; Tetracycline | 2002 |
[Long-term curative effects of suture plus proximal gastric vagotomy or triad-therapy for duodenal ulcer with acute perforation].
Topics: Acute Disease; Adolescent; Adult; Aged; Amoxicillin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer Perforation; Suture Techniques; Vagotomy, Proximal Gastric | 2002 |
Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Mexico; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2002 |
Identification of bacteria in acute endodontic infections and their antimicrobial susceptibility.
Topics: Abscess; Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Child; Clavulanic Acid; Clindamycin; Colony Count, Microbial; Dental Pulp Diseases; Drug Resistance, Bacterial; Female; Humans; Male; Metronidazole; Middle Aged; Penicillin V; Peptostreptococcus; Prevotella; Streptococcus | 2002 |
Antibiotic susceptibility of bacteria associated with endodontic abscesses.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Drug Resistance, Bacterial; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillin V; Periapical Abscess | 2003 |
[A case of pneumopericardium complicating a liver abscess in a patient infected with HIV].
Topics: Adult; AIDS-Related Opportunistic Infections; Amoxicillin; Anemia; Anti-Infective Agents; Blood Transfusion; Chest Pain; Combined Modality Therapy; Electrocardiography; Fatal Outcome; HIV Seropositivity; HIV-1; HIV-2; Humans; Immunocompromised Host; Liver Abscess; Male; Metronidazole; Penicillins; Pneumopericardium; Tachycardia | 1999 |
Primary resistance of Helicobacter pylori to antimicrobial agents in Polish children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Diseases; Metronidazole; Poland; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; RNA, Ribosomal, 23S; Sequence Analysis, DNA; Tetracycline | 2002 |
Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenitis; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests | 2003 |
Long-term follow-up of gastric metaplasia after eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Cicatrix; Convalescence; Drug Therapy, Combination; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Mucus; Omeprazole; Severity of Illness Index | 2003 |
Aspirin inhibits the growth of Helicobacter pylori and enhances its susceptibility to antimicrobial agents.
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Clarithromycin; Dose-Response Relationship, Drug; Drug Synergism; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Salicylates | 2003 |
Influence of co-administered antibiotics on the pharmacokinetic fate in rats of paeoniflorin and its active metabolite paeonimetabolin-I from Shaoyao-Gancao-tang.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Benzoates; Biotransformation; Bridged-Ring Compounds; Chromatography, High Pressure Liquid; Drug Combinations; Feces; Glucosides; Male; Medicine, Kampo; Metronidazole; Monoterpenes; Ofloxacin; Penicillins; Rats; Rats, Wistar | 2003 |
[Antimicrobial susceptibility tests and resistant strain of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Penicillins | 2003 |
Microbiology of mandibular third molar pericoronitis: incidence of beta-lactamase-producing bacteria.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacteroides; beta-Lactam Resistance; beta-Lactamases; Female; Humans; Male; Mandible; Metronidazole; Molar, Third; Penicillins; Pericoronitis; Prevotella; Pristinamycin; Spiramycin; Streptococcus; Veillonella | 2003 |
Gastric transitional zones, areas where Helicobacter treatment fails: results of a treatment trial using the Sydney strain mouse model.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Disease Models, Animal; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Penicillins; Pyloric Antrum | 2003 |
Antimicrobial resistance in Helicobacter pylori isolates from children.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Child; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Pediatric; Humans; Male; Metronidazole; Tetracycline; Victoria | 2003 |
[Failure of Helicobacter pylori eradication--suggestions for further therapy].
Topics: Age Distribution; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hungary; Metronidazole; Organometallic Compounds; Ranitidine; Rifabutin; Tinidazole; Treatment Failure | 2003 |
[Pharmacotherapy in complex treatment of ulcerous stenosis].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Pyloric Stenosis; Ranitidine; Time Factors | 2003 |
MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity.
Topics: Abdominal Abscess; Abdominal Neoplasms; Aged; Amoxicillin; Anti-Infective Agents; Carcinoid Tumor; Cerebellar Ataxia; Cerebellar Nuclei; Diffusion Magnetic Resonance Imaging; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dysarthria; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Metronidazole; Neurotoxicity Syndromes; Ofloxacin; Remission, Spontaneous | 2003 |
Streptococcus pneumoniae as an uncommon cause of superinfected pancreatic pseudocysts.
Topics: Amoxicillin; Drug Therapy, Combination; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Pancreatic Function Tests; Pancreatic Pseudocyst; Pneumococcal Infections; Risk Assessment; Streptococcus pneumoniae; Superinfection; Treatment Outcome; Ultrasonography, Doppler | 2003 |
A combination effect of epigallocatechin gallate, a major compound of green tea catechins, with antibiotics on Helicobacter pylori growth in vitro.
Topics: Amoxicillin; Anti-Bacterial Agents; Catechin; Clarithromycin; Colony Count, Microbial; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests | 2003 |
Effect of dental films containing amoxycillin and metronidazole on periodontal pathogens: microbiological response.
Topics: Absorbable Implants; Amoxicillin; Anti-Infective Agents; Bacteria; Bacteria, Anaerobic; Cariostatic Agents; Culture Media; Metronidazole; Microbial Sensitivity Tests; Penicillins; Periodontal Diseases; Solutions | 2003 |
Asthma-like syndrome in a teenager.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Albuterol; Amoxicillin; Androstadienes; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Asthma; Benzimidazoles; Bronchi; Bronchodilator Agents; Bronchoscopy; Carcinoid Tumor; Diagnosis, Differential; Drug Therapy, Combination; Fluticasone; Forced Expiratory Flow Rates; Forced Expiratory Volume; Gastroesophageal Reflux; Humans; Immunoglobulin E; Lung Neoplasms; Male; Metronidazole; Omeprazole; Pantoprazole; Radioallergosorbent Test; Respiratory Sounds; Sulfoxides; Syndrome; Tomography, X-Ray Computed; Tuberculin Test; Vital Capacity | 2003 |
[Necrobacillosis and Lemierre's syndrome: case report].
Topics: Amoxicillin; Anti-Infective Agents; Brain Diseases; Child, Preschool; Female; Fusobacterium Infections; Humans; Jugular Veins; Metronidazole; Otitis Media; Penicillins; Syndrome; Venous Thrombosis | 2003 |
[Possible treatment with immune system modulators of patients with pathology of the digestive organs. Informational letter].
Topics: Adjuvants, Immunologic; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antiviral Agents; Drug Therapy, Combination; Gastrointestinal Tract; Humans; Metronidazole; Omeprazole | 2003 |
Geographical difference in antimicrobial resistance pattern of Helicobacter pylori clinical isolates from Indian patients: Multicentric study.
Topics: Amoxicillin; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; India; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2003 |
Childhood Helicobacter pylori infection, clinical presentations, endoscopic, histologic features and results of treatment.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Omeprazole; Ranitidine; Retrospective Studies; Treatment Outcome | 2003 |
Repetitive administration of Shaoyao-Gancao-tang to rats restores the bioavailability of glycyrrhizin reduced by antibiotic treatment.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Area Under Curve; Biological Availability; Drug Administration Schedule; Drug Combinations; Drugs, Chinese Herbal; Glycyrrhizic Acid; Half-Life; Male; Metronidazole; Rats; Rats, Wistar | 2003 |
A national survey of primary care physicians' perceptions and practices related to Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Physicians, Family; Random Allocation; Surveys and Questionnaires; United States | 2004 |
Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001.
Topics: Adult; Age Factors; Amoxicillin; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Prospective Studies; Sex Factors; Time Factors; Treatment Outcome; United Kingdom | 2004 |
Effectiveness of antimicrobial adjuncts to scaling and root-planing therapy for periodontitis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Chlorhexidine; Chronic Disease; Combined Modality Therapy; Dental Scaling; Evidence-Based Medicine; Humans; Metronidazole; Minocycline; Periodontal Index; Periodontitis; Research Design; Root Planing; Tetracycline; Treatment Outcome | 2004 |
Treatment with omeprazole, metronidazole, and amoxicillin in captive South African cheetahs (Acinonyx jubatus) with spiral bacteria infection and gastritis.
Topics: Acinonyx; Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter; Helicobacter Infections; Male; Metronidazole; Omeprazole; Prospective Studies; Recurrence; Treatment Outcome | 2004 |
High level of resistance to metronidazole and clarithromycin in Helicobacter pylori isolated from pediatric patients in Poland (1997-2001).
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Poland; Stomach | 2004 |
DNA typing for Helicobacter pylori isolates from eradication-failed patients: comparison of the isolates before and after therapy.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Clarithromycin; DNA Fingerprinting; DNA, Bacterial; Drug Therapy, Combination; Electrophoresis, Gel, Pulsed-Field; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Polymerase Chain Reaction; Treatment Outcome | 2004 |
Pattern of antibiotic prescription in the management of oral diseases among dentists in Kuwait.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Clinical Competence; Cross-Sectional Studies; Deglutition Disorders; Drug Utilization; Edema; Face; Female; Fever; Humans; Kuwait; Male; Metronidazole; Middle Aged; Mouth Diseases; Postoperative Complications; Practice Patterns, Dentists'; Tooth Extraction | 2004 |
Resolution of Helicobacter pylori associated granulomatous gastritis in a child after eradication therapy.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Gastric Mucosa; Gastritis; Granuloma; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Treatment Outcome | 2004 |
Effects of Helicobacter pylori eradication among adults with intellectual disability.
Topics: Adult; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Intellectual Disability; Male; Mental Disorders; Metronidazole; Omeprazole; Outcome Assessment, Health Care; Treatment Outcome | 2004 |
Role of the rdxA and frxA genes in oxygen-dependent metronidazole resistance of Helicobacter pylori.
Topics: Amoxicillin; Anaerobiosis; Anti-Infective Agents; Bacterial Proteins; Chloramphenicol; Clarithromycin; Colony Count, Microbial; DNA, Bacterial; Drug Resistance, Bacterial; FMN Reductase; Gene Deletion; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Nitroreductases; Sequence Analysis, DNA; Tetracycline | 2004 |
[Resistance to antibiotics used in Helicobacter pylori infection in children].
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracyclines; Treatment Outcome | 2004 |
Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Proton Pump Inhibitors | 2004 |
Comparison of E-test and disk diffusion assay to evaluate resistance of Helicobacter pylori isolates to amoxicillin, clarithromycin, metronidazole and tetracycline in Costa Rica.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2004 |
Results of triple eradication therapy in Japanese children: a retrospective multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Humans; Infant; Lansoprazole; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Sulfoxides | 2004 |
Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retreatment; Time Factors | 2004 |
Standard treatment for Helicobacter pylori infection is suboptimal in non-ulcer dyspepsia compared with duodenal ulcer in Chinese.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Asian People; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Treatment Outcome | 2005 |
[Three cases of Yersinia pseudotuberculosis gastrointestinal infection having no apparent epidemiological relationship, caused by identical strains].
Topics: Abdominal Pain; Adult; Amoxicillin; Bacterial Typing Techniques; Child; Diarrhea; Doxycycline; Drug Resistance; Escherichia coli Infections; Female; Gastroenteritis; Humans; Male; Metronidazole; Phenotype; Shock, Septic; Spain; Yersinia pseudotuberculosis; Yersinia pseudotuberculosis Infections | 2005 |
Helicobacter pylori infection in Greenlandic patients with dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Dyspepsia; Esomeprazole; Greenland; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole | 2004 |
Long-term recurrence rate after treatment of Helicobacter pylori infection in children and adolescents in Estonia.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Estonia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Organometallic Compounds; Recurrence; Time Factors | 2004 |
Periodontal antimicrobials--finding the right solutions.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Chlorhexidine; Ciprofloxacin; Dental Plaque; Dental Scaling; Drug Combinations; Female; Gingivitis; Humans; Metronidazole; Periodontitis; Risk Factors; Sodium Hypochlorite | 2005 |
Susceptibilities to clarithromycin, amoxycillin and metronidazole of Helicobacter pylori isolates from the antrum and corpus in Tokyo, Japan, 1995-2001.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Stomach; Time Factors | 2005 |
Cultural recovery and determination of antimicrobial susceptibility in Helicobacter pylori by using commercial transport and isolation media.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Culture Media; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Specimen Handling | 2005 |
[Effect of acid suppression therapy for eradicating Helicobacter pylori infection on bismuth absorption from colloidal bismuth pectin].
Topics: Amoxicillin; Animals; Antacids; Bismuth; Colloids; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Kidney; Male; Metronidazole; Pectins; Random Allocation; Rats; Rats, Sprague-Dawley | 2005 |
Treatment failure of vaginal trichomoniasis in clinical practice.
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Algorithms; Ambulatory Care Facilities; Amoxicillin; Anti-Bacterial Agents; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Female; Humans; Metronidazole; Middle Aged; Retreatment; Retrospective Studies; Treatment Failure; Trichomonas Vaginitis; United Kingdom | 2005 |
In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Fosfomycin; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2005 |
[The effect of Helicobacter pylori eradication therapy on bismuth absorption of colloidal bismuth subcitrate].
Topics: Absorption; Amoxicillin; Animals; Antacids; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Kidney; Male; Metronidazole; Omeprazole; Organometallic Compounds; Random Allocation; Rats; Rats, Sprague-Dawley | 2005 |
A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Evaluation; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Prospective Studies; Treatment Outcome | 2005 |
Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Tetracycline | 2005 |
Eradication of Helicobacter spp. from a rat breeding colony.
Topics: Amoxicillin; Animal Feed; Animals; Animals, Laboratory; Clarithromycin; DNA Primers; Electrophoresis, Agar Gel; Feces; Helicobacter; Helicobacter Infections; Metronidazole; Omeprazole; Polymerase Chain Reaction; Rats; RNA, Ribosomal, 16S; Rodent Diseases | 2005 |
Antimicrobial resistance of Helicobacter pylori in Poland: a multicentre study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Poland; Tetracycline | 2005 |
Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Disease Progression; Disease-Free Survival; Drug Administration Schedule; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Multicenter Studies as Topic; Omeprazole; Organometallic Compounds; Prospective Studies; Severity of Illness Index; Stomach Neoplasms; Survival Analysis; Taiwan; Time Factors; Treatment Outcome | 2005 |
[Prevalence of Helicobacter pylori resistant to clarithromycin, amoxicillin and metronidazole in children].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Gastroscopy; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Prevalence | 2004 |
[Disseminated actinomycosis].
Topics: Actinomyces; Actinomycosis; Alcoholism; Amoxicillin; Brain Abscess; Brain Neoplasms; Bronchoalveolar Lavage Fluid; Consciousness Disorders; Diagnosis, Differential; Humans; Lung Diseases, Fungal; Male; Metronidazole; Middle Aged; Penicillanic Acid; Smoking; Tomography, X-Ray Computed | 2005 |
[Comparative study of 2 antibiotic combinations in the treatment of rapidly progressing periodontitis].
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clavulanic Acid; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Periodontitis | 2005 |
Nonsecretory variant of immunoproliferative small intestinal disease: a case report with pathologic, immunophenotypic, and molecular findings.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Benzimidazoles; Drug Therapy, Combination; Female; Gene Rearrangement, B-Lymphocyte, Light Chain; Humans; Immunophenotyping; Immunoproliferative Small Intestinal Disease; Intestine, Small; Lymph Nodes; Lymphoma, B-Cell, Marginal Zone; Mesentery; Metronidazole; Omeprazole; Pantoprazole; Retroperitoneal Space; Sulfoxides | 2005 |
Papillon-Lefèvre syndrome: a successful outcome.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Combined Modality Therapy; Dental Scaling; Follow-Up Studies; Humans; Male; Metronidazole; Oral Hygiene; Papillon-Lefevre Disease; Periodontal Diseases; Periodontitis; Root Planing; Surgical Flaps; Treatment Outcome | 2005 |
Antimicrobial prophylaxis in non-infected patients undergoing abdominal or vaginal hysterectomy or cesarean section. Comparative efficacy of a single preoperative dose of ceftriaxone and of multiple doses of combined amoxicillin plus metronidazole and of
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Ceftriaxone; Cesarean Section; Drug Therapy, Combination; Female; Humans; Hysterectomy; Hysterectomy, Vaginal; Metronidazole; Pregnancy; Surgical Wound Infection; Treatment Outcome | 1989 |
[The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Stomach Ulcer | 2005 |
Clinical, genetic, and biochemical findings in two siblings with Papillon-Lefèvre Syndrome.
Topics: Adenine; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Cathepsin C; Cathepsin G; Cathepsins; Child; Child, Preschool; Chlorhexidine; Dental Scaling; Drug Combinations; Female; Genes, Recessive; Guanine; Humans; Leukocyte Elastase; Metronidazole; Mutation; Papillon-Lefevre Disease; Root Planing; Serine Endopeptidases | 2005 |
Antibiotic susceptibility of the bacteria causing odontogenic infections.
Topics: Acetamides; Adolescent; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria, Anaerobic; Clindamycin; Drug Resistance, Bacterial; Female; Focal Infection, Dental; Humans; Linezolid; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Molar, Third; Oxazolidinones; Periapical Periodontitis; Pericoronitis; Tetracycline | 2006 |
Pharmaceutical prescribing for children. Part 3. Antibiotic prescribing for children with odontogenic infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Erythromycin; Focal Infection, Dental; Humans; Metronidazole; Penicillin V | 2006 |
In vitro evaluation of the antimicrobial effects of a root canal sealer-antibiotic combination against Enterococcus faecalis.
Topics: Aerobiosis; Amoxicillin; Anaerobiosis; Analysis of Variance; Anti-Bacterial Agents; Clindamycin; Doxycycline; Drug Combinations; Enterococcus faecalis; Metronidazole; Microbial Sensitivity Tests; Penicillins; Random Allocation; Root Canal Filling Materials; Statistics, Nonparametric; Zinc Oxide-Eugenol Cement | 2006 |
Efficacy and safety of rifabutin-containing 'rescue therapy' for resistant Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Rifabutin; Sulfoxides; Treatment Outcome | 2006 |
Biodegradable periodontal intrapocket device containing metronidazole and amoxycillin: formulation and characterisation.
Topics: Amoxicillin; Bacteria; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Gingiva; Hydrogen-Ion Concentration; Kinetics; Lactic Acid; Metronidazole; Microscopy, Electron, Scanning; Plasticizers; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Solubility; Surface Properties | 2006 |
Tetracycline, metronidazole and amoxicillin-metronidazole combinations in proton pump inhibitor-based triple therapies are equally effective as alternative therapies against Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Tetracycline | 2006 |
Efficacy of Helicobacter pylori eradication on the chronic mucosal inflammation of the remnant stomach after distal gastrectomy for early gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Gastrectomy; Gastric Mucosa; Gastric Stump; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Stomach Neoplasms | 2005 |
[Bilateral breast bacterial cellulite secondary to Streptococcus agalactiae septicemia].
Topics: Adenocarcinoma; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breast Diseases; Cellulitis; Clavulanic Acid; Colonic Polyps; Colonoscopy; Drug Therapy, Combination; Female; Humans; Metronidazole; Rifampin; Sepsis; Sigmoid Neoplasms; Streptococcal Infections; Streptococcus agalactiae; Time Factors; Treatment Outcome | 2006 |
Recurrence of Helicobacter pylori infection after several eradication therapies: long-term follow-up of 1000 patients.
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Recurrence; Risk Factors; Tetracycline | 2006 |
Review of successful treatment for Helicobacter species in laboratory mice.
Topics: Administration, Oral; Amoxicillin; Animals; Anti-Infective Agents; Bismuth; DNA, Bacterial; Drug Therapy, Combination; Feces; Female; Helicobacter; Helicobacter Infections; Metronidazole; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Polymerase Chain Reaction; Pregnancy; Rodent Diseases | 2006 |
Prospective multicentre study on antibiotic resistance of Helicobacter pylori strains obtained from children living in Europe.
Topics: Adolescent; Age Distribution; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Prospective Studies; Sex Distribution; Treatment Failure | 2006 |
Drug susceptibility pattern of Helicobacter pylori in patients with dyspepsia at the Kenyatta National Hospital, Nairobi.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Hospitals, Teaching; Humans; Kenya; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline | 2005 |
[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Child; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Species Specificity; Tetracycline; Virulence | 2006 |
Is there a role for sequential in sequential anti-H. pylori therapy?
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prognosis; Sensitivity and Specificity; Treatment Outcome | 2006 |
[Long term results of treatment by simple surgical closure of perforated gastroduodenal ulcer followed by eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Perforation; Randomized Controlled Trials as Topic; Recurrence; Tetracycline; Time Factors | 2006 |
[Successful platelet recovery after the second eradication of Helicobacter pylori with metronidazole in two patients with chronic idiopathic thrombocytopenic purpura].
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Platelet Count; Proton Pump Inhibitors; Purpura, Thrombocytopenic, Idiopathic | 2006 |
Helicobacter pylori antibiotic resistance in a Dutch region: trends over time.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Dyspepsia; Female; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Netherlands; Peptic Ulcer; Proton Pump Inhibitors; Time Factors | 2006 |
Development and validation of a simple HPLC method for simultaneous in vitro determination of amoxicillin and metronidazole at single wavelength.
Topics: Amoxicillin; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Delayed-Action Preparations; Drug Stability; Indicators and Reagents; Metronidazole; Penicillins; Quality Control; Reference Standards; Reproducibility of Results; Spectrophotometry, Ultraviolet; Tablets | 2007 |
Esomeprazole-based 1-week triple therapy directed by susceptibility testing for eradication of Helicobacter pylori infection in children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Patient Compliance; Prospective Studies; Treatment Outcome | 2006 |
Effect of CYP2C19*17 gene variant on Helicobacter pylori eradication in peptic ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Alleles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Gene Frequency; Genotype; Haplotypes; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Mixed Function Oxygenases; Odds Ratio; Pantoprazole; Peptic Ulcer; Polymorphism, Genetic; Treatment Outcome | 2006 |
Heresy? Treatment of chronic periodontitis with systemic antibiotics only.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Disease; Dental Scaling; Drug Combinations; Humans; Metronidazole; Periodontitis; Root Planing | 2006 |
Triple levofloxacin-based rescue therapy is an accepted empirical third-line treatment.
Topics: Amoxicillin; Ampicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Ofloxacin; Omeprazole; Protein Synthesis Inhibitors; Tetracycline; Treatment Failure | 2006 |
In vitro activity of a novel antimicrobial agent, TG44, for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Benzoates; Clarithromycin; Drug Resistance, Bacterial; Guanidines; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Molecular Structure | 2006 |
Periodontal therapy in siblings with Papillon-Lefèvre syndrome and tinea capitis: a report of two cases.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child, Preschool; Dental Plaque; Dental Scaling; Follow-Up Studies; Furcation Defects; Humans; Male; Metronidazole; Papillon-Lefevre Disease; Periodontal Attachment Loss; Periodontal Diseases; Periodontal Pocket; Tinea Capitis; Tooth Extraction; Tooth Mobility; Tooth, Deciduous | 2006 |
Primary resistance and antibiotic minimum inhibitory concentrations for Helicobacter pylori strains, in Split, Croatia.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cells, Cultured; Clarithromycin; Croatia; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests | 2006 |
Guidelines in the medical treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Clarithromycin; Dyspepsia; Europe; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Organometallic Compounds; Peptic Ulcer; Proton Pump Inhibitors | 2006 |
[Prospective study of 420 biopsies realised in patients with duodenal ulcer with positive Helicobacter pylori].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Duodenal Ulcer; Duodenum; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Stomach | 2006 |
[The trend of eradication rates of first-line triple therapy for Helicobacter pylori infection: single center experience for recent eight years].
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome | 2006 |
Helicobacter pylori: prevalence of antimicrobial resistance in clinical isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; DNA, Bacterial; Drug Resistance, Bacterial; Helicobacter pylori; Metronidazole; Mutation; Tetracycline | 2006 |
Antimicrobial resistance of Helicobacter pylori isolates from Iranian adults and children.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Tetracycline | 2006 |
Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003.
Topics: Adult; Aged; Alaska; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Population Groups; Sentinel Surveillance; Stomach; Tetracycline | 2006 |
Efficacy of two triple eradication regimens in children with Helicobacter pylori infection.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Child, Preschool; Clarithromycin; Drug Combinations; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Retrospective Studies; Salicylates; Treatment Outcome | 2006 |
The efficacy of non-surgical and systemic antibiotic treatment on smoking and non-smoking periodontitis patients.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Dental Plaque Index; Humans; Longitudinal Studies; Metronidazole; Middle Aged; Periodontal Index; Periodontal Pocket; Periodontitis; Smoking | 2006 |
Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Chronic Disease; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Fluoroquinolones; Gastritis; Helicobacter pylori; Humans; Metronidazole; Pyloric Antrum | 2006 |
Comparison of two invasive diagnostic tests for Helicobacter pylori after antimicrobial therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Pyloric Antrum; Sensitivity and Specificity; Treatment Outcome; Urease | 2007 |
[Helicobacter pylori infection and eradication are not related to glycosylated hemoglobin levels (HbA1c) in young patients with type 1 diabetes].
Topics: Adolescent; Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Follow-Up Studies; Glycated Hemoglobin; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prevalence; Sex Factors; Socioeconomic Factors; Time Factors | 2007 |
In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces.
Topics: Actinomyces; Actinomycosis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Clindamycin; Doxycycline; Fluoroquinolones; Humans; Metronidazole; Moxifloxacin; Periapical Periodontitis; Quinolines | 2007 |
Resistance rate to antibiotics of Helicobacter pylori isolates in eastern Taiwan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Patient Selection; Taiwan; Tetracycline | 2007 |
What is the best first choice treatment option for Helicobacter pylori?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Humans; Medication Adherence; Metronidazole; Pantoprazole; Tetracycline | 2007 |
Timing affects the clinical outcome of adjunctive systemic antibiotic therapy for generalized aggressive periodontitis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Dental Scaling; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Metronidazole; Periodontal Index; Periodontitis; Retrospective Studies; Severity of Illness Index; Time Factors; Treatment Outcome | 2007 |
Helicobacter pylori primary resistant strains over 11 years in French children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; France; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Time Factors | 2007 |
Clinical and microbiological effects of a combined mechanic-antibiotic therapy in subjects with Actinobacillus actinomycetemcomitans-associated periodontitis.
Topics: Actinobacillus Infections; Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Amoxicillin; Chi-Square Distribution; Ciprofloxacin; Combined Modality Therapy; Dental Scaling; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Periodontitis; Root Planing | 2007 |
Incomplete adherence to an adjunctive systemic antibiotic regimen decreases clinical outcomes in generalized aggressive periodontitis patients: a pilot retrospective study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Epidemiologic Methods; Female; Humans; Male; Metronidazole; Periodontitis; Radiography; Treatment Refusal | 2007 |
Susceptibility of oral obligate anaerobes to telithromycin, moxifloxacin and a number of commonly used antibacterials.
Topics: Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Blood; Clindamycin; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Anaerobic Bacteria; Hemin; Humans; Ketolides; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Penicillin Resistance; Periodontitis; Quinolines; Saliva; Vitamin K | 2007 |
Antibiotic resistance in an in vitro subgingival biofilm model.
Topics: Adult; Aged; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Clindamycin; Dental Pellicle; Dental Plaque; Dose-Response Relationship, Drug; Doxycycline; Drug Resistance, Bacterial; Durapatite; Erythromycin; Gingiva; Gram-Negative Bacteria; Humans; Metronidazole; Middle Aged; Minocycline; Periodontitis; Tetracycline; Time Factors | 2007 |
Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Sex Factors | 2007 |
Amoxicillin-associated hemorrhagic colitis in the presence of Klebsiella oxytoca.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Enterocolitis, Pseudomembranous; Humans; Klebsiella Infections; Klebsiella oxytoca; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sinusitis | 2007 |
[Antimicrobial susceptibility of H pylori strains obtained from Paraguayan patients].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Paraguay | 2007 |
[Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Child; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2007 |
An analysis of therapeutic, adult antibiotic prescriptions issued by dental practitioners in Jordan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Cephalosporins; Databases, Factual; Dental Audit; Dental Service, Hospital; Drug Therapy, Combination; Drug Utilization; Hospitals, University; Humans; Jordan; Metronidazole; Practice Guidelines as Topic; Practice Patterns, Dentists' | 2008 |
Levofloxacin-resistant Helicobacter pylori in Hong Kong.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; DNA Gyrase; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Hong Kong; Humans; Ketolides; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Point Mutation; Tetracycline | 2008 |
[Changing patterns of antibiotic resistance of Helicobacter pylori in patients with peptic ulcer disease].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Retrospective Studies | 2007 |
A new eradication resistance index as a predictor of metronidazole-containing second-line treatment of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Treatment Failure; Urea | 2007 |
The effect of Helicobacter pylori eradication on reducing the incidence of gastric cancer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Antibodies, Bacterial; Biopsy; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Stomach; Stomach Neoplasms; Treatment Outcome | 2008 |
[Sequential therapy regimen for Helicobacter pylori infection in children].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Multicenter Studies as Topic; Omeprazole; Prospective Studies; Time Factors | 2008 |
Effect of smoking on failure of H. pylori therapy and gastric histology in a high gastric cancer risk area of Colombia.
Topics: Amoxicillin; Anti-Infective Agents; Bismuth; Colombia; Drug Therapy, Combination; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metaplasia; Metronidazole; Organometallic Compounds; Precancerous Conditions; Regression Analysis; Salicylates; Smoking; Treatment Failure | 2007 |
Intussusception associated with pseudomembranous colitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Colonoscopy; Diagnosis, Differential; Enterocolitis, Pseudomembranous; Humans; Ileal Diseases; Intussusception; Lactobacillus; Male; Metronidazole; Probiotics; Treatment Outcome | 2008 |
Helicobacter pylori isolates recovered from gastric biopsies of patients with gastro-duodenal pathologies in Cameroon: current status of antibiogram.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Cameroon; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Pyloric Antrum; Sex Factors; Stomach; Tetracycline | 2008 |
Brain abscess as a sign of hereditary disease.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Brain Abscess; Ceftriaxone; Humans; Male; Metronidazole; Telangiectasia, Hereditary Hemorrhagic | 2008 |
Chronic urticaria and Helicobacter pylori.
Topics: Adolescent; Adult; Amoxicillin; Case-Control Studies; Chronic Disease; Comorbidity; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; India; Male; Metronidazole; Middle Aged; Omeprazole; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Urticaria; Young Adult | 2008 |
Ten-day sequential treatment for Helicobacter pylori eradication in clinical practice.
Topics: Amoxicillin; Anti-Infective Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Treatment Outcome | 2008 |
Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Case-Control Studies; Chi-Square Distribution; Clarithromycin; Colony Count, Microbial; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Tetracycline Resistance; Treatment Failure | 2008 |
Fast screening procedure for antibiotics in wastewaters by direct HPLC-DAD analysis.
Topics: Amoxicillin; Cefazolin; Chloramphenicol; Chromatography, High Pressure Liquid; Metronidazole; Molecular Structure; Reproducibility of Results; Sewage; Sulfamethoxazole; Time Factors; Water Pollutants, Chemical | 2008 |
Diversity of mucosa-associated microbiota in active and inactive ulcerative colitis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Case-Control Studies; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Intestinal Mucosa; Male; Metronidazole; Middle Aged; Polymorphism, Restriction Fragment Length; Severity of Illness Index; Tetracycline | 2009 |
Persistence of extracrevicular bacterial reservoirs after treatment of aggressive periodontitis.
Topics: Adolescent; Adult; Aged; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacteroides; Chlorhexidine; Colony Count, Microbial; Dental Plaque; Epithelial Cells; Female; Follow-Up Studies; Gram-Negative Bacteria; Humans; Male; Metronidazole; Middle Aged; Mouth Mucosa; Mouthwashes; Porphyromonas gingivalis; Prevotella intermedia; Root Planing; Treponema denticola; Young Adult | 2008 |
[Perforation and haemorrhage duodenal bulbar ulcers in a child: a case report].
Topics: Adrenergic Agonists; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Child; Drug Therapy, Combination; Duodenal Ulcer; Epinephrine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Pneumoperitoneum; Radiography, Abdominal; Time Factors; Treatment Outcome | 2008 |
Effects of helicobacter pylori eradication on chronic nonspecific pharyngeal symptoms.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Chronic Disease; Cohort Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Satisfaction; Pharyngeal Diseases; Probability; Prognosis; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2008 |
[What is currently the Helicobacter pylori eradication therapy of choice? Triple therapy (PPI, amoxicillin and clarithromycin) or sequential therapy (PPI and amoxicillin for 5 days followed by PPI, clarithromycin and metronidazole for a further 5 days)?].
Topics: Amoxicillin; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Multicenter Studies as Topic; Proton Pump Inhibitors; Randomized Controlled Trials as Topic | 2009 |
Placental retention in a bonobo (Pan paniscus).
Topics: Amoxicillin; Animals; Animals, Zoo; Ape Diseases; Female; Metronidazole; Oxytocin; Pan paniscus; Placenta, Retained; Pregnancy; Probiotics; Treatment Outcome | 2009 |
Minimally invasive flap surgery and enamel matrix derivative in the treatment of localized aggressive periodontitis: case report.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Bone Loss; Amoxicillin; Anti-Infective Agents; Bone Regeneration; Dental Enamel Proteins; Dental Scaling; Female; Humans; Metronidazole; Minimally Invasive Surgical Procedures; Surgical Flaps | 2009 |
Aggressive periodontitis: a case report.
Topics: Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Bone Loss; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Dental Scaling; Female; Humans; Metronidazole; Oral Hygiene; Porphyromonas gingivalis | 2008 |
Papillon-Lefèvre syndrome: a case report.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Consanguinity; Drug Combinations; Humans; Male; Metronidazole; Papillon-Lefevre Disease; Periodontitis; Retinoids; Vitamins | 2009 |
[Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents].
Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Gastroscopy; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin | 2009 |
Antibiotic susceptibility patterns in Helicobacter pylori strains from patients with upper gastrointestinal pathology in western Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Clarithromycin; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Peptic Ulcer; Polymerase Chain Reaction; Stomach; Tetracycline | 2009 |
Helicobacter pylori infection in patients with chronic urticaria: correlation with pathologic findings in gastric biopsies.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Biopsy; Case-Control Studies; Chronic Disease; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Severity of Illness Index; Stomach; Urticaria | 2009 |
Microbial changes in periodontitis successfully treated by mechanical plaque removal and systemic amoxicillin and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria; Biodiversity; Dental Scaling; DNA, Bacterial; DNA, Ribosomal; Female; Gingiva; Humans; Metronidazole; Middle Aged; Periodontitis; Phylogeny; Porphyromonas gingivalis; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Treponema | 2009 |
Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure; Young Adult | 2009 |
[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Spain; Tetracycline | 2009 |
Antimicrobial susceptibility and mutations involved in clarithromycin resistance in Helicobacter pylori isolates from patients in the western central region of Colombia.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Colombia; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Tetracycline | 2009 |
In vitro antagonism of rabeprazole and metronidazole upon clinical isolates of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Rabeprazole | 2009 |
Primary antimicrobial resistance of Helicobacter pylori in children during the past 9 years.
Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Helicobacter pylori; Humans; Metronidazole; Time Factors | 2010 |
Helicobacter pylori: antibiotic resistance and treatment options.
Topics: Amoxicillin; Anti-Bacterial Agents; Asian People; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Patient Selection; Prevalence; Taiwan; Time Factors; Treatment Failure | 2009 |
Comparisons of subgingival microbial profiles of refractory periodontitis, severe periodontitis, and periodontal health using the human oral microbe identification microarray.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacteroides; Bacteroidetes; Campylobacter; Chronic Periodontitis; Dental Plaque; Dental Scaling; Eikenella corrodens; Eubacterium; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Metronidazole; Microarray Analysis; Middle Aged; Peptostreptococcus; Periodontitis; Periodontium; Porphyromonas gingivalis; Prevotella; Proteobacteria; Root Planing; Selenomonas; Treponema | 2009 |
Drug resistance pattern and clonality in H. pylori strains.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents, Local; beta-Lactamases; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; India; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline | 2009 |
Antibiotic susceptibility of Helicobacter pylori isolates in Dakar, Senegal.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Bacterial; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Senegal; Stomach Ulcer | 2009 |
Antibiotics in periodontics: right or wrong?
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroidaceae Infections; Combined Modality Therapy; Dental Plaque; Dental Scaling; Drug Combinations; Humans; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Periodontitis; Porphyromonas gingivalis; Root Planing; Treatment Outcome | 2009 |
Oral and intravenous eradication of Helicobacter pylori.
Topics: Administration, Oral; Adult; Amoxicillin; Anti-Infective Agents; Bismuth; Female; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Infusions, Intravenous; Male; Metronidazole; Middle Aged; Pilot Projects; Ranitidine; Treatment Outcome | 2009 |
[Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Breath Tests; Clarithromycin; Enzyme-Linked Immunosorbent Assay; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Stomach Neoplasms; Tetracycline | 2009 |
Editorial: Sequential therapy for eradication of Helicobacter pylori: a new guiding light or a false dawn?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Meta-Analysis as Topic; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Tinidazole | 2009 |
Ten-day sequential therapy of Helicobacter pylori infection in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Patient Compliance; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Thailand; Time Factors; Treatment Outcome; Young Adult | 2010 |
Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Case-Control Studies; Female; Helicobacter Infections; Helicobacter pylori; Humans; Inflammation; Insulin Resistance; Lipids; Male; Metronidazole; Pantoprazole; Prospective Studies; Proton Pump Inhibitors | 2010 |
Antibiotic resistance of Helicobacter pylori in Israeli children.
Topics: Adolescent; Amoxicillin; Analysis of Variance; Anti-Bacterial Agents; Biopsy; Chi-Square Distribution; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Prospective Studies; Surveys and Questionnaires; Tetracycline; Treatment Failure | 2010 |
Effects of CYP2C19, MDR1, and interleukin 1-B gene variants on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxicillin, and metronidazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Aryl Hydrocarbon Hydroxylases; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytochrome P-450 CYP2C19; Drug Therapy, Combination; Female; Genetic Variation; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Interleukin-1beta; Male; Metronidazole; Middle Aged; Pantoprazole; Peptic Ulcer; Poland; Proton Pump Inhibitors; Treatment Failure; White People | 2010 |
High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Infective Agents; Clindamycin; Drug Resistance, Bacterial; Female; Humans; Male; Metronidazole; Periodontal Diseases; Porphyromonas gingivalis | 2010 |
Ten-day sequential therapy as first-line treatment for Helicobacter pylori infection in Korea: a retrospective study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Korea; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Time Factors; Treatment Outcome; Urea | 2010 |
Phenotypic and genetic characterization of antimicrobial profiles of Helicobacter pylori strains in Cuba.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clarithromycin; Cuba; Drug Resistance, Bacterial; Female; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Polymerase Chain Reaction; Sequence Analysis, DNA; Sex Factors; Species Specificity; Tetracycline; Young Adult | 2010 |
Marked susceptibility of South African Helicobacter pylori strains to ciprofloxacin and amoxicillin: clinical implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Erythromycin; Female; Gentamicins; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; South Africa; Tetracycline | 2010 |
Helicobacter pylori: prevalence and antibiotic susceptibility among Kenyans.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Black People; Child; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Kenya; Metronidazole; Microbial Sensitivity Tests; Prevalence | 2010 |
Increase in resistance rates of H. pylori isolates to metronidazole and tetracycline--comparison of three 3-year studies.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Chi-Square Distribution; Clarithromycin; Cohort Studies; Drug Resistance, Multiple, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Probability; Retrospective Studies; Sex Factors; Tetracycline; Young Adult | 2010 |
Antibiotic resistance of subgingival species in chronic periodontitis patients.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Anti-Infective Agents; Aza Compounds; Bacteriological Techniques; beta-Lactam Resistance; Chronic Periodontitis; Clindamycin; Colombia; Dental Plaque; Drug Resistance, Bacterial; Female; Fluoroquinolones; Fusobacterium nucleatum; Gingival Hemorrhage; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis; Prevotella; Quinolines | 2010 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Primary resistance to clarithromycin, metronidazole and amoxicillin of Helicobacter pylori isolated from Tunisian patients with peptic ulcers and gastritis: a prospective multicentre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Point Mutation; Polymerase Chain Reaction; Prospective Studies; Tunisia; Young Adult | 2010 |
Quadruple therapy with ecabet sodium, omeprazole, amoxicillin and metronidazole is effective for eradication of Helicobacter pylori after failure of first-line therapy (KDOG0201 Study).
Topics: Abietanes; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Pilot Projects; Treatment Outcome | 2010 |
Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Metronidazole; Proton Pump Inhibitors | 2010 |
Sequential therapy for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pantoprazole; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Young Adult | 2010 |
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Prognosis; Ranitidine; Smoking; Stomach; Time Factors | 2010 |
[Helicobacter pylori eradication therapy for gastric ulcer in elderly].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Administration Schedule; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Proton Pump Inhibitors; Stomach Ulcer | 2010 |
Antibiotic resistance of Helicobacter pylori in Mazandaran, North of Iran.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2010 |
Maintenance after a complex orthoperio treatment in a case of generalized aggressive periodontitis: 7-year result.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Bacteroides; Dental Plaque; Dental Plaque Index; Dental Scaling; Female; Follow-Up Studies; Humans; Malocclusion, Angle Class II; Metronidazole; Orthodontics, Corrective; Periodontal Attachment Loss; Periodontal Index; Porphyromonas gingivalis; Recurrence; Root Planing; Treatment Outcome | 2010 |
The efficacy and safety of long-term Helicobacter species quadruple therapy in asymptomatic cats with naturally acquired infection.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Cat Diseases; Cats; Clarithromycin; DNA, Bacterial; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Male; Metronidazole; Omeprazole; Stomach; Treatment Outcome | 2011 |
[Two cases of pulmonary gangrene in HIV-infected patients: favorable outcome without surgery].
Topics: Acetamides; Adult; Alcoholism; Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Gangrene; Gentamicins; HIV Infections; Humans; Imipenem; Linezolid; Lung; Male; Metronidazole; Necrosis; Ofloxacin; Oxazolidinones; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Smoking; Tomography, X-Ray Computed | 2011 |
[Initial therapy and prosthodontic treatment of a case with aggressive periodontitis combined with periodontal abscesses].
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Combined Modality Therapy; Dental Scaling; Denture, Partial, Fixed; Humans; Male; Metronidazole; Periodontal Abscess; Root Canal Therapy; Tooth Extraction; Toothbrushing | 2010 |
Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area.
Topics: Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Gastrointestinal Diseases; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pakistan; Prevalence; Statistics as Topic; Stomach Ulcer; Treatment Outcome; Young Adult | 2010 |
Additive or synergistic antimicrobial effects of amoxicillin and metronidazole on whole plaque samples: a preliminary report.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Biofilms; Colony Count, Microbial; Dental Plaque; Drug Combinations; Drug Synergism; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Periodontitis | 2011 |
Antibiotic susceptibility of cocultures in polymicrobial infections such as peri-implantitis or periodontitis: an in vitro model.
Topics: Acetamides; Actinobacillus Infections; Aggregatibacter actinomycetemcomitans; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Azithromycin; Capnocytophaga; Coculture Techniques; Coinfection; Drug Resistance, Bacterial; Fluoroquinolones; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Linezolid; Metronidazole; Microbial Interactions; Minocycline; Moxifloxacin; Oxazolidinones; Penicillin G; Peptostreptococcus; Peri-Implantitis; Periodontitis; Quinolines; Sulbactam | 2011 |
[Arcanobacterium haemolyticum brain abscess mimicking a brain tumor].
Topics: Actinomycetales Infections; Amoxicillin; Anti-Bacterial Agents; Arcanobacterium; Biopsy; Brain Abscess; Brain Neoplasms; Diagnosis, Differential; Drug Therapy, Combination; Humans; Male; Metronidazole; Middle Aged; Mouth; Oral Hygiene; Paresis; Stereotaxic Techniques | 2011 |
Studies of distribution and recurrence of Helicobacter spp. gastric mucosa of dogs after triple therapy.
Topics: Amoxicillin; Animals; Anti-Infective Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Gastric Mucosa; Helicobacter; Helicobacter Infections; Metronidazole; Organometallic Compounds; Prevalence; Recurrence | 2011 |
[Regional difference of antibiotic resistance of helicobacter pylori strains in Korea].
Topics: Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Ofloxacin; Quinolines; Republic of Korea; Tetracycline | 2011 |
Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastritis, Atrophic; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Pepsinogens; Platelet Count; Purpura, Thrombocytopenic, Idiopathic; Treatment Outcome | 2011 |
Improvements in Helicobacter pylori eradication rates through clinical CYP2C19 genotyping.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Aryl Hydrocarbon Hydroxylases; Clarithromycin; Cytochrome P-450 CYP2C19; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Pharmacogenetics; Proton Pump Inhibitors; Rabeprazole; Young Adult | 2011 |
Ranitidine bismuth citrate in the first-line of Helicobacter pylori treatment.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2011 |
[Update on current care guidelines: antimicrobials in acute dentistry].
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Clavulanic Acid; Disease Susceptibility; Humans; Metronidazole; Penicillin V; Periodontal Abscess; Practice Guidelines as Topic | 2011 |
Primary antibiotic resistance of Helicobacter pylori strains isolated from Portuguese children: a prospective multicentre study over a 10 year period.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Portugal; Prospective Studies; Tetracycline | 2011 |
Mass eradication of Helicobacter pylori: feasible and advisable?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Drugs, Generic; Feasibility Studies; Female; Health Policy; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Latin America; Male; Metronidazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Stomach Neoplasms | 2011 |
Preliminary phytochemical screening and in vitro anti-helicobacter pylori activity of extracts of the stem bark of Bridelia micrantha (Hochst., Baill., Euphorbiaceae).
Topics: Acetates; Acetone; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Euphorbiaceae; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Phytotherapy; Plant Bark; Plant Extracts; Plant Stems; South Africa | 2011 |
Resistance of Helicobacter pylori strains to antibiotics in Korea with a focus on fluoroquinolone resistance.
Topics: Adult; Aged; Amoxicillin; Ampicillin Resistance; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Point Mutation; Republic of Korea; Tetracycline | 2012 |
Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Ofloxacin; Poland | 2011 |
Regression of multiple duodenal hyperplastic polyps following Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Breath Tests; Clarithromycin; Drug Therapy, Combination; Duodenal Diseases; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyps; Metronidazole; Middle Aged; Rabeprazole | 2011 |
Aqueous and organic solvent-extracts of selected south African medicinal plants possess antimicrobial activity against drug-resistant strains of Helicobacter pylori: inhibitory and bactericidal potential.
Topics: Acetone; Amoxicillin; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Ethanol; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Plant Extracts; Plants, Medicinal; Solvents; South Africa; Species Specificity; Water | 2011 |
[The effects of pronase on drugs concentrations for treatment of Helicobacter pylori infection in gastric tissue].
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Anti-Ulcer Agents; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Metronidazole; Mice; Mice, Inbred C57BL; Omeprazole; Pronase | 2011 |
Clinical and microbiologic evaluation, by real-time polymerase chain reaction, of non-surgical treatment of aggressive periodontitis associated with amoxicillin and metronidazole.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Load; Bacteroides; Dental Plaque; Dental Plaque Index; DNA Probes; Drug Combinations; Female; Fluorescent Dyes; Follow-Up Studies; Gingival Hemorrhage; Gram-Negative Anaerobic Straight, Curved, and Helical Rods; Humans; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Porphyromonas gingivalis; Real-Time Polymerase Chain Reaction; Treponema denticola | 2012 |
Anti-infective surgical therapy of peri-implantitis. A 12-month prospective clinical study.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Debridement; Decontamination; Dental Prosthesis Retention; Female; Humans; Jaw, Edentulous, Partially; Male; Metronidazole; Middle Aged; Peri-Implantitis; Prospective Studies; Regression Analysis; Treatment Outcome | 2012 |
An outcome audit of three day antimicrobial prescribing for the acute dentoalveolar abscess.
Topics: Abscess; Acute Disease; Adult; Amoxicillin; Anti-Bacterial Agents; Clindamycin; Dental Audit; Drainage; Evidence-Based Dentistry; Follow-Up Studies; Guideline Adherence; Humans; Metronidazole; Practice Guidelines as Topic; Retrospective Studies; Tooth Diseases; Tooth Extraction; Treatment Outcome | 2011 |
Is quadruple therapy the new triple therapy for H pylori?
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2012 |
Treatment of Helicobacter pylori in Latin America.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors | 2012 |
Treatment of Helicobacter pylori in Latin America.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors | 2012 |
Treatment of Helicobacter pylori in Latin America.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors | 2012 |
Impact of periodontal therapy on the subgingival microbiota of severe periodontitis: comparison between good responders and individuals with refractory periodontitis using the human oral microbe identification microarray.
Topics: Amoxicillin; Anti-Infective Agents; Bacteria; Chi-Square Distribution; Chronic Periodontitis; Dental Plaque; Dental Scaling; DNA, Bacterial; Drug Combinations; Female; Humans; Male; Metronidazole; Middle Aged; Molecular Typing; Oligonucleotide Array Sequence Analysis; Oral Surgical Procedures; RNA, Ribosomal, 16S; Statistics, Nonparametric | 2012 |
Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Croatia; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2012 |
Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the Americas.
Topics: Americas; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Metronidazole; Pharmaceutical Preparations; Zidovudine | 2012 |
High-dose, ten-day esomeprazole, amoxicillin and metronidazole triple therapy achieves high Helicobacter pylori eradication rates.
Topics: Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Metronidazole; Middle Aged | 2012 |
Anti-Helicobacter pylori potential of artemisinin and its derivatives.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Antimalarials; Artemisia annua; Artemisinins; Cell Line, Tumor; Cell Survival; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Plant Components, Aerial | 2012 |
Local concentration of systemic amoxicillin and metronidazole in healthy and inflamed gingiva: a comparative in vivo study.
Topics: Administration, Oral; Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Drug Combinations; Gingiva; Gingivitis; Humans; Metronidazole; Periodontal Pocket; Periodontitis | 2012 |
High prevalence and resistance rates to antibiotics in anaerobic bacteria in specimens from patients with chronic balanitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Balanitis; Clindamycin; Clostridioides difficile; Drug Resistance, Multiple, Bacterial; Humans; Inhibitory Concentration 50; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2012 |
Factors modulating the outcome of treatment for the eradication of Helicobacter pylori infection.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Biopsy; Drug Resistance, Bacterial; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Peptic Ulcer; Treatment Outcome | 2012 |
Benefits of early systemic antibiotics in localized aggressive periodontitis: a retrospective study.
Topics: Adolescent; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Black or African American; Child; Clinical Trials as Topic; Combined Modality Therapy; Dental Prophylaxis; Drug Administration Schedule; Drug Therapy, Combination; Female; Gingival Crevicular Fluid; Humans; Longitudinal Studies; Male; Metronidazole; Periodontal Index; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult | 2012 |
Preclinical experiments on the release behavior of biodegradable nanofibrous multipharmaceutical membranes in a model of four-wall intrabony defect.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Biocompatible Materials; Biopsy, Fine-Needle; Cell Survival; Collagen; Delayed-Action Preparations; Drug Evaluation, Preclinical; Electrochemical Techniques; Escherichia coli; Fibroblasts; Guided Tissue Regeneration; Humans; Lidocaine; Metronidazole; Microbial Sensitivity Tests; Rabbits; Staphylococcus aureus; Tibia | 2013 |
In vitro invasion and survival of Porphyromonas gingivalis in gingival fibroblasts; role of the capsule.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Capsules; Bacterial Proteins; Cells, Cultured; Female; Fibroblasts; Gingiva; Humans; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Middle Aged; Mutation; Porphyromonas gingivalis | 2012 |
Effectiveness of esomeprazole-based triple therapy of H. pylori in young patients in Japan.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Esomeprazole; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Middle Aged | 2013 |
Therapeutic management of a case of generalised aggressive periodontitis in an 8-year old child: 18-month results.
Topics: Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Child; Dental Plaque; Follow-Up Studies; Gingivitis; Humans; Male; Metronidazole; Patient Care Planning; Periodontal Debridement; Periodontal Pocket; Porphyromonas gingivalis; Tooth Mobility; Tooth, Deciduous | 2012 |
Outcomes of conservative treatment of 134 cases of umbilical pilonidal sinus.
Topics: Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Combined Modality Therapy; Drainage; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Metronidazole; Pilonidal Sinus; Povidone-Iodine; Recurrence; Skin Care; Treatment Outcome; Umbilicus; Young Adult | 2013 |
Evolution of Helicobacter pylori susceptibility to antibiotics during a 10-year period in Lithuania.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Multiple, Bacterial; Evolution, Molecular; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lithuania; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prevalence; Tetracycline | 2013 |
Prevalence of β-lactamase-producing bacteria in human periodontitis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Bacteriological Techniques; beta-Lactamase Inhibitors; beta-Lactamases; Chronic Periodontitis; Dental Plaque; Drug Resistance, Bacterial; Enzyme Inhibitors; Female; Fusobacterium nucleatum; Gingiva; Gram-Negative Bacteria; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Prevotella; Prevotella intermedia; Prevotella nigrescens | 2013 |
Antimicrobial susceptibility and resistance patterns among Helicobacter pylori strains from The Gambia, West Africa.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; DNA Mutational Analysis; Drug Resistance, Bacterial; Erythromycin; Female; Gambia; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nitroreductases; RNA, Ribosomal, 16S; Tetracycline | 2013 |
Primary antibiotic resistance and associated mechanisms in Helicobacter pylori isolates from Senegalese patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Clarithromycin; DNA Gyrase; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Ofloxacin; RNA, Ribosomal, 23S; Senegal; Tetracycline; Young Adult | 2013 |
Antimicrobial prophylaxis in open reduction and internal fixation of compound mandibular fractures: a collaborative regional audit of outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Child; Clarithromycin; Dental Audit; England; Female; Fracture Fixation, Internal; Fractures, Open; Humans; Male; Mandibular Fractures; Metronidazole; Middle Aged; Postoperative Care; Prospective Studies; Surgical Wound Infection; Treatment Outcome; Young Adult | 2013 |
High Helicobacter pylori resistance to metronidazole and clarithromycin in Brazilian children and adolescents.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Brazil; Child; Child, Preschool; Clarithromycin; Developing Countries; Disease Eradication; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline; Young Adult | 2013 |
Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Enzyme Inhibitors; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Pakistan; Plant Extracts; Plants, Medicinal; Tetracycline; Urease | 2013 |
Assessment of viable periodontal pathogens by reverse transcription quantitative polymerase chain reaction.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Azides; Bacteria; Bacterial Load; Bacteroides; Dental Plaque; DNA, Bacterial; Humans; Metronidazole; Microbial Viability; Periodontitis; Porphyromonas gingivalis; Propidium; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial; RNA, Ribosomal; Treponema denticola | 2013 |
Antibiotic resistance in human peri-implantitis microbiota.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Biofilms; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Microbial; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peri-Implantitis; Retrospective Studies | 2014 |
Prevalence of Helicobacter pylori and its recurrence after successful eradication in a developing nation (Morocco).
Topics: Adult; Amoxicillin; Anti-Infective Agents; Breath Tests; Carbon Isotopes; Clarithromycin; Developing Countries; Drug Therapy, Combination; Educational Status; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Hospitals, University; Humans; Lost to Follow-Up; Male; Medication Adherence; Metronidazole; Middle Aged; Morocco; Omeprazole; Prevalence; Prospective Studies; Proton Pump Inhibitors; Recurrence; Urea; Urease; Young Adult | 2013 |
[Acute cholecystitis].
Topics: Adult; Amoxicillin; Analgesics, Opioid; Anti-Bacterial Agents; Butylscopolammonium Bromide; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Combined Modality Therapy; Cooperative Behavior; Drug Therapy, Combination; Emergencies; Female; General Practice; Humans; Interdisciplinary Communication; Metronidazole; Pentazocine; Ultrasonography | 2013 |
Microcalorimetric determination of the effects of amoxicillin, metronidazole, and their combination on in vitro biofilm.
Topics: Amoxicillin; Anaerobiosis; Anti-Bacterial Agents; Bacterial Adhesion; Bacterial Load; Bacteriological Techniques; Biofilms; Calorimetry; Culture Media; Drug Combinations; Drug Resistance, Bacterial; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Fusobacterium nucleatum; Humans; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Porphyromonas gingivalis; Streptococcus sanguis; Temperature; Time Factors | 2014 |
Pilot study: miscellaneous therapy is highly successful for Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastric Acidity Determination; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Metronidazole; Middle Aged; Peptic Ulcer; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Surveys and Questionnaires; Treatment Outcome | 2013 |
Validation of antibiotic efficacy on in vitro subgingival biofilms.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bacterial Load; Bacteriological Techniques; Biofilms; Campylobacter rectus; Culture Media; Doxycycline; Drug Combinations; Fusobacterium nucleatum; Gingiva; Gingival Crevicular Fluid; Humans; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Microscopy, Fluorescence; Porphyromonas gingivalis; Prevotella intermedia; Streptococcus anginosus; Time Factors | 2014 |
Antimicrobial resistance and prevalence of resistance genes of obligate anaerobes isolated from periodontal abscesses.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Proteins; Bacteriological Techniques; Bacteroidaceae Infections; beta-Lactam Resistance; beta-Lactamases; Cefixime; Cephradine; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Female; Genes, Bacterial; Humans; Imipenem; Male; Methyltransferases; Metronidazole; Middle Aged; Periodontal Abscess; Prevotella; Roxithromycin; Tetracycline Resistance | 2014 |
Bismuth + metronidazole + tetracycline. Why risk adding bismuth?
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Tetracycline | 2013 |
Antibiotic resistance in human chronic periodontitis microbiota.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Candida; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Dental Plaque; Doxycycline; Drug Resistance, Bacterial; Enterococcus faecalis; Female; Fusobacterium nucleatum; Humans; Male; Metronidazole; Middle Aged; Periodontal Pocket; Prevotella intermedia; Prevotella nigrescens; Staphylococcus aureus; Streptococcus constellatus | 2014 |
Delay of second-line eradication therapy for Helicobacter pylori can increase eradication failure.
Topics: Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Time Factors; Treatment Failure; Treatment Outcome | 2013 |
Amoxicillin/metronidazole therapy may improve the effectiveness of scaling and root planing in patients with periodontitis.
Topics: Amoxicillin; Anti-Infective Agents; Chronic Periodontitis; Dental Scaling; Humans; Metronidazole | 2013 |
Rational Helicobacter pylori therapy: evidence-based medicine rather than medicine-based evidence.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Failure | 2014 |
Trends of second-line eradication therapy for Helicobacter pylori in Japan: a multicenter study in the Tokyo metropolitan area.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Tokyo; Young Adult | 2013 |
The 1-year treatment outcome of generalized chronic periodontitis may be enhanced by the systemic use of metronidazole alone or in combination with amoxicillin as adjuncts to scaling and root planing.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Female; Humans; Male; Metronidazole | 2013 |
What is the impact of Helicobacter pylori density on the success of eradication therapy: a clinico-histopathological study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Breath Tests; Case-Control Studies; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Proton Pump Inhibitors; Stomach; Tetracycline; Treatment Outcome; Urea; Young Adult | 2013 |
Antibiotic resistance of Helicobacter pylori in Mashhad, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Chi-Square Distribution; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Iran; Male; Metronidazole; Middle Aged; Sensitivity and Specificity; Tetracycline; Urease | 2013 |
In vitro characterization of the anti-bacterial activity of SQ109 against Helicobacter pylori.
Topics: Adamantane; Amoxicillin; Antitubercular Agents; Cell Membrane; Chloramphenicol; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Duodenal Ulcer; Duodenitis; Ethylenediamines; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron; Stomach Ulcer | 2013 |
[Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition].
Topics: Amoxicillin; Anti-Bacterial Agents; Aspirin; Bismuth; Breath Tests; Clarithromycin; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Metaplasia; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors; Republic of Korea; Stomach Neoplasms; Tetracycline | 2013 |
Efficacy of cefixime plus metronidazole therapy for Helicobacter pylori eradication: a retrospective study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Cefixime; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Outcome | 2013 |
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Stomach Ulcer; Young Adult | 2013 |
Effect of periodontal treatment on peak serum levels of inflammatory markers.
Topics: Acute-Phase Proteins; Amoxicillin; Anti-Infective Agents; Biomarkers; Combined Modality Therapy; Cytokines; Dental Scaling; Female; Humans; Male; Metronidazole; Middle Aged; Periodontitis; Root Planing; Treatment Outcome | 2014 |
Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Disease Eradication; DNA Gyrase; Doxycycline; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Prospective Studies; Proton Pump Inhibitors; RNA, Ribosomal, 23S; Treatment Failure | 2014 |
Revascularization outcomes: a prospective analysis of 16 consecutive cases.
Topics: Amoxicillin; Anti-Bacterial Agents; Apexification; Bicuspid; Blood Coagulation; Child; Ciprofloxacin; Dental Pulp Cavity; Dental Pulp Necrosis; Dentin; Female; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Incisor; Male; Metronidazole; Neovascularization, Physiologic; Periapical Diseases; Prospective Studies; Radiography, Bitewing; Regeneration; Root Canal Irrigants; Root Canal Preparation; Tooth Apex; Treatment Outcome | 2014 |
Letter to the editor: Re: The clinical effect of scaling and root planing and the concomitant administration of systemic amoxicillin and metronidazole: a systematic review; Re: Effectiveness of systemic amoxicillin/metronidazole as adjunctive therapy to s
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Periodontitis; Dental Scaling; Humans; Metronidazole; Root Planing | 2014 |
Letter to the editor: Authors' response.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Chronic Periodontitis; Dental Scaling; Humans; Metronidazole; Root Planing | 2014 |
Patterns and predictors of self-medication in northern Uganda.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Artemether, Lumefantrine Drug Combination; Artemisinins; Cross-Sectional Studies; Drug Combinations; Drug Resistance; Ethanolamines; Female; Fluorenes; Health Knowledge, Attitudes, Practice; Humans; Male; Metronidazole; Self Care; Self Medication; Surveys and Questionnaires; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2014 |
Metronidazole and amoxicillin susceptibility of Aggregatibacter actinomycetemcomitans.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Humans; Metronidazole; Microbial Sensitivity Tests; Pasteurellaceae Infections | 2014 |
Efficacy of tailored Helicobacter pylori eradication treatment based on clarithromycin susceptibility and maintenance of acid secretion.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Treatment Outcome | 2014 |
Combinatorial effects of amoxicillin and metronidazole on selected periodontal bacteria and whole plaque samples.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Anti-Bacterial Agents; Dental Plaque; Drug Resistance, Bacterial; Drug Synergism; Eikenella corrodens; Fusobacterium nucleatum; Humans; In Vitro Techniques; Metronidazole; Microbial Sensitivity Tests; Periodontitis; Prevotella nigrescens | 2014 |
Resistance of Helicobacter pylori to tetracycline, amoxicillin, clarithromycin and metronidazole in Israeli children and adults.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2014 |
Investigating the dissolution profiles of amoxicillin, metronidazole, and zidovudine formulations used in Trinidad and Tobago, West Indies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Antitrichomonal Agents; Capsules; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Liberation; Drugs, Generic; Metronidazole; Solubility; Tablets; Trinidad and Tobago; Zidovudine | 2014 |
Challenges and opportunities to use biowaivers to compare generics in China.
Topics: Algorithms; Amoxicillin; Capsules; Chemistry, Pharmaceutical; China; Chromatography, High Pressure Liquid; Drugs, Generic; Metronidazole; Solubility; Tablets | 2014 |
In vitro dissolution of generic immediate-release solid oral dosage forms containing BCS class I drugs: comparative assessment of metronidazole, zidovudine, and amoxicillin versus relevant comparator pharmaceutical products in South Africa and India.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Antitrichomonal Agents; Chemistry, Pharmaceutical; Dosage Forms; Drug Liberation; Drugs, Generic; India; Metronidazole; Solubility; South Africa; Zidovudine | 2014 |
Does standard triple therapy still have a role in first-line Helicobacter pylori eradication in Korea?
Topics: Amoxicillin; Clarithromycin; Communicable Disease Control; Disease Eradication; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Republic of Korea; Tinidazole | 2014 |
Spectrophotometric analysis of crown discoloration induced by various antibiotic pastes used in revascularization.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Calcium Hydroxide; Cattle; Cefaclor; Ciprofloxacin; Color Perception; Doxycycline; Metronidazole; Random Allocation; Regeneration; Root Canal Filling Materials; Root Canal Irrigants; Root Canal Preparation; Root Canal Therapy; Sodium Hypochlorite; Spectrophotometry; Time Factors; Tooth Crown; Tooth Discoloration | 2014 |
The clinical relevance of microbiology specimens in head and neck space infections of odontogenic origin.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Child; Child, Preschool; Drainage; Female; Follow-Up Studies; Humans; Infant; Length of Stay; Male; Metronidazole; Middle Aged; Retrospective Studies; Smoking; Streptococcal Infections; Tooth Diseases; Viridans Streptococci; Young Adult | 2014 |
Microbiological examination and antibiotic sensitivity of infections in the head and neck. Has anything changed?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Bacteria; Bacteria, Anaerobic; Child; Child, Preschool; Female; Gram-Positive Cocci; Humans; Infant; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Periapical Diseases; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Streptococcal Infections; Submandibular Gland Diseases; Tooth Diseases; Viridans Streptococci; Young Adult | 2014 |
Combination of oral antibiotics may be effective in severe pediatric ulcerative colitis: a preliminary report.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; C-Reactive Protein; Child; Colitis, Ulcerative; Doxycycline; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Metronidazole; Remission Induction; Retreatment; Retrospective Studies; Severity of Illness Index; Tumor Necrosis Factor-alpha; Vancomycin | 2014 |
Diagnosis and prescribing pattern of antibiotics and painkillers among dentists.
Topics: Adolescent; Adult; Amoxicillin; Analgesics; Anti-Bacterial Agents; Child; Child, Preschool; Cross-Sectional Studies; Dental Caries; Dental Deposits; Drug Prescriptions; Female; Humans; Male; Metronidazole; Middle Aged; Needs Assessment; Pakistan; Periodontitis; Practice Patterns, Dentists'; Pulpitis; Tooth Diseases; Young Adult | 2015 |
Centipeda periodontii in human periodontitis.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biofilms; Chronic Periodontitis; DNA, Bacterial; Doxycycline; Female; Gingivitis; Gram-Negative Anaerobic Bacteria; Humans; Male; Metronidazole; Microbial Sensitivity Tests | 2015 |
Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori Infection.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Infective Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Retrospective Studies; Tetracycline; Treatment Outcome | 2015 |
Primary actinomycosis of the breast caused by Actinomyces turicensis with associated Peptoniphilus harei.
Topics: Actinomyces; Actinomycosis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Breast Diseases; Coinfection; Female; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Metronidazole; Penicillin G; Young Adult | 2015 |
Antibiotic susceptibility of periodontal Streptococcus constellatus and Streptococcus intermedius clinical isolates.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Bacteriological Techniques; Chronic Periodontitis; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Female; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Penicillin Resistance; Streptococcus; Streptococcus intermedius; Tetracycline Resistance | 2014 |
[Antibiotic resistance of Helicobacter pylori: prevalence in one region in the southern Netherlands and implications for treatment].
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Netherlands; Prevalence; Proton Pump Inhibitors; Retrospective Studies | 2014 |
Antibiotics in the treatment of periodontal disease: a guide for the general dental practitioner.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Biofilms; Chronic Periodontitis; Combined Modality Therapy; Female; Gingivitis, Necrotizing Ulcerative; Humans; Inappropriate Prescribing; Metronidazole; Periodontal Abscess; Periodontal Debridement; Periodontal Diseases; Practice Guidelines as Topic | 2014 |
An audit to assess compliance with antimicrobial prescribing in the management of acute dentoalveolar infections with associated facial swelling.
Topics: Amoxicillin; Anti-Bacterial Agents; Dental Audit; Dental Service, Hospital; Drainage; Drug Administration Schedule; Edema; Face; Guideline Adherence; Humans; Metronidazole; Periodontal Abscess; Practice Guidelines as Topic; Prospective Studies | 2014 |
The efficacy of moxifloxacin-containing triple therapy after standard triple, sequential, or concomitant therapy failure for Helicobacter pylori eradication in Korea.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Cohort Studies; Drug Therapy, Combination; Female; Fluoroquinolones; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Republic of Korea; Retrospective Studies; Salvage Therapy; Stomach; Tetracycline; Treatment Failure; Treatment Outcome; Urea | 2014 |
Helicobacter pylori Infection in Children. Antimicrobial Resistance and Treatment Response.
Topics: Adolescent; Amoxicillin; Anti-Infective Agents; Breath Tests; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Remission Induction; Retrospective Studies; Treatment Outcome; Urea | 2015 |
[Ten day concomitant therapy is superior to ten day sequential therapy for Helicobacter pylori eradication].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Logistic Models; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Treatment Outcome | 2014 |
Periodontology: antibiotics protocol.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Humans; Metronidazole; Periodontitis | 2014 |
Comparison of bond strength of self-etch adhesive to pulp chamber dentin after placement of calcium hydroxide and various antibiotic pastes.
Topics: Amoxicillin; Anti-Bacterial Agents; Calcium Hydroxide; Cefaclor; Ciprofloxacin; Composite Resins; Dental Bonding; Dental Pulp Cavity; Dental Stress Analysis; Dentin; Dentin-Bonding Agents; Drug Combinations; Edetic Acid; Humans; Materials Testing; Metronidazole; Minocycline; Random Allocation; Resin Cements; Root Canal Irrigants; Sodium Hypochlorite; Stress, Mechanical; Tensile Strength | 2015 |
Genotypic and clinical differences of seropositive Helicobacter pylori children and adults in the Polish population.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antibodies, Bacterial; Antigens, Bacterial; Bacterial Proteins; Child; Child, Preschool; Clarithromycin; Cross-Sectional Studies; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Infant; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Poland; Prospective Studies; Tetracycline; Young Adult | 2014 |
Direct analysis of six antibiotics in wastewater samples using rapid high-performance liquid chromatography coupled with diode array detector: a chemometric study towards green analytical chemistry.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Green Chemistry Technology; Metronidazole; Ofloxacin; Sulfadiazine; Sulfamerazine; Sulfamethoxazole; Wastewater; Water Pollutants, Chemical | 2015 |
Effects of azithromycin, metronidazole, amoxicillin, and metronidazole plus amoxicillin on an in vitro polymicrobial subgingival biofilm model.
Topics: Actinomyces; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Biofilms; Metronidazole; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Streptococcus; Veillonella | 2015 |
A 15-year-old boy with abdominal pain, growth retardation, and anemia secondary to Helicobacter pylori-associated peptic ulcer.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Clarithromycin; Drug Therapy, Combination; Growth Disorders; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Peptic Ulcer; Proton Pump Inhibitors | 2015 |
Effects of therapy with two combinations of antibiotics on the imbalance of MMP-2÷TIMP-2 in chronic periodontitis.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Drug Therapy, Combination; Female; Gene Expression Regulation; Gingiva; Humans; Inflammation; Male; Matrix Metalloproteinase 2; Metronidazole; Middle Aged; Spiramycin; Tissue Inhibitor of Metalloproteinase-2 | 2015 |
The Primary Resistance of Helicobacter pylori in Taiwan after the National Policy to Restrict Antibiotic Consumption and Its Relation to Virulence Factors-A Nationwide Study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Taiwan; Tetracycline; Virulence Factors | 2015 |
Periodontitis associated with plasminogen deficiency: a case report.
Topics: Adolescent; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Conjunctivitis; Female; Follow-Up Studies; Gingival Hemorrhage; Gingival Hyperplasia; Humans; Metronidazole; Periodontal Attachment Loss; Periodontal Debridement; Periodontal Pocket; Periodontitis; Plasminogen; Skin Diseases, Genetic; Tooth Mobility | 2015 |
Antibiotics prescription in Nigerian dental healthcare services.
Topics: Acquired Immunodeficiency Syndrome; Amoxicillin; Anaphylaxis; Anti-Bacterial Agents; Antibiotic Prophylaxis; Attitude of Health Personnel; Dental Care; Dentists; Diabetes Mellitus; Drug Combinations; Drug Prescriptions; Drug Resistance, Bacterial; Education, Dental; Female; Heart Diseases; Hip Prosthesis; HIV Infections; Humans; Male; Metronidazole; Nigeria; Practice Patterns, Dentists'; Rheumatic Fever; Tetracycline; Tooth Discoloration | 2014 |
In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein Inactivation.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Proteins; Binding Sites; Clarithromycin; Computer-Aided Design; Curcumin; Drug Design; Helicobacter Infections; Helicobacter pylori; Metronidazole; Molecular Docking Simulation; Pantoprazole; Pattern Recognition, Automated; Protein Binding; Protein Conformation; Proton Pump Inhibitors; Structure-Activity Relationship | 2015 |
Development and validation of HPLC-DAD method for the simultaneous determination of amoxicillin, metronidazole and rabeprazole sodium. Application to spiked simulated intestinal fluid samples.
Topics: Amoxicillin; Anti-Bacterial Agents; Body Fluids; Calibration; Chromatography, High Pressure Liquid; Drug Stability; Humans; Metronidazole; Proton Pump Inhibitors; Rabeprazole; Reproducibility of Results | 2015 |
Maintenance periodontal therapy after systemic antibiotic and regenerative therapy of generalized aggressive periodontitis. A case report with 10-year follow-up.
Topics: Adult; Aggressive Periodontitis; Alveolar Bone Loss; Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Dental Enamel Proteins; Drug Combinations; Follow-Up Studies; Furcation Defects; Guided Tissue Regeneration, Periodontal; Humans; Longitudinal Studies; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Subgingival Curettage; Surgical Flaps | 2015 |
Efficiency of Moxifloxacin in the Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Female; Fluoroquinolones; Helicobacter Infections; Humans; Male; Metronidazole; Organometallic Compounds; Rabeprazole; Tetracycline | 2015 |
Importance of blood cultures to aid the diagnosis of Lemierre's syndrome.
Topics: Amoxicillin; Anti-Infective Agents; Female; Fusobacterium necrophorum; Humans; Jugular Veins; Lemierre Syndrome; Metronidazole; Microbiological Techniques; Sepsis; Thrombophlebitis; Tomography, X-Ray Computed; Tonsillectomy; Treatment Outcome; Young Adult | 2015 |
Treatment of low-grade gastric MALT lymphoma using Helicobacter pylori eradication.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Clarithromycin; Disease-Free Survival; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lymphoma, B-Cell, Marginal Zone; Male; Metronidazole; Middle Aged; Neoplasm Grading; Proton Pump Inhibitors; Stomach Neoplasms; Treatment Outcome | 2015 |
Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antigens, Bacterial; Barrett Esophagus; Bismuth; Breath Tests; Clarithromycin; Disease Management; Drug Therapy, Combination; Dyspepsia; Feces; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Italy; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Stomach Neoplasms; Urea | 2015 |
The best and worst treatments for Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors | 2015 |
Parotid Abscess with Involvement of Facial Nerve Branches.
Topics: Abscess; Amoxicillin; Anti-Infective Agents; Biopsy, Fine-Needle; Facial Paralysis; Humans; Male; Metronidazole; Parotid Diseases; Parotid Gland; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; Ultrasonography; Young Adult | 2015 |
Akkermansia muciniphila and Helicobacter typhlonius modulate intestinal tumor development in mice.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Carcinogenesis; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Goblet Cells; Helicobacter; Helicobacter Infections; Intestinal Neoplasms; Intestines; Male; Metronidazole; Mice, Inbred C57BL; Omeprazole; Verrucomicrobia | 2015 |
Linezolid susceptibility in Helicobacter pylori, including strains with multidrug resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Linezolid; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2015 |
Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Taiwan; Tetracycline; Time Factors | 2015 |
Interdisciplinary management of aggressive periodontitis.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Combined Modality Therapy; Connective Tissue; Dental Scaling; Drug Combinations; Female; Gingiva; Gingival Recession; Humans; Metronidazole; Patient Care Planning; Patient Care Team; Root Planing; Surgical Flaps; Tooth Migration; Tooth Mobility; Tooth Movement Techniques | 2015 |
How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery?
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Gastric Bypass; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Obesity, Morbid; Portugal; Prospective Studies; Proton Pump Inhibitors; Treatment Outcome; Young Adult | 2016 |
What do consumers want to know about antibiotics? Analysis of a medicines call centre database.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Australia; Child; Child, Preschool; Ciprofloxacin; Consumer Health Information; Databases, Factual; Drug Administration Schedule; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Help-Seeking Behavior; Humans; Infant; Infant, Newborn; Information Seeking Behavior; Lactation; Male; Metronidazole; Middle Aged; Motivation; Retrospective Studies; Young Adult | 2016 |
Does emerging Clarithromycin resistance signal an obituary to empirical standard triple therapy for Helicobacter pylori infection?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Longitudinal Studies; Metronidazole; Omeprazole; Prospective Studies; Rifabutin; Tetracycline; Treatment Failure | 2015 |
Evaluation of antimicrobial resistance of Helicobacter pylori in the last 15 years in West Poland.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Poland | 2015 |
In vitro antimicrobial susceptibility of Helicobacter pylori to nine antibiotics currently used in Central Italy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Child; Ciprofloxacin; Clarithromycin; Drug Resistance, Multiple, Bacterial; Dyspepsia; Female; Fluoroquinolones; Gastric Fundus; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Moxifloxacin; Pyloric Antrum; Rifabutin; Tetracycline; Young Adult | 2016 |
The impact of bismuth addition to sequential treatment on Helicobacter pylori eradication: A pilot study.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Breath Tests; Clarithromycin; Drug Resistance, Bacterial; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Pilot Projects; Proton Pump Inhibitors; Treatment Outcome | 2015 |
Nonsurgical therapy of chronic periodontitis with adjunctive systemic azithromycin or amoxicillin/metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Chemotherapy, Adjuvant; Chronic Periodontitis; Dental Scaling; Female; Gingival Crevicular Fluid; Humans; Male; Metronidazole; Periodontal Index; Root Planing; Treatment Outcome | 2016 |
In vitro synergistic effect of Hibiscus sabdariffa aqueous extract in combination with standard antibiotics against Helicobacter pylori clinical isolates.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Drug Therapy, Combination; Flowers; Helicobacter Infections; Helicobacter pylori; Hibiscus; Humans; Metronidazole; Microbial Sensitivity Tests; Phytotherapy; Plant Extracts; Plants, Medicinal | 2016 |
Levofloxacin, bismuth, amoxicillin and esomeprazole as second-line Helicobacter pylori therapy after failure of non-bismuth quadruple therapy.
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Retreatment; Treatment Outcome | 2016 |
[Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province].
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Drug Resistance, Microbial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole | 2016 |
[Application of anaerobic bacteria detection in oral and maxillofacial infection].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria, Anaerobic; Bacterial Infections; Beijing; Gram-Positive Bacteria; Humans; Metronidazole; Microbial Sensitivity Tests; Mouth | 2016 |
Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Cohort Studies; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prevalence; Proton Pump Inhibitors; Retrospective Studies; RNA, Ribosomal, 23S; Treatment Failure; United States; Young Adult | 2016 |
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Biopsy; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Gastroscopy; Gentamicins; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2016 |
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Breath Tests; Clarithromycin; Cohort Studies; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Proportional Hazards Models; Proton Pump Inhibitors; Pyloric Antrum; Retrospective Studies; Risk Factors; Stomach; Stomach Neoplasms | 2016 |
[10-day triple therapy with esomeprazole 40 mg/12 h vs. quadruple concomitant non-bismuth therapy as first line treatment for Helicobacter pylori infection].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Spain; Stomach Ulcer | 2016 |
Four-times-daily Dosing of Rabeprazole with Sitafloxacin, High-Dose Amoxicillin, or Both for Metronidazole-Resistant Infection with Helicobacter pylori in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Hospitals, University; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Treatment Outcome | 2017 |
Nationwide survey of Helicobacter pylori treatment for children and adolescents in Japan.
Topics: Adolescent; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Practice Patterns, Physicians'; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2017 |
An assessment of the efficacy of first-line Helicobacter pylori-eradication therapy based on clarithromycin susceptibility.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Lansoprazole; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies | 2016 |
Emerging trends of antimicrobial resistance in Helicobacter pylori isolates obtained from Pakistani patients: The need for consideration of amoxicillin and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Pakistan | 2016 |
[Cuadruple concomitant non-bismuth therapy vs. classical triple therapy as first line therapy for Helicobacter pylori infection].
Topics: Adult; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2016 |
Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2016 |
Angina, back pain and septic shock.
Topics: Amoxicillin; Angina, Unstable; Anti-Bacterial Agents; Back Pain; Fusobacterium necrophorum; Humans; Lemierre Syndrome; Male; Metronidazole; Middle Aged; Shock, Septic; Tomography, X-Ray Computed | 2017 |
Role of concomitant therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2016 |
Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Rabeprazole; Retrospective Studies; Sulfonamides | 2017 |
Emerging Helicobacter pylori levofloxacin resistance and novel genetic mutation in Nepal.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Base Sequence; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Endoscopy; Female; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mutation; Nepal; Nitroreductases; Point Mutation; Prevalence; Prokaryotic Initiation Factor-2; RNA, Ribosomal, 23S; Tetracycline; Young Adult | 2016 |
Bismuth and Non-bismuth Quadruple Therapy for Helicobacter pylori Eradication: Time to Make the Switch in Clinical Practice?
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Antidiarrheals; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Outcome | 2017 |
Surveillance of Helicobacter pylori Antibiotic Susceptibility in Indonesia: Different Resistance Types among Regions and with Novel Genetic Mutations.
Topics: Adolescent; Adult; Aged; Amoxicillin; Clarithromycin; Drug Resistance, Microbial; Endoscopy; Female; Frameshift Mutation; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Mutation, Missense; Point Mutation; RNA, Ribosomal, 23S | 2016 |
A Comparative Study of a New Class of Gastric Acid Suppressant Agent Named Vonoparazan versus Esomeprazole for the Eradication of Helicobacter pylori.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2016 |
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection.
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Salvage Therapy; Treatment Failure | 2017 |
Triple therapy versus sequential therapy for the first-line Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Failure | 2017 |
Levofloxacin or Clarithromycin-based quadruple regimens: what is the best alternative as first-line treatment for Helicobacter pylori eradication in a country with high resistance rates for both antibiotics?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Portugal; Proton Pump Inhibitors; Retrospective Studies; Tinidazole; Treatment Outcome; Young Adult | 2017 |
The Effect of Nonsurgical Periodontal Therapy on HNP1-3 Level in Gingival Crevicular Fluid of Chronic Periodontitis Patients.
Topics: alpha-Defensins; Amoxicillin; Anti-Infective Agents; Chronic Periodontitis; Defensins; Dental Scaling; Gingival Crevicular Fluid; Humans; Immunity, Innate; Metronidazole; Middle Aged; Mouth; Treatment Outcome; Up-Regulation | 2017 |
Comparative study: Vonoprazan and proton pump inhibitors in
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Patient Safety; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2017 |
Adjunctive Use of Systemic Antibiotics (Amoxicillin 500 MG plus Metronidazole 500 MG 3 times a Day for 3 or 7 Days) to Nonsurgical Periodontal Therapy may Improve Clinical Outcomes in Treating Severe Chronic Periodontitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Double-Blind Method; Humans; Metronidazole | 2017 |
Effect of biofilm formation by clinical isolates of
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biofilms; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Erythromycin; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; RNA, Ribosomal, 16S; Tetracycline | 2017 |
Generalized aggressive periodontitis: microbiological composition and clinical parameters in non-surgical therapy.
Topics: Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Dental Plaque; Female; Humans; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Pocket; Porphyromonas gingivalis | 2016 |
Moxifloxacin, but not Metronidazole can be used in therapeutic regimens against Helicobacter pylori.
Topics: Amoxicillin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Moxifloxacin | 2017 |
Amoxycillin and Metronidazole Therapy for Helicobacter pylori Eradication: A 10-Year Trend in Turin, Italy.
Topics: Amoxicillin; Anti-Bacterial Agents; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Metronidazole | 2017 |
Secondary antibiotic resistance of Helicobacter pylori isolates in Israeli children and adults.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline; Young Adult | 2017 |
Second-line therapy for Helicobacter pylori eradication causing antibiotic-associated hemorrhagic colitis.
Topics: Abdominal Pain; Aged; Amoxicillin; Biopsy; Colitis; Colon; Colonoscopy; Female; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Hemorrhage; Humans; Klebsiella oxytoca; Metronidazole; Mucous Membrane; Pyrroles; Rare Diseases; Sulfonamides | 2017 |
[The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Fluoroquinolones; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies; Topoisomerase II Inhibitors; Treatment Failure; Treatment Outcome | 2017 |
Microbiologic Response to Periodontal Therapy and Multivariable Prediction of Clinical Outcome.
Topics: Adult; Aged; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Infective Agents; Bacterial Load; Chronic Periodontitis; Combined Modality Therapy; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Metronidazole; Middle Aged; Periodontal Debridement; Porphyromonas gingivalis; Prevotella intermedia; Tannerella forsythia; Treatment Outcome; Treponema denticola | 2017 |
Genetic variation among Clostridium perfringens isolated from food and faecal specimens in Lagos.
Topics: Amoxicillin; Bacterial Typing Techniques; Clostridium perfringens; DNA, Bacterial; Enterotoxins; Feces; Food Microbiology; Foodborne Diseases; Genetic Variation; Humans; Metronidazole; Microbial Sensitivity Tests; Nigeria; Polymerase Chain Reaction; Polymorphism, Genetic | 2017 |
Efficacy and tolerability of culture-guided treatment for Helicobacter pylori infection.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Body Mass Index; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; Rifampin; Tetracycline | 2017 |
Antimicrobial susceptibility of Helicobacter pylori strains isolated from children in Israel.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2018 |
The Resolution of Helicobacter suis-associated Gastric Lesions after Eradication Therapy.
Topics: Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Drug Therapy, Combination; Esomeprazole; Gastric Mucosa; Helicobacter heilmannii; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Polymerase Chain Reaction | 2018 |
Diagnostic Accuracy of Global Pharma Health Fund Minilab™ in Assessing Pharmacopoeial Quality of Antimicrobials.
Topics: Amoxicillin; Anti-Infective Agents; Azithromycin; Cefuroxime; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; False Negative Reactions; False Positive Reactions; Levofloxacin; Metronidazole; Quality Control; Reproducibility of Results | 2018 |
Clinical Outcomes of Standard Triple Therapy Plus Probiotics or Concomitant Therapy for
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Dietary Supplements; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medical Records, Problem-Oriented; Metronidazole; Middle Aged; Probiotics; Proton Pump Inhibitors; Republic of Korea; Retrospective Studies; Treatment Outcome | 2018 |
Inappropriate treatment in Helicobacter pylori eradication failure: a retrospective study.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies; Treatment Failure; Young Adult | 2018 |
Using amoxicillin plus metronidazole as an adjunct to nonsurgical periodontal treatment results in little benefit, and there seems to be no difference among regimens.
Topics: Amoxicillin; Dental Scaling; Metronidazole; Root Planing | 2018 |
Comment on Helicobacter pylori eradication using metronidazole.
Topics: Amoxicillin; Bismuth; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Moxifloxacin | 2018 |
Pylera and sequential therapy for first-line Helicobacter pylori eradication: a culture-based study in real clinical practice.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Italy; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Organometallic Compounds; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Tinidazole; Treatment Outcome | 2018 |
Impact of primary antibiotic resistance on the effectiveness of sequential therapy for Helicobacter pylori infection: lessons from a 5-year study on a large number of strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Treatment Outcome | 2018 |
Spectrophotometric analysis of discoloration and internal bleaching after use of different antibiotic pastes.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Ciprofloxacin; Doxycycline; Humans; Hydrogen Peroxide; In Vitro Techniques; Lasers, Solid-State; Metronidazole; Minocycline; Spectrophotometry; Tooth Bleaching; Tooth Discoloration | 2019 |
The need for a patient-tailored Helicobacter pylori eradication protocol prior to bariatric surgery.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bariatric Surgery; Body Mass Index; Clinical Protocols; Drug Therapy, Combination; Esomeprazole; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Mass Screening; Metronidazole; Middle Aged; Obesity, Morbid; Precision Medicine; Preoperative Care; Retrospective Studies; Young Adult | 2018 |
Combination Antibiotics Improves Disease Activity and Alters Microbial Communities in Children With Ulcerative Colitis.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Child; Colitis, Ulcerative; Doxycycline; Female; Fluconazole; Gastrointestinal Microbiome; Humans; Male; Metronidazole; Retrospective Studies; Vancomycin; Young Adult | 2018 |
Development of a LC-MS method for simultaneous determination of amoxicillin and metronidazole in human serum using hydrophilic interaction chromatography (HILIC).
Topics: Acetonitriles; Amoxicillin; Anti-Bacterial Agents; Calibration; Chromatography, Liquid; Humans; Hydrophobic and Hydrophilic Interactions; Limit of Detection; Metronidazole; Reproducibility of Results; Serum; Tandem Mass Spectrometry | 2018 |
[Phylogenetic study of drug resistance genes from clinical isolates of Helicobacter pylori].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Phylogeny; Tetracycline; Tibet | 2018 |
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell; Metronidazole; Middle Aged; Organometallic Compounds; Rabeprazole; Salicylates | 2018 |
CRAG rocks.
Topics: Amoxicillin; Animals; Clavulanic Acid; Diarrhea; Dogs; Metronidazole; Primary Health Care | 2018 |
Clinical and microbiological effects of scaling and root planing, metronidazole and amoxicillin in the treatment of diabetic and non-diabetic subjects with periodontitis: A cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Cohort Studies; Combined Modality Therapy; Dental Plaque; Dental Scaling; Diabetes Mellitus, Type 2; Humans; Metronidazole; Periodontitis; Root Planing | 2018 |
Helicobacter pylori antimicrobial resistance in a pediatric population.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Prospective Studies | 2018 |
[Efficacy of bismuth containing quadruple therapies on Helicobacter pylori eradication in patients with history of antibiotic treatment].
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Tinidazole; Treatment Outcome | 2018 |
The Microbial Composition of Bacteroidetes Species in Ulcerative Colitis Is Effectively Improved by Combination Therapy With Fecal Microbiota Transplantation and Antibiotics.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteroidetes; Colitis, Ulcerative; Combined Modality Therapy; Dysbiosis; Fecal Microbiota Transplantation; Feces; Fosfomycin; Gastrointestinal Microbiome; Humans; Metronidazole; Remission Induction; Treatment Outcome | 2018 |
Effective antimicrobial activity of rifabutin against multidrug-resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Infective Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Furazolidone; Helicobacter pylori; Metronidazole; Microbial Sensitivity Tests; Rifabutin; Tetracycline | 2018 |
Dynamics of antimicrobial resistance of Helicobacter pylori isolates in the Smolensk region of Russian Federation.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Tetracycline; Young Adult | 2018 |
Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial.
Topics: Adult; Amoxicillin; Anti-Infective Agents; Clinical Protocols; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Multicenter Studies as Topic; Organometallic Compounds; Phenotype; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Republic of Korea; Tetracycline; Treatment Outcome | 2018 |
Effect of periodontal treatment on Aggregatibacter actinomycetemcomitans colonization and serum IgG levels against A. actinomycetemcomitans serotypes and Omp29 of aggressive periodontitis patients.
Topics: Adolescent; Adult; Aggregatibacter actinomycetemcomitans; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Colony Count, Microbial; Female; Humans; Immunoglobulin G; Male; Metronidazole; Periodontal Attachment Loss; Periodontal Index; Prospective Studies; Root Planing; Serogroup; Young Adult | 2019 |
An audit of antimicrobial prescribing by dental practitioners in the north east of England and Cumbria.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Infective Agents; Child; Child, Preschool; England; Female; Humans; Inappropriate Prescribing; Infant; Male; Medical Audit; Metronidazole; Middle Aged; Practice Patterns, Dentists'; Young Adult | 2018 |
How and when investigating and treating Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Endoscopy, Digestive System; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Incidental Findings; Metronidazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Tinidazole | 2018 |
Six-month clinical outcomes of non-surgical periodontal treatment with antibiotics on apoptosis markers in aggressive periodontitis.
Topics: Adult; Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents, Local; Apoptosis; Caspase 3; Chlorhexidine; Combined Modality Therapy; Disinfection; Female; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Interleukin-10; Interleukin-1beta; Male; Metronidazole; Root Planing; Time Factors; TNF-Related Apoptosis-Inducing Ligand; Treatment Outcome; Tumor Necrosis Factor-alpha; Tumor Suppressor Protein p53; Young Adult | 2019 |
One-year follow-up of the immune profile in serum and selected sites of generalized and localized aggressive periodontitis.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Cell Movement; Cytokines; Gingival Crevicular Fluid; Humans; Metronidazole; Prospective Studies; Root Planing | 2019 |
Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Metronidazole; Middle Aged; Moxifloxacin; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2019 |
Effect of Age on Effectiveness of Vonoprazan in Triple Therapy for Helicobacter pylori Eradication.
Topics: Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Odds Ratio; Proton Pump Inhibitors; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2019 |
Removal of metronidazole and amoxicillin mixtures by UV/TiO
Topics: Amoxicillin; Anti-Bacterial Agents; Hydroxyl Radical; Metronidazole; Photolysis; Titanium; Water Pollutants, Chemical; Water Purification | 2019 |
[Eradication Rates of 10-day Sequential Therapy for
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Republic of Korea; Tertiary Care Centers; Treatment Outcome | 2019 |
A novel hybrid first-line therapy for H. pylori eradication: results of a pilot study.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Bacterial Load; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Esomeprazole; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Organometallic Compounds; Pilot Projects; Prospective Studies; Proton Pump Inhibitors; Tetracycline; Time Factors; Treatment Outcome | 2019 |
No evidence to support benefit of 14-day courses of amoxicillin-plus-metronidazole as adjunct to non-surgical periodontal treatment at three months.
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Humans; Metronidazole | 2019 |
Effect of Helicobacter pylori Treatment on Unexplained Iron Deficiency Anemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anemia, Iron-Deficiency; Anti-Bacterial Agents; California; Causality; Clarithromycin; Cohort Studies; Comorbidity; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Retrospective Studies; Young Adult | 2019 |
A Potassium-Competitive Acid Blocker-Based Regimen as Second-Line Therapy Improves Helicobacter pylori Eradication.
Topics: Adult; Aged; Amoxicillin; Antacids; Anti-Bacterial Agents; Drug Administration Schedule; Drug Therapy, Combination; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Potassium; Propensity Score; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2020 |
Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin.
Topics: Amoxicillin; Anti-Bacterial Agents; Biofilms; Clarithromycin; Drug Combinations; Helicobacter pylori; Humans; Kinetics; Metronidazole; Microbial Viability; RNA, Ribosomal, 16S | 2019 |
Nationwide antibiotic resistance mapping of Helicobacter pylori in Korea: A prospective multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Prospective Studies; Republic of Korea; Tetracycline; Young Adult | 2019 |
Granulomatous lobular mastitis-Another paradigm shift in treatment.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Biopsy, Large-Core Needle; Clavulanic Acid; Corynebacterium Infections; Doxycycline; Female; Granulomatous Mastitis; Humans; Mammography; Metronidazole | 2019 |
UPLC/MS/MS assay for the simultaneous determination of seven antibiotics in human serum-Application to pediatric studies.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Azithromycin; Blood Chemical Analysis; Calibration; Cefotaxime; Child; Child, Preschool; Chromatography, High Pressure Liquid; Ciprofloxacin; Escherichia coli Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid, Acute; Limit of Detection; Male; Meropenem; Metronidazole; Pediatrics; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry | 2019 |
Risk of Adverse Reactions to Oral Antibiotics Prescribed by Dentists.
Topics: Administration, Oral; Adverse Drug Reaction Reporting Systems; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Clindamycin; Dentists; England; Humans; Metronidazole; Penicillins | 2019 |
Tailored Helicobacter pylori eradication based on prior intake of macrolide antibiotics allows the use of triple therapy with optimal results in an area with high clarithromycin resistance.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Electronic Health Records; Female; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Macrolides; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quinolones; Tetracycline; Young Adult | 2019 |
Effect of Drug Combination on Omeprazole Metabolism by Cytochrome P450 2C19 in Helicobacter pylori Eradication Therapy.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Clarithromycin; Cytochrome P-450 CYP2C19; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Molecular Structure; Omeprazole; Tinidazole | 2019 |
Helicobacter pylori: Multiple resistance in patients from Bogotá, Colombia
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Biopsy; Clarithromycin; Colombia; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Gastritis; Gastroscopy; Genes, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged | 2019 |
Antibiotics Used in Regenerative Endodontics Modify Immune Response of Macrophages to Bacterial Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Humans; Macrophages; Metronidazole; Regenerative Endodontics | 2019 |
[Use of antimicrobial agents in periodontology].
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Chlorhexidine; Humans; Metronidazole; Periodontal Debridement; Periodontitis | 2019 |
Polysorbate 80 add-on therapy in the treatment of Helicobacter pylori infection: Polysorbate 80 and HP antibiotic resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Combinations; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Polysorbates | 2019 |
Helicobacter pylori eradication regimens in an antibiotic high-resistance European area: A cost-effectiveness analysis.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cost-Benefit Analysis; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Greece; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Young Adult | 2020 |
Comparing antibiotic adjuncts in periodontitis.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Humans; Metronidazole; Root Planing | 2019 |
Response to Letter to the Editor.
Topics: Amoxicillin; Azithromycin; Chronic Periodontitis; Humans; Metronidazole; Root Planing | 2019 |
Periodontal therapy increases neutrophil extracellular trap degradation.
Topics: Adult; Amoxicillin; Animals; Anti-Bacterial Agents; Cells, Cultured; Chronic Disease; Extracellular Traps; Female; Humans; Immunity, Innate; Male; Metronidazole; Middle Aged; Neutrophils; Periodontitis | 2020 |
An uncommon cause for a breast abscess:
Topics: Abscess; Actinomycetaceae; Adult; Amoxicillin; Anti-Bacterial Agents; Breast Diseases; Female; Firmicutes; Humans; Metronidazole | 2019 |
[Helicobacter pylori infection in the HIV + population: a comorbidity to think about].
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-HIV Agents; Anti-Ulcer Agents; Clarithromycin; Comorbidity; Drug Therapy, Combination; Dyspepsia; Female; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; HIV Infections; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Retrospective Studies; Spain | 2020 |
Reverse hybrid therapy achieves a similar eradication rate as standard hybrid therapy for Helicobacter pylori infection.
Topics: Adult; Aged; Amoxicillin; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Medication Adherence; Metronidazole; Middle Aged; Proton Pump Inhibitors; Retrospective Studies | 2020 |
Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Breath Tests; Child; China; Clarithromycin; Cross-Sectional Studies; Cytochrome P-450 CYP3A Inhibitors; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Prospective Studies; Proton Pump Inhibitors | 2020 |
Helicobacter pylori Infection Facilitates the Expression of Resistin-like Molecule Beta in Gastric Carcinoma and Precursor Lesions.
Topics: Adenocarcinoma; Adult; Aged; Amoxicillin; Cell Line, Tumor; Female; Gene Expression Regulation, Neoplastic; Helicobacter Infections; Helicobacter pylori; Humans; Intercellular Signaling Peptides and Proteins; Intestinal Mucosa; Male; Metaplasia; Metronidazole; Middle Aged; Stomach Neoplasms; Up-Regulation | 2020 |
Helicobacter pylori eradication therapy outcome according to clarithromycin susceptibility testing in Japan.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Male; Metronidazole; Middle Aged; Pyrroles; Retrospective Studies; Sulfonamides; Treatment Outcome | 2020 |
Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors.
Topics: Amoxicillin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Peptic Ulcer; Tetracycline; Vietnam | 2020 |
Population-based study of Helicobacter pylori infection and antibiotic resistance in Bhutan.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bhutan; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Prevalence; Tetracycline | 2020 |
Significant Short-Term Shifts in the Microbiomes of Smokers With Periodontitis After Periodontal Therapy With Amoxicillin & Metronidazole as Revealed by 16S rDNA Amplicon Next Generation Sequencing.
Topics: Amoxicillin; Anti-Bacterial Agents; DNA, Ribosomal; Follow-Up Studies; High-Throughput Nucleotide Sequencing; Humans; Metronidazole; Microbiota; Periodontitis; RNA, Ribosomal, 16S; Smokers | 2020 |
Helicobacter pylori Infection in Pediatric Patients Living in Europe: Results of the EuroPedHP Registry 2013 to 2016.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Male; Metronidazole; Registries; Turkey | 2020 |
Comparison of antimicrobial prescribing for dental and oral infections in England and Scotland with Norway and Sweden and their relative contribution to national consumption 2010-2016.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Infections; Clindamycin; Drug Prescriptions; England; Humans; Metronidazole; Norway; Penicillin V; Retrospective Studies; Scotland; Spiramycin; Sweden | 2020 |
Apparent Intracellular Helicobacter pylori Detected by Immunohistochemistry: The Missing Link in Eradication Failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Immunohistochemistry; Metronidazole; Proton Pump Inhibitors | 2021 |
Use of antibacterials in the management of symptoms of acute respiratory tract infections among children under five years in Gulu, northern Uganda: Prevalence and determinants.
Topics: Amoxicillin; Anti-Bacterial Agents; Child, Preschool; Cough; Cross-Sectional Studies; Female; Health Surveys; Humans; Infant; Logistic Models; Male; Metronidazole; Multivariate Analysis; Prevalence; Respiratory Tract Infections; Risk Factors; Rural Health Services; Rural Population; Trimethoprim, Sulfamethoxazole Drug Combination; Uganda | 2020 |
[Effect of systemic use of amoxicillin and metronidazole during mechanical therapy on the periodontal microorganisms in subgingival plaque and saliva of patients with aggressive periodontitis].
Topics: Aggressive Periodontitis; Amoxicillin; Anti-Bacterial Agents; Dental Plaque; Dental Scaling; Humans; Metronidazole; Saliva | 2020 |
Rifabutin-Based Triple Therapy Or Bismuth-Based Quadruple Regimen As Rescue Therapies For Helicobacter pylori Infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Rifabutin; Treatment Outcome | 2020 |
Analysis of fitness costs associated with metronidazole and amoxicillin resistance in Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; Drug Resistance, Bacterial; Genetic Fitness; Helicobacter pylori; Metronidazole; Mutation; Nitroreductases; Penicillin-Binding Proteins; Salt Stress | 2020 |
Helicobacter pylori and antibiotic resistance in the pediatric population: an update from Vietnam.
Topics: Amoxicillin; Bismuth; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Probiotics; Proton Pump Inhibitors; Vietnam | 2020 |
Lack of significant differences between gastrointestinal tract microbial population structure of Helicobacter pylori-infected subjects before and 2 years after a single eradication event.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Microbiome; Helicobacter Infections; Humans; Latvia; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors | 2020 |
High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort study.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Prevalence; Prospective Studies; Risk Factors | 2020 |
Microbiome changes in young periodontitis patients treated with adjunctive metronidazole and amoxicillin.
Topics: Amoxicillin; Bacteria; Dental Plaque; Humans; Metronidazole; Microbiota; Periodontitis; RNA, Ribosomal, 16S; Treponema | 2021 |
Impact of previous metronidazole exposure on metronidazole-based second-line quadruple therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2020 |
Efficacy of a novel sequential treatment regimen containing bismuth for Helicobacter pylori eradication in Turkish children.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bismuth; Child; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Treatment Outcome; Turkey | 2020 |
Clinical factors associated with initial Helicobacter pylori eradication therapy: a retrospective study in China.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Esomeprazole; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Peptic Ulcer; Proton Pump Inhibitors; Rabeprazole; Retrospective Studies | 2020 |
Survey of the antimicrobial resistance of Helicobacter pylori in France in 2018 and evolution during the previous 5 years.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; France; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Rifampin | 2021 |
Helicobacter pylori Eradication Rates in Slovenia in the Period from 2017 to 2019: Data from the European Registry on H. pylori Management.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Disease Eradication; Drug Therapy, Combination; Female; Health Plan Implementation; Helicobacter Infections; Helicobacter pylori; Humans; Intention to Treat Analysis; Levofloxacin; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Registries; Slovenia | 2021 |
Modified bismuth quadruple therapy with low-dose metronidazole as first-line therapy for Helicobacter pylori infection.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Pilot Projects; Prospective Studies | 2021 |
Tailored Helicobacter pylori eradication therapy in obese patients undergoing bariatric surgery.
Topics: Amoxicillin; Anti-Bacterial Agents; Bariatric Surgery; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Obesity; Prospective Studies; Proton Pump Inhibitors | 2021 |
In vitro sensitivity of 30 anaerobic bacterial strains of the human intestinal core microbiota to antibiotics: Culture and LC-MS/MS approaches.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, Liquid; Gastrointestinal Microbiome; Humans; Mass Screening; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Sulfamethoxazole; Tandem Mass Spectrometry | 2021 |
Recent Developments Pertaining to H. pylori Infection.
Topics: Adenocarcinoma; Amoxicillin; Antacids; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Practice Guidelines as Topic; Proton Pump Inhibitors; Pyrroles; Rifabutin; Stomach Neoplasms; Sulfonamides; Tetracycline; Treatment Outcome | 2021 |
Room for Improvement in the Treatment of Helicobacter pylori Infection: Lessons from the European Registry on H. pylori Management (Hp-EuReg).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Proton Pump Inhibitors; Registries | 2022 |
Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Drugs, Chinese Herbal; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2021 |
Gastric mucosal changes, and sex differences therein, after Helicobacter pylori eradication: A long-term prospective follow-up study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Atrophy; Clarithromycin; Female; Follow-Up Studies; Gastric Mucosa; Gastritis, Atrophic; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metaplasia; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Sex Factors; Young Adult | 2021 |
The effect of previous eradication failure on antibiotic resistance of Helicobacter pylori: A retrospective study over 8 years in Beijing.
Topics: Amoxicillin; Anti-Bacterial Agents; Beijing; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies | 2021 |
Antimicrobial susceptibility pattern of oral gram negative anaerobes from Indian subjects.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clindamycin; Drug Resistance, Bacterial; Female; Gram-Negative Anaerobic Bacteria; Humans; India; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Mouth | 2021 |
Trends in Australian dental prescribing of antibiotics: 2005-2016.
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Stewardship; Australia; Humans; Metronidazole | 2021 |
Early Life Antibiotics Influence In Vivo and In Vitro Mouse Intestinal Epithelium Maturation and Functioning.
Topics: Amoxicillin; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Models, Animal; Enterocytes; Gene Expression Profiling; Gene Expression Regulation; Gene Regulatory Networks; Intestines; Metronidazole; Mice; Oligonucleotide Array Sequence Analysis; Permeability; Postnatal Care; Vacuoles; Vancomycin | 2021 |
A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Health Facilities; Humans; Metronidazole; Nigeria; Prevalence; Surveys and Questionnaires; Tertiary Care Centers; Tertiary Healthcare | 2022 |
Antimicrobial Resistance and the Successful Eradication of
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Asian People; Child; Child, Preschool; Clarithromycin; Disease Eradication; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Peptic Ulcer; Tetracycline | 2021 |
Favorable outcomes of rescue second- or third-line culture-based Helicobacter pylori eradication treatment in areas of high antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Low Adherence to Society Guidelines for the Management of Helicobacter Pylori Among Pediatric Gastroenterologists.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Gastroenterologists; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Retrospective Studies | 2021 |
Targeting antibiotic tolerance in anaerobic biofilms associated with oral diseases: Human antimicrobial peptides LL-37 and lactoferricin enhance the antibiotic efficacy of amoxicillin, clindamycin and metronidazole.
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Peptides; Bacteria, Anaerobic; Bacterial Infections; Biofilms; Clindamycin; Humans; Lactoferrin; Metronidazole; Microbial Sensitivity Tests; Mouth Diseases | 2021 |
Evaluation of amoxicillin, metronidazole and gentamicin dosage regimens for use in antibiotic prophylaxis in colorectal surgery.
Topics: Amoxicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Colorectal Surgery; Gentamicins; Humans; Metronidazole | 2021 |
Clinical audit of current
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Clinical Audit; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Singapore; Treatment Outcome | 2022 |
CE-DAD-MS/MS in the simultaneous determination and identification of selected antibiotic drugs and their metabolites in human urine samples.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Clindamycin; Electrophoresis, Capillary; Humans; Linezolid; Metronidazole; Tandem Mass Spectrometry | 2022 |
Community pharmacists' management of self-limiting infections: a simulation study in Akwa Ibom State, South-South Nigeria.
Topics: Amoxicillin; Anti-Bacterial Agents; Common Cold; Community Pharmacy Services; Diarrhea; Humans; Inappropriate Prescribing; Metronidazole; Nigeria; Patient Simulation; Pharmacists; Tetracycline | 2021 |
Direct current exerts electricidal and bioelectric effects on Porphyromonas gingivalis biofilms partially via promoting oxidative stress and antibiotic transport.
Topics: Amoxicillin; Anti-Bacterial Agents; Biofilms; Electricity; Humans; Metronidazole; Microbial Sensitivity Tests; Microbial Viability; Oxidative Stress; Periodontitis; Porphyromonas gingivalis; Reactive Oxygen Species | 2022 |
Mutations associated with Helicobacter pylori antimicrobial resistance in the Ecuadorian population.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Ecuador; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Mutation; RNA, Ribosomal, 16S | 2022 |
Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2022 |
Comparison of Drug Resistance of Helicobacter pylori Between Children and Adults in Jilin, China.
Topics: Adult; Amoxicillin; Amplified Fragment Length Polymorphism Analysis; Anti-Bacterial Agents; Child; China; Clarithromycin; Drug Resistance; Drug Resistance, Multiple, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; RNA, Ribosomal, 16S; Tetracyclines | 2021 |
Clinical Effect of Clarithromycin Combined with Tinidazole on Helicobacter pylori-Related Gastritis and Its Influence on COX-2 Expression.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cyclooxygenase 2; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Stomach; Stomach Neoplasms; Tinidazole | 2021 |
RP-HPLC-DAD Method Development and Validation for Simultaneous Determination of Lansoprazole, Tinidazole, Amoxicillin, and Naproxen in Their Raw Materials and Combined Dosage Form: DOE Approach for Optimization of the Proposed Method.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Metronidazole; Naproxen; Omeprazole; Research Design; Tinidazole | 2022 |
Antibiotic resistance patterns and therapeutic outcomes of pediatric Helicobacter pylori infection in a high-migrant Singaporean cohort.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Transients and Migrants; Treatment Outcome | 2022 |
Impact of local and systemic antimicrobials on leukocyte- and platelet rich fibrin: an in vitro study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteria; Healthy Volunteers; Humans; Intercellular Signaling Peptides and Proteins; Membranes; Metronidazole; Middle Aged; Platelet-Rich Fibrin; Young Adult | 2022 |
A HPLC-MS/MS method for screening of selected antibiotic adulterants in herbal drugs.
Topics: Amoxicillin; Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Ciprofloxacin; Methanol; Metronidazole; Sulfamethoxazole; Tandem Mass Spectrometry; Trimethoprim; Water | 2022 |
Establishment of a reference panel of Helicobacter pylori strains for antimicrobial susceptibility testing.
Topics: Agar; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2021 |
Geospatial analysis of Helicobacter pylori infection in South Australia: Should location influence eradication therapy?
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; South Australia | 2022 |
Second-line Therapy for Helicobacter Pylori Eradication: State of the Art.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Proton Pump Inhibitors; Tetracycline | 2022 |
Interplay between Amoxicillin Resistance and Osmotic Stress in Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Osmotic Pressure; Penicillin-Binding Proteins; Sodium Chloride | 2022 |
Age of eradication and failure rates of clarithromycin-containing triple therapy for Helicobacter pylori: A 15-year population-based study.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cohort Studies; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Retrospective Studies | 2022 |
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Omeprazole; Protein Synthesis Inhibitors; Tetracycline | 2022 |
Direct Detection of Antibiotic Resistance in Chinese
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2022 |
Synergistic activity and molecular modelling of fosfomycin combinations with some antibiotics against multidrug resistant Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Fosfomycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Rifampin | 2022 |
[Important rise in antibiotic resistance rates inHelicobacter pyloriin the Netherlands].
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Netherlands; Retrospective Studies | 2022 |
A Survey of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests | 2022 |
The Activity of Liposomal Linolenic Acid Against
Topics: alpha-Linolenic Acid; Amoxicillin; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Liposomes; Metronidazole; Microbial Sensitivity Tests | 2022 |
Increase in amoxicillin resistance in Helicobacter pylori from Bulgarian patients over 15 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
Adverse events of metronidazole and amoxicillin: Retrospective analysis of a large data set of five randomized clinical trials.
Topics: Amoxicillin; Anti-Bacterial Agents; Chronic Periodontitis; Dental Scaling; Diarrhea; Double-Blind Method; Female; Humans; Metronidazole; Middle Aged; Randomized Controlled Trials as Topic; Retrospective Studies | 2022 |
Concise evaluation and therapeutic guidelines for severe periodontitis: A public health perspective.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Infective Agents, Local; Ciprofloxacin; Dental Scaling; Humans; Metronidazole; Periodontitis; Public Health; Sodium Hypochlorite; Valacyclovir; Water | 2022 |
Antibiotic resistance status of helicobacter pylori strains isolated from initial eradication patients in Ningbo, China, from 2017 to 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Fosfomycin; Furazolidone; Gatifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ornidazole; Rifampin; Tinidazole | 2022 |
Antibiotic resistance patterns of Helicobacter pylori strains isolated from the Tibet Autonomous Region, China.
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Microbial Sensitivity Tests; Rifampin; Tetracycline; Tibet | 2022 |
Adverse events of metronidazole and amoxicillin.
Topics: Amoxicillin; Anti-Bacterial Agents; Drug Therapy, Combination; Metronidazole | 2022 |
Comparative Study of Helicobacter Pylori Resistance to Clarithromycin and Metronidazole and Its Association with Epidemiological Factors in A Moroccan Population.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests | 2022 |
Smoking negatively impacts the clinical, microbiological, and immunological treatment response of young adults with Grade C periodontitis.
Topics: Aggregatibacter actinomycetemcomitans; Amoxicillin; Follow-Up Studies; Gingival Crevicular Fluid; Humans; Interleukin-4; Metronidazole; Periodontitis; Porphyromonas gingivalis; Smoking; Young Adult | 2022 |
Region-specific genomic signatures of multidrug-resistant Helicobacter pylori isolated from East and South India.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Genomics; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Phylogeny; Polymorphism, Single Nucleotide; Virulence Factors | 2022 |
Antibiotic resistance patterns of Helicobacter pylori in North Israel - A six-year study.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Israel; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Rifampin | 2022 |
Genomic and Therapeutic Analyses of
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Animals; Anti-Bacterial Agents; Cattle; Endometritis; Enrofloxacin; Female; Genomics; Gentamicins; Methicillin-Resistant Staphylococcus aureus; Metronidazole; Microbial Sensitivity Tests; Phylogeny; Staphylococcal Infections; Staphylococcus aureus | 2022 |
Predicting the Physician's Specialty Using a Medical Prescription Database.
Topics: Amoxicillin; Databases, Factual; Humans; Metronidazole; Physicians; Practice Patterns, Physicians'; Prescriptions | 2022 |
Single-capsule bismuth-based quadruple therapy as a rescue therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Rates of Antimicrobial Resistance in Helicobacter pylori Isolates From Clinical Trial Patients Across the US and Europe.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Europe; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Proton Pump Inhibitors | 2023 |
Effects of Quadruple Therapy Combined with Probiotics on
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Gastrins; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Motilin; Pectins; Peptic Ulcer; Probiotics; Proton Pump Inhibitors; Somatostatin; Tablets, Enteric-Coated | 2022 |
Alarming antibiotics resistance of Helicobacter pylori from children in Southeast China over 6 years.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracyclines | 2022 |
Effect of metronidazole resistance on Helicobacter pylori eradication regimens.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2022 |
Management of Helicobacter pylori infection in paediatric patients in Europe: results from the EuroPedHp Registry.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Europe; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Proton Pump Inhibitors; Treatment Outcome | 2023 |
Weak direct current exerts synergistic effect with antibiotics and reduces the antibiotic resistance: An in vitro subgingival plaque biofilm model.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Biofilms; Dental Plaque; Drug Resistance, Microbial; Humans; Metronidazole | 2023 |
Primary Helicobacter pylori resistance to antimicrobials in the Brussels area in 2021.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests | 2023 |
Antimicrobial Resistance of Helicobacter Pylori Among Low-resource Chinese Minorities.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; China; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; East Asian People; Female; Gentamicins; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Moxifloxacin; Rifampin | 2023 |
An eco-friendly multi-analyte high-performance thin layer chromatographic densitometric determination of amoxicillin, metronidazole, and famotidine in their ternary mixtures and simulated gastric juice: A promising protocol for eradicating Helicobacter py
Topics: Amoxicillin; Chromatography, Thin Layer; Famotidine; Gastric Juice; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Tablets | 2023 |
A Vonoprazan, Clarithromycin, and Metronidazole Regimen as Helicobacter pylori Eradication Therapy for Patients with Penicillin Allergy in Light of Clarithromycin Resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Hypersensitivity; Metronidazole; Penicillins; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
Importance of Metronidazole in Vonoprazan-based Helicobacter pylori Treatment in Japan.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Japan; Metronidazole; Proton Pump Inhibitors | 2023 |
Geographic distribution of antibiotic resistance of Helicobacter pylori: A study in Bulgaria.
Topics: Amoxicillin; Anti-Bacterial Agents; Bulgaria; Clarithromycin; COVID-19; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Pandemics | 2023 |
Clarithromycin-based Helicobacter pylori eradication therapy is not associated with higher treatment failure compared with non-clarithromycin-based regimens in a tertiary referral hospital in Switzerland.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Retrospective Studies; Switzerland; Tertiary Care Centers; Treatment Failure; Treatment Outcome | 2023 |
Antibiotic Resistance of
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Cross-Sectional Studies; Drug Resistance, Microbial; Duodenal Ulcer; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Peptic Ulcer; Tetracycline; Ulcer | 2022 |
A true point-of-care molecular testing method for tailored therapy for
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Molecular Diagnostic Techniques; Point-of-Care Systems; Proton Pump Inhibitors | 2023 |
Molecular Characterization of Clarithromycin Resistance in Helicobacter pylori Strains.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; RNA, Ribosomal, 23S; Tetracycline | 2023 |
Price and affordability of key essential medicines for children in Sri Lanka, a lower-middle-income country: comparison of two national cross-sectional surveys done 8 years apart.
Topics: Amoxicillin; Child; Chlorpheniramine; Clotrimazole; Cross-Sectional Studies; Developing Countries; Drugs, Essential; Drugs, Generic; Humans; Mebendazole; Metronidazole; Sri Lanka | 2023 |
Antibiotic Resistance among Fusobacterium, Capnocytophaga, and Leptotrichia Species of the Oral Cavity.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents; Capnocytophaga; Ciprofloxacin; Clindamycin; Doxycycline; Drug Resistance, Bacterial; Fusobacterium; Humans; Leptothrix; Leptotrichia; Metronidazole; Microbial Sensitivity Tests; Moxifloxacin; Periodontal Diseases | 2023 |
Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: A retrospective study in Ningxia.
Topics: Aged; Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Resistance, Microbial; Female; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies; Tetracycline | 2023 |
Antibiotic resistance characteristics and risk factors analysis of
Topics: Amoxicillin; Anti-Bacterial Agents; China; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Risk Factors; Tetracycline | 2023 |
Current Trends in the Management of Helicobacter pylori Infection in Serbia: Preliminary Results from the European Registry on H. pylori Management.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Quinolones; Registries; Serbia; Tetracycline; Treatment Outcome | 2023 |
The Outcome of Prescribing Antibiotics for the Management of Patients with Endodontic Infections.
Topics: Amoxicillin; Anti-Bacterial Agents; Clindamycin; Humans; Metronidazole; Penicillins | 2023 |
Susceptibility patterns and virulence genotypes of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Egypt; Genotype; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Virulence | 2023 |
Twice-daily intake of bismuth-based quadruple therapy for first-line Helicobacter pylori eradication: A retrospective study on 10-day, 14-day, and half-dose antibiotic therapy.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Retrospective Studies; Treatment Outcome | 2023 |
Diagnostic and Treatment Practices for Helicobacter Pylori Infection in an Academic Pediatric Hospital.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Hospitals, Pediatric; Humans; Metronidazole; Proton Pump Inhibitors; Retrospective Studies; Treatment Outcome | 2023 |
Ten-day tegoprazan-based concomitant therapy as a first-line treatment for Helicobacter pylori eradication.
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Prospective Studies; Treatment Outcome | 2023 |
Antibiotic resistance, heteroresistance, and eradication success of Helicobacter pylori infection in children.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Tetracycline | 2023 |
Antibiotic resistance profile of
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Clarithromycin; Doxycycline; Drug Resistance, Bacterial; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline | 2023 |
Bismuth quadruple three-in-one single capsule three times a day increases effectiveness compared with the usual four times a day schedule: results from the European Registry on
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Proton Pump Inhibitors; Registries | 2023 |
Antibiotic resistance and heteroresistance in Helicobacter pylori isolates from symptomatic Vietnamese children: A prospective multicenter study.
Topics: Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Prospective Studies; Southeast Asian People; Tetracycline | 2023 |
Roles of Lipopolysaccharide Glycosyltransferases in Maintenance of
Topics: Amoxicillin; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Cell Wall; Clarithromycin; Glycosyltransferases; Helicobacter Infections; Helicobacter pylori; Humans; Lipopolysaccharides; Metronidazole; Microbial Sensitivity Tests; Permeability; Rifampin | 2023 |
Helicobacter pylori Antimicrobial Resistance Using Next-Generation Sequencing in Stool Samples in a Pediatric Population.
Topics: Agar; Amoxicillin; Anti-Bacterial Agents; Child; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; High-Throughput Nucleotide Sequencing; Humans; Metronidazole; Microbial Sensitivity Tests | 2023 |
Real-world practice of Helicobacter pylori management: A survey among physicians in Southeast Asia.
Topics: Amoxicillin; Anti-Bacterial Agents; Asia, Southeastern; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Physicians; Proton Pump Inhibitors; Surveys and Questionnaires | 2023 |
Antibiotic-Resistant Strains of Helicobacter pylori in 50 Antibiotic Treatment-Naive Children in Northeast Poland Diagnosed by Gastric or Duodenal Biopsy Between February 2019 and May 2022.
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Biopsy; Child; Child, Preschool; Clarithromycin; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Poland | 2023 |
Developing Operational Definitions Related to
Topics: Amoxicillin; Anti-Bacterial Agents; Helicobacter pylori; Humans; Metronidazole; Proton Pump Inhibitors; Research Design | 2023 |
Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance.
Topics: Amoxicillin; Anti-Bacterial Agents; Australia; Clarithromycin; Drug Resistance, Bacterial; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Retrospective Studies | 2023 |
Pleural penetration of amoxicillin and metronidazole during pleural infection: An ambispective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Cohort Studies; Communicable Diseases; Female; Humans; Male; Metronidazole; Middle Aged; Pleural Effusion | 2023 |
High incidence of antibiotic resistance amongst isolates of
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Microbial; Helicobacter Infections; Helicobacter pylori; Humans; Incidence; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Tetracycline; United Kingdom | 2023 |
Management of Helicobacter pylori treatment failures: A large population-based study (HP treatment failures trial).
Topics: Amoxicillin; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Retrospective Studies; Treatment Failure | 2023 |